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ABSTRACT 
The conjunctiva is a translucent mucous membrane consisting of epithelial cells and goblet 
cells (GCs). It protects the eye from external insults and prevents desiccation of the ocular 
surface by producing mucins of the tear film. Severe scarring due to injuries and diseases 
could lead to its anatomical and functional impairment. Moreover, the success of a limbal 
or a corneal transplant is dependent on the presence of a healthy ocular surface and a tear 
film. Various grafts and substrates employed to replace the damaged conjunctiva to date, 
have advantages and disadvantages peculiar to the material. Therefore, there is scope for 
the development of a better substrate for conjunctival cell transplantation. Understanding 
the protein composition of the extracellular matrix (ECM) of the conjunctiva that regulates 
cellular functions, could guide the development of a substrate. The aims of the present 
study, therefore, were to determine the role of ECM proteins on the growth of conjunctival 
cells and to investigate cell growth and behaviour on surface modified poly-epsilon-lysine 
(PεK) hydrogels. 
 
The ECM proteins of a conjunctival epithelial cell line, HCjE-Gi cell line, were isolated using 
1% ammonium hydroxide. The protein composition of the cell-secreted ECM from days 1 to 
42 was determined using immunofluorescence and mass spectrometry experiments. The 
growth of cells on cell-secreted ECM of days 3 to 28 over seven days was determined by 
immunocytochemistry (ICC). The maximum adsorption of type IV collagen, laminin 111 and 
fibronectin onto tissue culture polystyrene (TCP) was determined using indirect enzyme-
linked immunosorbent assays. The adhesion and growth of cells over seven days on TCP 
with pre-adsorbed type IV collagen, laminin 111, fibronectin and α-2-Heremans Schmid-
glycoprotein (α-2-HS-GP) were determined by ICC. The expression of stem cell (SC) and GC 
protein markers over fourteen days on TCP with pre-adsorbed proteins were determined by 
ICC. The cell adhesion, growth and expression of MUC5AC protein over fourteen days on 
PεK hydrogels with and without pre-adsorbed proteins were determined by ICC staining.  
 
Type XVIII collagen, a structural collagen, was present in the ECM of HCjE-Gi cells in vitro. 
The peptides of chains that give rise to laminin 332 were the most abundant glycoproteins 
present in the ECM. The peptide abundance of α-2-HS-GP was highest in the day 1 ECM, 
whereas that of fibronectin, nephronectin and vitronectin were highest in the day 7 ECM. 
Perlecan and agrin were the most abundant proteoglycans in the ECM. The day 7 ECM 
contained the highest proportion of growth factors and their binding proteins. The 
proportion of proteases and their inhibitors increased and decreased, respectively, with 
time. The adsorption of type IV collagen and fibronectin onto TCP reached a saturation 
point when pre-adsorbed from 5µg/mL solutions, whereas the adsorption of laminin 111 
onto TCP reached a saturation point when pre-adsorbed from a 0.5µg/mL solution. Type IV 
collagen and fibronectin increased the adhesion, and type IV collagen, α-2-HS-GP and cell-
secreted ECM of days 3 and 5 increased the growth of HCjE-Gi cells. The expression of SC 
and GC protein markers reduced and increased, respectively, in vitro. Azelaic and suberic 
acid cross-linked PεK hydrogels supported the adhesion and growth of HCjE-Gi cells ex vivo. 
However, pre-adsorption of proteins onto PεK hydrogels did not affect the adhesion or the 
growth compared to those without pre-adsorbed proteins. There was evidence of GC 
differentiation on azelaic acid cross-linked PεK hydrogels with and without pre-adsorbed 
proteins and on suberic acid cross-linked PεK hydrogels with pre-adsorbed fibronectin. 
 
PεK hydrogels are a promising substrate for the ex vivo expansion of conjunctival cells for 
conjunctival cell transplantation purposes. Functional peptides of ECM proteins identified 
to enhance the growth and differentiation of conjunctival cells may be employed to 
develop a substrate for conjunctival cell transplantation in the future.  
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1 INTRODUCTION 
1.1 THE EYE 
1.1.1 ANATOMY AND PHYSIOLOGY 
The eyes are specialised organs responsible for the perception of vision (figure 1.1).(1) They 
are protected within two bony cavities in the skull. The adult eye (volume 6.5mL) has an 
antero-posterior diameter of 21-26mm and a transverse diameter of approximately 
24mm.(1, 2) It is made up of corneo-scleral, uveal and neural layers.(1) These surround the 
lens and three intraocular compartments (anterior chamber, posterior chamber and 
vitreous cavity). It can be approximated by a smaller anterior sphere comprising the cornea 
that contributes to one-sixth of the total circumference of the eye, whereas a larger 
posterior sphere making up the sclera accounts for the remainder of the circumference. 
The transparent cornea is the major refracting surface of the eye and transmits light rays to 
be focused on the retina. The opaque and fibrous sclera protects the intraocular tissues and 
maintains the shape of the eye. The uveal layer consists of the iris, ciliary body and choroid. 
The iris forms a central circular aperture, pupil, which controls the amount of light entering 
the eye. The ciliary body and the zonules alter the refractive power of the lens, thus 
allowing the eye to focus on either near or distant objects.(1, 2) The vascular choroid 
nourishes the outer retina.(1) The neural layer (neurosensory retina and retinal pigment 
epithelium) converts light energy into electrical impulses that are relayed, via the visual 
pathway, to the higher cortical centres in the brain to be processed to form an image.(1) 
 
The anterior chamber is between the cornea and the anterior surface of the iris, whereas 
the posterior chamber is between the posterior surface of the iris and the lens.(1, 2) The 
ciliary processes of the ciliary body produce aqueous humour at a rate of 2-4µL per minute, 
which is secreted into the posterior chamber.(1) From here, the aqueous humour flows 
through the pupil into the anterior chamber and is removed chiefly via the Schlemm’s canal 
that is adjacent to the trabecular meshwork, to maintain a stable intraocular pressure. The 
vitreous cavity between the posterior surface of the lens and the inner surface of the 
neurosensory retina occupies two-thirds of the volume of the eye. The vitreous humour, 
predominantly consisting of water, acts as a shock absorber and maintains the position of 
the neurosensory retina as well as the shape of the eye. The ocular appendages, namely the 
eyelids, the conjunctiva and the lacrimal apparatus, all aid towards the principal function of 
the eye, which is photoreception.(1) 
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The human eye 
 
 
 
Figure 1.1: The human eye. The cornea transmits light rays from the environment, which 
then travel through the anterior chamber, the crystalline lens and the vitreous cavity to 
focus on the neurosensory retina, where the photoreceptors (rods and cones) convert light 
energy into electrical impulses that are transmitted to the brain to be processed to form 
an image. (Adapted from: Forrester JV, Dick AD, McMenamin PG, Roberts F, Pearlman E. 
The Eye: Basic Sciences in Practice. 4th ed. UK: Elsevier; 2016. Figure 1.10, Schematic 
diagram of the human eye in horizontal section; p. 14) 
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1.1.2 EMBRYOLOGY 
The ocular tissues originate from two of the three primitive embryonic layers: the ectoderm 
and the mesoderm (table 1.1).(3) The ectoderm is divided into the surface ectoderm and its 
derivative, neural crest cells, and the neural ectoderm. The eye commences its 
development approximately on day 22 of a human embryo (figure 1.2).(1) Optic sulci 
appear as shallow pits on the inner surface of the neural ectoderm prior to their closure to 
form the neural tube or the future forebrain.(1, 3) The optic sulci out-pocket towards the 
surface ectoderm to form optic vesicles.(1, 3) On day 25, the hollow optic vesicles become 
surrounded by mesenchymal cells (neural crest cells and mesoderm), except at the apex 
adjacent to the surface ectoderm.(1) The disk-shaped neural ectoderm, called the retinal 
disk, is positioned posterior to the surface ectoderm. On day 27, the portion of the surface 
ectoderm that is adjacent to the neural ectoderm increases in thickness to form the lens 
placode, which overlaps the formation of the optic stalk that connects the developing eye 
to the forebrain. The optic vesicle invaginates further to form an optic cup with two layers 
of cells: the inner cell layer that will become the neurosensory retina, and the outer cell 
layer that will develop to be the retinal pigment epithelium. By day 29, the lens placode 
also invaginates to form a lens vesicle, which will eventually separate from the surface 
ectoderm to form the future lens. The surface ectoderm will give rise to the corneal 
epithelium (day 35 to day 42), whereas waves of mesenchymal cells form the stroma and 
the endothelium of the cornea (day 49).(1, 4) The surface ectoderm also gives rise to the 
future conjunctival epithelium, ocular adnexal gland epithelia, lacrimal gland and eyelid 
epidermis.(1)  
 
The inferior aspect of the developing optic vesicle consists of a groove called the optic 
fissure, where the hyaloid vessels enter to nourish the developing eye.(1) Approximately on 
day 44, the optic fissure will close enclosing the hyaloid vessels within the canal of the optic 
stalk. The proximal ends of the hyaloid vessels will eventually persist as the central retinal 
artery and vein that nourish the inner portion of the neurosensory retina. By the end of the 
embryonic period (day 56), the eye is approximately 1.5-2.0mm in diameter with a double-
layered retina derived from the neural ectoderm, lens and ocular surface epithelia derived 
from the surface ectoderm, and mesenchyme-derived corneal stroma, corneal 
endothelium, choroid and sclera.(1)  
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Embryological origins of the ocular tissues 
SURFACE ECTODERM NEURAL CREST CELLS NEURAL ECTODERM MESODERM 
Conjunctival epithelium 
 
Corneal stroma Neurosensory retina Vitreous 
Corneal epithelium 
 
Corneal endothelium Retinal pigmented epithelium Extra-ocular muscles 
Epithelia of adnexal glands 
 
Trabecular meshwork endothelium 
 
Ciliary epithelium Vascular endothelium 
Lacrimal gland 
 
Iris stroma Iris pigmented epithelium  
Lens 
 
Choroidal stroma Iris dilator and sphincter muscles  
Eyelid epidermis 
 
Ciliary muscles Optic nerve fibres and glia  
 Scleral fibroblasts 
 
  
 Vitreous 
 
  
 Optic nerve meninges   
Table 1.1: Embryological origins of the ocular tissues. 
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Embryology of the human eye 
 
 
 
Figure 1.2: Embryology of the human eye. (Adapted from: Forrester JV, Dick AD, 
McMenamin PG, Roberts F, Pearlman E. The Eye: Basic Sciences in Practice. 4th ed. UK: 
Elsevier; 2016. Figure 2.1, Diagrammatic summary of ocular embryonic development from 
day 22 to week 8; p. 104-5) 
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1.2 THE OCULAR SURFACE 
1.2.1 ANATOMY AND PHYSIOLOGY 
The ocular surface (OS), as described by Thoft in 1978, consists of the external anterior 
segment of the eye, which includes the cornea, conjunctiva, lacrimal gland and the 
eyelids.(5) This definition was further expanded by Gipson in 2007, who took into account 
the embryological origins and functions of the OS, to describe it as the integrated unit of 
‘surface and glandular epithelia of the cornea, conjunctiva, lacrimal gland, accessory 
lacrimal glands, meibomian glands and their apical (tears) and basal (connective tissue) 
matrices; eyelashes with their associated glands of Moll and Zeis; those components of the 
eyelids responsible for the blink and the nasolacrimal duct’.(5, 6) The rationale for this 
definition was that all the tissues of the OS are linked to each other by a continuous 
epithelium that originated from the surface ectoderm (table 1.1) and that they are all linked 
via the vascular, nervous, immune and endocrine systems to give rise to the OS system 
(figure 1.3).(5, 6)  
 
The external appearance of the OS (figure 1.4) includes the transparent cornea in the 
centre surrounded by the sclero-conjunctival areas, seen as the white of the eye.(5) The 
transition zone between the cornea and the conjunctiva is known as the limbus. A tear film 
forms a smooth and transparent layer over the external surface of the OS.(1) The upper and 
lower eyelids meet at the medial and lateral canthi at the angles of the palpebral fissure.(5) 
Due to its exposure to the environment, the cornea responsible for the refraction and 
transmission of light rays into the eye; is particularly prone to injury, disease and 
desiccation.(6) Thus, the primary function of the OS system is to protect the cornea and 
maintain its smooth refractive surface. The OS system has evolved to entail a variety of 
protective structures and mechanisms.(7) The bony orbit and eyelids protect the eye from 
traumatic injuries. The tear film provides physical and chemical protection against 
desiccation and pathogens. The epithelial cells of the OS consist of a variety of defence 
mechanisms of the innate and adaptive immune systems. Damage to one or more 
components of the OS system can give rise to secondary dysfunction of the other 
components of the system and subsequent pathology.(6, 8)  
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The ocular surface system 
 
 
 
 
Figure 1.3: The ocular surface system. A sagittal section of the ocular surface system 
showing  the continuous epithelia of the ocular surface (pink) and the overlying tear film 
(blue) (A), which are linked via the vascular, nervous, immune and endocrine systems (B). 
(Adapted from: Gipson IK. The ocular surface: the challenge to enable and protect vision: 
the Friedenwald lecture. Invest Ophthalmol Vis Sci. 2007;48(10):4390-8. Figure 1, 
Diagrams depicting the Ocular Surface System; p. 4392) 
A 
B 
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Surface anatomy of the human eye 
 
 
 
Figure 1.4: Surface anatomy of the human eye. 
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1.2.1.1 CORNEA 
Gross structure and functions 
The cornea is a transparent, avascular tissue in the centre of the OS (figure 1.4).(5) When 
viewed anteriorly it is ovoid in shape with a vertical diameter of approximately 10.6mm and 
a horizontal diameter of approximately 11.7mm.(1) The central radius of the anterior 
surface of the cornea is approximately 7.8mm with the curvature reducing peripherally.(1) 
The cornea accounts for two-thirds of the total refractive power of the eye and transmits 
light into the eye to be detected by the photoreceptors in the retina.(6) In addition, it 
functions to protect the delicate inner structures of the eye and as a support for the 
overlying tear film.(9) Due to its avascular nature, the cornea receives nutrition from the 
tear film and the aqueous humour in the anterior chamber.(1) 
 
Histology 
The cornea has a central thickness of approximately 520µm and the thickness increases to 
670µm towards the periphery.(1) Histologically, it consists of five distinct layers: 
epithelium, Bowman’s layer, stroma, Desҫemet’s membrane and the endothelium (figure 
1.5).(1) The corneal epithelium is a 50-60µm thick stratified and non-keratinised 
epithelium.(1, 5) It has five to seven layers of epithelial cells of varying morphology: two to 
three layers of superficial flattened squamous cells, several layers of wing cells and a 
monolayer of columnar basal cells.(5) The apical surfaces of the superficial cells have 
microplicae that holds the glycocalyx of the OS.(1) The cells in all layers are linked by tight 
junctions, which is demonstrated clinically by the lack of fluorescein staining observed on a 
healthy corneal epithelium.(4) Additionally, the basal cell layer is connected to the 
underlying basement membrane (BM) via hemidesmosomes and to the stroma via 
anchoring fibrils.(1) Abnormal or lack of these cellular and extracellular components lead to 
epithelial defects and recurrent epithelial erosions.(4) The epithelium lacks melanocytes.(1) 
The main functions of the epithelium are to maintain a smooth OS for refraction and to act 
as a physical barrier to injury and entry of pathogens.(10) 
 
Bowman’s layer is a 8-12µm thick modified acellular layer of the stroma.(1) It consists of 
randomly arranged type I, III, V and VI collagen fibrils that are 20-30nm in diameter.(1) The 
anterior margin is well delineated from the BM of the epithelium, whereas the posterior 
margin merges with the stroma.(1) The Bowman’s layer ends abruptly at the limbus.(1) 
When damaged, the Bowman’s layer does not regenerate but leads to scar tissue 
formation.(4) In contrast, the corneal stroma is made up of 2µm thick 200-250 flattened 
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layers of collagenous lamellae orientated parallel to the surface of cornea.(1) The adjacent 
lamellae are orientated right angles to each other, except in the anterior stroma, where the 
lamellae are orientated more obliquely. The major type of collagen in the stroma is type I 
collagen with small amounts of type III, V and VI collagens.(1) Each collagen fibre has a 
diameter of approximately 30nm, which is maintained by type V collagen that wraps 
around the type I collagen fibrils. Keratocytes, which are modified fibroblasts, lie between 
the collagenous lamellae in a corkscrew pattern at an average density of 2-2.4x104 
cells/mm3.(1) These cells are linked via gap junctions. Glycosaminoglycans (GAGs), 
predominantly keratan sulphate and chondroitin sulphate, regulate the inter-fibrillary 
distance between the collagen fibres, and this together with the regular diameter of the 
fibres help to maintain a transparent cornea.(1, 5) As in the epithelium, the stroma lacks 
blood and lymphatic vessels.(1) Sensory nerve fibres from the long ciliary nerve (ophthalmic 
and sometimes maxillary divisions of the trigeminal nerve) enter the cornea peripherally 
just below the anterior one-third of the stroma.(1) As they travel towards the centre, 
approximately 1mm from the limbus, the nerve fibres lose the perineurium and the myelin 
sheath, thus contributing to the maintenance of the overall transparency of the cornea. The 
nerve fibres change direction to travel towards the epithelium, pierce the Bowman’s layer 
to form the sub-epithelial plexus. Some fibres travel through the epithelial cell layers to 
form the intra-epithelial plexus that terminate in the superficial layer. These sensory nerve 
fibres are Aδ and C fibres that carry information regarding pain and temperature.(1) There 
are seven thousand sensory receptors per square millimetre in the epithelium of the 
human cornea.(1) Damage to the stroma leads to remodelling of the stroma by myo-
fibroblasts and subsequent scar tissue formation.(4) 
 
Desҫemet’s membrane, a modified BM of the corneal endothelium, is a 8-12µm thick layer 
that increases with age.(1, 5) It has an anterior banded region produced by the endothelial 
cells before birth, and a posterior non-banded region secreted after birth.(1, 4) It contains 
the major proteins found in BMs, type IV collagen, laminin and other glycoproteins.(1) The 
Schwalbe’s line demarcates the transition zone between the Desҫemet’s membrane and 
the cortical zone of the trabecular meshwork.(1, 4) The posterior-most layer of the cornea, 
the endothelium, is a monolayer of cells involved in the active transport of fluid from the 
corneal stroma to the aqueous humour, thus maintaining the hydration of the corneal 
stroma and its transparency.(1) The cells (approximately 18-20µm in diameter and 5-6µm in 
height) are arranged in a hexagonal array with numerous lateral inter-digitations as well as 
gap and tight junctions.(1, 4) Additionally, there are Na+/K+-ATPase pumps in the cell 
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membranes that are involved in the active transport of fluid across the endothelium.(4) The 
endothelium has an approximate cell density of 3-4x103 cells/mm2 at birth, reducing to 
2.5x103 cells/mm2 in middle age and 2x103 cells/mm2 in old age.(1) The endothelium has a 
low regenerative capacity and when cells are lost, they are replaced by spreading of 
adjacent cells that are heterogeneous in size and shape.(1) When the cell density reduces 
below 800 cells/mm2, the role of fluid transport becomes disrupted and the stroma 
becomes oedematous with subsequent reduction or loss in transparency of the cornea.(1) 
A minimum endothelial cell density of 1.5x103 cells/mm2 of the donor cornea is required 
when considering potential use in corneal transplantation.(1) Lack of antigen presenting 
cells in the central cornea and its avascular nature allow for the successful transplantation 
of  donor corneas.(1) 
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Histology of the cornea 
 
 
 
Figure 1.5: Histology of the cornea. The cornea consists of five distinct layers: epithelium 
(superficial, wing and basal cells), Bowman’s layer, stroma, Desҫemet’s membrane and 
endothelium. 
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1.2.1.2 LIMBUS 
Gross structure and functions 
The limbus is a 1.5-2.0mm wide transition zone between the conjunctiva and the 
cornea.(11) The surgical limbus appears as a blue-grey zone around the transparent cornea 
on external examination of the OS (figure 1.4).(1) The line in between these two zones 
represents the site of Schwalbe’s line and incisions made here will pass anterior to the 
trabecular meshwork and the Schlemm’s canal, thus giving a safe access site into the 
anterior chamber for surgery involving the anterior segment of the eye.(1, 5) The limbus 
plays numerous roles: source of stem cells for wound healing and nourishment of the 
cornea, immunosurveillance and  hypersensitivity responses of the OS, and aqueous 
humour outflow and regulation of the intraocular pressure.(1) 
 
Histology 
The limbus consists of an uneven stratified squamous epithelium, a BM and an underlying 
loosely arranged connective tissue stroma.(9) Anatomically, the limbus is described as the 
transition zone where the regularly arranged corneal collagen lamellae become randomly 
arranged scleral lamellae (figure 1.6).(1) This is in contrast to the definition used by 
pathologists, who describe this region as a block of tissue bordered by two lines: one line 
passing through Schwalbe’s line and the junction of the corneal and conjunctival epithelia 
(stratified non-keratinised corneal epithelium becomes stratified non-keratinised 
conjunctival epithelium with goblet cells), and a second line drawn perpendicularly from 
the scleral spur to the tangent of the OS.(1) Immunocompetent cells, such as major 
histocompatibility complex class II-positive dendritic cells, mast cells, plasma cells and 
lymphocytes, as well as vascular capillaries and lymphatics that are absent in the cornea 
appear in the connective tissue of the limbus and conjunctiva.(1) 
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The limbus 
 
 
 
Figure 1.6: The limbus. Solid blue lines represent the limbus as described by pathologists 
and the green dotted line represents the limbus as described by anatomists. (Adapted 
from: Fundamentals and Principles of Ophthalmology. Basic and Clinical Science Course. 
San Francisco: American Academy of Ophthalmology; 2011-2012. Figure 2.7, Anterior 
chamber angle and limbus, depicting the concept of the limbus; p. 49) 
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1.2.1.3 CONJUNCTIVA 
Gross structure and functions 
The conjunctiva is a thin and translucent mucous membrane that overlies the sclera (figure 
1.4).(5) It extends from the limbus to cover the majority of the OS, extends over the 
posterior surfaces of the eyelids and ends at the muco-cutaneous junctions (figure 1.7).(1, 
5) Grossly, the conjunctiva is divided into three regions: bulbar, forniceal and palpebral 
conjunctiva.(5) The palpebral conjunctiva, attached to the tarsal plate, lines the posterior 
aspect of the eyelids.(1) The epithelium of the conjunctiva in this region is continuous with 
that of the nasal cavity via the lacrimal puncta that open into the inferior meatus (figure 
1.3). The bulbar conjunctiva covers the majority of the OS and the forniceal conjunctiva is 
the region in between the bulbar and palpebral conjunctivae.(1) The superior and inferior 
forniceal conjunctivae meet at the canthi to form a cul de sac.(1) The total surface area of 
the conjunctiva is greater than the area that the conjunctiva is in contact with the eyeball 
and eyelids.(8) The surplus tissue forms folds in the forniceal region, and this together with 
the loosely attached conjunctival tissue to fascial sheaths of extraocular muscles, allow the 
free movement of the eyeball.(1, 8) Moreover, the lacrimal gland and accessory lacrimal 
glands empty into the superotemporal fornix.(1) There are specialized regions in the medial 
conjunctiva called plica semilunaris and the caruncle (figure 1.4).(1) These are highly 
vascular regions of the conjunctiva, the former is rich in goblet cells (GCs) and 
immunocompetent cells, whereas the latter contains accessory lacrimal and sebaceous 
glands.(1) The conjunctiva contains its own pool of stem cells for epithelial and GC 
renewal.(9) The conjunctiva functions as a physical barrier against injury and pathogens, as 
well as an immunological defence barrier against pathogens.(12-14) The GCs secrete 
mucins that contribute to the overlying tear film.(1) Overall, it is an important structure of 
the OS that functions to prevent desiccation of the epithelia and protect the eye from 
external insults.(14)  
 
Histology 
Histologically, the conjunctival epithelium is a stratified, non-keratinised epithelium with 
approximately six cell layers at the limbus and may increase to up to twelve cell layers at 
the fornices (figure 1.8).(5, 12) It is replaced by a keratinised, stratified squamous 
epithelium of the skin at the muco-cutaneous junction.(12) The cells of the epithelium are 
arranged into superficial, intermediate and basal cell layers.(1) The thickness of the bulbar 
conjunctival epithelium, as examined by laser scanning confocal microscopy (LSCM) in vivo, 
was found to be approximately 40% thinner than that of the cornea (approximately 33µm), 
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the superior conjunctival epithelium being significantly thinner than that in other 
regions.(15) LSCM studies have shown that the density of superficial cells in the bulbar 
conjunctiva is 221.2 ± 78.2x103 cells/cm2, whereas that in the basal cell layer is 236.8 ± 
74.1x103 cells/cm2.(15) A similar study by Messmer et al. however, gave values that were 
approximately double these values, although an explanation for this was not clear.(15) The 
basal cell density in the superior palpebral conjunctiva was 297.9 ± 51.0x103 cells/cm2.(16) 
As in the cornea, the superficial cells of the conjunctiva have microplicae that support the 
glycocalyx of the tear film.(1) The conjunctiva consists of muco-secretory GCs, which 
together with the epithelial cells lie on a BM.(8, 13) The density of GCs in the bulbar 
conjunctiva as studied by LSCM is 11.1 ± 5.8x103 cells/cm2; the nasal bulbar conjunctiva 
having significantly higher number of GCs than the rest of the conjunctiva.(15) Studies on 
the palpebral conjunctiva showed higher GC densities, 105.0 ± 49.5x103 cells/cm2 superiorly 
and 197.2 ± 86.2x103 cells/cm2 inferiorly.(16) However, other studies have demonstrated 
that the largest densities of GCs are found within the forniceal regions of the conjunctiva 
and the plica semilunaris.(1, 8, 17) In contrast to the corneal epithelium, the conjunctival 
epithelium contains melanocytes, major histocompatibility complex class II-positive 
dendritic cells and lymphocytes.(1)  
 
The conjunctival stroma is divided into two major layers: superficial adenoid layer and a 
posterior fibrous layer.(15) The adenoid layer contains conjunctiva associated lymphoid 
tissues, a type of mucosa associated lymphoid tissue, consisting of immune cells, such as T 
and B lymphocytes, plasma cells, macrophages and dendritic cells, all of which serve a role 
in the immune defence system of the OS.(5) The fibrous layer of the conjunctival stroma is 
highly vascular receiving branches from the anterior ciliary arteries and palpebral arteries 
and their accompanying veins.(1, 5) The lymph from the medial and lateral aspects of the 
conjunctiva drains into submandibular nodes and superficial pre-auricular nodes, 
respectively.(5) Innervation is from the ophthalmic and maxillary divisions of the trigeminal 
nerve and consists of sensory and autonomic nerve fibres. (1, 5)  
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Gross anatomy of the conjunctiva 
 
 
 
Figure 1.7: Gross anatomy of the conjunctiva. The conjunctiva is divided into palpebral 
(red), forniceal (purple) and bulbar (blue) conjunctivae. (Adapted from: Fundamentals and 
Principles of Ophthalmology.  Basic and Clinical Science Course. San Francisco: American 
Academy of Ophthalmology; 2011-2012. Figure 1.31, The conjunctiva consists of bulbar, 
forniceal and palpebral portions; p. 30) 
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Histology of the conjunctiva 
 
 
 
Figure 1.8: Histology of the conjunctiva. The conjunctival epithelium consists of stratified 
epithelial cells (superficial, intermediate and basal cells) and goblet cells, which lie on a 
basement membrane. The underlying stroma consists of extracellular matrix proteins, 
dendritic cells, lymphocytes, melanocytes, blood vessels, lymphatic vessels and nerves. 
The immunocompetent cells and melanocytes may also be present within the epithelium. 
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1.2.1.4 TEAR FILM  
The traditional model of the tear film consisted of three distinct layers: lipid layer secreted 
by the meibomian glands in the tarsal plates of eyelids, aqueous layer secreted by the 
lacrimal gland and the accessory lacrimal glands, and the mucous layer secreted by the GCs 
of the conjunctiva and the epithelial cells of the cornea and conjunctiva.(5) Currently, a two 
layer model combining the mucous and the aqueous layers is described, where secreted 
mucins of the mucous layer co-exist with the aqueous layer (figure 1.9).(6) The thickness of 
the tear film has been studied with no conclusive results; the majority of the studies have 
shown the thickness to be between 3 and 10µm in humans, whereas one study using 
confocal microscopy has shown it to be 40µm.(18, 19) This variation is thought to be due to 
the dynamic nature of the tear film during blinking, humidity of the environment, as well as 
patient factors, such as age and sex.(19) In addition, the inconsistencies between the 
results could be due to the different measurement methods employed, and if the 
microplicae of the cells and the glycocalyx were taken into account in the measurement 
process.(19)  
 
The lipid layer consists of polar and neutral lipids of melting point 35°C so that it takes the 
liquid form on the OS.(1) The hydrophobic neutral lipids are found anteriorly where they 
provide a barrier to foreign bodies. The hydrophilic polar lipids bind to lipocalin in the 
aqueous layer, thus providing stability to the tear film by lowering the surface tension, and 
allow spreading of the tear film during blinking to prevent formation of hydrophobic areas 
on the OS. The lipid layer has multiple other functions, such as preventing evaporation of 
tears, providing a transparent optical medium for light transmission, preventing spill-over 
of tears at lid margins and preventing migration of skin lipids onto the OS.(1) The aqueous 
layer consists of more than one thousand and five hundred proteins, as recognised by 
proteomic analysis, and electrolytes.(1) The electrolytes maintain a constant osmolality and 
a pH that allow maintenance of epithelial integrity.(20) The major types of proteins found in 
the aqueous layer are antimicrobials, such as lysozyme, lactoferrin, lipocalin, defensin and 
transferrin, as well as immunoglobulin A, a component of the adaptive immune system.(1, 
18) Thus, the proteins in the aqueous layer play a major role in the protection of the OS.  
 
The mucous layer that gives the tear film its viscosity, consists of the glycocalyx of the 
epithelial cells and secreted mucins.(1) Mucins are glycoproteins that take the shape of a 
bottle-brush, where the hairs of the brush are multiple O-glycosylated short oligosaccharide 
chains on a protein ‘handle’ containing threonine and serine residues.(1) The heavy 
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glycosylation make the mucins highly negatively charged, thus are hydrophilic.(20) The 
mucins interact with hydrophobic, hydrophilic and charged molecules to form the mucous 
layer.(1) To date, there are nineteen types of mucins identified in the human that are 
categorized into two groups named, secreted and membrane-associated mucins.(6) Five 
out of seven secreted mucins (MUCs 2, 5AC, 5B, 6 and 19) are called gel-forming mucins, 
which form large polymers that may be 600kDa in size, due to the presence of cysteine-rich 
domains.(6) The small soluble secreted mucins (MUCs 7 and 9) lack these domains. The 
secretory mucins collect debris, which are removed via the nasolacrimal duct during 
blinking. Additionally, MUC7 mainly produced by the lacrimal gland, has also been found to 
have antimicrobial properties. The membrane-associated mucins functioning mainly as an 
anti-adhesive layer have a short cytoplasmic tail, a transmembrane domain, and most have 
a large highly O-glycosylated extracellular domain.(6, 20) These extracellular domains found 
in the apical membranes of epithelial cells extend up to 500nm above the surface to form a 
heavily glycosylated hydrophilic layer on the surface of the eye, the glycocalyx, that forms a 
thick barrier to pathogens and provide lubrication allowing smooth movement of the 
eyelids over the OS.(6, 20) In addition, MUCs 1 and 4 serve as cell-signalling 
glycoproteins.(6) The membrane-associated mucins may be secreted into the aqueous layer 
via the action of metalloproteinases.(1) 
 
MUCs 1 and 16 are expressed uniformly throughout the human OS.(6) MUC4 is also 
expressed on the OS; however, its expression increases towards the conjunctiva. Moreover, 
the gel-forming mucin, MUC5AC, produced by the conjunctival GCs is also present in the 
human tear film. Studies on mouse eyes have shown that MUC5AC appear on day seven 
following birth coinciding with the appearance of conjunctival GCs, whereas the 
membrane-associated mucins appear on day fourteen coinciding with eyelid opening.(6) 
Vitamin A has been shown to be important for the regulation of MUCs 4, 16 and 5AC.(6) 
The GCs also produce trefoil factor family peptides 1 and 3 that have anti-apoptotic 
properties.(21) The basal and reflex tear secretion is mainly by the accessory lacrimal 
glands and the lacrimal gland, respectively, which are under parasympathetic nervous 
control.(1) Overall, the tear film functions to protect and lubricate the OS and prevent 
desiccation of the epithelia (figure 1.10).(1, 5) Moreover, the physiological process of 
blinking gives rise to a smooth refractive surface by continuous replenishment of tears that 
is removed by the lacrimal system.(6) Lastly, the tear film provides nutrients and removes 
metabolic waste products produced by the avascular cornea.(5)  
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The tear film 
 
 
 
Figure 1.9: The tear film. The two layer model of the tear film and their components that 
overlie the ocular surface epithelia and the glycocalyx. (Adapted from: Gipson IK. 
Distribution of mucins at the ocular surface. Exp Eye Res. 2004;78(3):379-88. Figure 5, 
Diagram of the gel-forming and membrane-associated mucins superimposed on an 
electron micrograph of the apical portion of a goblet cell and adjacent cells of the 
conjunctiva; p. 384) 
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Figure 1.10: Functions of the tear film. 
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1.2.2 EPITHELIAL RENEWAL 
Stem cells (SCs) are cells that have the proliferative capacity to self-renew and are able to 
differentiate into different types of cells.(22) Within all self-renewing tissues, such as that 
of the OS, hair follicle and haematopoietic system, there are populations of SCs that give 
rise to two daughter cells with each mitotic division.(9) One cell remains as a SC to maintain 
the SC pool and the other becomes a transient amplifying cell (TAC); the young TACs are 
able to divide more times than the mature TACs. Once the TACs reach the end of their 
proliferating capacity they become post-mitotic differentiated cells. There is increasing 
evidence that the TACs can resume a SC phenotype in the presence of appropriate 
stimuli.(9) The niche, a specialised microenvironment, consists of extracellular proteins, as 
well as specific anatomical and functional features, that regulate the self-renewal, 
proliferation and activation of SCs.(23, 24) The extracellular component include, 
extracellular matrix (ECM) proteins and signalling molecules secreted by cells and blood 
vessels, that act to stimulate cells in an outside-in mechanism.(11) SC niches are able to de-
differentiate progenitor cells from one tissue into a different cell type of another tissue, for 
example, corneal progenitor cells can be differentiated into epidermal cells of the skin 
when cultured on an embryonic dermal niche, thus providing evidence of these niches as a 
modulator of the plasticity of progenitor cells.(23)  
 
To date, an exclusive SC marker is undefined, however, the combination of morphological, 
biochemical and cell kinetic criteria aid in the identification of SCs.(9, 11) Morphologically 
they are characterised as small cells with a high nucleus to cytoplasm ratio.(22) They may 
be heavily pigmented in sun-exposed areas of the body to protect themselves against 
damage from ultraviolet light.(9) SCs are thought to have unique distribution patterns 
within tissues and are able to proliferate and undergo neoplastic transformation in 
response to certain stimuli.(9) Biochemically, they express specific protein markers that are 
identified by immunocytochemistry (ICC): nuclear isoform ΔN of tumour protein p63 
(ΔNp63) and transmembrane ATP-binding cassette sub-family G member 2 (ABCG2) are 
expressed by adult SCs.(11, 22) SCs are thought to lack specific cell-cell junction proteins 
expressed by cells that have undergone terminal differentiation, such as connexin 43 of gap 
junctions and desmoglein 3 of desmosomes.(11) Lastly, SCs are known to have long cell 
cycles that allow maintenance of their proliferative capacity and reduce errors that may be 
caused by DNA replication.(9) Thus, they are known as slow-cycling or label-retaining 
cells.(9) In comparison to TACs, SCs can proliferate for more generations producing larger 
and tightly packed colonies.(25)  
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The epithelia of the cornea and the conjunctiva originate from separate pools of SCs that 
reside in the limbus and conjunctiva, respectively (sections 1.2.1.2 and 1.2.1.3).(9, 12) A 
study looking at the gene expression of epithelial cells of the OS has shown more than two-
hundred transcripts that were unique to the conjunctiva and more than one-hundred 
transcripts that were unique to corneo-limbal cells.(25) These finding demonstrate the 
presence of unique genes that determines the phenotype of the different tissues of the OS. 
For example, the epithelial cells of the OS express different keratin pairs and are able to 
produce different phenotypic SC epithelial cysts in athymic mice injected with either 
corneal or conjunctival epithelial cells.(9) The cysts with a corneal epithelial phenotype 
consisted of a stratified epithelium with basal, wing and superficial cells, whereas those 
with a conjunctival phenotype produced cysts that consisted of both epithelial cells and 
GCs.(9) It is essential that the epithelia are able to maintain adequate numbers of self-
renewing SCs throughout a person’s life to ensure homeostasis of the OS.(22)  
 
The SCs of the cornea reside in the epithelia of the anatomically protected inter-palisade 
ridges of palisades of Vogt of the limbus.(11) These specialised niches are abundant in 
immunocompetent cells and melanocytes and are therefore highly pigmented.(23) The 
limbal palisades that extend upwards into the BM, are fenestrated allowing close 
association of the limbal epithelial cells and the underling stroma.(23) The limbal stroma 
consists of a dense vascular and neuronal supply providing the cells with nutrients and 
growth factors.(11) The limbal cells express transmembrane proteins, integrin α9 and N-
cadherin, that allow interaction of these cells with specific extracellular proteins.(23) The 
limbal BM is made up of α2 and β2 chains of laminin, and α1 and α2 chains of type IV 
collagen that are absent in the corneal BM, which may confer the ability of the limbus to 
maintain SCs.(23) Other ECM proteins, γ3 chain of laminin, fibulin 2, type XVI collagen, 
secreted protein acidic and rich in cysteine (SPARC), tenascin C and agrin have also been 
found in the limbal ECM in close association with SC populations.(24) Additionally, the BM 
sequester specific concentrations of growth factors and cytokines optimal for the 
maintenance of SCs.(23) SCs in the basal epithelium of the limbus differentiate into TACs 
that proliferate and migrate from this specialised niche centripetally and apically towards 
the central cornea to undergo terminal differentiation into corneal epithelial cells.(11) The 
corneal epithelium is thought to take one to two weeks to differentiate following which the 
superficial cells are desquamated into the overlying tear film.(10) During wound healing of 
the corneal epithelium, the SCs are able to proliferate and differentiate spontaneously to 
repair any damage to its integrity.(1) 
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The conjunctiva is also a self-renewing tissue with its own population of SCs that are 
essential for the maintenance of the OS system.(9, 12, 13) Conjunctival SCs are able to 
differentiate into non-secretory and muco-secretory conjunctival epithelial cells throughout 
life, thus are bi-potent.(13) Stewart et al., carried out studies on human conjunctival tissue 
as a whole.(14) They showed the presence of SCs throughout the conjunctiva with the 
medial canthal and inferior forniceal areas having the highest colony forming efficiency and 
highest expression of SC markers in cultured primary cells, as well as in fixed tissue. In fixed 
tissue, the highest amount of staining was observed in the basal cells. Although there is a 
lack of literature regarding the conjunctival SC niche, there are certain features of these SC-
rich conjunctival regions that are similar to other SC niches: the medial canthus and inferior 
fornix provide greater physical protection, and the medial canthal region is highly 
vascularised, richer in GCs, melanocytes and immune cells, compared to other regions of 
the conjunctiva.(14) 
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1.3 CONJUNCTIVAL INJURY AND DISEASE 
Despite the existence of multiple defence mechanisms of the OS, due to its exposure to the 
environment, the conjunctiva is prone to injury and entry of pathogens.(6) The conjunctiva 
may be damaged by chemical and physical injuries (thermal and ionising radiation injuries), 
mechanical trauma or iatrogenic injury during ophthalmic surgeries.(26) Damage may also 
be caused by microbial infections or systemic autoimmune diseases, such as mucous 
membrane pemphigoid and Sjögren's syndrome.(26) Stevens–Johnson syndrome (SJS) is a 
systemic disease that is a type III hypersensitivity reaction involving abnormal immune 
complex deposition secondary to drugs or infections.(26) Whatever the mechanism of 
injury, the wound healing response is activated involving several steps: inflammation due to 
the recruitment of neutrophils, macrophages and lymphocytes, fibroblast activation and 
ECM protein deposition and lastly, remodelling by uniaxial alignment of collagen fibres 
leading to a fibrous scar and wound contracture.(8, 27)  
 
Severe scarring may lead to anatomical and functional impairment of the conjunctiva.(28) 
Chronic inflammation leads to squamous metaplasia of the epithelium with keratinisation 
of the OS and loss of GCs.(27) Deficiencies in mucin production lead to loss of lubrication 
and symptoms of dry eyes (pain, irritation and redness). The deposited keratin layer rubs 
against the OS leading to mechanical irritation, further aggravating the inflammation and 
symptoms. Scarring may obstruct the outflow systems of the lacrimal and accessory 
lacrimal glands, leading to a reduction in the aqueous component of the tear film and 
exacerbation of symptoms of dry eyes.(27) Anatomically, scarring between the palpebral 
and bulbar conjunctiva will give rise to symblepharon formation, which will affect the tear 
reservoir due to shortening of the fornices (figure 1.11).(27) The subsequent abnormal 
anatomy of the eyelids and eyelashes will further aggravate the disease process due to 
abnormal blinking, blink-related mechanical trauma to the OS and greater evaporation of 
tears due to defects in eye closure.(19) Inappropriate scar formation may also affect the 
free movement of the eyeball.(8) In severe cases, there may be limbal SC deficiency (LSCD) 
with corneal epithelial defects, stromal scarring and conjunctivalisation of the cornea, 
which will eventually lead to impairment of vision.(21) In cases where a limbal or a corneal 
transplantation is required, the presence of ongoing inflammation of the OS and tear 
deficiency, will affect the success of the transplant.(8, 22) Thus, it is imperative that the 
health of the conjunctiva is restored prior to repair of the limbus or the cornea. When 
considering management of OS disorders, it is essential that the OS system as a whole is 
taken into account in preference to targeting a single component of the system.(6) 
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Scarring of the conjunctiva 
 
 
 
Figure 1.11: Scarring of the conjunctiva. Severe conjunctival scarring and shortening of 
fornices secondary to mucous membrane pemphigoid. (From: Professor S. B. Kaye, St 
Paul’s Eye Unit, Royal Liverpool University Hospital) 
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1.3.1 CURRENT MANAGEMENT 
1.3.1.1 MEDICAL MANAGEMENT  
Appropriate management of conjunctival injuries and diseases is required to prevent 
subsequent complications that may arise due to severe scarring. Moreover, it is important 
that a stable and healthy OS is present for potential limbal and corneal transplantation 
procedures in the future. The management includes anatomical and/or functional 
restoration of the OS. Initial therapy in most cases is aimed at adequate symptom control 
with analgesics, and prevention of progression of the damage.(14) To prevent ongoing 
damage to the OS, chemical injuries should be treated with ample irrigation, drugs should 
be stopped in cases of SJS and infections should be treated with appropriate antimicrobial 
medication.(26) Autoimmune diseases are treated with numerous topical and systemic 
immunosuppressive agents and although good control of inflammation is observed, the 
serious adverse effects to other organs lead to poor patient compliance.(29) As previously 
mentioned, the scarring caused by injuries and diseases can have significant effects on the 
tear film leading to symptoms of dry eyes. Thus, early detection and treatment with 
frequent lubrication with preservative-free artificial tears is essential.(30) A limitation of 
artificial tears is that they lack many of the integral components of the natural tear film, 
such as vitamin A and growth factors.(30) Punctal occlusion of the lacrimal drainage system 
is carried out in cases where there is a patent system without significant scarring, to 
preserve the natural and artificial tear volume on the OS.(30) Additionally, minor surgical 
procedures such as removal of abnormally positioned eyelashes and correction of 
abnormally positioned eyelids should be carried out where indicated to prevent mechanical 
damage to the OS.(26) Symblepharon rings may be used to prevent formation of 
symblephara in the acute phase.(26) Generally, all the medical treatment options described 
above are palliative giving short-term relief and do not replace the damaged tissue with 
healthy tissue.  
 
1.3.1.2 SURGICAL MANAGEMENT  
When there is extensive scarring, medical management may not be optimal to avoid the 
long-term consequences of the injury or disease. In these cases the management may 
require a surgical intervention to remove the damaged tissue and replace with a suitable 
tissue graft, in an attempt to restore the integrity of the OS.(8) The choice of surgery 
depends on the amount of conjunctiva damaged, whether the damage is unilateral or 
bilateral, and if the whole of the OS is involved requiring restoration of the limbus and the 
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cornea.(27) Surgery also depends on the chief function of OS that is lost requiring 
restoration. For example, in cases where there is fornix shortening, grafts that are flexible 
and cause less wound contracture are ideal, whereas in cases where there is tear or mucus 
deficiency, a graft that supports GCs is required.(28) In many indications the ideal graft has 
been found to be conjunctival autografts.(28) An autograft is a piece of healthy tissue 
obtained from a patient that is used to replace damaged tissue in the same patient.(31) 
 
Conjunctival transplantation using autografts were first described by Thoft in 1977 for 
reconstruction of a unilateral chemical injury.(32, 33) The autografts contain conjunctival 
epithelial cells, GCs and their BM, thus are able to restore the normal architecture of the 
tissue and their function.(34) They are used for conjunctival defects that are small and 
unilateral.(8, 27) Although transplantation of allogenic conjunctival tissue from living 
relatives may be an option in cases of bilateral disease, this is associated with risks of 
microbial disease transmission, such as viral (hepatitis B and C and human 
immunodeficiency virus), bacterial and fungal infections.(35) Despite the use of 
immunosuppressive agents, this procedure carries the risk of donor tissue rejection.(35) 
Kwitko et al. has shown this risk to be 25% when grafts were obtained from living donors in 
the presence of incompatible human leukocyte antigen donor pairs, and suggested that 
identical or haplo-identical pairs were adequate for transplantation purposes.(36) Daya et 
al. showed that the post-operative use of immunosuppressive agents did not change the 
incidence of graft rejection, however, the presence of severe inflammation pre-operatively 
increased the incidence of early graft rejection.(37) Rejection can occur as early as one 
month or up to two years post-operatively.(36, 37) Additionally, the immunosuppressive 
agents used post-operatively are also associated with adverse effects including systemic 
infections.(35) 
 
Conjunctival autografts are the gold standard treatment following excision of pterygia (a 
fibrovascular growth of tissue on the OS) that other treatment options are compared to in 
most clinical trials.(32) The main complication following excision of pterygia is recurrence. 
When the scleral bed is left bare following excision unacceptable recurrence rates (60%) 
were observed, whereas when reconstructed with a conjunctival autograft, recurrence 
rates were substantially lower (2-39%).(27, 32) The recurrence rates have also shown to be 
less with the use of limbal-conjunctival autografts, especially in cases of recurrent pterygia 
in high-risk regions, where the inclusion of the limbal autograft is thought to restore the 
barrier function of the limbus preventing conjunctival tissue from migrating onto the 
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cornea.(38) Conjunctival autografts have been studied with plasma derived fibrin glue 
instead of sutures that may be associated with higher rates of inflammation.(39) Lower 
recurrence rates and post-operative inflammation were observed with the use of fibrin 
glue. It creates a network of cross-linked fibrin from fibrinogen in the presence of thrombin, 
thus holding the graft in place. Moreover, fibrin glue is associated with a shorter surgical 
time and lower post-operative discomfort. It also requires less surgical expertise although 
some training is required since there is a chance of wound dehiscence and graft 
displacement if not applied appropriately.(39) The disadvantages of fibrin glue are higher 
cost, risk of viral disease transmission (parvovirus B19, hepatitis and human 
immunodeficiency virus) and anaphylaxis.(40) Autologous blood and electro-cautery pen 
have been investigated in place of fibrin glue, although further studies are required to 
prove any benefit compared to fibrin glue or sutures.(39, 40) Limitations of conjunctival 
autografts and living-donor allografts include lack of sufficient amounts of tissue to cover 
large defects, lack of remaining healthy tissue for future glaucoma surgery and risks of 
damage to the donor site with potential fibrosis and scarring.(27, 41) 
 
1.3.2 SUBSTRATES FOR CONJUNCTIVAL CELL AND TISSUE TRANSPLANTATION  
Regenerative medicine is increasingly popular in the field of medicine as a potential 
treatment to replace damaged tissues.(42) Within this field, tissue engineering (TE) 
provides a promising method by which prospective tissue constructs may be formed that 
can replace damaged tissue.(42) This may be done by developing biological substitutes to 
be used as grafts or by implanting a biomaterial scaffold containing ex vivo cultured cells 
and/or biological molecules to accelerate the regeneration of new tissue, which can replace 
the damaged tissue and maintain the anatomical structure and functions of the original 
tissue.(8, 42, 43) Ex vivo expansion of cells enable formation of confluent sheets of cells 
from small biopsies, which is important when there is a lack of heathy tissue due to injury 
or disease.(35) In cases of limbal allograft transplantation, up to 50% of healthy limbal 
tissue may be resected placing the donor eye at risk of developing LSCD.(44) Moreover, 
transplantation of ex vivo expanded conjunctival tissue has been shown to result in faster 
re-epithelialisation, reduce post-operative inflammation, and subsequent rapid healing 
reduces the risks of scleral necrosis and secondary infection and perforation.(45) This 
concept was first introduced by Rheinwald and Green in the 1970s, when they used ex vivo 
expanded epidermal cell sheets in the management of thermal skin burns.(46) Following 
that, Pellegrini et al. successfully transplanted an autologous corneal epithelial sheet to 
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restore a damaged human cornea in 1997.(46) Since then TE has become increasingly 
popular in the management of OS diseases. The success of a tissue construct depends on 
three factors: the source of cells and the presence of SCs, the carrier substrate and the 
presence of growth factors.(33) The substrate provides the initial support for the cultured 
cells and physical and biological cues for growth of cells.(47) Additionally, it facilitates the 
delivery of cultured cells to the site of interest and provides a three-dimensional scaffold 
for the formation of new tissue.(48) During regeneration, the substrate may be replaced by 
secreted ECM proteins of the cells.(47) A large number of studies have been carried out to 
investigate various biological and synthetic substrates that are optimal for the in vitro 
culture of epithelial cells.  
 
Characteristics of an ideal substrate for conjunctival cell and tissue transplantation: 
1. Thin and porous material that allow interaction between the graft and the 
underlying host tissue allowing rapid exchange of nutrients and metabolic waste 
products in and out cells, respectively.(8, 35, 43) 
2. Flexible and able to conform to different surfaces, especially the conjunctival 
fornices.(8, 35)  
3. Optimal mechanical properties that allow easy handling and suturing, however, are 
similar to that of the natural tissue as it guides cellular functions.(35, 43)  
4. Biocompatible, that is, the material is tolerated without causing inflammation or 
rejection by the host’s immune system.(8, 35) 
5. Support the adhesion, migration and proliferation of epithelial cells and mucus-
producing GCs.(8)  
6. Presence of SCs to ensure long-term survival of the transplant.(21) 
7. Biodegradability is desired but not essential. If the substrate is biodegradable, it is 
important that this occurs in a controlled manner to ensure that the substrate 
remains until the transplanted tissue incorporates into the surrounding tissue of 
the host by producing ECM proteins. If the substrate breaks down too quickly the 
transplanted cells will also be lost prior to them forming strong adhesions with the 
underlying tissue, thus the scaffolds lose their cell carrier function.(43, 45, 49) If 
the substrate is biodegradable, it is important that the by-products are not toxic.  
8. Low in vivo shrinkage.(35) 
The various biological and synthetic substrates that have been studied for TE of the 
conjunctiva to date, and their advantages and disadvantages will be discussed in the next 
sections (table 1.2).  
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1.3.2.1 BIOLOGICAL SUBSTRATES 
Biological or natural substrates are generally biodegradable and contain biologically active 
domains that support various cellular functions, however, they lack superior mechanical 
properties and may elicit an immunological reaction in vivo.(49)  
 
1.3.2.1.1 AMNIOTIC MEMBRANE 
Amniotic membrane (AM) is the innermost layer of the placenta that has been used in 
ophthalmology for many years, mainly as a BM substitute for reconstruction of damaged 
OS tissue.(50) It was first used in skin transplantation by Davis in 1910.(51) The first 
ophthalmological use was in 1940 when De Rotth used both AM and the chorion of the 
placenta to reconstruct the conjunctiva following lysis of symblepharon secondary to a 
chemical burn.(51-53) However, for unknown reasons, there is no mention of its 
ophthalmological use in the literature until 1993, when Batlle et al. used AM as a 
conjunctival substitute to repair fornices, and Kim and Tseng (1995) used preserved AM to 
reconstruct the cornea in rabbits with total LSCD.(41, 44) Since then, AM has been a 
popular substrate used in the reconstruction of damaged OS tissue and in TE for the ex vivo  
expansion of epithelial cells.(51) AMs are obtained from placentas delivered via Caesarean 
section, due to the risks of microbial contamination following vaginal delivery.(44) The 
donor mothers undergo serology investigations prior to delivery and six months after 
delivery to rule out the presence of infectious agents, such as human immunodeficiency 
virus and hepatitis B and C.(50) These allogenic membranes are then cryopreserved and 
stored under sterile conditions for up to one to two years for use in transplantation.(50) 
Although cryopreservation devitalises the epithelial cells, it has been shown to preserve the 
biological properties of the native tissue.(50) 
 
Histology 
The AM is a translucent membrane that consists of cuboidal-columnar epithelial cells with 
microvilli on their apical surface, a thick BM and an underlying almost acellular stroma.(50, 
51) The thickness of AM varies greatly from 20µm to 500µm.(50) The epithelial cells obtain 
nutrients from the surrounding tissue, via diffusion, and produce energy, mainly via 
anaerobic glycolysis.(51) The BM is a permeable barrier to macromolecules.(50, 51) AM, 
which provides protection to the fetus, contains a collagen-rich stroma that imparts 
elasticity and ability to withstand external forces.(51) Blood vessels, lymph vessels and 
nerves are absent in the stroma.(51) 
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Biological properties (Figure 1.12) 
AM is known to support the adhesion, growth and differentiation of epithelial cells and 
prevent apoptosis of cells.(44, 50) This is thought to be mainly due to the BM, the 
composition of which closely resembles that of the OS.(44) One study showed that the 
isomers of α chains of type IV collagen in the BM of AM are similar to that in the 
conjunctiva, suggesting that AM may be more suitable for culture of conjunctival cells than 
corneal cells.(53) In contrast, other studies have shown the BM of AM to be similar to that 
of the limbus and cornea, indicating its suitability in the culture of limbal and corneal 
epithelial cells.(24, 54) Studies have shown the ability of AM to produce a well-
differentiated corneal epithelium with progressive reduction in progenitor cells during ex 
vivo expansion of limbal epithelial cells suggesting that the AM lack specific limbal ECM 
components that contribute to the maintenance of SCs.(24)  
 
The AM, derived from the epiblast (source of all germ layers of the embryo), is thought to 
contain pluripotent cells that have the capacity to differentiate into any cell type of the 
human body.(51) However, during the preservation process the cells become unviable. 
Moreover, the AM contains various growth factors that are important for wound 
healing.(50, 51) The anti-inflammatory properties of AM are due to the inhibition of pro-
inflammatory cytokines by expressing interleukin 1 and 10 receptor antagonists, the ability 
to trap inflammatory cells within the stroma and the presence of pro-apoptotic properties 
against neutrophils.(50, 51) Fetal hyaluronic acid inhibits transforming growth factor β 
(TGFβ) signal transduction and proliferation of fibroblasts, thus it has anti-scarring 
properties beneficial in reconstructing damaged OS tissue.(44, 50) Moreover, AM provides 
a physical barrier to pathogens and produces antimicrobial molecules, such as β-lysin and 
lysozyme.(44, 51) Its anti-angiogenic properties, due to the presence of endostatin and 
thrombospondin 1, are beneficial in inhibiting neovascularisation of the cornea.(51) 
Although an allogenic material, tissue rejection following transplantation is very rare due to 
the low expression of human leukocyte antigens by amniotic epithelial cells in fresh AM, as 
well as the lack of immunogenicity due to devitalised epithelial cells in cryopreserved 
AM.(50, 51) Thus, there is no requirement for immunosuppression of patients following 
transplantation and this avoids complications that are associated with its use. Additionally, 
the transparency, easy surgical handling, and the ability to preserve membranes for a long 
period of time make AM a popular substrate for use in ophthalmology.(44, 52) Other 
beneficial non-biological properties of AM are, that they are readily available and are 
associated with few ethical issues.(51) 
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Use in reconstruction of the ocular surface 
AM is a useful alternate to autologous conjunctival tissue in the reconstruction of the 
conjunctiva, especially where there is limited availability of tissues due to bilateral disease, 
where a large graft is required and when the conjunctiva needs to be preserved for future 
filtration surgery in glaucoma patients.(44) AM has been used in the reconstruction of the 
conjunctiva and fornices following various injuries and diseases, including chemical burns, 
autoimmune diseases, and defects following excision of pterygia and tumours.(50) The 
primary aims are to promote epithelialisation and to reduce the inflammation, so that a 
healthy anatomical and functional OS is restored to ensure the success of subsequent 
limbal and corneal transplantation. Different surgical procedures and techniques are used 
to apply the AM for OS reconstruction. AM may be used as a graft that is sutured BM side 
up, and therefore provides a BM substitute to which neighbouring OS epithelial cells can 
migrate on to and close an epithelial defect.(50) It may be used as a single layer graft to 
close epithelial defects or as a multilayer graft to close deep corneal ulcers.(44) The graft 
may last for months or even years and will gradually be integrated into the surrounding 
host tissue.(50) Chemical injuries lead to severe inflammation and breakdown of the 
epithelium; an AM used as a patch sutured either BM side up or stromal side up is useful in 
reducing the surrounding inflammation, especially in the acute stages, and aid in rapid re-
epithelialisation.(50, 53) When the patch covers the whole of the OS including the fornices, 
it can be used to prevent symblepharon formation due to its anti-scarring properties.(44) It 
acts as a biological shield against mechanical damage that may be caused during blinking by 
abnormally positioned eyelashes and eyelids.(44) It is only a temporary treatment and 
requires weekly replacement, as the preserved AM becomes depleted of the anti-
inflammatory molecules.(50) A combination of these methods are used in cases of severe 
ulcers where the graft promotes epithelialisation, whereas the patch protects the graft and 
the rest of the OS.(50) With advances in TE, AM has also become a popular substrate for 
the ex vivo expansion of epithelial cells of the OS. The AM provides a BM substitute that 
supports the growth of conjunctival epithelial cells and GCs.(44)  
 
Studies investigating AM as grafts have shown a success rate (complete and partial) of 92-
92.5% with complete re-epithelialisation within one to three weeks, even when large grafts 
were used.(41, 55) Recurrence of primary pterygia following resection has been shown to 
be higher than when autologous conjunctiva is used, however, with extensive removal of 
fibrovascular tissue, a recurrence rate of 3% has been reported.(44, 53) In addition to the 
advantages described above, AM transplantation to cover epithelial defects following 
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tumour resection is beneficial since recurrence of the tumour can be clinically monitored 
due to the transparent nature of the AM.(44) Similarly, it can also be used to reconstruct 
epithelial defects following symblepharon lysis, although the outcome is poor in the 
presence of ongoing inflammation.(44) Prabhasawat et al. observed a failure rate of 23.1% 
following symblepharon lysis secondary to multiple surgeries for pterygia, which is thought 
to be due to increased fibroblastic activity that invade the graft and cause shrinking of the 
graft, scar formation and recurrence of the symblephara.(41) In these cases, success was 
only seen once a limbal allograft was transplanted. Another important factor that 
determines the success of AM grafts is the vascular supply; when AM was used as scleral 
grafts for scleral necrosis secondary to β irradiation or mitomycin C (anti-scarring effects) 
use during surgery for pterygia, there was a tendency for the graft to rapidly melt and 
dissolve over the ischaemic scleral bed.(41) Success was obtained when the AM was 
transplanted with a conjunctival flap that restored the vascular supply. Other prognostic 
factors that lead to poor outcomes following AM transplantation are the presence of dry 
eye syndrome, total destruction of SCs and use of immunosuppression.(55) AM has also 
been used as an adjunct in glaucoma surgery to reduce scarring during filtration surgery, to 
repair leaking blebs and to cover valve procedures.(44) Whatever the indications for AM 
transplantation, all studies have shown that AM was associated with significant reduction in 
pain. Although the exact mechanism of this is not yet determined, the biological effects, 
such as anti-inflammatory properties and the ability to act as a physical barrier to trauma 
caused by abnormally positioned eyelids and eyelashes, may contribute to this process.  
 
AM has also been used to reconstruct corneas that are damaged due to persistent 
epithelial defects, LSCD, corneal ulcers and corneal perforations with a success rate of 
85.7%.(44, 55) As described previously, the success of a corneal transplant depends on the 
presence of a healthy OS with SCs. AM transplantation has been successful in managing 
patients with partial LSCD, however, in total LSCD, this is an adjunct treatment to limbal SC 
transplantation, since AM can only optimise the function of existing SCs.(44) In such cases, 
it is better to culture autologous limbal SCs ex vivo on AM and transplant the AM with an 
intact epithelial cell sheet to the OS.(44)  
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Limitations 
Risks of transmission of microbial infections persist if the donors are not screened 
adequately or if the AMs are not processed or stored under sterile conditions.(44) Some 
diseases, such as Creutzfeld-Jacob disease, do not have screening tests, thus it is impossible 
to completely rule out all microbes that may be transmitted on to the host.(53) Incidence of 
microbial infections has been reported to be 1.6-8% in the literature, most being due to 
growth of gram positive bacteria.(44) Another limitation is the early degradation of the 
graft prior to complete re-epithelialisation and integration into the host tissue, especially in 
the presence of host inflammation, that may require further surgery.(44, 56) AM is not a 
standardised product and carries inter- and intra-donor variations affecting clinical 
results.(52) If the AMs are not processed and stored properly there is also further possibility 
for there to be alterations to the constituents.(52) AM is prone to contraction in the 
presence of active inflammation, thus may not be a suitable substrate in cases where there 
is shortening of fornices due to inflammatory autoimmune disorders and recurrent 
pterygia.(21) Moreover, AM has failed to show adequate repopulation of GCs despite the 
addition of biomolecules, such as retinoic acid, air-lifting, co-culture with fibroblasts or 
culture on the stromal side of AM.(8) As previously described, the preserved AM does not 
have SCs, thus an adequate source of SCs in the remainder of the OS is a prerequisite for 
successful and complete epithelialisation. Lastly, the cost of preserved AM may limit the 
availability of grafts in developing countries.(8)  
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Biological properties of amniotic membrane 
 
 
 
Figure 1.12: Biological properties of amniotic membrane. 
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1.3.2.1.2 AUTOLOGOUS MUCOSAL MEMBRANES 
Autologous mucosal membranes (figure 1.13) of the nasal and oral cavities are employed as 
alternatives to conjunctival autografts avoiding the use of allogenic ocular tissue.(27, 46) 
Nasal mucosa consists of non-keratinising epithelial cells and mucus producing GCs.(34) It 
was first used by Naumann et al. in 1990 to repair a OS with severe mucus deficiency 
syndrome.(34) A study by Kuckelkorn et al. used mucosa of the inferior concha to 
reconstruct fornices in seventeen patients with symblepharon or ankyloblepharon 
secondary to chemical and thermal burns.(34) The middle concha is used as a surgical 
landmark during nasal surgery and is in close proximity to the olfactory receptors and the 
base of the skull, thus carries more surgical risks. Moreover, larger grafts can be obtained 
from the inferior than the middle concha. After an average follow-up time of twenty 
months, complete or partial success was seen in 76% of the cases with no complications to 
the donor site. There was evidence of presence of GCs in 35% of the patients up to eighteen 
months.(34) Another study carried out nasal mucosal grafts in fifty-five eyes; thirty-eight 
eyes with chemical, thermal or radiation-related injury and seventeen eyes with systemic 
mucosal diseases.(57) The major complication observed was persistent or recurrent 
symblepharon formation in 24% of the cases, which was predominantly in patients affected 
by systemic diseases. More than 90% of the patients reported improved symptoms of dry 
eye and ocular pain, and 42% had improved vision. There was evidence of GCs in the grafts 
up to ten years post operatively. Only 26% of the corneal transplants remained transparent 
during follow-up and the transplant survival at two years was 21% for those with chemical 
and thermal burns, whereas 0% for those with systemic mucosal diseases. Thus, nasal 
mucosa presents a viable option for cases where there is bilateral conjunctival damage and 
when there is severe loss of GCs with mucus deficiency.  
 
Although the above studies have shown the presence of GCs clinically, one study that 
biopsied the mucosal graft only observed a few glands in the sub-mucosa.(58) However, 
this study had a small sample size of five eyes. The limitations of nasal mucosal grafts are 
difficulty obtaining sufficient amounts of tissue to cover large defects and complexity of 
surgery requiring partial resection of the inferior or middle nasal turbinate, removal of bone 
or cavernous tissue and thinning of the mucosa.(21) Although all mucosal grafts carry the 
risk of morbidity to the donor site, it is a rare complication.(21) Nasal septal cartilage has 
also been investigated, which has been found to be a useful graft in the reconstruction of 
the posterior lamellar of eyelids where the tarsus is absent, although these grafts have 
lower number of GCs.(28) More recently, mucosa from the floor of the nasal cavity has 
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been investigated, where larger grafts may be obtained, although similar to the septum, the 
number of GCs was less.(59) This procedure is thought to carry fewer risks, such as 
bleeding, compared to surgery involving the nasal turbinates.  
 
Oral mucosal grafts for the reconstruction of the conjunctiva has involved obtaining tissue 
from the hard palate, buccal or labial mucosa.(28) Grafts from the hard palate are thicker 
and more difficult to harvest.  However, they contract the least and are more suitable for 
the reconstruction of fornices. Split-thickness oral mucosal grafts have been found to 
contract more than full-thickness grafts, thus are not suitable to reconstruct fornices. Oral 
mucosal tissue do not contain GCs, therefore are not suitable in cases of mucus 
deficiency.(28) Kheirkhah et al. operated on thirty-two eyes with high grade symblephara 
secondary to chemical and thermal injuries and autoimmune diseases.(60) They used oral 
mucosal grafts with AM and intra-operative mitomycin C to reconstruct the OS. They 
observed restoration of deep fornices in 84% of the cases after an average follow-up time 
of sixteen months. Fu et al. demonstrated the use of inferior labial mucosal grafts in 
reconstructing lid margins.(61) Of the twenty-two eyes, there was complete success in 68% 
of the eyes, with improvement in symptoms in 77% and increased visual acuity in 59% of 
the patients after an average follow-up time of sixteen months. The authors showed that 
these mucosal grafts increased the height of the lid margin allowing complete closure of 
the palpebral fissure, and that the grafts were able to stop the ingrowth of the keratinised 
epithelium of the skin. When harvesting oral mucosal grafts, it is recommended to obtain a 
graft that is 20% larger than the defect to prevent post-operative shrinkage.(61) A study 
comparing the histology of the mucosal grafts post-transplantation showed that the hard 
palate grafts used to reconstruct posterior eyelid surfaces had an epithelium similar to that 
in the donor site with evidence of keratinisation, whereas buccal mucosa used in one 
patient had a non-keratinised squamous epithelium.(58)    
 
Nasal and oral mucosal cells have also been cultured in vitro to obtain epithelial sheets that 
can be used to reconstruct the OS. Kobayashi et al. co-cultured human nasal mucosal 
epithelial cells with human mesenchymal SCs on denuded AM and subsequently 
transplanted epithelial sheets onto conjunctival defects in rabbits.(62) They reported the 
presence of a stratified conjunctival epithelium with expression of conjunctival cell 
differentiation markers keratins 4 and 13, junctional proteins, BM-related proteins, 
progenitor cell marker tumour protein p75, and MUCs 1, 16 and 5AC, two weeks post-
operatively. Moreover, a significantly higher level of MUC5AC was observed in cultured 
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nasal mucosal cells than in cultured conjunctival cells. Madhira et al. showed that buccal 
mucosal cells from healthy volunteers cultured on AM without a feeder layer gave rise to a 
stratified non-keratinised epithelium.(63) The cells were smaller and slower to grow 
compared to conjunctival and limbal cells, although presence of a feeder layer was shown 
to give a more rapid growth in vitro.(63, 64) The cells expressed differentiation markers 
keratins 3, 4 and 13, with evidence of progenitor cells, however, no GCs were observed.(63) 
Hori et al. showed mRNA expression of MUCs 1, 4 and 16 in cultured oral mucosal cells 
obtained from healthy volunteers that were co-cultured with a feeder layer on 
temperature-responsive dishes.(65) Further studies are required to investigate the protein 
expression of these mucins, if the expression is similar when grafts are taken from patients 
with systemic mucosal diseases and if the expression is maintained in vivo post-
transplantation. Although the presence of cell-cell junctions were observed in cultured 
cells, a study by Satake et al. investigating the barrier function of the transplanted stratified 
mucosal epithelial sheets showed that the epithelia were highly permeable to molecules 
less than 1kDa, in contrast to conjunctival epithelia and pathological corneal epithelia, 
questioning their barrier function.(63, 66)  
 
Studies investigating the oral mucosa as a substitute for conjunctival tissue are limited due 
to the lack of GCs, which is in contrast to studies on reconstruction of the limbus and 
cornea. Autologous oral mucosal cells cultured on AM have been used to reconstruct the 
OS with LSCD secondary to various causes. There was re-epithelialisation of the cornea 
within one week following surgery in all the studies. Successful outcomes where there was 
no evidence of corneal epithelial defects, corneal vascularisation, conjunctival inflammation 
or symblepharon formation, were seen in 66-70% of the cases with improved visual acuity 
in 67-100% of the cases, during the follow-up period that lasted up to four years in one 
study.(46, 64, 67) Patients who had failed outcomes had an initial diagnosis of SJS, which is 
characterised by chronic inflammation of the OS, tear deficiency and lid abnormalities.(64, 
67) These results further demonstrate the importance of controlled inflammation of the OS 
prior to transplantation. However, the failed outcomes in cases of SJS may be due to the 
systemic disease affecting all mucosal surfaces including that in the oral cavity. All studies 
reported evidence of peripheral neovascularisation between the AM and the corneal 
stroma, suggesting that this may be due to either pro-angiogenic or lack of anti-angiogenic 
factors in the transplanted tissue.(46, 64, 67) Interestingly, the neovascularisation peaked 
between three and six months, declining thereafter and remained stable after one year. 
The blood vessels did not encroach on to the visual axis in any of the cases.  
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Advantages of autologous mucosal membranes 
 
 
 
 
Figure 1.13: Advantages of autologous mucosal membranes as conjunctival grafts. 
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1.3.2.1.3 OTHER BIOLOGICAL SUBSTRATES 
Safinaz et al. studied the use of autologous fibrin in ex vivo expansion of autologous 
conjunctival cells.(45) The epithelial cell sheets were then transplanted on to conjunctival 
epithelial defects in rabbits and monitored for six weeks. The rate of re-epithelialisation 
was found to be comparable with AM. Although there was less stratification with both 
fibrin and AM substrates compared to the native tissue, there was evidence of GC 
differentiation. Thus, fibrin may be an alternative substrate to AM that is cheap and 
tolerated in animals. Although fibrin is highly degraded, this may be controlled with 
protease inhibitors to increase the graft survival.(45)   
 
An elastin-like polymer produced from bioengineered Escherichia Coli has been investigated 
for growth of conjunctival epithelial cells.(68) These polymers contain four domains: two 
elastin-derived, one fibronectin and one proteolytic domain that is active when released. 
Conjunctival epithelial cells adhered significantly more on polymer treated glass coverslips 
than untreated glass coverslips and tissue culture treated coverslips. The proliferation of 
conjunctival cells on polymer treated glass coverslips was significantly higher on culture day 
five compared to the untreated coverslips, but was similar to those on tissue culture 
treated coverslips. All the cells expressed keratin 7, a conjunctival cell differentiation 
marker, and junctional proteins. The authors suggested that this increased biological 
activity may be particularly due to the cell adhesion peptide REDV found in the fibronectin 
domain that may be interacting with the cell integrins.(68)  
 
Borrelli et al. investigated keratin films made of human hair and gelatin (a softening agent) 
as a substitute for corneal epithelial and stromal defects.(69) In vivo studies in rabbits 
showed that the corneas were mostly transparent with no epithelial defects and induced a 
minimal inflammatory reaction. The keratin films were degraded within four weeks of 
transplantation. A limitation of this study was that the phenotype of the transplanted cells 
was not investigated, especially since the keratin found in hair is not found in epithelial cells 
of the OS and this may affect the biological characteristics of the cells.(31) Although keratin 
has good biomechanical strength, these may be too stiff for use as an OS substitute, 
especially in the conjunctival fornices. (8, 31) 
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1.3.2.2 SYNTHETIC SUBSTRATES 
As described above, the use of biological substrates are limited due to limitations in 
availability of sufficient healthy tissue, inconsistent tissue composition, risks of microbial 
disease transmission and risks of immunological rejection by the host. Therefore, there is 
much scope for investigating synthetic substrates for use in conjunctival transplantation. 
Although a large amount of literature exists regarding the use of biological substrates as 
conjunctival grafts or substrates for conjunctival cell and tissue transplantation, there is 
very limited literature regarding the use of synthetic substrates. To date, synthetic 
substrates investigated for use in TE include synthetic polymers, for example, poly(ε-
Caprolactone) (PCL) and poly(lactide-co-glycolide) (PLGA), which are approved by the Food 
and Drug Administration for specific applications in humans.(31, 70) There are numerous 
advantages to employing synthetic substrates in TE (figure 1.14) and due to the limitations 
of biological substrates, there is much scope for exploring non-biological options.(35, 70) 
The disadvantages of using synthetic substrates are lack of structure similar to that in vivo 
and lack of tissue-specific extracellular environment that guide cellular functions.(71)  
 
Ang et al. investigated PCL membranes in the cultivation of rabbit conjunctival epithelial 
cells.(35) They stretched the membranes to produce 6µm thick membranes that were 
treated with sodium hydroxide. The sodium hydroxide made the surface more hydrophilic 
by converting the ester groups on the membrane to hydroxyl and carboxyl groups.(35) 
Wettability as well as surface chemistry, charge, roughness and rigidity affect the 
attachment of cells onto a synthetic substrate.(72) The stretching process gave the PCL 
membranes superior characteristics: the stretched membranes were transparent, had 
higher surface roughness with a fibrillary structure, higher tensile strength and were more 
flexible than un-stretched PCL membranes.(35) In comparison to human AM, the stretched 
PCL membranes had higher tensile strength but were stiffer. The stretched PCL membranes 
were able to support the growth of rabbit conjunctival cells expressing conjunctival cell 
differentiation markers keratins 4 and 19. The sodium hydroxide treated membranes had a 
greater number of proliferating cells with cell morphology similar to that on AM and 
demonstrated more stratification than untreated membranes. Both treated and untreated 
stretched PCL membranes supported the growth of GCs that was comparable to that on 
AM, although numbers were significantly less than that in the native rabbit conjunctiva. The 
authors showed that the cells were able to synthesise ECM proteins and form 
hemidesmosomes important for the attachment of the cells to the ECM. When these PCL 
membranes were transplanted onto immune-deficient mice, the cells underwent further 
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stratification and differentiation.(35) The disadvantages of this material is that it may be 
difficult to integrate into the host and its uniaxially aligned fibrillar architecture may be 
predisposed to scar formation.(8)  
 
Sharma et al. used PCL membranes that were treated with helium-oxygen plasma to culture 
human corneal and limbal epithelial cells in vitro.(73) Plasma consists of partially ionised 
gas containing ions, electrons, neutral particles and free radicals.(73) In the presence of 
oxygen, the active species on plasma coated membranes form functional groups that are 
hydrophilic.(73) This treatment also made the membranes more transparent, which is 
important for corneal reconstruction.(73) The treated and untreated PCL membranes were 
able to support the growth of corneal and limbal cells, however, the treated membranes 
supported better adhesion and proliferation of cells. In addition, the corneal cells were able 
to maintain their differentiated phenotype and the limbal epithelial cells expressed SC 
markers. Shin et al. carried out animal studies to investigate the biocompatibility and 
biodegradability of the PCL membranes in vivo.(74) They showed that PCL membranes 
without cells induced an inflammatory reaction similar to AM when transplanted on to the 
OS of rabbits and re-epithelialised within two weeks with GC differentiation. Moreover, the 
authors showed that when the PCL membranes carrying a layer of conjunctival cells were 
transplanted on to abdomen of mice, the membranes were absorbed and replaced by 
surrounding host tissue within five weeks.(74)  
 
The other synthetic substrate that has been studied for use in conjunctival transplantation 
is PLGA. Lee et al. studied the growth of corneal epithelial cells on PLGA and PLGA treated 
with type I collagen alone or with hyaluronic acid in vitro and in vivo.(75) Type I collagen is a 
hydrophilic protein containing RGD sequence domains that support attachment of cells, 
whereas hyaluronic acid is a GAG that is present in ECMs. The treated and untreated 
membranes were flexible that could be easily handled during surgery. However, these 
membranes were not transparent, although this is not a problem in the case of conjunctival 
transplantation.(31) All the surface modifications enhanced cell attachment and 
proliferation compared to untreated PLGA, with the combination of type I collagen and 
hyaluronic acid having a greater effect than type I collagen alone.(75) The PLGA that was 
treated with type I collagen and hyaluronic acid were transplanted on to conjunctival 
defects in rabbits. The conjunctival defects completely re-epithelialised and started to 
stratify four weeks post-operatively, although this was much slower than that observed 
with the ungrafted wounds. The ungrafted wounds contracted significantly more than the 
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grafted wounds with forniceal shortening. The collagen fibres were arranged regularly in 
the ungrafted wounds, whereas the grafted wounds showed random collagen orientation 
similar to the native tissue. The random pattern may be due to the presence of type I 
collagen and/or the porous structure of the PLGA that allowed the randomly aligned 
deposition of collagen fibres by the fibroblasts.(75) The PLGA grafts had a slower 
degradation time than PCL, which were found to be undegraded even at four weeks post-
operatively.(75) Degradation of synthetic substrates depends on their chemical structure 
and presence of hydrolytically unstable bonds.(72) Rates of degradation of PLGA can be 
altered depending on their glycolic acid content, for example, 50:50 and 85:15 poly(ᴅι-
lactide-co-glycolide) have degradation times of two to four months and six to twelve 
months, respectively.(76) Moreover, the addition of carbonate units increases the 
degradation time as observed with 70:30 PGLA:poly(ι-lactide-co-1,3-trimethylene 
carbonate), which takes one to two years to degrade.(76) 
 
As described above, when investigating synthetic substrates it is important that the surface 
is hydrophilic as the ECM proteins secreted by the cells have higher affinity for binding to a 
hydrophilic surface than a hydrophobic surface.(73) The integrins on the cell membranes 
will then interact with specific domains on the ECM proteins to allow cell adhesion and 
growth. Other characteristics important for supporting culture of cells on synthetic 
substrates are the pore size and the number of pores, which affects attachment and 
spreading of cells as well as the diffusion of nutrients.(73) This is important when substrates 
with cells are transplanted in vivo, to ensure that the nutrients and waste products can 
diffuse from and to the vascular supply in the connective tissue stroma, respectively. 
Although many of the synthetic substrates may have superior mechanical properties than 
biological substrates that allow easy handling, lack of elasticity may limit their use in 
reconstructing fornices.(21) Moreover, the studies so far have been carried out in animals 
with wounds that were made surgically, therefore warranting further studies regarding the 
degradation times in the presence of active inflammation in vivo.(21)  
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Advantages of synthetic substrates 
 
 
 
Figure 1.14: Advantages of synthetic substrates for use in tissue engineering. 
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Comparison of substrates investigated for tissue engineering of the conjunctiva 
 Amniotic 
membrane 
Autologous 
nasal mucosa 
Autologous 
oral mucosa 
Autologous 
fibrin 
Elastin-like 
polymer 
Keratin films Surface 
modified PCL 
Surface 
modified 
PLGA 
Transparent 
 
Yes      Yes Yes  No  
Suitable 
thickness 
Yes 
(20-500µm) 
 Varies 
depending on 
the site of the 
oral cavity 
 
   6µm thick 
(stretched 
substrates) 
 
Flexibility and 
surgical handle-
ability 
Good      Good 
biomechanical 
strength but 
may be too 
stiff  
High tensile 
strength and 
flexible (stiffer 
than amniotic 
membrane) 
 
Yes  
Biocompatible Yes, non-
antigenic 
Yes, non-
antigenic 
Yes, non-
antigenic 
Yes, non-
antigenic 
 
  Yes  Yes  
Risk of 
microbial 
disease 
transmission 
Potential risk Autologous 
product 
Autologous 
product 
Autologous 
product 
Made from 
bio-
engineered 
bacteria 
No No No 
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 Amniotic 
membrane 
Autologous 
nasal mucosa 
Autologous 
oral mucosa 
Autologous 
fibrin 
Elastin-like 
polymer 
Keratin films Surface 
modified PCL 
Surface 
modified 
PLGA 
Support 
epithelial cell 
growth 
Yes Yes Yes Yes  Yes Yes but 
unknown 
phenotype 
 
Yes  Yes  
Support goblet 
cell 
differentiation 
Yes but lower 
than native 
tissue 
Yes No Yes   Yes but lower 
than native 
tissue 
 
 
Support 
maintenance of 
stem cells 
 
No  Yes Yes    Yes   
Biodegradability Biodegradable   Highly 
degraded but 
could be 
controlled 
 
 Degrade 
within four 
weeks in vivo 
Degrade 
within five 
weeks in vivo 
Slower than 
PCL 
(undegraded 
at four weeks) 
Low in vivo 
shrinkage 
Prone to in 
vivo shrinkage 
 Prone to in 
vivo shrinkage 
   May be prone 
to scar tissue 
formation 
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 Amniotic 
membrane 
Autologous 
nasal mucosa 
Autologous 
oral mucosa 
Autologous 
fibrin 
Elastin-like 
polymer 
Keratin films Surface 
modified PCL 
Surface 
modified 
PLGA 
Accessibility Readily 
available 
Complex 
surgery – 
limited size of 
donor tissue 
 
Yes depending 
on the site of 
the oral cavity 
Readily 
available 
Readily 
available 
Readily 
available 
Readily 
available 
Readily 
available 
Standardised 
product  
No Autologous 
product 
 
Autologous 
product 
 Yes Yes Yes Yes 
Risk to donor 
site 
n/a Yes Yes  n/a n/a n/a n/a n/a 
Table 1.2: Comparison of substrates investigated for tissue engineering of the conjunctiva.  
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1.4 EXTRACELLULAR MATRIX AND BASEMENT MEMBRANE 
1.4.1 STRUCTURE AND FUNCTIONS 
The ECM is a non-cellular component of tissues consisting of biomolecules secreted by the 
resident cells.(42, 77) There are two forms of ECMs: the BM and the interstitial matrix.(42) 
The BM, also known as the basal lamina, was first observed by histologists as an electron-
dense sheet-like structure basolateral to all cell monolayers, separating them from the 
underlying stroma, on transmission electron microscopy.(77, 78) Since then, BMs have 
been found in all tissues, specifically on the basal side of epithelial cells (figure 1.15), 
adjacent to vascular endothelial cells and Schwann cells of peripheral nerves and encircling 
smooth, cardiac and skeletal muscle fibres.(79) The BM, consists of large insoluble proteins 
that are highly cross-linked by undergoing self-assembly, which is guided by cellular 
receptors.(77) Transmission electron microscopy studies have measured the thickness to be 
between 50 and 100nm containing two layers, lamina lucida (approximately 25nm) and 
lamina densa (approximately 50nm).(1, 78) The ocular lens capsule, tracheal BM and 
Desҫemet’s membrane of the cornea are exceptions to this where the thickness is in the 
micrometre range.(79) However, recent studies involving atomic force microscopy show 
that the BMs are two-folds thicker than previously measured using transmission electron 
microscopy.(79) BMs are formed during the embryonic period to establish polarity in the 
epiblast.(80) In humans, the BM of the cornea is first detected during gestation weeks eight 
and nine, and the epithelium is seen to be separated from the underlying stroma by week 
sixteen.(81) In contrast to BMs, the interstitial matrix is a three-dimensional amorphous gel 
surrounding the cells and acts as the ‘glue’ that holds the cells in place within tissues.(42) 
This form of ECM is mainly found surrounding cells of mesenchymal origin, such as 
adipocytes, chondrocytes, myoblasts and osteoblasts.(43) The protein profile of the 
interstitial matrix may differ from that of BMs, having more collagen, elastin and 
fibronectin.(42) Additionally, interstitial matrices are less dense and more porous than BMs. 
The ECM is an integral structure in eukaryotic tissues that regulates their development, 
function and homeostasis.(80)   
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Functions of the ECM: 
1. Structural support for cells.(77, 78) 
2. Anchorage site for cells by providing ligands to cell receptors.(78) 
3. Divides different types of tissues of an organ into compartments.(77)  
4. Provides a semi-permeable selective barrier, for example in the kidneys, the 
proteins of the glomerular BM provide charged molecules required for appropriate 
filtration of blood and the mechanical strength to sustain this function.(78)  
5. Contributes to the mechanical properties of tissues by providing tensile 
strength.(77, 82)  
6. Individual proteins have multiple binding sites for cell surface receptors that initiate 
intracellular signalling pathways influencing cellular processes, such as cell 
migration, proliferation and differentiation, thus are involved in the outside-in 
signalling of cells.(11, 42, 78) Studies have shown that when conjunctival epithelial 
cells have been cultured on substrates containing ECM proteins of the cornea, 
these cells differentiate to express cornea-specific protein markers, displaying the 
ability of ECM proteins to govern the differentiation of cells.(83) In addition, 
specific proteins are responsible for the self-renewal, maintenance and activation 
of SCs.(11) 
7. Provides a reservoir of growth factors and cytokines that influence behaviour of 
cells in both physiological and pathological states.(42, 78) 
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The basement membrane 
 
 
 
Figure 1.15: The basement membrane of epithelial cells. Epithelial cells sit on a 
basement membrane that separates them from the underling connective tissue 
stroma. 
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1.4.2 COMPONENTS OF THE EXTRACELLULAR MATRICES AND BASEMENT MEMBRANES 
The composition of ECM/BMs are diverse, tissue-specific and dynamic.(78) The ECM 
composition has been studied largely by means of immunohistochemistry, in particular by 
investigating the BM of the mouse Engelbreth-Holm-Swarm (EHS) sarcoma in the 1980s.(79, 
84) A major limitation of this is that the ECM of a tumour is different to that of a healthy 
tissue in their composition and structure, where the former is less cross-linked.(77, 78) 
Thus, it is important that these protein structures are studied in their physiological healthy 
states. Studies carried out since then have shown that the matrisome consisting of 1-1.5% 
of the mammalian proteome, is made up of more than three-hundred proteins, although 
this is not an exhaustive list.(82, 84) ECMs consist of structural proteins, such as collagens, 
glycoproteins (GPs) and proteoglycans (PGs).(42, 78) Additionally, cell receptors such as 
integrins, growth factors (GFs) and matrix metalloproteinases (MMPs) also constitute the 
ECM.(42) The multi-domain structures of the ECM proteins allow interaction with each 
other to form protein polymers.(78, 79) 
 
Although all BMs in the human body may appear similar under electron microscopy, the 
combination of protein composition and their isomers is diverse and unique to each type of 
tissue, conferring tissue specificity and dictating their individual functions within an 
organ.(77, 78) Moreover, this heterogeneity is accounted for by the different amounts of 
each type of protein and their isomers, their splice variants and post-translational 
modifications giving rise to variable binding affinities to other proteins.(78) Isomers of type 
IV collagen and laminin are thought to account for the major differences between ECMs of 
tissues, whereas the specific composition of the other minor proteins adds to further tissue 
specificity and heterogeneity.(78, 85) The differences in assembly of the major and minor 
components of ECMs also confer tissue specificity.(85) For example, laminin α1, α3 and α5 
chains are predominantly present in epithelial BMs, whereas the α2 chain is found mainly in 
BMs of skeletal and cardiac muscles and α4 chain in vascular BMs.(78) Moreover, the 
mammalian kidney is an example where the composition of ECMs varies between the 
different types of tissues present within an organ, portraying the unique cellular function of 
that particular tissue: glomerular BM has been shown to consist of α3α4α5 protomers of 
type IV collagen, whereas Bowman’s capsular BM consists of α5α5α6 and α1α2α1 
protomers.(78) Thus, studying the unique composition of ECMs of different tissues and 
their structure could uncover information regarding the effects of cellular 
microenvironments on the regulation of the functionality of the resident cells.(77) 
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In addition to variations in composition between different types of tissues, the ECM is a 
dynamic structure in which the composition and assembly of proteins and the 
biomechanical properties differ for each tissue type depending on the physiological states, 
such as ageing, and pathological states.(78, 79) The constant remodelling of the ECM 
proteins may expose cryptic binding sites on the proteins allowing cells to interact with 
different domains of the same molecule to give rise to distinct cellular functions.(77) During 
ageing, there is an overall reduction in synthesis of proteins, especially type I collagen.(42) 
However, synthesis of proteins, such as fibronectin and MMPs, increase relative to the 
other proteins.(42) These differences during ageing have shown to alter the cellular 
functions, for example, the ECM laid down by fetal SCs was found to be superior to that laid 
down by adult SCs for chondrogenic cell proliferation and differentiation.(42) Moreover, 
there are higher levels of hyaluronic acid in ECM of fetal skin wounds than in adult 
wounds.(42) Increasing levels of hyaluronic acid in adult skin wounds have been shown to 
reduce scar formation by altering collagen synthesis and enhancing cell proliferation and 
migration.(42) Defects in BMs have been shown to give rise to various disease processes 
within the human body. One example is Alport syndrome, where mutations in type IV 
collagen α5 chain gives rise to the loss of α3α4α5 protomers in the glomerular BM and 
replacement with α1α1α2 protomers that are unable to withstand the glomerular pressures 
with subsequent loss of structural integrity of the BM and kidney failure.(77, 78) Collagen 
proteins may also be affected by autoimmune diseases, such as Goodpasture syndrome of 
the kidneys, where there are auto-antibodies against type IV collagen α3 chain in the 
glomerular BM.(77) These studies emphasise the importance of the correct combination of 
components and their assembly in the ECM of a given tissue.(77)  
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1.4.2.1 COLLAGENS 
Collagens are the most abundant proteins in the human body, especially in connective 
tissues.(42) It is the main protein found within ECMs functioning as the principle structural 
protein providing tensile strength to tissues and serving a role in cellular processes, such as 
cell adhesion and migration.(42, 84) There are twenty-eight types of collagens in 
vertebrates that are grouped into three major categories: fibrillar (I, II, III, V, XI, XXIV, XXVII), 
fibril-associated collagens with interrupted triple helices (IX, XII, XIV, XVI, XIX, XX, XXI, XXII) 
and non-fibrillar collagens.(80, 86) The latter is further divided into network forming BM 
collagens (IV), microfibrillar (VI), anchoring fibrils (VII), short chain (VIII, X), multiplexins (XV, 
XVIII) and membrane-associated collagens with interrupted triple helices (XIII, XVII, XXIII). 
All collagens are made up of three α polypeptide chains that wind around each other to 
form a triple helix.(82)  
 
1.4.2.1.1 TYPE IV COLLAGEN 
Although type I collagen is the most abundant collagen in the human body, type IV collagen 
accounts for 50% of all BM proteins.(77, 78) It is first expressed on embryonic stage day 4.5 
in mice.(78) Protomer, the basic building unit of collagens, consists of three α chains (each 
400nm long, 170kDa) that form a triple-helix.(77, 78) These protomers interact with each 
other to form a network.(77) Each protomer consists of the triple helical collagenous 
domain consisting of Glycine-X-Y sequence, where X and Y amino acids are hydroxylysine 
and lysine or hydroxyproline and proline.(77, 78) The triple helical collagenous domain 
provide the collagen protomer with structural integrity, however, about twenty-two short 
sequence interruptions within this domain provide flexibility.(78) The C-terminal of the 
protomers have globular non-collagenous domains and the N-terminal consists of 7S 
domains containing interrupted Glycine-X-Y repeats.(78) The non-collagenous domain is 
hydroxyproline free but is rich in amino acids cysteine and lysine thought to be important 
for the self-assembly of type IV collagen.(77, 78) There are six types of type IV collagen α 
chains in mammals, which give rise to fifty-six possible combinations of protomers.(77, 78) 
Homology between these chains are thought to differ mostly in their non-collagenous 
domains.(78) The main in vivo combinations of type IV collagens are α1α1α2 and α3α4α5, 
where the former is found in most epithelial and endothelial BMs.(43, 78) The non-
collagenous domains limit the random association between the α chains ensuring specific 
protomer combinations in vivo.(78) Early studies on EHS tumours have shown that correct 
formation of the type IV collagen network is essential for BM stability and assembly.(77)    
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1.4.2.1.2 OTHER COLLAGENS 
Type XV collagen is a non-fibril forming collagen that forms homotrimers consisting of three 
α1 chains observed in a variety of tissue ECMs with highest expression in the BMs of the 
heart and skeletal muscles.(77) Studies on type XV collagen deficient mice have shown 
normal development of blood vessels, however, the vessels were collapsed suggesting a 
vital structural role in the vasculature of these tissues.(77, 78) This collagen is highly 
homologous to type XVIII collagen in the BM.(77) Type XVIII collagen, a non-fibrillar type 
collagen-heparan sulphate PG (HSPG), is mainly found in epithelial and vascular endothelial 
BMs.(86) Both type XV and XVIII collagens are thought to be found at the interface between 
the BM and the underlying stroma, possibly forming connections between the two 
regions.(87) Type XVIII is made up of three α1 chains that form a triple helix, which is 
interrupted by non-collagenous regions.(88) These non-triple helical domains provide a 
good degree of flexibility between the triple-helical regions and allow formation of collagen 
polymers.(88) Moreover, they provide binding sites for heparan sulphate side chains that 
interact with GFs and various receptors on cell membranes.(88) There are three isoforms, 
long, medium and short isoforms that differ in their N-termini non-collagenous regions and 
their tissue distribution.(89) The non-collagenous domain at the C-terminal consists of 
three regions: proximal region involved in formation of the triple-helix, hinge domain that is 
highly susceptible to proteases and distal globular domains.(88) These globular domains 
contain an anti-angiogenic fragment called endostatin.(77, 78) Endostatin has been shown 
to interact with integrin α5β1, glypican, domain V of perlecan, nidogen and the laminin 
complex.(88) Proteolysis studies have shown that the non-collagenous domains of type IV 
collagen also have anti-angiogenic fragments, such as arrestin (α1 chain), canstatin (α2 
chain) and tumstatin (α3 chain).(77, 78) Type XVIII collagen is thought to play a role in the 
development of the vasculature of the retina, where a mutation is associated with Knoblach 
syndrome characterised by failed development of retinal vasculature and affected 
individuals have retinal degeneration and blindness.(77)  
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1.4.2.2 GLYCOPROTEINS 
GPs are proteins that have covalently attached carbohydrates. There are approximately 
two-hundred GPs in the matrisome having various roles in individual tissues.(84) 
 
1.4.2.2.1 LAMININS 
Laminins are the most abundant non-collagenous proteins in BMs and is involved in a 
variety of cellular processes, such as adhesion and differentiation.(42, 78) Laminin trimers 
are the basic building unit of the laminin network.(77) Three polypeptide chains, α, β and γ 
form a trimeric three-pronged fork-like structure that is between 400 and 800kDa in 
size.(77, 78, 82) There are twelve genes encoding five α-chains, three β-chains and three γ-
chains, which are able to form fifteen trimeric combinations of laminin and all have been 
found in BMs, laminin 111 (α1β1γ1 or laminin 1) being the most abundant type in BMs.(78, 
80) The C-terminal of the α chain (400kDa, 160nm) consists of five homologous globular 
domains, which is the major site for cell attachment.(78) The β (200kDa, 60nm) and γ 
(200kDa, 40nm) chains lack these domains. The C-termini of all three chains form a triple α-
helical coiled-coil (“handle” of the fork) and consists of domains I and II of the laminin 
trimer.(78) The short arms of the three chains (“prongs” of the fork) contain domains III, IV, 
V and VI.(78) Some α and β chains of laminin have short truncated arms.(78) The α chain 
mainly plays a role in cell adhesion, whereas the β and the γ chains are mainly involved in 
the self-polymerisation of laminin and binding to nidogen.(87) Laminin 111 is the first 
laminin detected in mice on embryonic stage day 4.5.(78) Laminin 511 (α5β1γ1 or laminin 
10) has also been found to be important for the early embryonic development.(87) Among 
the first proteins of the ECM to be expressed in embryos, laminins have been shown to be 
important for differentiation where a defect in their expression can have fatal results in the 
embryo or they manifest as serious conditions affecting various organs.(42) Laminin γ1 
chain is shown to be a common component in all BMs, whereas other isoforms have a 
tissue-specific distribution.(85) Laminins 111, 211 (α2β1γ1 or laminin 2) and 121 (α1β2γ1 or 
laminin 3) have three short arms in which the N-termini provide the binding sites for self-
polymerization to form a network.(43) On the other hand, laminins 411 (α4β1γ1 or laminin 
8), 421 (α4β2γ1 or laminin 9) and 423 (α4β2γ3 or laminin 14) have only two short arms, which 
require other molecules for assembly, and laminin 332 (α3β2γ2 or laminin 5) has one short 
arm that bind to other laminins and proteins within the ECM.(43)  
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1.4.2.2.2 FIBRONECTIN 
Fibronectin plays a role in cell adhesion, migration and the wound healing response to 
injury.(42, 82) It prevents terminal differentiation of keratinocytes by down-regulating the 
expression of involucrin.(48) The absence of fibronectin during embryonic development is 
found to be fatal in mice.(42) There are two forms of fibronectin, as a component in blood 
plasma, and as a cellular and extracellular protein produced predominantly by 
fibroblasts.(42) Fibronectin monomers are approximately 250kDa in size and are made up 
of repeating units of three types of modules: types I, II and III.(42, 82) Each monomer 
contains binding sites for integrins, collagen, heparin and other fibronectin monomers.(90) 
The FNIII10 repeat contains a RGD peptide sequence that is important for cell adhesion.(42, 
82) Fibronectin is secreted as dimers by forming two disulphide bonds between C-termini 
of two monomers.(90) The dimers then interact with each other to form a multimeric 
fibronectin fibril mesh.(42, 82) The mesh provides a structural support for the cells to grow 
on.(90)   
 
1.4.2.2.3 VITRONECTIN 
Vitronectin, a cell adhesive protein, is predominantly found in loose connective tissue in 
healthy tissues, and like fibronectin, is deposited during wound healing responses where it 
contributes to the provisional matrix.(80, 91) Similar to fibronectin, vitronectin is also found 
in blood plasma.(48) It binds to integrins on cell membranes and extracellular collagen, 
heparin and plasminogen activator inhibitor.(48) Vitronectin knock-out mice have been 
shown to have delayed wound healing and a defective inflammatory response.(92)   
 
1.4.2.2.4 NEPHRONECTIN 
Nephronectin is a GP that has been found to be essential for the development of the 
urinary tract system, including the kidneys.(87) This is mediated by binding of the RGD 
peptide sequence on the protein to integrin α8β1 on cell membranes.(87) Nephronectin has 
also been found in tissues of other organs, including the eyes and skin.(87) 
 
1.4.2.2.5 THROMBOSPONDINS 
The thrombospondin family consists of five isomers (1-5), of which 1 and 2 form 
homotrimers, whereas 3, 4 and 5 form homopentamers.(93) Thrombospondins 1 and 2 are 
approximately 400kDa in size and contain von Willebrand factor type C, anti-angiogenic and 
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epidermal GF (EGF)-like domains. They bind to multiple proteins in the ECM, including type 
I-V collagens, laminin, fibronectin and heparin. They modulate cell adhesion via integrin 
subunits β1 and β3. They bind to other cell membrane proteins, such as syndecans and 
cluster of differentiation 36 (CD36, also known as platelet glycoprotein 4). The interaction 
between CD36 and thrombospondin 1 leads to cell apoptosis. Moreover, thrombospondin 1 
modulates the expression of other proteins within the ECM, such as GFs and MMPs. This 
together with CD36 mediated endothelial cell apoptosis gives rise to the anti-angiogenic 
properties of thrombospondin 1. In diabetic patients, the expression of thrombospondin 1 
in the aqueous and vitreous humour has been shown to be reduced, which may explain the 
neovascularisation seen in these patients, thus plays a significant role in the growth of 
retinal blood vessels.(93) Thrombospondin 1 is important for normal wound healing 
responses of the cornea where it has been shown to be synthesised within four hours of 
injury supporting cell migration and inhibiting angiogenesis, thus ensuring transparency of 
the cornea.(93) Moreover, studies have shown the development of a chronic inflammatory 
response of the OS with age in thrombospondin 1-null mice that was absent at birth.(94) 
There was also a reduction in mucin producing GCs that may have contributed to the 
increased inflammation of the OS.(94) Thus, thrombospondin 1 has been associated with an 
immunomodulatory role on the OS.  
 
1.4.2.2.6 NIDOGEN 
Nidogen is a GP that accounts for 2-3% of all BM proteins.(78) Its core consists of three 
globular-like domains, where G1 is at the N-terminal and G3 is at the C-terminal of the core 
protein. A short rod separates G1 and G2 domains, whereas a longer rod separates G2 and 
G3 domains. Two genes encode for two isomers, each approximately 150kDa, nidogen 1 
(30nm) and nidogen 2 (40nm).(78, 79) Both are found in all BMs of the human body, 
although nidogen 2 shows a more restricted expression, predominantly found in vascular 
BMs.(78) Their expression is first detected on embryonic stage day 10.5 in mice.(78) They 
mainly function as bridging proteins between the laminin and type IV collagen networks, 
however, they also bind to other proteins, such as perlecan, fibronectin and fibrinogen.(78) 
Studies have shown that laminin provides more than one binding site for nidogen 2 
suggesting separate functions for the two isomers.(78) Double-null mice have been found 
to be peri-natally lethal, whereas mice lacking a single gene show that nidogen is not 
required for formation of BMs, however is essential for the correct functioning of BM, in 
particular that of the lungs and the heart.(78) 
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1.4.2.2.7 TENASCINS 
Tenascins are GPs of the ECM, in particular within connective tissues where it plays a role in 
load bearing.(42) They are also found in ECMs of the brain and skin.(42) Tenascin C was 
discovered first following which four other isomers namely, tenascins Y, X, W and R were 
described.(42, 95) All types form trimers, except for tenascin C, which forms hexamers.(95) 
The tenascin C molecule contains a tenascin assembly domain, an EGF-like domain, a FNIII 
domain and a fibrinogen-like domain.(95) Although it has been suggested that tenascin is 
not present in normal adult tissue, this protein is found in the provisional matrix during 
development and pathological states, such as wound healing.(42) In particular, the absence 
of tenascin C has been shown to lead to impaired regeneration following an injury.(42) 
Tenascin C has been shown to enhance migration of fibroblasts to wound sites to lay down 
a provisional matrix made up of fibrin and fibronectin supporting the adhesion and 
migration of cells.(42) Substrate coating with tenascin C, however, has been shown to 
prevent cell adhesion.(42) Moreover, tenascin C has been shown to be associated with SC 
niches, especially in neural tissues where it appears to regulate GF activity.(11, 42) 
Moreover, on the OS, tenascin C was noted to be a component of the limbal SC niche.(24)  
 
1.4.2.2.8 α-2-HEREMANS SCHMID-GLYCOPROTEIN   
α-2-Heremans Schmid-glycoprotein (α-2-HS-GP), also known as Fetuin A (bovine 
homologue), is a GP found in humans and animals that belongs to the cystatin 
superfamily.(96, 97) Depending on the carbohydrate content, it has a molecular mass of 51-
67kDa.(98) It was first detected in fetal and new born calf serum.(96) In humans, it is 
primarily produced by hepatocytes in adults where its production is regulated by systemic 
inflammation.(97, 99) However, it has been found in other organs, such as the brain and 
kidney, as well in the amniotic fluid of the fetus.(96, 99) In humans, the concentration of α-
2-HS-GP is approximately five times higher in the fetus than that in the adult.(96) However, 
the concentration has been shown to be high around hair follicles and at epidermal-dermal 
junctions in adult skin tissue.(97) α-2-HS-GP has been shown to have various biological 
roles: roles in brain development, in bone remodelling and as an inhibitor of ectopic 
calcium deposition, inhibitor of TGFβ signalling and as an anti-inflammatory acute phase 
protein.(96, 99) Moreover, it has been shown to play a role in insulin resistance in type II 
diabetes by inhibiting insulin receptor tyrosine kinase. α-2-HS-GP, as a component of fetal 
calf serum, is known to support the attachment and migration of cells cultured in vitro.(96, 
100)  
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1.4.2.3 PROTEOGLYCANS 
PGs (approximately thirty-six in the matrisome) are made up of a protein backbone 
covalently attached to GAG side chains, where GAGs are linear anionic chains made up of 
repeating units of disaccharides.(82, 84) There are four types of GAGs, hyaluronic acid, 
heparan sulphate, keratan sulphate and dermatan/chondroitin sulphate.(82) The anionic 
GAG chains are able to bind to water and divalent cations, thereby acting as space-filling 
and lubricating components in the ECM.(82) These proteins maintain the hydration of the 
ECM, thus have a role in regulating the biomechanical properties, such as the thickness and 
stiffness of BMs.(79) Moreover, GAGs in particular heparan sulphate, bind to GFs and GF 
receptors to play a role in cell signalling and other biological functions.(82, 84) The PGs are 
categorised into large (aggrecan, versican), small leucine-rich (decorin, lumican), BM-
associated (perlecan, agrin), and cell-surface associated (syndecan, glypican, CD44) PGs. 
(82, 84, 95) The cell surface-associated PGs act as receptors for other ECM proteins, such as 
GFs, fibronectin, thrombospondin and collagen.(48) 
 
1.4.2.3.1 PERLECAN 
Perlecan is a large HSPG with a core protein containing five domains (I-V) resembling 
“pearls on a string”.(78) Domain I at the N-terminus is covalently linked to three GAG 
chains.(78) In humans, the core protein is approximately 470kDa and the addition of the 
GAG chains can give rise to a protein that is more than 800kDa.(88) The core protein 
consists of protein sequences that are shared by other ECM proteins and cell membrane 
receptors, which are evolutionarily related to having roles in metabolism of nutrients, 
cellular adhesion and growth.(88) Perlecan binds to laminin, type IV and XVIII collagens, 
fibronectin, thrombospondin, nidogen, heparin, GFs and integrins.(88) Mouse studies show 
its first expression on embryonic stage day 10.5 with predominant expression in the heart 
and major blood vessels.(78) It has also been detected in the connective tissue outside 
BMs, where it is thought to play a role in chondrogenesis.(78) The main functions of HSPGs 
are to bind to GFs and to connect the laminin and type IV collagen protein networks.(79)  
 
1.4.2.3.2 AGRIN 
Agrin is a 150kDa HSGP detected in muscular, neuromuscular and neural BMs.(78) They 
contain the globular domains of laminin, EGF domains and Kazal-type serine protease 
inhibitor domains.(80) 
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1.4.2.4 GROWTH FACTORS  
The ECM acts as a reservoir for GFs.(82) GFs are proteins that modulate cellular functions, 
such as migration, proliferation and differentiation.(49) As previously mentioned PGs 
interact with GFs, such as fibroblast GF (FGF) and TGFβ, and other developmental control 
factors (Wnt factors).(42, 82) The ECM proteins are known to regulate controlled release 
and actions of GFs and conversely, GFs are involved in the remodelling of the ECM and 
tissues, especially during injury by activating ECM proteins.(42) For example, TGFβ is 
involved in the up-regulation of ECM-related genes and production of ECM proteins by 
interacting with latent TGFβ binding protein (LTBP), which in turn bind to fibrillins and to 
fibronectin-rich matrices.(82, 84)  
 
1.4.2.5 MATRIX METALLOPROTEINASES 
The ECM is dynamic and is constantly degraded and remodelled by the action of proteins, 
such as MMPs, a disintegrin and metalloproteinase (ADAM), a disintegrin and 
metalloproteinase with thrombospondin motifs (ADAMTS) and other proteases.(82) To 
ensure controlled action of these proteases, they are regulated at the transcription level 
and are held in a quiescent state within the ECM until activated.(42) There are also 
inhibitors, such as tissue inhibitors of MMPs (TIMPs).(42) There are more than twenty 
MMPs identified that were initially named according to substrate specificity, for example 
collagenases (MMPs 1, 8 and 13), gelatinases (MMPs 2 and 9), stromelysins (MMPs 3, 10 
and 11), and matrylisins (MMPs 7 and 26).(95) However, MMPs were found to have 
overlapping substrate specificity.(42) MMPs are predominantly expressed in response to 
cytokines and GFs, and may be secreted or transmembrane.(95) Degradation and 
remodelling of the ECM proteins cause cryptic domains to be exposed causing changes to 
cell behaviour, for example type IV collagen binds to integrins α1β1 and α2β1 of endothelial 
cells leading to their proliferation and migration, however, when degraded by MMPs they 
bind to integrin αvβ3 inhibiting these processes.(77) In addition, MMPs also play a role in 
cleaving precursor proteins and releasing bioactive domains, such as GFs and anti-
angiogenic molecules from the parent proteins.(82) Enzymes, such as heparanases and 
sulfatases, are also present within ECMs that degrade GAGs and alter the properties of 
PGs.(84)  
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1.4.3 ASSEMBLY OF THE BASEMENT MEMBRANE 
Correct assembly of BM components is essential for normal development.(90) Abnormal 
assembly leads to fibrosis and formation of tumours, whereas delayed assembly gives rise 
to malformation of anatomical structures and chronic wounds.(90) Components of the BM 
contain all the essential information required to promote self-assembly via specific binding 
sites.(77) Type IV collagen and laminin form independent supra-structures via 
intermolecular self-assembly, forming the basic framework for the formation of a stable 
sheet-like BM (figure 1.16).(77, 78) This type IV collagen-laminin network has a pore size of 
approximately 10nm.(87)  
 
Initially, laminin trimers are formed in the Golgi apparatus of cells where the three chains 
are linked by disulphide bonds.(78) Upon secretion, laminin self-assembles into a 
honeycomb-like structure by interaction of the VI domains at the N-termini of each chain, 
that is thought to be a calcium-dependent process.(78) The laminin polymer being the 
centrepiece of the BM is formed underneath the cells in association with cellular receptors 
and is thought to provide the main cell-binding activity, whereas the type IV collagen 
network is deposited later on the stromal side and provides a scaffold, which is considered 
the main stabilising structure.(77, 79) Protomers of type IV collagen are also formed in the 
Golgi apparatus of cells, where alignment of the non-collagenous domains at the C-termini 
of the three α chains initiates the formation of a triple helix.(78) These protomers are then 
secreted into the ECM where they self-assemble to form a network.(78) Initially, non-
collagenous regions at the C-termini of two protomers interact with each other.(77, 78) The 
7S domains at the N-termini of four protomers also associate with each other to eventually 
form a type IV collagen network.(77, 78) Studies on protomer α3α4α5 of type IV collagen 
have shown that the 7S domain localises to the stromal side, whereas its non-collagenous 
domain is found at the epithelial side co-localising with laminin.(79) The precise formation 
of this type IV collagen network is important for the integrity and the structural 
organisation of the remaining BM.(77) In contrast, studies have also shown that abnormal 
assembly of the laminin network initially leads to subsequent abnormalities in the assembly 
of the type IV collagen network.(77)  
 
The other major proteins of the BM, perlecan and nidogen, are secreted as single molecules 
and do not undergo self-assembly to form supra-structures. Instead they act as bridging 
proteins between the laminin and type IV collagen superstructures, stabilising them and 
promoting structural integrity of the BM complex.(77, 78) Nidogen G3 domain binds to 
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domain III of the laminin γ chain, whereas the G2 domain binds to the triple-helical 
collagenous domain of type IV collagen.(78) The G2 domain also binds to perlecan and 
fibulin.(78) The perlecan core protein binds to the triple-helical collagenous domain of type 
IV collagen, whereas the GAG chains may interact with the non-collagenous domains of 
type IV collagen and globular domains of the laminin α chain.(78)   
 
Fibronectin is secreted by cells as dimers by forming disulphide bonds between C-termini of 
two monomers.(90) Fibronectin dimers then bind to integrins that cause integrins to cluster 
leading to high concentrations of bound fibronectin locally.(90) This stimulates 
phosphorylation of cellular proteins that enhance cell contractility and the force generated 
causes the fibronectin to change its conformation exposing cryptic sites of the protein that 
allow self-assembly into fibrils.(80, 90) This is guided by fibrillar adhesions between the 
cells and fibronectin formed near the centre of the cells.(90) The fibronectin dimers interact 
with each other to give rise to fibrils that increase in length as well as thickness.(90) 
Fibronectin fibrils (10-1000nm in thickness) form linear and branched networks around the 
cells, which support the growth of cells.(42, 90) 
 
Previous transmission electron microscopy studies showed the thickness of BMs to be less 
than 100nm posing limitations when modelling the large proteins within this thickness.(79) 
However, recent measurements using atomic force microscopy show that the BM is a 
thicker structure making it easier for modelling the protein distribution and 
architecture.(79) Specifically, this means that type IV collagen, which is 400nm long, does 
not have to be arranged in a flat and stretched-out configuration that limits its ability to 
stretch laterally. Lack of lateral elasticity of tissue would lead to functional defects during 
development. The current proposed theory is that having this protein in a meshed network 
would provide greater extensibility of BMs, essential for the development of tissues and 
organs that are constantly undergoing changes to their shape. The difference in the 
thickness of BM seen with transmission electron microscopy and atomic force microscopy is 
attributed to the high water content of BMs.(79) HSPGs with their GAG side chains have 
negative charges that bind ions and therefore large quantities of water. Transmission 
electron microscopy requires tissue samples to be dehydrated and therefore the 
measurements were taken without their normal water content. Studies done with and 
without GAG chains show that the BMs shrink by 50% in the absence of these side 
chains.(79)    
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Assembly of basement membrane proteins 
 
 
 
Figure 1.16: Assembly of basement membrane proteins. 
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1.4.4 CELLULAR RECEPTORS AND THEIR INTERACTIONS WITH BASEMENT MEMBRANE 
PROTEINS 
BM proteins interact with cells via receptors on cell membranes.(82) Integrins, major 
cellular receptors for BM proteins, are heterodimeric proteins consisting of an α and a β 
chain, together forming a large extracellular domain, a transmembrane domain and short 
cytoplasmic domain.(82) In vertebrates, there are eighteen α chains and eight β chains that 
form twenty-four integrin heterodimers. Integrins are involved in the bi-directional 
signalling within tissue.(87) The main integrin that binds to BM proteins is β1 that interacts 
with collagens, laminins and fibronectin.(82) Binding of integrins to BM proteins lead to 
outside-in signalling by activating intracellular phosphorylation cascades to regulate cell 
processes.(82) Similarly, the intracellular proteins can change the shape of integrins that 
affect their binding to specific BM proteins, thus are involved in inside-out signalling of 
cells.(82) Integrins involved with collagens are α1β1 and α2β1, which down-regulate the 
production of collagens through negative feedback and enhance the production of 
collagens, respectively.(42) Laminin 332 predominantly binds to integrin α6β4, whereas 
laminin 511 is a ligand for integrin α3β1.(87) Integrin α5β1 is the main cellular receptor for 
fibronectin.(42) Other non-integrin receptors include proteoglycans, such as syndecans and 
CD44.(48) Both contain GAG side chains that bind to a variety of BM proteins to modulate 
intracellular signalling pathways.  
 
Hemidesmosomes connect epithelial cells to their BM and the underlying stroma (figure 
1.17).(101) Integrin α6β4 and type XVII collagen on the basal aspect of epithelial cells 
interact with laminin 332 that connect cells and the BM, which in turn is connected to the 
stroma by type VII collagen anchoring fibrils.(101, 102) The β4 subunit interacts with 
intracellular keratin by associating with type XVII collagen (bullous pemphigoid antigen 
180), bullous pemphigoid antigen 230 and plectin.(102) Calcium is required for the 
formation of hemidesmosomes.(6) Focal adhesions mediate interactions between cells and 
BM proteins via integrins α2β1, α3β1 and α5β1 (figure 1.17).(102) These connect BM proteins 
to the actin cytoskeleton via a combination of intracellular proteins, actinin, paxillin, 
vinculin and talin. Focal adhesions include signalling proteins, such as focal adhesion kinase, 
and are therefore involved in outside-in and inside-out signalling.(102) When BM proteins 
bind to integrins, the shape of the integrin changes and the cytoplasmic domain binds to 
focal adhesion complex proteins.(82) This causes the integrins to cluster, modulate 
activities of focal adhesion kinases and formation of focal adhesion complexes by 
organising the actin cytoskeleton.(82, 87) The cell-BM interactions via focal adhesion 
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complexes lead to changes in cell shape as well as modulation of intracellular signalling 
pathways by phosphorylation of proteins.(48) In general, hemidesmosomes mediate 
interactions between the BM and the keratin cytoskeleton, whereas the focal adhesions 
mediate interactions between the BM and the actin cytoskeleton.(102) However, 
hemidesmosomes are also thought to interact with the actin cytoskeleton, which is 
important for cell migration.(103) Abnormal or loss of hemidesmosomes or focal adhesions 
can lead to blistering diseases, where the epithelial cell layer detaches from the underlying 
stroma.(102)  
 
1.4.5 MECHANICAL PROPERTIES OF BASEMENT MEMBRANES 
As well as the chemical cues from BM proteins, their physical properties, such as rigidity, 
porosity and topography, also regulate cell processes.(82) These physical properties are 
sensed by integrins that activate specific intracellular signals, thereby modulating cellular 
processes. Focal adhesion complexes are formed by cells when cultured on stiff substrates, 
whereas dynamic adhesion complexes are observed on softer substrates.(42) Additionally, 
migrating cells also form dynamic adhesion complexes and once completed these 
complexes disassemble to form more stable focal adhesion complexes.(42) These focal 
adhesion complexes transmit signals from the BM to cells regarding the mechanical 
properties of the substrate. The cells respond by altering the ECM protein production, the 
cytoskeletal structure and re-organising the forces the cells exert on the outside 
environment. The specific assembly of proteins of the BM that account for the side-specific 
variations in their protein composition give rise to variations in their biomechanical 
properties.(79) Studies on human BMs show that the laminin-rich epithelial side of BMs are 
approximately twice as stiff as the collagenous stromal side. Cell adhesion experiments 
showed that the cells adhered more strongly and faster when cultured on the epithelial 
side in contrast to the stromal side. Epithelial cells are biomechanically weak and require a 
strong substrate for support. Rigidity of matrices also affect the differentiation of SCs, for 
example, mesenchymal SCs take an osteogenic path and a neurogenic path when cultured 
on stiff and soft matrices, respectively.(82) Changes in the composition and structure of 
BMs observed with advancing age also alter their biomechanical properties.(79) BM of 
many tissues deteriorate due to reduced amount of proteins formed by the cells and 
increased MMP activity that lead to breakdown of proteins.(42) These studies have shown 
reduced amount of collagen synthesis and an increase to the cross linking of this protein 
with ageing giving rise to undesirable mechanical properties of the BM.(42, 79)   
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Interactions between cell receptors and basement membrane proteins 
 
 
 
Figure 1.17: Interactions between cell receptors and basement membrane proteins. 
Hemidesmosomes and focal adhesion complexes form interactions between cells and the 
underlying basement membrane as well as the stroma; BP 230 - bullous pemphigoid 
antigen 230 and FAK – focal adhesion kinase.  
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1.4.6 BASEMENT MEMBRANE OF THE CONJUNCTIVA 
Numerous studies have been done over the years to investigate the BM components of the 
OS, including the conjunctiva (table 1.3). All these are immunohistochemical studies looking 
at the distribution of the structural protein components. Type IV collagen is found 
throughout the OS with variations in the distribution of its isomers.(11) The chains α1 and 
α2 were present within limbal and conjunctival BMs, whereas the α3 chain was present in 
the corneal BM with weaker staining in the limbal BM.(11) Type IV collagen chains α5 and α6 
chains were found throughout the OS, however, the intensity was reduced in the 
conjunctiva compared to the rest of the OS.(11) The α4 chain was absent within the BMs of 
the OS.(11) Other collagens found throughout the OS were type VII, XV, XVII and XVIII 
collagens.(11) A study by Maatta et al. however showed the absence of type XV collagen in 
the BM of normal corneas.(104) Type V collagen was found only in the corneal BM, whereas 
type XVI collagen staining was observed as a sub-epithelial band in association with the BM 
in the corneo-limbal transition zone.(11)  
 
Laminin α3, β3 and γ2 chains that make up laminin 332 were found in uniform distribution 
throughout the OS.(11) A study by Messmer et al. however showed staining for the β3 chain 
in only 7% and γ2 chain in 34% of the normal conjunctival samples.(85) Chains α5, β2 and γ1 
were found in the limbal and conjunctival BM and generally absent within the corneal 
BM.(11) Laminin chains α1, α2 and β1 predominantly stained the limbal BM and the γ3 chain 
was exclusively found within the BM of the limbus.(11) The absence of the α2 and β2 chains 
within the cornea was also shown by Ljubimov et al.(105) Whereas Schlotzer-Schrehardt et 
al. did not observe staining for α1 chain in the conjunctiva, two other studies reported the 
presence of this chain in the conjunctival BM.(11, 85, 101) The differential distribution of 
isomers between studies, especially those of laminins, may be due to differences in the 
sites of tissue harvesting and specificity of antibodies used.(85) Laminin α4 chain was absent 
throughout the OS.(11)  
 
Other GPs found throughout the OS were nidogen (isomers 1 and 2), fibronectin and 
matrillins 2 and 4.(11) The staining for fibronectin was thicker and stronger in the BMs of 
the limbus and conjunctiva than compared to the corneal BM.(11, 83) Thrombospondin 4 
was also present in patchy distribution throughout the OS, with intensity of staining 
increasing towards the conjunctiva.(11) The limbus specific GPs include SPARC and tenascin 
C, with some focal staining of the latter protein in the conjunctiva.(11) The corneo-limbal 
transition zone consisted of fibulin 2 (a calcium binding protein associated with BMs and 
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extracellular elastic fibres) and vitronectin, the latter however was mainly found as a sub-
epithelial band in association with the BM.(11) The cornea specific components are fibrillins 
1 and 2 (a component of elastic microfibrils) and thrombospondin 1.(11) A study involving 
corneal and conjunctival cell lines showed significantly higher production of 
thrombospondin 1 in the cornea, which was forty times higher than that in the 
conjunctiva.(106) The presence of thrombospondin 1, an anti-angiogenic protein, may 
contribute to the maintenance of the avascular cornea. Another study by Sekiyama et al. 
showed little or no expression of thrombospondin 1 mRNA and protein in the conjunctiva 
compared to the BM of the cornea and limbus, where high expression was particularly 
observed in the basal cells.(107) Perlecan was found throughout the OS, whereas agrin was 
predominantly found in the limbal BM compared to the rest of the OS.(11)  
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Basement membrane proteins of the ocular surface tissues 
 
Table 1.3: Basement membrane proteins of the ocular surface tissues as summarised by 
integrating the literature to date; O – present and X – absent. 
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1.4.7 EXTRACELLULAR MATRIX AS A SUBSTRATE FOR CELL AND TISSUE 
TRANSPLANTATION  
The dynamic composition of the ECM and its architecture regulate the growth and 
differentiation of cells by providing specific biological and physical cues.(42, 47) Gaining 
knowledge about the composition and structure of the ECM, as well as the functions of the 
various components of the ECM will benefit in investigating methods by which the ECM can 
be used in TE applications, in particular as substrates for cell and tissue transplantation.(42) 
Advantages of using ECM or ECM-mimicking substrates for TE are retained anatomical 
structure, reduced immunological response due to lack of cellular components, and 
retained ECM composition and architecture providing similar biological and physical cues to 
that in vivo.(72) There are various types of ECM-related substrates studied to date, namely, 
decellularised ECMs from cultured cells, tissues or organs, substrates with pre-adsorbed 
individual or a combination of ECM proteins, and substrates with attached functional 
peptides of ECM proteins. These methods are especially useful when studying synthetic 
substrates for TE, which lack tissue-specific biological niches that guide cellular functions.  
 
ECM scaffolds may be obtained by decellularisation of cultured cells or cadaveric tissues or 
organs.(47) The goal of decellularisation is to remove all the cellular components and 
therefore all antigenic molecules, without altering the composition, the biological functions 
or the mechanical integrity of the remaining ECM to produce a physiologically active 
scaffold.(72) Decellularisation may be done using physical (agitation, sonication or freeze-
thaw cycles), chemical (acid, alkali, detergents or hypo/hyper-tonic solutions) or enzymatic 
(proteases) methods.(47) Each method disrupts the ultrastructure of the ECM to variable 
extents, thus an optimal method or a combination of methods are used for each type of 
cultured cells, tissue or organ. The ECMs of various organs have been studied for the 
purposes of TE, for example that of the skin, bone, bladder, small intestine submucosa, 
heart and lungs.(47) Of these, Alloderm (acellular skin matrix) and CryoValve SG Pulmonary 
Valve (acellular human cardiac valve) are Food and Drug Administration-approved ECM-
based products used clinically for therapeutic use.(47, 71)  
 
Wen et al. transplanted allogenic acellular conjunctival ECM grafts onto iatrogenic 
conjunctival defects in rabbits, who observed a stratified conjunctival epithelium with 
evidence of GCs four weeks post-operatively.(108) In contrast, they observed a T cell 
mediated immune reaction in the group that was transplanted with allogenic conjunctival 
grafts containing cells. Zhao et al. studied porcine acellular conjunctival ECM as a substrate 
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for ex vivo expansion of rabbit limbal epithelial cells, as an alternative to the denuded 
AM.(56) They showed that both substrates had similar transparency, however, the 
conjunctival ECM was thicker (53µm vs 35µm) and had a higher tensile strength compared 
to denuded AM. Moreover, they showed that the denuded AM completely degraded within 
one hour of collagenase treatment in vitro and between one and two weeks in vivo. In 
comparison, conjunctival ECM was unchanged following collagenase treatment for one 
hour in vitro and degraded between three and four weeks in vivo. The conjunctival ECMs 
with cultured rabbit limbal epithelial cells were used to reconstruct rabbit LSCD models. 
Clinically, the eyes that were transplanted with conjunctival ECM with cultured epithelial 
cells showed the best outcome with no corneal haze or evidence of neovascularisation, 
whereas minimal corneal haze and limbal neovascularisation were observed in those 
transplanted with denuded AM containing cultured cells. Interestingly, there was moderate 
corneal haze and evidence of peripheral corneal neovascularisation involving 50% of the 
cornea or more in eyes that were treated with acellular conjunctival ECM without cultured 
epithelial cells. This may be due to the presence of angiogenic factors in the ECM of 
conjunctiva and the presence of limbal epithelial cells may remodel the ECM scaffold to one 
that is more suitable for growth and differentiation of corneal epithelial cells. Rabbits 
grafted with conjunctival ECM containing cultured limbal epithelial cells showed complete 
re-epithelialisation by day thirty with evidence of epithelial stratification, expression of 
corneal keratins and the absence of GCs. ECM obtained from decellularised tissues and 
organs have limitations: scarcity of donor tissue, variations of ECM composition and 
architecture between donors and different developmental stages, and immunological 
reactions and potential pathogen transfer if allogenic or xenogenic ECM scaffolds are 
used.(47, 109)  
 
ECM produced by autologous cells would be a useful alternative to acellular autologous 
tissues and organs as they can be cultured in vitro and maintained under sterile 
conditions.(109) Autologous cells can be expanded from a small tissue biopsy and will 
prevent undesired immunological reactions once transplanted.(109) Isolation and use of 
cell-secreted ECM has been reported since the 1970s.(47) Cultured cell-secreted ECMs will 
have a similar protein composition to that in vivo, however, there may be alterations to its 
architecture.(47) ECM of tissues may be used to culture cells of a different tissue but this is 
not always successful due to tissue specific composition and architecture of the ECMs.(47) 
The ECM derived from native tissue has been shown to induce optimal cellular growth and 
function.(47) 
74 
 
Substrates pre-adsorbed with ECM proteins have been used to culture conjunctival 
epithelial cells, type I collagen being the most common, others being laminin, fibronectin, 
matrigel and gelatin-chitosan.(70) Type I collagen, the most abundant protein in stromal 
tissue, has been used to form hydrogels.(8) Zhou et al. studied vitrified type I collagen gels, 
where controlled evaporation of water produced gels with randomly aligned dense network 
of collagen fibrils.(8) They showed that these substrates supported the growth of rabbit 
conjunctival epithelial cells and GCs in vitro and in vivo. These gels have been shown to 
have suitable physical and mechanical properties for transplantation and also prevent scar 
formation and wound contracture.(8, 26) Zhu et al. showed that rabbit conjunctival 
epithelial cells cultured on membranes made up of gelatin (processed type I collagen) and 
chitosan (a GAG) exhibited similar morphology to those grown on tissue culture polystyrene 
and expressed the conjunctival differentiation marker keratin 4.(110) Fibronectin with or 
without type I collagen has been shown to support growth of conjunctival epithelial cells as 
monolayers, however, without GCs.(70) Matrigel, a mixture of laminin, type IV collagen, 
HSPG and GFs derived from the mouse EHS sarcoma, has been shown to promote 
aggregates of conjunctival epithelial cells with some evidence of GCs.(70) 
 
ECM-mimicking substrates can be developed by attaching functional peptides of ECM 
proteins, which may be cell adhesive, sensitive to degradation enzymes or those that bind 
to GFs.(49) There are well-established small functional peptides of larger ECM proteins 
identified as motifs that guide specific cell functions.(43) The RGD sequence initially 
described on fibronectin is a well-known cell-binding domain. To date, other ECM proteins, 
such as laminin, thrombospondin and tenascin are known to contain this motif that binds to 
twelve types of integrins. It has been shown that cell adhesion on substrates can be 
enhanced by coating them with this peptide, however, when added as a solution into a cell 
culture system, inhibit cell adhesion by blocking the integrins. Laminin α1 and β1 chains 
contain peptide sequences IKVAV and YIGSR, respectively, which have roles in promoting 
endothelial cell adhesion and neuronal cell migration. Other functional peptides on ECM 
proteins are KQAGDV and REDV on fibronectin, DGEA and GFOGER on collagens, and VAPG 
on elastin.(49) These small ECM peptide sequences are easier to incorporate into scaffolds 
than the large ECM proteins, easy to produce in large scale and provide further consistency 
between substrates.(43, 49) In addition, these peptides are relatively more stable than the 
larger proteins, which may be subjected to denaturation and degradation in vivo.(49) 
However, the assumption when employing these small peptides are that they retain the 
biological functional specificity when isolated from the native protein.(49)  
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1.5 POLY-EPSILON-LYSINE HYDROGELS 
Hydrogels are three-dimensional structures made of hydrophilic polymers that are either 
physically or chemically cross-linked.(49) These polymer gels are insoluble, however, swell 
in the presence of water.(49) They have good biocompatibility, are able to entrap and 
release biologically active molecules, and have high permeability to oxygen, nutrients and 
other water-soluble molecules.(49) The latter property is advantageous in TE involving the 
OS, especially the avascular cornea, where the epithelium depends on diffusion of oxygen 
from the environment. There are numerous methods of classifying hydrogels: their 
structure (crystalline or non-crystalline), constituents (homopolymer or co-polymer), origin 
of the constituents (natural, synthetic or hybrid), ionic charge (cationic, neutral or anionic) 
or type of cross-linking (chemical or physical).(49) The type and the degree of cross-linking 
determines the physical properties of the hydrogels, such as swelling properties and the 
elastic modulus.(49) As previously mentioned, synthetic substrates may be considered 
superior to biological substrates due to the ability to synthesise them with reproducible and 
constant composition and varying mechanical properties, which are important for TE. 
Synthetic polymers may be non-biodegradable or biodegradable.(49) Non-biodegradable 
polymers (poly(ethylene glycol) and poly(vinyl alcohol) based) need to maintain their 
physical and mechanical properties, where an optimal degree of cross-linking needs to be 
attained to ensure balance between strength and flexibility of the product.(49) 
Biodegradable polymers are mostly polyesters (poly(lactic acid), poly(glycolic acid) and 
poly(caprolactone) based) and polypeptides.(49) An optimal hydrogel for TE should model 
the biological and the physical properties of the ECM of the native tissue. Surface 
modification of synthetic polymers by attaching ECM-derived peptides is becoming 
increasingly popular as a method for manufacturing bioactive substrates for TE.  
 
Poly-epsilon-lysine (PεK) is a homopolymer made up of ι-lysine amino acids that are linked 
by peptide bonds between their ε-amino and the α-carboxyl groups.(111) It is a naturally 
occurring, biodegradable and non-toxic polymer to humans and to the environment that is 
approved by the Food and Drug Administration as a food preservative.(111, 112) 
Industrially, PεK is produced by aerobic fermentation of bacteria, Streptomyces albulus, 
which produces residues that are 25-35 amino acids long.(111, 113) It is known to be stable 
in acidic and alkaline conditions, and at high temperatures, including at autoclaving 
temperatures of 120°C.(113) The homopolymer carries positive charges on their amino 
groups that are able to bind to biomolecules, including negatively charged cell surfaces of 
microbes by electrostatic adsorption.(111, 113) This antimicrobial property allows its use as 
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a food preservative and as a disinfectant.(111) Other uses of PεK are as an emulsifying 
agent and as a drug delivery carrier.(111)  
 
SpheriTech Limited Company has developed a PεK-based hydrogel that could be employed 
as a substrate for TE of the OS. The homopolymer of PεK is chemically cross-linked with 
dicarboxylic acids that are also naturally-occurring products produced from oxidation of 
longer chain fatty acids in animals and plants.(112) These hydrogels are transparent with a 
high water content allowing adequate diffusion of oxygen. Moreover, these peptide-based 
hydrogels are able to form bonds with biomolecules, thus allowing surface chemistry to be 
altered to suit requirements. Physical properties, such as tensile strength and transparency, 
of these hydrogels can be altered by changing the density of PεK, cross-linking density and 
the type of dicarboxylic acid used for cross-linking.(112) Gallagher et al. carried out 
cytotoxicity studies on a corneal cell line over eight days that showed cytocompatibility of 
these hydrogels.(112) The advantageous properties of PεK hydrogels make them a potential 
substrate for use in TE of the OS, in particular in developing a conjunctival tissue substitute 
(figure 1.18).  
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Properties of poly-epsilon-lysine hydrogels 
 
 
 
Figure 1.18: Properties of poly-epsilon-lysine hydrogels that are advantageous in tissue 
engineering of the conjunctiva. 
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1.6 HUMAN CONJUNCTIVAL EPITHELIAL CELL LINE (HCjE-Gi cells) 
The immortalised Human Conjunctival Epithelial cell line – Gipson laboratory 2003 (HCjE-Gi 
cells) is a conjunctival epithelial cell line that consists of epithelial cells as well as GCs. 
Gipson et al. immortalised conjunctival epithelial cells derived from the supero-temporal 
bulbar conjunctival tissue from patients undergoing phacoemulsification surgery.(114) They 
first transduced cells with specific proteins that inactivated the cell cycle pathway by 
altering the functions of p16 and p53 proteins, thus allowing cells to bypass senescence. 
Then the cells were transduced to express human telomerase reverse transcriptase 
(hTERT), the catalytic subunit of telomerase. This allowed the cells to retain their telomeres 
and divide indefinitely (figure 1.19). In somatic cells, cell division results in telomere 
shortening and eventual senescence.(115) Telomeres are repetitive nucleotide sequences 
of DNA located at the ends of chromosomes that act as protective structures. Telomerase 
prevents telomere shortening by adding nucleotide sequences to telomeres by reverse 
transcribing the RNA template and compensating for the loss of telomeres with normal cell 
division. Expression of exogenous hTERT induces telomerase activity in the cells. 
Immortalisation of epithelial cells by preventing telomere shortening has been shown to 
give rise to indefinite replication ability without the loss of differentiation potential of 
cells.(114) This is in contrast to immortalisation with viral oncogenes, such as that of the 
Simian vacuolating virus 40, which disrupts differentiation pathways of cells. However, the 
alterations of the normal functioning of p16 and p53 proteins may affect the progress of 
differentiation. Toouli et al. showed that immortalisation of human mammary epithelial 
cells by hTERT expression resulted in fewer karyotypic and phenotypic alterations than did 
when immortalised by expression of Simian vacuolating virus 40 genes, however, it 
required the prior loss of p16INK4a expression.(115)  
 
Primary cells have a finite proliferative capacity in culture in vitro and become senescent, 
thus are a limited resource.(115) This is overcome by using immortalised cell lines, which in 
theory gives rise to an unlimited number of divisions. However, a limitation of immortalised 
cell lines is the unknown extent to which the cells lose the differentiated characteristics of 
the native cells.(115) This raises concerns over the applicability of results observed in vitro 
to that observed in vivo. Although this is overcome by using primary cells in studies, they 
come with their own limitations. In addition to the limited proliferative potential, there is 
inter-donor variability with primary tissue giving rise to inconsistent results, whereas cell 
lines allow reproducibility of the observed results. There is limited availability of donor 
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tissue to obtain primary cells from and extensive optimisation experiments are required 
prior to employing them in studies. 
 
OS epithelial cells share similar characteristics to other epidermal systems such as the skin. 
They are stratified epithelial cells in which the basal cells have features of low 
differentiation and high proliferative capacity, express tissue-specific keratins and contain 
populations of SCs for rapid renewal of epithelial cells.(25) They differ from epithelia of the 
skin by the lack of a cornified layer on the apical aspect of the superficial cells that is 
present in the skin. Under physiologic conditions, the epithelia of the OS have an 
abundance of tear retinoids that prevent the formation of a cornified layer that would 
affect the normal functioning of these cells.(25) Keratins (40-70kDa) are a group of 
intermediate filaments that contribute to the cytoskeleton of epithelial cells.(10, 22) 
Keratins 1 to 8 belong to the acidic group of keratins (genes expressed on chromosome 21), 
whereas keratins 9 to 20 (genes located on chromosome 17, except that for keratin 18 
found on chromosome 21) belong to the neutral or basic group of keratins.(10) The 
epithelial cells produce more than one type of keratin that co-polymerise to form the 
keratin filament system.(21) The keratins are expressed in a tissue-specific manner, thus 
are used to characterise the phenotype of cells and are used as differentiation markers.(10, 
21) In the epidermal keratinocytes, expression of keratins change from keratins 5 and 14 
expressed by immature cells to keratins 1 and 10 expressed by mature cells.(22) Similarly, 
immature epithelial cells of the OS express keratins 5 and 14. When the corneal epithelial 
cells differentiate they are known to express the keratin pair 3 and 12, whereas the 
conjunctival epithelial cells express the keratin pair 4 and 13.(22)  
 
Keratins 4 and 19 are differentiation markers of HCjE-Gi cells as suggested by the 
manufacturers of the cell line.(116) Keratin 4 is a marker of non-keratinised stratified 
epithelial cells, whereas keratin 19 is a marker of simple epithelial cells.(117) Gipson et al. 
showed that the HCjE-Gi cells expressed keratin 19 similar to that expressed by the native 
conjunctival tissue.(114) Ramirez-Miranda et al. showed that keratin 19 is expressed by the 
epithelial cells of the entire OS, the intensity reducing towards the central cornea, whereas 
keratin 13 is expressed by the suprabasal cells of the posterior limbus and by all the layers 
of the conjunctival epithelium.(118) They further showed that expression of keratins 12 and 
13 are mutually exclusive suggesting that keratin 13 may be a more specific marker of 
conjunctival epithelial cells than keratin 19.  
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Gipson et al. reported that the HCjE-Gi cells do not undergo stratification to the same 
degree in vitro as that observed in the native conjunctival tissue.(114) Studies have shown 
that the expression of keratin 4 coincided with the deposition of α2 and β2 laminin chains, 
thus have been shown to be important for the differentiation of conjunctival epithelial 
cells.(119, 120) The conjunctival cell line HC0597 (virally transformed) has been used in 
previous studies since they express keratin 4 and deposit laminin 211 in culture, thus 
modelling the in vivo conjunctival cells.(120) Moreover, the expression of keratin 4 has 
shown to be rescued by culturing conjunctival cells on exogenous placental laminins that 
contain the β2 chain of laminin.(119) However, the presence of GCs in this cell line has not 
been shown. 
 
Gipson et al. also showed that the HCjE-Gi cell line expressed mucins that are expressed by 
the native conjunctival tissue, although the mRNA expression of these mucins was lower in 
the cell line.(114) They showed that only a very small number of HCjE-Gi cells differentiated 
into GCs expressing the GC protein, MUC5AC, after seven days in culture in the 
differentiation and stratification medium. The authors suggested that this could be due to 
three reasons: the immortalisation technique altered the GC differentiation pathway, only 
few SCs were present in the primary cultures that were available to be transduced with 
hTERT and these cells gave rise to the small population of GCs, or the culture niche is 
different to that of the native tissue that is required for GC differentiation.(114) To date 
and to our knowledge, this is the only conjunctival epithelial cell line that has been shown 
to differentiate into GCs.  
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Cell immortalisation by hTERT expression and maintenance of 
telomere lengths 
 
 
 
 
Figure 1.19: Cell immortalisation by hTERT expression and maintenance of telomere 
lengths. (Adapted from http://jeb.biologists.org/content/218/1/59) 
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1.7 HYPOTHESIS, AIMS AND OBJECTIVES 
Hypothesis 
The surface modification of PεK hydrogels with ECM proteins of the native tissue enables 
the growth and differentiation of conjunctival epithelial cells.  
 
Aims and objectives 
Aim 1: To establish the role of ECM proteins on the cellular functions of HCjE-Gi cells. 
 
Objective 1: To identify and quantify the protein composition of the ECM secreted 
by HCjE-Gi cells over a culture period of six weeks. 
 
Objective 2: To determine the adhesion and growth of HCjE-Gi cells cultured on 
pre-adsorbed proteins modelling the natural ECM composition over a culture 
period of seven days.  
 
Objective 3: To determine the stem cell and goblet cell expression by HCjE-Gi cells 
cultured on pre-adsorbed proteins modelling the natural ECM composition over a 
culture period of fourteen days. 
 
Aim 2: To establish the cellular response of HCjE-Gi cells cultured on surface modified PεK 
hydrogels.   
 
Objective 1: To determine the adhesion of HCjE-Gi cells on PεK hydrogels with and 
without pre-adsorbed proteins.  
 
Objective 2: To determine the growth and differentiation of HCjE-Gi cells on PεK 
hydrogels with and without pre-adsorbed proteins over a culture period of 
fourteen days.  
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2 THE ROLE OF EXTRACELLULAR MATRIX 
PROTEINS ON CELLULAR FUNCTIONS OF HCjE-
Gi CELLS 
 
2.1 AIMS AND OBJECTIVES 
To establish the role of ECM proteins on the cellular functions of HCjE-Gi cells.  
 
1. To identify and quantify the protein composition of the ECM secreted by HCjE-Gi 
cells over a culture period of six weeks. 
 
2. To determine the adhesion and growth of HCjE-Gi cells cultured on pre-adsorbed 
proteins modelling the natural ECM composition over a culture period of seven 
days.  
 
3. To determine the stem cell and goblet cell expression by HCjE-Gi cells cultured on 
pre-adsorbed proteins modelling the natural ECM composition over a culture 
period of fourteen days. 
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2.2 METHODS 
2.2.1 HCjE-Gi CELL LINE 
2.2.1.1 CELL CULTURE MEDIA 
Culture and maintenance of the immortalised Human Conjunctival Epithelial cell line – 
Gipson laboratory 2003 (HCjE-Gi cells) involved several different media for culturing, sub-
culturing, differentiation and stratification and cryopreservation.(116) 
 
2.2.1.2 CELL CULTURE AND SUB-CULTURE 
The immortalised HCjE-Gi cells was cultured in keratinocyte serum-free (KSF) media (table 
2.1) in a humidifying incubator set at 37°C with 5% carbon dioxide (CO2). The cells were 
maintained in 75cm2 flasks (Greiner 658175) and fresh media was supplied three times a 
week.  
 
Once the cell cultures were approximately 75% confluent in a flask, the KSF media was 
removed and 6mL of 1X Trypsin-Ethylenediaminetetraacetic acid (EDTA) solution (Sigma 
T4174; 2mL of stock mixed with 18mL sterile phosphate buffered saline) was added. The 
cells were incubated at 37°C for approximately ten to fifteen minutes until the cells 
rounded and detached spontaneously from the flask. Next, 6mL of neutralisation media 
(table 2.2) was mixed with the Trypsin-EDTA solution to stop the protein digestion. The 
solution was transferred into two 15mL tubes (Greiner bio-one 188271) in equal volumes 
and was centrifuged (Thermo Scientific Heraeus Multifuge X1) at 112 x g for five minutes. 
The supernatant in each tube was removed and the cell pellet was re-suspended in 1mL of 
KSF media. The cell suspension was mixed thoroughly prior to counting with a 
haemocytometer (Fisher Scientific 12634546). The cells were seeded in culture vessels at 
appropriate cell densities and volumes of KSF media, as required for subsequent 
experiments. All cell culture experiments were carried out inside a class II biosafety cabinet 
that was appropriately disinfected following the local guidelines.  
 
2.2.1.3 DIFFERENTIATION AND STRATIFICATION 
When required, the culture medium was switched to the differentiation and stratification 
medium (table 2.3) to induce differentiation and stratification of HCjE-Gi cells. This was 
done on culture day seven, when the cell layer was approximately 70-80% confluent.  
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2.2.1.4 CRYOPRESERVING AND THAWING FROZEN CELLS 
The cells were sub-cultured as described above to obtain 2x106 cell suspension in 1mL KSF 
media. An equal volume of 2X freezing media (table 2.4) at room temperature (RT) was 
added. The cell suspension was mixed and divided into two cryogenic vials (Star Lab E3110-
6122) with 1x106 cells per cryogenic vial. The cells were slow frozen initially in a Mr FrostyTM 
Cryo 1°C freezing container (Thermo Scientific 5100-0001) containing isopropanol (Sigma 
I9516), which was stored in a -80°C freezer (approximately 1-3°C/minute cooling rate) 
overnight. Then the cryogenic vials containing the cells were transferred into liquid nitrogen 
for storage. The dimethyl sulfoxide in the freezing media is a cryoprotective agent that 
reduces the freezing point and prevent rapid cooling of the media.(121) This reduces the 
risk of ice crystal formation that can lead to cell death.(121)    
 
To thaw frozen cells, the cryogenic vial was immersed in a water bath set at 37°C for one to 
two minutes. The cell suspension was transferred into a 15mL tube, 7mL of neutralisation 
media was added slowly and the solution was mixed thoroughly. The cells were centrifuged 
at 1370 x g for four minutes and re-suspended in 1mL of KSF media. Next, the cell 
suspension was transferred into 75cm2 flasks (approximately 5x105 cells per flask) with 8mL 
of KSF media, which were maintained inside a humidifying incubator (37°C, 5% CO2). Fresh 
media was added the following day and then three times a week thereafter.  
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Components of the keratinocyte serum-free media 
CELL CULTURE MEDIUM  SOURCE VOLUME 
1. Keratinocyte serum-free media 1X 
(include L-Glutamine) 
 
Life Technologies 
37010-022 
500mL 
2. Bovine pituitary extract (12.6mg/mL) 
Final concentration of 25μg/mL 
 
Supplied with the 
media bottle  
1.1mL 
3. Human recombinant epidermal growth factor  
1-53 (0.0395835μg/µL) 
Final concentration of 0.2ng/mL 
 
Supplied with the 
media bottle 
3µL 
4. Calcium chloride (1M) 
Final concentration 0.4mM  
 
Sigma C4901 200µL 
5. Penicillin-Streptomycin (100X) 
Final concentration 1X 
 
Sigma P0781  5.1mL 
The media bottle was protected from light and stored at 4°C for approximately one 
month. 
Table 2.1: Components of the keratinocyte serum-free media used for culture of HCjE-Gi 
cells. 
 
 
Components of the neutralisation media 
NEUTRALISATION MEDIUM SOURCE VOLUME 
1. Dulbecco’s Modified Eagle’s Medium/Nutrient 
Mixture F-12 Ham media (1:1 mix) with L-
Glutamine, 15mM HEPES and sodium bicarbonate 
 
Sigma D8437  500mL 
2. Fetal bovine serum 
Final concentration 10% 
 
Biosera FB-1090  55mL 
3. Penicillin-Streptomycin (100X) 
Final concentration 1X   
Sigma P0781 5.5mL 
Table 2.2: Components of the neutralisation media used for sub-culture of HCjE-Gi cells. 
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Components of the differentiation and stratification media 
DIFFERENTIATION AND STRATIFICATION MEDIUM SOURCE  VOLUME 
1. Dulbecco’s Modified Eagle’s Medium/Nutrient 
Mixture F-12 Ham media (1:1 mix) with L-
Glutamine, 15mM HEPES and sodium bicarbonate 
 
Sigma D8437 500mL 
2. Fetal bovine serum 
Final concentration 10% 
 
Biosera FB-1090 55mL 
3. Penicillin-Streptomycin (100X) 
Final concentration 1X 
 
Sigma P0781 5.5mL 
4. Human recombinant epidermal growth factor 1-
53 (0.0395835μg/µL) 
Final concentration of 10ng/mL  
Supplied with the 
KSF media (Life 
Technologies 
37010-022) 
 
149µL 
5. Calcium chloride (1M) 
Final concentration  1mM 
Sigma C4901 500µL 
Table 2.3: Components of the differentiation and stratification media. 
 
 
Components of the freezing media 
2X FREEZING MEDIUM SOURCE  VOLUME 
1. Dulbecco’s Modified Eagle’s Medium/Nutrient 
Mixture F-12 Ham media (1:1 mix) with L-
Glutamine, 15mM HEPES and sodium bicarbonate 
 
Sigma D8437  500mL 
2. Dimethyl sulfoxide Hybri-Max 
Final concentration 20% 
 
Sigma D2650 100mL 
3. Fetal bovine serum 
Final concentration 20% 
 
Biosera FB-1090 100mL 
The solution was mixed and incubated at room temperature for two hours (or at 4°C 
overnight). The solution was filter sterilised, divided into plastic tubes and placed in -80°C 
to freeze-solid. The aliquots were stored in -20°C.    
Table 2.4: Components of the freezing media used for cryopreserving HCjE-Gi cells.  
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2.2.1.5 CHARACTERISTICS OF THE HCjE-Gi CELL LINE 
The HCjE-Gi cells were cultured in ninety-six well plates (Greiner bio-one 655180) to 
determine their growth curve. The cells maintained in KSF media were cultured with initial 
seeding densities of 5x103, 1x104 and 1x105 cells/cm2. On culture days one, three, five and 
seven, the media was removed and the cells were washed three times with phosphate 
buffered saline (PBS) (Thermo Scientific Oxoid BR0014G; 1 tablet per 100mL distilled water 
(dH2O)). The cells were then fixed with 100% ice cold methanol (Fisher Scientific 11976961) 
for two minutes and air dried. Methanol acts as a fixative as well as a permeabilising 
agent.(122) It dehydrates the cells, precipitates soluble proteins and solubilises cytoplasmic 
and transmembrane lipids. The cell nuclei were stained with 4',6-Diamidino-2-Phenylindole, 
Dilactate (DAPI) (Life Technologies D3571; 5mg/mL), diluted 1:30 000 in PBS, for five 
minutes at RT. DAPI binds to adenine-thymine nucleic acids in the minor groove of double 
stranded DNA to give rise to blue fluorescence. Images were taken with a 10X objective 
from five fixed positions within each well using a Nikon Eclipse Ti-E microscope (Japan). The 
number of nuclei per view (0.011cm2) was determined using the Image-based Tool for 
Counting Nuclei plugin on Image J software (figure 2.1). The raw image was first converted 
into an inverted eight-bit image. An estimation of the width of cells and the minimum 
distance between the cells were entered into the plugin (20 and 10 pixels, respectively for 
images taken using a 10X objective). A threshold of 0.1 was entered and the plugin was set 
to detect dark peaks on the image. The mean number of nuclei per view was calculated to 
determine the number of cells per cm2 in each well at each culture time point. The 
experiments were carried out in three sets of triplicates.  
 
To determine the cell morphology, the cells were stained for the cytoskeletal 
microfilament, filamentous actin. The cells were seeded in ninety-six well plates at an initial 
seeding density of 1x104 cells/cm2 and were maintained KSF media. On culture days one 
and seven, the cells were washed three times in PBS and fixed with 10% neutral buffered 
formalin (NBF) (Sigma HT501128) for ten minutes at RT. NBF cross-links proteins to 
preserve the in vivo architecture of the cellular constituents.(122) Methanol is not suitable 
as a fixative agent in this case as it breaks down hydrogen bonds thereby destroying the 
tertiary structure of proteins.(122) The fixed cells were washed three times in PBS and 
permeabilised with 0.2% Triton X-100 (Sigma-Aldrich T9284) for fifteen minutes at RT. 
Permeabilisation with a non-ionic detergent solubilises lipids and disrupts the cell 
membranes allowing large molecules such as antibodies to enter the cell.(122) The cells 
were again washed three times in PBS and were stained with Alexa Fluor 488 Phalloidin 
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(Life Technologies A12379; 200units/mL), diluted 1:1000 in PBS, at 37°C for thirty minutes. 
Phalloidin, which binds to filamentous actin, is a method of visualising the cytoskeleton of 
cells. The cells were then stained with DAPI following three further washes. Images were 
taken with a 20X objective of a Nikon Eclipse Ti-E microscope.   
 
Additionally, the expression of differentiation markers of HCjE-Gi cells, keratins 4 and 19, 
were evaluated. The cells were cultured in ninety-six well plates with an initial seeding 
density of 1x104 cells/cm2 for seven days with KSF media, and then switched to the 
differentiation and stratification media. The cells were cultured for a further seven days. On 
culture days one, seven and fourteen, the cells were washed three times in PBS and fixed 
with 10% NBF for ten minutes at RT. Next, the cells were permeabilised with 0.2% Triton X-
100 for fifteen minutes at RT following three PBS washes. The samples were blocked with 
10% goat serum (Sigma G9023) for one hour at RT. Goat serum contains an excess of 
charged proteins that bind to non-specific binding sites on cells, thus preventing antibodies 
(via the Fc region) from binding to these sites, which will give rise to background 
staining.(122) The cells were incubated with the primary antibodies (table 2.5A), diluted in 
1% bovine serum albumin (BSA), overnight at 4°C. Following three washes with PBS 
containing 0.1% Tween 20 (Sigma P1379) (PBST), the cells were incubated with the 
appropriate secondary antibodies (table 2.5B), diluted in 1% BSA, for another one hour at 
37°C and counterstained with DAPI. PBS containing Tween 20, a non-ionic detergent, was 
used for washes following antibody incubation to ensure more stringent washes and reduce 
further background staining. Images were taken with a 20X objective of a Nikon Eclipse Ti-E 
microscope. PBS was used instead of the primary antibody to ensure the specificity of the 
secondary antibodies. Mouse or rabbit immunoglobulins were used instead of the primary 
antibody as an isotype control to ensure the specificity of the immunoglobulins of the 
antibodies. Additionally, this study was repeated using a retinal pigment epithelial cell line 
(A19 cells) to ensure the specificity of the primary antibodies. 
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Image-based Tool for Counting Nuclei plugin on Image J 
 
 
Figure 2.1: Image-based Tool for Counting Nuclei plugin on image J software used to 
count the number of nuclei. 
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Antibodies used to identify the expression of conjunctival cell 
differentiation markers by HCjE-Gi cells 
A 
PRIMARY ANTIBODIES  SOURCE DILUTION 
Keratin 4 mouse monoclonal [6B10] 1mg/mL Abcam ab9004 1:100 
 
Keratin 19 rabbit monoclonal [EP15804] 0.808mg/mL Abcam ab52625 1:500 
 
B 
SECONDARY ANTIBODIES  SOURCE DILUTION 
Goat anti-mouse, Alexa Fluor 488 2mg/mL  Life Technologies  
A-11029 
 
1:500 
Goat anti-rabbit, Alexa Fluor 594 2mg/mL Life Technologies  
A-11012 
1:500 
Table 2.5: Primary (A) and secondary (B) antibodies used to identify the expression of 
conjunctival cell differentiation markers by HCjE-Gi cells. 
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2.2.2 ISOLATION OF THE EXTRACELLULAR MATRIX  
Ammonium hydroxide (NH4OH) was used to remove the cells and isolate the underlying 
ECM.(123) NH4OH disrupts the cell membranes and solubilises the cellular organelles 
leaving behind the adsorbed ECM proteins and the transmembrane proteins associated 
with the ECM. To determine the optimal NH4OH concentration required, the cells were 
cultured in forty-eight well plates (Greiner bio-one 677180) with an initial seeding density of 
1x104 cells/cm2 for seven days in KSF media. The media was removed and the cells were 
washed three times with PBS. NH4OH solutions (Fisher Scientific 10305220, Ammonia 
solution 35%) of 0.1%, 0.2%, 0.5% and 1% concentrations were prepared. The cells were 
incubated with the different concentrations of NH4OH solutions for 2.5, 5 or 10 minutes at 
37°C. The NH4OH solution was removed and the wells were washed vigorously three times 
with PBS. Images were taken using a bright-field microscope.  
 
To ensure that the underlying ECM was not damaged with the NH4OH treatment, the ECM 
was stained for the laminin α3 chain. The samples treated with 0.1% NH4OH for 2.5 minutes, 
1% for 5 minutes and 1% for 10 minutes were fixed with 100% ice cold methanol for two 
minutes and air dried. Then, the samples were blocked with 10% goat serum for one hour 
at RT. Next, the samples were probed with a mouse monoclonal antibody against the 
laminin α3 chain (prepared in Dr Kevin Hamill’s Lab), diluted 1:200 in PBS, at 37°C for one 
hour. Following three PBST washes, secondary antibody goat anti-mouse Alexa Fluor 514 
(Life Technologies A-31555; 2mg/mL), diluted 1:500 in PBS, was added and incubated at 
37°C for one hour. The samples were washed three times in PBST and counterstained with 
DAPI for five minutes at RT. Images were taken using a 20X objective of a Nikon Eclipse Ti-E 
microscope.    
 
2.2.3 IDENTIFICATION OF HCjE-Gi CELL-SECRTED EXTRACELLULAR MATRIX PROTEINS BY 
IMMUNOFLUORESCENCE STAINING 
The HCjE-Gi cells were seeded at 1x104 cells/cm2 and maintained in KSF media. On culture 
days one, three, five, seven, fourteen, twenty-one, twenty-eight and forty-two, 
immunofluorescence (IF) staining was carried out to determine the presence or absence of 
four ECM proteins. The ECM was isolated by incubating the cells with 1% NH4OH for five 
minutes at 37°C. The samples were fixed with 100% ice cold methanol for two minutes and 
air dried. Then, the samples were blocked with 10% goat serum for one hour at RT and then 
incubated with the primary antibodies (table 2.6A), diluted in PBS, at 4°C overnight. 
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Following three PBST washes, the samples were incubated with the appropriate secondary 
antibody (table 2.6B), diluted in PBS, for one hour at 37°C. The samples were 
counterstained with DAPI following a further three washes with PBST. Images were taken 
using a 20X objective of a Nikon Eclipse Ti-E microscope. The samples with the cells intact 
were used as positive controls. ECM samples with mouse or rabbit immunoglobulins 
instead of the primary antibodies were used to ensure the specificity of the 
immunoglobulins, whereas samples with PBS instead of the primary antibodies were used 
to ensure the specificity of the secondary antibodies used. 
  
 
Antibodies used to identify the extracellular matrix proteins secreted 
by HCjE-Gi cells 
A 
PRIMARY ANTIBODIES  SOURCE DILUTION 
Type IV collagen rabbit polyclonal 1mg/mL  Abcam ab6586 1:100 
 
Type XVIII collagen rabbit polyclonal 1mg/mL Invitrogen PA5-
38894 
 
1:100 
Laminin α3 chain mouse monoclonal [RG13] 
600µg/mL 
Prepared in Dr Kevin 
Hamill’s Lab 
 
1:200 
Fibronectin rabbit polyclonal 0.6mg/mL  Sigma F3648 1:400 
 
B 
SECONDARY ANTIBODIES  SOURCE DILUTION 
Goat anti-mouse, Alexa Fluor 488 2mg/mL  Life Technologies  
A-11029 
 
1:500 
Goat anti-rabbit, Alexa Fluor 594 2mg/mL Life Technologies  
A-11012 
1:500 
Table 2.6: Primary (A) and secondary (B) antibodies used to identify the extracellular 
matrix proteins secreted by HCjE-Gi cells by immunofluorescence staining. 
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2.2.4 IDENTIFICATION AND QUANTIFICATION OF HCjE-Gi CELL-SECRETED 
EXTRACELLULAR MATRIX PROTEINS BY MASS SPECTROMETRY  
HCjE-Gi cells were seeded in forty-eight well plates at a density of 1x104 cells/cm2 and were 
maintained in KSF media for a period of six weeks. On culture days one, seven, fourteen, 
twenty-eight and forty-two, the ECM was isolated using 1% NH4OH. The samples were dried 
and stored at -20°C until all the samples were collected. The samples were given to the 
Centre for Proteome Research (University of Liverpool) to carry out mass spectrometric 
analysis.  
 
On the day of the experiment, the samples were thawed to RT. First, 285µL of 0.052% (w/v) 
RapiGest surfactant (Waters Corporation UK, 186001861) reconstituted in ammonium 
bicarbonate (NH4HCO3) (Sigma A6141) was added to each sample well (final concentration 
0.05%). The samples were incubated with the RapiGest solution for thirty minutes at RT on 
a plate shaker (IKA-VIBRAX-VXR) and then for ten minutes at 80°C. RapiGest is an anionic 
surfactant that improves in-solution protein digestion and peptide recovery by unfolding 
hydrophobic proteins that are resistant to proteolysis.(124) Then, the samples were cooled 
to RT and transferred into 1.7mL low bind tubes (Corning 3207) to prevent non-specific 
adsorption of proteins to the surface. Each well was rinsed with further 100µL of RapiGest 
and this was transferred to the same low bind tubes. The samples were then vortexed 
(Heidolph Reax) gently. Half the protein extract (192.5µL) was aspirated into new low bind 
tubes and 2.5µL of 60mM dithiothreitol (DTT) (Melford Biolaboratories Ltd, MB1015), 
reconstituted in 25mM NH4HCO3 (final concentration of 0.75mM), was added. The samples 
were vortexed and incubated at 60°C for ten minutes. The DTT is a reducing agent that 
converts disulphide bonds between cysteine residues into free sulfhydryl groups.(125) 
Next, 2.5µL of 180mM iodoacetamide (Sigma-Aldrich I1149), reconstituted in 25mM 
NH4HCO3 (final concentration of 2.25mM), was added and incubated for thirty minutes at 
RT in the dark. This acts as an alkylating agent that reacts with the sulfhydryl groups, 
preventing the formation of disulphide bonds and ensuring that trypsin is able to access its 
cleavage sites on proteins.(125) Lastly, 100ng/µL trypsin (Trypsin Gold Mass Spectrometry 
Grade, Promega V5280) was made by diluting 200ng/µL stock solution in 50mM acetic acid 
(VWR 20103.320) with an equal volume of 25mM NH4HCO3. The samples were incubated at 
37°C overnight with 2.5µL of trypsin. Trypsin contains a catalytic triad of histidine-
aspartate-serine. The negatively charged aspartate attracts positively charged lysine and 
arginine and cleaves peptides chains by targeting the carboxyl ends of these amino acids. 
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The following day, the samples were acidified by the addition of 1µL of trifluoroacetic acid 
(TFA) (Biosolve 20234131) to stop the protein digestion. The samples were incubated at 
37°C for forty-five minutes and then centrifuged at 17 200 x g for thirty minutes. The 
clarified digests were transferred to fresh low-bind tubes and the centrifugation step 
repeated before transfer to total recovery vials for liquid chromatography–mass 
spectrometry/mass spectrometry (LC-MS/MS) analysis.  
 
Data-dependent LC-MS/MS analyses were conducted by the Centre for Proteome Research 
(appendix 1). Due to the present study being a time course study with a concomitant 
increase in cell numbers throughout, the raw data were incorporated into downstream 
analyses. The raw peptide counts were divided by the total peptide count for each time 
point to determine the proportion of each protein within a sample. 
 
2.2.5 GROWTH OF HCjE-Gi CELLS ON CELL-SECRETED EXTRACELLULAR MATRIX  
The HCjE-Gi cells were cultured in forty-eight well plates at an initial seeding density of 
1x104 cells/cm2 in KSF media. On culture days three, five, seven, fourteen, twenty-one and 
twenty-eight, the cell-secreted ECM was isolated using 1% NH4OH. Following thorough 
washes with sterile PBS, the cells were re-seeded on the cell-secreted ECM at a density of 
1x104 cells/cm2 with KSF culture media. HCjE-Gi cells cultured on tissue culture polystyrene 
(TCP) on the same well plate that were also treated with 1% NH4OH, were used as controls. 
On culture days one, three, five and seven, the cells were fixed with 100% ice cold 
methanol and stained with DAPI. Images were taken with a 10X objective from five fixed 
positions of each well using a Nikon Eclipse Ti-E microscope and the number of nuclei per 
view was determined. The number of nuclei per view on cell-secreted ECM was divided by 
the number of nuclei of the corresponding view on TCP to obtain ECM:TCP cell number 
ratios (figure 2.2). The ECM:TCP cell number ratios per view for each culture day were used 
in the downstream analysis. All experiments were carried out in three sets of triplicates. 
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The arrangement of the well plates used to determine the growth of 
HCjE-Gi cells on cell-secreted extracellular matrix 
 
        
        
        
        
        
        
 
Figure 2.2: The arrangement of the well plates used to determine the growth of HCjE-Gi 
cells on cell-secreted extracellular matrix. Images were taken from five fixed positions of 
each well as shown. The number of nuclei per view on the cell-secreted ECM (dark grey) 
was divided by the number of nuclei of the corresponding view on tissue culture 
polystyrene (light grey) to obtain ECM:TCP cell number ratios that were used in the 
downstream analyses. 
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2.2.6 ADSORPTION OF PROTEINS ONTO TISSUE CULTURE POLYSTYRENE 
An indirect enzyme-linked immunosorbent assay (ELISA) was carried out to determine the 
adsorption of proteins onto TCP. Type IV collagen, laminin 111 and fibronectin proteins 
were diluted in PBS to make solutions of protein concentrations 0.5, 1, 2, 5, 10 and 
20µg/mL (table 2.7A). Type IV collagen protein was diluted in PBS as well as 0.5M acetic 
acid (Sigma A6283), as per manufacturer’s instructions, to determine if there is a significant 
difference in the adsorption of type IV collagen when diluted in these solutions. Protein 
solutions were added into ninety-six well plates (100µL of protein solution per well) and 
incubated for one hour at 37°C. PBS or 0.5M acetic acid was added into control wells 
(0µg/mL protein). The wells were washed three times with PBS and non-specific binding 
sites were blocked with 2% goat serum for one hour at RT. The wells were washed three 
more times with PBS prior to incubating with the appropriate primary antibody (table 2.7B), 
diluted in PBS, at 37°C for one hour. The appropriate secondary antibodies conjugated with 
alkaline phosphatase (table 2.7C), diluted in PBS, were added and incubated for one hour at 
37°C following a further three washes in PBS. Alkaline phosphatase yellow (p-
nitrophenylphosphate (pNPP)) liquid substrate system for ELISA (Sigma P7998) warmed to 
37°C was added as a substrate. A colour change from colourless to yellow was observed 
(figure 2.3) and the reaction was stopped with 1M sodium hydroxide (BDH 102524X) after 
one minute. The absorbance was read at 405nm on a plate reader (FLUOstar OPTIMA, BMG 
LABTECH). TCP that did not have pre-adsorbed proteins and were not probed with a 
primary antibody were used as a negative control. The background measurements from the 
negative control were subtracted from the raw readings. The experiments were carried out 
as three sets of triplicates.  
 
 
Chemical reaction of pNPP with alkaline phosphatase 
 
Figure 2.3: Chemical reaction of pNPP with alkaline phosphatase. pNPP is converted to p-
nitrophenol (yellow end-product) when hydrolysed by alkaline phosphatase. (Adapted 
from:  
http://www.sigmaaldrich.com/catalog/product/sigma/p7998?lang=en&region=GB)  
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Reagents used to determine the protein adsorption onto tissue 
culture polystyrene 
A 
PROTEINS SOURCE DILUENT 
Collagen IV from human placenta 1mg/mL Sigma C7521 PBS or 
acetic acid 
 
Laminin from EHS murine sarcoma 1mg/mL Sigma L2020 PBS 
 
Fibronectin from human plasma 1mg/mL Sigma F2006 PBS 
 
B 
PRIMARY ANTIBODIES SOURCE DILUTION 
Fibronectin mouse monoclonal [IST-4] 4.5mg/mL Sigma F0916 1:5000 
 
Type IV collagen mouse monoclonal [Col-94]  Sigma C1926 1:5000 
 
Laminin rabbit polyclonal 0.5mg/mL  Sigma L9393 1:2500 
 
C 
SECONDARY ANTIBODIES SOURCE DILUTION 
Goat anti-mouse – Alkaline Phosphatase 1.3mg/mL Sigma A3562 1: 20 000 
 
Goat anti-rabbit – Alkaline Phosphatase 1mg/mL Promega S3731 1: 10 000 
Table 2.7: Reagents used to determine the protein adsorption onto tissue culture 
polystyrene; proteins that were pre-adsorbed onto tissue culture polystyrene and their 
diluents (A), and the primary (B) and secondary antibodies (C) used in ELISA experiments. 
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2.2.7 ADHESION OF HCjE-Gi CELLS ON PRE-ADSORBED PROTEINS 
Adhesion of HCjE-Gi cells on pre-adsorbed type IV collagen, laminin 111, fibronectin and α-
2-HS-GP was determined as described below. Solutions containing 0.5-10µg/mL type IV 
collagen, 0.1-1µg/mL laminin 111, 0.5-10µg/mL fibronectin and 0.5-20µg/mL α-2-HS-GP 
(Sigma G0516, 1mg/mL) were prepared in PBS. Ninety-six well plates were pre-adsorbed 
with protein solutions by incubating for one hour at 37°C. HCjE-Gi cells cultured on TCP 
(0µg/mL protein) were used as controls. The wells were washed three times with PBS and 
HCjE-Gi cells were seeded at a density of 3x104 cells/cm2. The cells were incubated for three 
hours at 37°C and 5% CO2, as per protocol by the Gipson lab.(116) The media was removed 
and washed once gently with PBS. The cells were fixed with 100% ice cold methanol for two 
minutes and air dried. Then, the cells were stained with DAPI for five minutes at RT and 
washed three times with PBS. Images were taken with a 10X objective from five fixed 
positions of each well using the Nikon Eclipse Ti-E microscope. The mean number of nuclei 
per view (0.011cm2) was calculated to determine the number of cells per cm2 in each well. 
The experiments were carried out in three sets of triplicates.  
 
2.2.8 GROWTH AND DIFFERENTIATION OF HCjE-Gi CELLS ON PRE-ADSORBED PROTEINS 
Solutions containing 0.5-10µg/mL type IV collagen, 0.1-1µg/mL laminin 111, 0.5-10µg/mL 
fibronectin and 0.5-20µg/mL α-2-HS-GP proteins were prepared in PBS. Ninety-six well 
plates were pre-adsorbed with protein solutions by incubating for one hour at 37°C. HCjE-Gi 
cells cultured on TCP (0µg/mL protein) were used as controls. The wells were washed three 
times with PBS and HCjE-Gi cells were seeded at a density of 1x104 cells/cm2 and 
maintained in a humidifying incubator (37°C, 5% CO2). On culture days one, three, five and 
seven, KSF media was removed and the cells were washed three times with PBS. The cells 
were fixed with 100% ice cold methanol for two minutes and air dried. Then, the cells were 
stained with DAPI for five minute at RT and again washed in PBS. Images were taken with a 
10X objective from five fixed positions of each well using the Nikon Eclipse Ti-E microscope. 
The mean number of nuclei per view was calculated to determine the number of cells per 
cm2 in each well at each culture time point and a growth curve was drawn for each test 
condition. The experiments were carried out in three sets of triplicates. Additionally, on 
culture day seven, separate wells with cells cultured on pre-adsorbed proteins were fixed 
with 10% NBF and permeabilised with 0.2% Triton X-100 to evaluate the expression of 
conjunctival cell differentiation markers (keratins 4 and 19) as described in section 2.2.1.5.  
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2.2.9 EXPRESSION OF STEM CELL AND GOBLET CELL MARKERS BY HCjE-Gi CELLS ON 
PRE-ADSORBED PROTEINS 
The expression of SC and GC markers by HCjE-Gi cells cultured on pre-adsorbed proteins 
was analysed using ICC. Ninety-six well plates were pre-adsorbed with type IV collagen from 
2 and 10µg/mL solutions, laminin 111 from 0.5 and 1µg/mL solutions and fibronectin from 
2 and 10µg/mL solutions. PBS was added to control wells (0µg/mL protein). HCjE-Gi cells 
were seeded at a density of 1x104 cells/cm2 and were maintained in KSF medium for seven 
days and switched to the differentiation and stratification medium for a further seven days. 
On culture days one, seven and fourteen, the cells were fixed in 10% NBF, permeabilised 
with 0.2% Triton X-100 and non-specific binding sites were blocked with 10% goat serum. 
The expression of two SC markers, ABCG2 and ΔNp63 localised in the cell membrane and 
the nucleus, respectively, were investigated. Similarly, the expression of two GC markers, 
MUC5AC and the co-expression of keratin 7 and Ulex Europaeus Agglutinin I (UEAI), were 
investigated. Keratin 7 is a cytoplasmic protein, whereas UEAI is a lectin that binds to 
glycoproteins and glycolipids in the cells. MUC5AC may be found intracellularly in the 
cytoplasm or extracellularly when secreted. The cells were incubated with primary 
antibodies (table 2.8A and B), diluted in 1% BSA, at 4°C overnight. The samples were 
washed with PBST prior to incubating with the appropriate secondary antibody (table 2.8C), 
diluted in 1% BSA, for one hour at 37°C. The samples that were probed for keratin 7 were 
counter-stained with UEAI, which was conjugated with fluorescein. Lastly, all the samples 
were counterstained with DAPI following three PBST washes. Images were taken from five 
fixed positions with a 20X objective of the Nikon Eclipse Ti-E microscope. The percentage of 
cells with positive staining for each protein per field of view (0.003cm2) was determined. 
Next, the mean percentage of cells with positive staining per field of view at each time 
point for each substrate investigated was calculated. These experiments were carried out in 
one set of duplicates. Mouse or rabbit immunoglobulins and PBS were used instead of the 
primary antibody to ensure specificity of the immunoglobulins and secondary antibodies, 
respectively.  
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Antibodies used to identify the expression of stem cell and goblet cell 
markers by HCjE-Gi cells 
A 
PRIMARY ANTIBODIES  SOURCE DILUTION 
ABCG2 mouse monoclonal [BXP-21] 0.25mg/mL Millipore MAB4146 1:100 
 
ΔNp63 rabbit polyclonal [poly6190] 0.28mg/mL Biolegend 619002 1:1000 
 
B 
PRIMARY ANTIBODIES SOURCE DILUTION 
MUC5AC mouse monoclonal [45M1] 0.2mg/mL Abcam ab3649 1:200 
 
Keratin 7 mouse monoclonal [OV-TL 12/30] 
0.2mg/mL 
 
Abcam ab9098 1:200 
Fluorescein labelled Ulex Europaeus Agglutinin I 
2mg/mL 
Vector Laboratories 
FL-1061 
1:500 
 
C 
SECONDARY ANTIBODIES SOURCE DILUTION 
Goat anti-mouse, Alexa Fluor 488 2mg/mL  Life Technologies  
A-11029 
 
1:500 
Goat anti-mouse, Alexa Fluor 594 2mg/mL Life Technologies  
A-11032 
 
1:500 
Goat anti-rabbit, Alexa Fluor 488 2mg/mL Life Technologies 
A-11008 
 
1:500 
Goat anti-rabbit, Alexa Fluor 594 2mg/mL Life Technologies  
A-11012 
1:500 
Table 2.8: Primary antibodies used to identify the expression of stem cell (A) and goblet 
cell (B) markers by HCjE-Gi cells by immunocytochemistry and the corresponding 
secondary antibodies (C).  
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2.2.10 STATISTICS 
All data were analysed using the SPSS Statistics 22 software. 
 
One-way analysis of variance (ANOVA) 
 Raw peptide abundances of proteins from ECM day 1 to 42 
 Adsorption of proteins onto tissue culture polystyrene 
 Adhesion of HCjE-Gi cells on pre-adsorbed proteins  
 
Outliers were determined by inspection of boxplot diagrams. Shapiro-Wilk test was carried 
out to determine the normal distribution of the data, whereas Levene’s test was 
undertaken to assess the homogeneity of variances. When outliers were present, analysis 
was done by excluding these to determine if there was a difference to the overall result. 
Data that did not assume normal distribution were included in the analysis, since one-way 
ANOVA is robust to deviations from normality when sample sizes are equal. Where 
homogeneity of variances was violated, results of Welch’s ANOVA were reported. Tukey 
post hoc test was used when there was homogeneity of variances, whereas Games-Howell 
post hoc test was carried out when this assumption was violated. A significance level of p < 
0.05 was set for all the experiments. 
 
Two-way ANOVA 
 Abundance of ECM and non-ECM peptides obtained by LC-MS/MS 
 Peptide abundance of protein categories from ECM day 1 to 42  
 Adsorption of type IV collagen diluted in acetic acid or PBS  
 Growth of HCjE-Gi cells on pre-adsorbed proteins  
 Expression of ΔNp63 and ABCG2 by HCjE-Gi cells on pre-adsorbed proteins 
 Expression of MUC5AC and co-expression of keratin 7 and UEA1 by HCjE-Gi cells on 
pre-adsorbed proteins 
 
Residual analysis was performed to test for the assumptions of two-way ANOVA. Outliers 
were determined by inspection of boxplot diagrams. Shapiro-Wilk test was carried out to 
determine the normal distribution of the data, whereas Levene’s test was undertaken to 
assess the homogeneity of variances. When outliers were present, analysis was done by 
excluding these to determine if there was a difference to the overall result. Data that did 
not assume normal distribution were included in the analysis since two-way ANOVA is 
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considered robust to deviations from normality. Data that violated the assumption of 
homogeneity of variances were also included in the analysis since the sample sizes were 
equal, although small.  
 
First, the data were analysed to determine if there was an interaction effect between the 
two independent variables. Analysis of the main effect for each independent variable was 
performed when there was no significant interaction effect between the two. If this was 
found to be significant, all pairwise comparisons were run, where the reported p values 
were Bonferroni-adjusted. When there was a significant interaction effect between the two 
independent variables, analysis of the simple main effect was performed. All pairwise 
comparisons were run for each simple main effect, where the reported p values were 
Bonferroni-adjusted. A significance level of p < 0.05 was set for all the experiments. 
 
Generalised linear model 
 Growth of HCjE-Gi cells on cell-secreted ECM proteins  
 
A significance level of p < 0.05 was set for this experiment. 
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2.3 RESULTS 
2.3.1 CHARACTERISTICS OF HCjE-Gi CELL LINE 
2.3.1.1 GROWTH CURVE 
A typical growth curve of cultured cells consists of four phases: lag phase, log phase, 
plateau phase and decline phase (figure 2.4).(126) The lag phase represents the time taken 
by the cells to recover following trypsinisation and adapt to the new culture conditions by 
re-assembling their cytoskeleton and secreting ECM proteins.(126) This phase ensures that 
the cells have adhered onto the substrate prior to entering a new cell cycle.(126) Moreover, 
new DNA and structural proteins are synthesised by the cells during this time.(127) The lag 
phase may last from a few hours to up to forty-eight hours.(128) The log phase is when 
there is an exponential increase in the cell number.(127) The time period taken for the cell 
number to double is known as the population doubling time and is characteristic for each 
cell line.(128) As the culture becomes confluent, the growth rate reduces and the cells 
enter the plateau phase.(128) This is due to the lack of nutrients, accumulation of 
metabolic waste products and lack of physical space.(127, 128) Certain types of cells may 
remain as a monolayer before entering the decline phase where there is a reduction in the 
cell number due to cell death, however, some cells may differentiate and become multi-
layered with continued replenishment of nutrients.(128)  
 
The growth curves of HCjE-Gi cells did not exhibit the typical sigmoid shape of a growth 
curve over the seven days in culture in KSF media (figure 2.5). When seeded at an initial 
seeding density of 5x103 and 1x104 cells/cm2, only the lag and log phases of the growth 
curve were demonstrated. The HCjE-Gi cells had a lag phase of approximately 48 to 72 
hours. The cells then entered the log phase of the growth curve where they proliferated 
exponentially between culture days three and seven. The population doubling time during 
this phase was 25.4 hours when seeded at a density of 5x103, whereas the doubling time 
was 31.1 hours when seeded at a density of 1x104 cells/cm2. This is in keeping with the 
doubling times stated by the manufactures of this cell line.(116) When seeded at a density 
of 1x105 cells/cm2, the growth curve over the seven days represented the late stages of the 
log phase when the growth rate reduced with time before entering the plateau phase. By 
culture day seven, the cells seeded at initial densities of 1x104 and 1x105 cells/cm2 were 
more than 80% confluent, whereas those seeded at 5x103 cells/cm2 was about 50% 
confluent (figure 2.6). A seeding density of 1x104 cells/cm2 was chosen for the subsequent 
experiments. 
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2.3.1.2 CELL MORPHOLOGY 
On culture day one, the HCjE-Gi cells have commenced rebuilding their cytoskeleton as 
evidenced by the positive staining for the cytoskeletal microfilament, filamentous actin 
(figure 2.7). The cells spread to form discrete colonies of cells. Following seven days in 
culture in KSF media, the HCjE-Gi cells formed a monolayer of cells that resembled a 
cobblestone appearance in keeping with the epithelial cell morphology. The individual cells 
were polygonal in shape and were approximately 20-40µm in diameter. There were a few 
cells that were larger with a diameter of approximately 75-100µm. These cells are thought 
to be post-mitotic cells expressing the differentiation marker, involucrin (not done).(116) 
 
2.3.1.3 EXPRESSION OF CONJUNCTIVAL CELL DIFFERENTIATION MARKERS 
All the HCjE-Gi cells, which were cultured in KSF media for seven days and in the 
differentiation and stratification media for a further seven days, stained positive for keratin 
19 from culture days one to fourteen (figure 2.8). Few cells stained positive for keratin 4 
from day seven onwards. Qualitatively, there was no increase to the number of cells 
stained positive for keratin 4 after culturing the cells in the differentiation and stratification 
medium. However, culture of these cells in the differentiation and stratification medium did 
induce stratification of at least two layers of cells, which was observed during microscopy. 
Qualitatively, there was no significant positive staining observed in the negative controls 
used for these experiments demonstrating the specificity of the primary and secondary 
antibodies as well as the immunoglobulins of the antibodies (figure 2.9). A limitation of the 
present study is that I have not shown the lack of expression of corneal epithelial markers, 
keratins 3 and 12, or the expression of keratin 13 by the HCjE-Gi cells, which has been 
suggested to be a more specific marker of conjunctival epithelial cells than keratin 19.   
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Growth curve of cultured cells 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Growth curve of cultured cells. A schematic diagram illustrating the typical 
sigmoid shape of a growth curve of cultured cells with lag, log, plateau and decline 
phases. 
 
 
Growth curve of HCjE-Gi cells 
 
Figure 2.5: Growth curve of HCjE-Gi cells over seven days in culture in keratinocyte serum-
free media. Data are presented as mean number of cells/cm2 (x103) ± 1SD, n = 9. A 
seeding density of 1x104 cells/cm2 was chosen for the subsequent experiments. 
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Phase-contrast images of HCjE-Gi cells 
 
Figure 2.6: Phase-contrast images of HCjE-Gi cells on culture days one and seven in 
keratinocyte serum-free media. By culture day seven, the cells seeded at initial densities 
of 1x104 and 1x105 cells/cm2 were more than 80% confluent, whereas those seeded at 
5x103 cells/cm2 was about 50% confluent. 
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Cytoskeletal morphology of HCjE-Gi cells 
 
Figure 2.7: Cytoskeletal morphology of HCjE-Gi cells demonstrated by staining for filamentous actin on culture days one and seven in keratinocyte serum-
free media (initial seeding density 1x104 cells/cm2); Alexa Fluor® 488 Phalloidin (green) and DAPI (blue). Phalloidin, which binds to filamentous actin, is a 
reagent used to visualise the filamentous cytoskeleton of cells. 
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Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
 
Figure 2.8: Expression of conjunctival cell differentiation markers by HCjE-Gi cells over a 
culture period of fourteen days (cultured in keratinocyte serum-free media for seven days 
and in the differentiation and stratification media for a further seven days). There was 
positive staining in all cells for keratin 19, a marker of simple epithelial cells, over the 
culture period, whereas only few cells stained positive for keratin 4, a marker of non-
keratinised stratified epithelial cells, between culture days seven and fourteen. There was 
evidence of stratification by culture day fourteen as observed during microscopy; K4 - 
keratin 4 (green), K19 - keratin 19 (purple) and DAPI (blue).   
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Negative controls for immunocytochemistry 
 
Figure 2.9: Negative controls for immunocytochemistry used to ensure the specificity of 
the primary antibodies (A19 cells, retinal pigment epithelial cell line), secondary 
antibodies and immunoglobulins of the antibodies. Qualitatively, there was no significant 
positive staining in any of the controls.  
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2.3.2 ISOLATION OF THE EXTRACELLULAR MATRIX 
Treatment of HCjE-Gi cells with NH4OH caused the cells to swell, round up and detach from 
the TCP (figure 2.10). The cells were still present when treated with NH4OH concentrations 
of 0.1-0.5% for 2.5 minutes. Almost all the cells were completely removed when treated 
with 1% NH4OH for 2.5 minutes, 0.5-1% for 5 minutes and 0.1-1% for 10 minutes. Vigorous 
washes were required to remove all the visible cell debris.  
 
To ensure that the underlying ECM proteins were not altered following treatment with 
NH4OH, the ECM obtained from samples treated with 0.1% NH4OH for 2.5 minutes, 1% for 5 
minutes and 1% for 10 minutes were stained for the ECM protein, laminin α3 chain (figure 
2.11). The samples were also counterstained with DAPI to ensure the absence of nuclei, 
therefore the absence of cells. The samples treated with 0.1% NH4OH for 2.5 minutes were 
not completely decellularised, whereas those treated with 1% NH4OH, for either 5 or 10 
minutes, did not stain positive for DAPI. Qualitatively, the staining for laminin α3 chain was 
similar in samples treated with 1% NH4OH for either 5 or 10 minutes. Therefore, in the 
subsequent experiments, it was decided to treat cells with 1% NH4OH for five minutes to 
successfully isolate the ECM and the transmembrane proteins associated with the ECM.  
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Optimisation of the ammonium hydroxide protocol to isolate the 
extracellular matrix  
 
 
Figure 2.10: Optimisation of the concentration and incubation time of ammonium 
hydroxide to isolate the extracellular matrix. Almost all the cells were removed when the 
samples were treated with 1% ammonium hydroxide for 2.5 minutes, 0.5-1% ammonium 
hydroxide for 5 minutes and 0.1-1% ammonium hydroxide for 10 minutes. Vigorous 
washes with PBS were required to remove all the visible cell debris.  
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Immunofluorescence staining for laminin α3 chain following 
ammonium hydroxide treatment 
 
 
Figure 2.11: Immunofluorescence staining for the extracellular matrix protein, laminin α3 
chain, following ammonium hydroxide treatment. Nuclear staining was present when the 
cells were treated with 0.1% ammonium hydroxide for 2.5 minutes, however, this was 
absent when treated with 1% ammonium hydroxide for 5 or 10 minutes. Qualitatively, 
there was no difference in the staining for laminin α3 chain when treated with 1% 
ammonium hydroxide for 5 or 10 minutes. The cells were treated with 1% ammonium 
hydroxide for five minutes at 37°C to isolate the extracellular matrix in the subsequent 
experiments.   
114 
 
2.3.3 IDENTIFICATION OF HCjE-Gi CELL-SECRETED EXTRACELLULAR MATRIX PROTEINS 
BY IMMUNOFLUORESCENCE STAINING  
HCjE-Gi cells cultured for one, three, five, seven, fourteen, twenty-one, twenty-eight and 
forty-two days were treated with 1% NH4OH to isolate the ECM and were stained for type 
IV collagen, type XVIII collagen, laminin α3 chain and fibronectin (figures 2.12-2.19). 
Samples with cells that were not treated with NH4OH were used as positive controls. 
Negative controls did not demonstrate significant staining that affected the accurate 
interpretation of the IF staining results (figure 2.20).  
 
The protein expression for laminin α3 chain was present from day one and continued to 
increase until day forty-two. During the culture period of six weeks, various staining 
patterns for laminin α3 were observed. Initially, laminin was deposited in a rosette-like 
pattern with a few trail-like patterns between days one and seven. This has previously been 
described as the pattern of laminin deposition by stationary and migrating cultured 
keratinocytes, respectively.(129) With time, there was a mixture of these two patterns with 
larger rosettes and some areas of diffuse staining. In the positive controls, with the cells 
intact, a network of laminin around the cells was observed. 
 
The antibody used to detect type IV collagen in the current study targeted the α1 chain. 
Positive staining for type IV collagen was only evident from day twenty-one onwards and 
was present until day forty-two. The staining for type IV collagen co-localised with that of 
the laminin α3 chain. The positive control demonstrated intracellular staining only. The 
antibody used to detect type XVIII collagen targeted the α1 chain, specifically the endostatin 
domain at the C-terminal. Similar to type IV collagen, there was positive staining for type 
XVIII collagen from days twenty-one to forty-two. There was diffuse granular staining 
observed with no specific pattern or co-localisation with the laminin α3 chain. The positive 
controls showed some weak staining intracellularly. 
 
Fibronectin was present at the early time points, however, from day seven the staining 
reduced. A linear ‘spike-like’ staining pattern was observed, mainly around the staining for 
the laminin α3 chain. The staining for fibronectin was observed intracellularly and 
extracellularly in the positive controls.  
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Day 1 extracellular matrix 
Figure 2.12: Day 1 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 3 extracellular matrix 
Figure 2.13: Day 3 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 5 extracellular matrix 
Figure 2.14: Day 5 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 7 extracellular matrix 
Figure 2.15: Day 7 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 14 extracellular matrix 
Figure 2.16: Day 14 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 21 extracellular matrix 
Figure 2.17: Day 21 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 28 extracellular matrix 
Figure 2.18: Day 28 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Day 42 extracellular matrix 
Figure 2.19: Day 42 extracellular matrix; LNα3 - laminin α3 chain (green), CollIV – type IV 
collagen (purple), CollXVIII – type XVIII collagen, FN - fibronectin (purple), and DAPI (blue). 
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Negative controls for immunofluorescence staining 
Figure 2.20: Negative controls for immunofluorescence staining used to ensure the 
specificity of the secondary antibodies and immunoglobulins of the antibodies. This figure 
is a representative image showing the non-specific staining of the extracellular matrix 
samples (A) and the cell samples (B) on day forty-two. Qualitatively, there was no 
significant staining in any of the controls that affected the accurate interpretation of the 
immunofluorescence staining results.  
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2.3.4 IDENTIFICATION AND QUANTIFICATION OF HCjE-Gi CELL-SECRETED 
EXTRACELLULAR MATRIX PROTEINS BY MASS SPECTROMETRY  
LC-MS/MS experiments detected peptides of 928 proteins of which only 101 were 
identified as ECM or ECM-associated proteins using the Uniprot database. The total 
abundances of ECM and non-ECM peptides followed a similar pattern, where there were 
statistically significantly lower amount of peptides in the day 1 samples compared to day 7 
(p < 0.001), similar abundance of peptides from days 7 to 28, and statistically significantly 
higher abundance of peptides in the day 42 samples compared to day 28 (p < 0.05) (figure 
2.21). The abundances of the non-ECM peptides were statistically significantly higher than 
that of the ECM peptides at all the time points (p < 0.05). The ECM or ECM-associated 
proteins were categorised into three major categories: structural (21%), transmembrane 
(27%) and secreted (52%) proteins (figure 2.22). The structural proteins were sub-
categorised into collagens (1%), glycoproteins (16%) and proteoglycans (4%); 
transmembrane proteins were sub-categorised into integrins (8%) and other (16%); and 
secreted proteins were sub-categorised into growth factors, binding proteins and cytokines 
(14%), proteases and inhibitors (17%) and other (24%).   
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Peptide abundances of extracellular matrix and non-extracellular 
matrix proteins 
 
 
Figure 2.21: Peptide abundances of extracellular matrix and non-extracellular matrix 
proteins obtained by LC-MS/MS. Data are presented as log10 of total abundance of 
peptides, n = 4. The total abundances of extracellular matrix and non- extracellular matrix 
peptides followed a similar pattern: there were significantly higher abundance of 
peptides in the day 7 samples compared to day 1 (p < 0.001), similar abundance of 
peptides from days 7 to 28, and significantly higher abundance of peptides in the day 42 
samples compared to day 7 (p < 0.05). The total abundance of extracellular matrix 
peptides was significantly lower compared to the non-extracellular matrix peptides at all 
the time points (p < 0.05). (Two-way ANOVA; Bonferroni post hoc test).  
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Extracellular matrix proteins secreted by HCjE-Gi cells 
 
 
 
 
 
Figure 2.22: Extracellular matrix proteins secreted by HCjE-Gi cells. 
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Peptide abundances of protein categories  
 
 
 
 Peptide abundance (%) 
 Day 1 Day 7 Day 14 Day 28 Day 42 
Collagens 0.18 0.10 0.13 0.21 0.33 
Glycoproteins 29.80 34.25 31.62 36.75 29.69 
Proteoglycans 0.95 0.91 1.32 1.23 0.97 
Integrins 16.21 21.08 22.76 22.13 31.37 
Transmembrane - other 9.85 7.03 9.70 9.00 10.16 
GFs, binding proteins + cytokines 17.53 17.08 11.60 7.26 4.44 
Proteases + inhibitors 7.10 14.49 16.00 14.74 15.12 
Secreted - other 18.40 5.06 6.87 8.68 7.92 
 
Figure 2.23: A. Peptide abundances of protein categories from extracellular matrix days 1 
to 42. Data are presented as mean peptide abundance (%), n = 4. There were significantly 
higher percentage of integrins (p < 0.001), and proteases and their inhibitors (p < 0.001) in 
the day 42 extracellular matrix compared to the day 1 extracellular matrix. There were 
significantly lower percentage of growth factors, their binding proteins and cytokines (p < 
0.001), and other secreted proteins (p < 0.001) in the day 42 extracellular matrix 
compared to the day 1 extracellular matrix. (Two-way ANOVA; Bonferroni post hoc test). 
B: Mean peptide abundances (%) of protein categories.    
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Raw peptide abundances of proteins  
 
Figure 2.24: Raw peptide abundances of proteins from extracellular matrix days 1 to 42.  
Day 1 Day 7 Day 14 Day 28 Day 42
Collagen α1(XVIII) 85893.78 721109.14 548997.79 1359793.50 5301773.40
α-2-HS-GP 2083234.80 1707513.42 264008.90 360219.21 323144.29
Fibronectin 398540.89 4923114.46 1404979.22 1283281.63 2296536.12
Lactadherin 105634.41 1384108.65 837775.29 1004466.61 2152926.04
Laminin α3 3524280.23 106704413.25 60163700.52 97188944.30 198904909.77
Laminin α5 84341.84 893968.64 1572790.38 1100243.78 1486269.28
Laminin β1 3910.91 123814.24 86096.03 124343.13 362973.58
Laminin β3 2697283.42 46556912.05 27807733.48 48795788.49 80125820.12
Laminin γ1 14565.75 220153.88 144079.98 101942.83 269148.42
Laminin γ2 3550809.41 39394267.90 21342688.32 34070496.40 64471370.42
Matrilin 2 855.88 128598.41 72010.05 108619.42 260938.72
Nephronectin 1258.44 217271.75 52082.65 58918.96 120983.42
Tenascin C 448351.48 2868723.73 2101528.40 6445032.19 9498508.82
Thrombospondin 1 1340194.63 31431773.91 18786972.00 40063227.59 73864516.20
Thrombospondin 2 6266.44 84935.17 119543.94 287767.29 275945.61
TIN Ag-like 76210.64 1578933.02 1825608.31 2588002.50 4268996.55
Vitronectin 36868.03 440663.37 111015.69 206034.18 318013.13
Agrin 179697.00 2817811.30 2577505.53 4291314.22 7832699.26
Perlecan 272727.23 3533524.68 3094285.83 3353530.87 5886213.32
Prolyl 3-hydroxylase 1 62.60 2315.06 4899.88 5050.73 12230.10
Tsukushin 4119.79 51082.66 53026.33 155288.60 208005.38
Integrin α2 60321.01 1091898.98 366551.73 253530.19 2545305.81
Integrin α3 248980.52 1671126.51 1055305.93 1029605.81 4254499.71
Integrin α5 22653.52 408419.57 573475.97 228583.41 723630.82
Integrin α6 3746150.65 70468776.41 49607929.99 63569258.76 184118671.55
Integrin αV 38846.20 557746.34 305230.61 240876.44 1099845.63
Integrin β1 448181.53 5382140.02 2730795.30 2650876.11 11698893.62
Integrin β4 3287507.88 66059716.38 41748179.85 80197640.61 264777156.31
Integrin β6 24515.52 167294.87 78969.46 82379.11 292264.41
BCAM 144019.18 1716180.30 1609268.98 1106506.39 9794177.75
Basigin 439472.30 9948369.82 10593947.67 12511626.42 25843408.54
Cadherin 1 825665.57 6281556.41 6922606.07 7264009.66 7957981.61
CD44 291512.75 3410424.81 2381278.36 2438154.45 7936590.14
CD47 28759.51 240711.73 309211.74 261145.00 665116.23
CD109 664.54 72596.41 29786.18 26096.25 118837.45
CD151 94515.61 979153.54 1239594.90 1400408.10 3581575.91
Collagen α1(XVII) 890007.06 9487028.74 6012916.92 6340464.23 31726583.46
EGF receptor 201782.37 3106415.36 1209196.68 1896117.77 8524097.70
EDDR 1 2316.17 15816.11 1762.85 13467.07 88465.00
Glypican 1 155383.61 2584377.62 897520.14 1924006.86 10055871.68
LYPD 3 61640.26 395969.92 336766.59 581690.88 1064956.41
Putative GGT 3 39594.04 22883.07 17889.66 25938.10 200749.76
Syndecan 1 21064.52 211970.63 294288.23 292987.97 874002.15
Syndecan 4 5787.61 94450.21 89680.16 227238.23 689959.87
TACST 2 1548778.99 10019679.14 8705862.85 22086229.37 40993377.38
CXCL 11 2648.69 163940.53 110773.39 60310.40 61833.52
CXCL 14 7076.60 37983.27 47897.11 118432.86 91111.70
Dermokine 2254.99 37293.89 30790.15 40019.74 185411.77
FGFBP 1 1102579.79 26250731.36 8116908.98 9590750.02 17287884.54
Granulins 6288.74 33173.04 12354.23 36008.75 124618.52
GDF 15 72861.92 781619.04 9945130.49 4990921.14 5723838.05
Insulin 5483128.66 31610906.73 4471388.47 18915734.07 17847672.28
IGFBP 3 423416.89 7370292.75 4950808.23 1248264.76 1570873.65
IGFBP 10 610395.79 25968978.73 10673070.84 6115475.07 8439882.28
LTBP 2 507.79 49520.33 10675.93 4366.10 6883.24
Macrophage MIF 13285.24 56484.04 17208.53 60834.02 177667.63
Midkine 63913.15 2264422.01 2399557.11 618703.76 844572.17
PDGF-A 2004.97 41204.52 54053.07 50677.32 57432.71
TGFβ ig-h3 871889.53 25024450.60 9421466.69 6622215.15 13049269.69
ADAM 10 4400.14 100991.88 47132.95 152447.01 434476.65
ADAM 17 65.25 18308.16 20289.56 44450.32 95838.31
ADAMTS-like protein 6 133623.82 1053013.16 1061674.72 1746619.97 2178424.07
Antileukoproteinase 163020.20 317009.70 359939.68 842259.96 1870278.65
Elafin 2041.20 8246.06 3481.84 14800.23 241272.28
Glia-derived nexin 4625.92 64019.03 55848.01 82838.90 98699.06
HAI 1 18139.24 204655.33 205896.53 223893.73 725640.19
MMP 14 23605.66 345582.11 284781.77 239938.76 1209848.41
MMP 28 12249.49 60763.14 29925.07 149770.06 341202.32
MT-SP 1 122294.06 943738.08 583164.31 884193.00 2699544.94
PAI 1 383335.71 1865190.29 1184975.82 1129833.94 1740556.50
RISC 3818.31 65117.75 77640.61 303199.48 789424.80
Serine protease 23 8113.92 1827281.55 362317.98 1328425.59 4270538.88
Serine protease HTRA1 1067138.80 74675865.99 58395924.74 85198184.15 205083651.57
Serpin B5 471248.28 1380459.78 794684.11 1833961.47 4746042.99
TFPI 2 950445.37 17781684.05 7971086.67 5213198.64 4000204.53
TIMP 3 54559.31 727733.73 357719.14 598162.85 1476544.17
ADM 5982.87 24324.13 56907.16 32285.94 29179.60
Annexin A2 5575283.55 7461760.51 3851580.93 6511081.37 25536113.56
Apolipoprotein E 11685.14 96014.61 117526.29 145278.15 474129.02
Apolipoprotein J 130254.03 2031973.18 2506690.45 3158176.37 4801484.69
β-2-microglobulin 99227.89 1404333.18 842140.55 1128379.26 9130495.94
CCDC 80 47620.96 1851715.83 839781.38 364521.54 592498.54
Dkk 1 5666.27 47485.74 20293.95 6342.90 1263.57
Endothelial lipase 147949.36 960515.72 447637.55 1267494.79 3761050.12
Galectin 1 34640.42 820183.19 525311.90 367348.40 1537384.95
Galectin 3 19219.82 11278.52 6645.57 8335.17 60741.58
Galectin-3-binding protein 896632.53 9585370.14 18006139.82 37198870.04 58783404.85
Hemopexin 9633.78 261667.43 21089.00 198602.20 860584.39
ITI heavy chain H4 11669.33 103092.69 20964.92 62562.34 119735.44
Peroxidasin homolog 68417.69 1571560.75 267089.06 505744.85 1038335.72
Peroxiredoxin 4 60524.11 100529.40 26091.61 75296.52 202159.81
PL transfer protein 268.56 20362.72 7083.00 29721.38 97274.47
Protein Wnt 6 253.96 2099.75 2138.08 8015.51 38756.84
Protein Wnt 7a 21014.41 114697.54 85838.20 200353.82 341230.44
Protein Wnt 7b 1.67 60200.38 58852.73 135148.50 100215.63
Protein Wnt 10a 66816.08 246060.67 207545.45 627695.80 1797005.85
Serotransferrin 919140.97 4254066.31 929921.74 2438528.31 5172906.31
Serum albumin 790076.02 1434003.56 369569.13 474631.16 815332.47
SAA 1 6806.41 96698.72 22099.49 39250.06 209407.66
Tissue factor 9155.29 2646624.67 97670.72 187832.43 4431656.46
AVP-NPII 37487.27 73522.39 23483.88 63927.69 65073.78
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Figure 2.25: Protein composition of day 1 extracellular matrix secreted by HCjE-Gi cells. Data are presented as mean peptide abundance: total peptide 
abundance ± 1SD, n = 4. 
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Figure 2.26: Protein composition of day 7 extracellular matrix secreted by HCjE-Gi cells. Data are presented as mean peptide abundance: total peptide 
abundance ± 1SD, n = 4.  
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Figure 2.27: Protein composition of day 14 extracellular matrix secreted by HCjE-Gi cells. Data are presented as mean peptide abundance: total peptide 
abundance ± 1SD, n = 4. 
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Figure 2.28: Protein composition of day 28 extracellular matrix secreted by HCjE-Gi cells. Data are presented as mean peptide abundance: total peptide 
abundance ± 1SD, n = 4. 
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Figure 2.29: Protein composition of day 42 extracellular matrix secreted by HCjE-Gi cells. Data are presented as mean peptide abundance: total peptide 
abundance ± 1SD, n =4. 
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2.3.4.1 STRUCTURAL PROTEINS (Figures 2.23-2.30) 
Collagens 
LC-MS/MS experiments did not show the presence of type IV collagen. However, it did 
identify the α1 chain of type XVIII collagen in all the samples at all the time points 
investigated. The mean raw peptide abundance increased from day 1 to 42, the highest 
being present in the day 42 ECM sample. The peptides of the structural collagens only 
contributed 0.18% of the day 1 ECM and 0.33% of the day 42 ECM, which was not found to 
be statistically significant (p = 1.000). 
 
Glycoproteins 
Sixteen GPs were identified in the HCjE-Gi cell-secreted ECM, all of which contributed to 
29.69-36.75% of the ECM, highest observed on day 28. There was a statistically significantly 
higher percentage of GPs in the day 7 ECM compared to day 1 ECM (p = 0.003), and in the 
day 28 ECM compared to day 14 ECM (p < 0.001). There was a statistically significant 
reduction to the percentage of GPs in the day 42 ECM compared to day 28 (p < 0.001). 
There was, however, no statistically significant difference to the percentage of GPs 
between the day 1 and day 42 ECM samples (p = 1.000). 
 
Laminin α3 chain was the most abundant GP throughout all the time points contributing to 
7.3% of all peptides in the day 1 ECM and 13.2% of all peptides in the day 42 ECM. The raw 
peptide abundance of this protein increased statistically significantly on day 7 compared to 
day 1 (p = 0.007) and then continued to increase, highest peptide abundance being 
observed on day 42. There was no significant difference between the raw peptide 
abundances in the day 7 and day 42 ECM samples (p = 0.250). The raw peptide abundances 
of laminin β3 and γ2 also followed a similar pattern increasing statistically significantly on 
day 7 compared to day 1 (p = 0.009 and p = 0.009, respectively) and continued to increase 
with time, highest being observed on day 42. The proportion of laminin β3 peptides 
remained relatively stable throughout the six weeks (approximately 5.5%), whereas that of 
laminin γ2 reduced (7.4% in the day 1 ECM and 4.4% in the day 42 ECM). Other laminin 
chains that were detected by LC-MS/MS were α5, β1 and γ1, all of which increased in 
abundance and contributed to less than 1% of the ECM at all the time points investigated. 
There was a statistically significant increase in the raw peptide abundance of laminin α5 
chain from day 1 to 7 (p = 0.009), laminin β1 chain from day 1 to 14 (p = 0.001) and laminin 
γ1 chain from day 1 to 14 (p = 0.017). 
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Thrombospondins 1 and 2 were present in the ECM secreted by the HCjE-Gi cells 
throughout the six weeks. The peptide abundance of thrombospondin 1 was higher than 
that of thrombospondin 2, contributing to 2.8% of the day 1 ECM and 5.1% of the day 42 
ECM. The proportion of peptides of thrombospondin 2 in the ECM was negligible, 0.01% in 
the day 1 ECM and 0.02% in the day 42 ECM. The raw peptide abundance of 
thrombospondin 1 increased statistically significantly from day 1 to 7 (p= 0.001), from day 
14 to 28 (p = 0.014) and from day 28 to 42 (p < 0.001). There was a statistically significant 
increase in the raw peptide abundance of thrombospondin 2 from day 14 to 28 (p = 0.018) 
and no significant differences were observed thereafter.  
 
Three adhesive proteins, fibronectin, nephronectin and vitronectin were detected on mass 
spectrometry, highest raw peptide abundance being observed in the day 7 ECM. The raw 
peptide abundance of fibronectin was significantly higher on day 7 compared to all the 
other time points investigated (p < 0.05). It contributed to 0.8% of the day 1 ECM and 
reduced gradually to contribute 0.2% of the day 42 ECM. Nephronectin and vitronectin 
contributed in negligible amounts to the ECM of the HCjE-Gi cells. The raw peptide 
abundance of nephronectin was statistically significantly higher on day 7 compared to that 
in the day 1 and day 14 ECM samples (p = 0.004 and p = 0.003, respectively). However, the 
higher raw peptide abundance of vitronectin observed on day 7 was not statistically 
significant compared to the other time points (p > 0.05).  
 
The raw peptide abundance of α-2-HS-GP was highest on day 1 and statistically significantly 
reduced from day 14 onwards (p = 0.01). It contributed to 4.3% of the day 1 ECM, 0.3% of 
the day 7 ECM and continued to reduce thereafter. Other GPs detected were lactadherin, 
matrillin 2, tenascin C and tubulointerstitial nephritis antigen-like (TIN Ag-like) proteins. The 
raw peptide abundances of all increased over the six weeks, highest being observed in the 
day 42 ECM, which was significantly higher than that observed on day 1 (p < 0.05). All these 
proteins contributed to less than 1% of the ECM at all the time points. 
 
Proteoglycans 
There were four PGs that were identified in the ECM of the HCjE-Gi cells. The total peptide 
abundance contributed by the PGs remained relatively stable over the six weeks in culture 
(0.91-1.32%), the highest percentage being observed on day 14. There was no statistically 
significant difference in the percentage of PGs in the day 1 ECM compared to the day 42 
ECM (p = 1.000).  
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The raw peptide abundance of perlecan significantly increased between days 1 and 7 (p = 
0.022) and remained relatively constant over the six weeks, highest being on day 42. 
Similarly, the raw peptide abundance of agrin also increased over the six weeks, highest 
being on day 42, which was significantly higher than all the other time points. Perlecan was 
the most abundant PG on day 1 (0.6% of the ECM) and its proportion reduced by day 42 
(0.4% of the ECM), highest proportion being observed in the day 14 ECM (0.7%). In 
contrast, the proportion of agrin in the ECM increased with time, surpassing perlecan on 
day 28 and was the most abundant PG in the day 42 ECM (0.5%). The raw peptide 
abundance of tsukushin increased statistically significantly from day 14 to day 28 (p = 
0.008) and no significant differences were observed thereafter. Prolyl 3-hydroxylase 1 was 
only present in one sample of the four day 1 ECM samples. The abundance of this protein 
statistically significantly increased from day 1 to 7 (p = 0.039) and continued to increase 
until day 42, although not statistically significant. Tsukushin and prolyl 3-hydroxylase 1 
contributed to less than 1% of the ECM at all the time points investigated.  
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Figure 2.30: Proportions of structural proteins in the extracellular matrix from days 1 to 42. Data are presented as mean peptide abundance: total 
peptide abundance ± 1SD, n = 4. 
-0.05
0
0.05
0.1
0.15
0.2
M
e
an
 p
e
p
ti
d
e
 a
b
u
n
d
an
ce
 : 
to
ta
l p
e
p
ti
d
e
 a
b
u
n
d
an
ce
Structural proteins of the extracellular matrix
Day 1
Day 7
Day 14
Day 28
Day 42
138 
 
2.3.4.2 TRANSMEMBRANE PROTEINS (Figures 2.23-2.29 and 2.31) 
Integrins 
Integrins α2, α3, α5, α6, αV, β1, β4 and β6 were identified in all the ECM samples at all the time 
points. In the day 1 ECM, integrins contributed to 16.21% of all ECM proteins and increased 
with time to contribute to 31.37% of all ECM proteins by day 42, which was statistically 
significant (p < 0.001). The percentage of integrins in the ECM between days 7 and 28 was 
not found to be statistically significant (p = 1.000). 
 
In general, all the integrins increased with time and the highest raw peptide abundance was 
observed on day 42. Only the increase in raw peptide abundances for integrins α5, α6, αv, β1 
and β4 were statistically significant in the day 42 ECM compared to the day 1 ECM (p < 
0.05). Integrin α6 was the most abundant integrin in the day 1 to 14 ECM samples (7.7% and 
11.6% of the ECM, respectively), whereas integrin β4 was the most abundant integrin in day 
28 and day 42 ECM samples (11.9% and 17.6%, respectively). All other integrins contributed 
to less than 1% of the ECM proteins throughout the six weeks in culture, integrin β1 being 
the most abundant, next α3, α2, αV, α5 and β6 being the least abundant in the day 42 ECM 
secreted by the HCjE-Gi cells.   
 
Transmembrane - other 
LC-MS/MS experiments showed the presence of peptides of sixteen other transmembrane 
proteins, of which the raw peptide abundances increased over the six weeks, highest being 
observed in the day 42 ECM. Their proportion relative to the total ECM proteins remained 
relatively stable (7.03-10.16%), highest observed in the day 42 ECM sample. There was no 
statistically significant difference between the percentage in the day 1 and day 42 ECM 
samples (p = 1.000)  
 
The hemidesmosome proteins, α1 chain of type XVII collagen and CD151, contributed to 1-
2% and 0.1-0.3% of the ECM, respectively. The raw peptide abundances of these proteins 
were significantly higher on day 42 compared to that in the day 1 ECM (p < 0.05). After the 
integrins, the next most abundant transmembrane proteins were tumour-associated 
calcium signal transducer 2 (TACST 2), basigin, glypican 1 and basal cell adhesion molecule 
(BCAM), which contributed to 2.8%, 1.8%, 0.6% and 0.6% of the day 42 ECM, respectively. 
Only the increase in raw peptide abundances observed for TACST 2 and basigin in the day 
42 ECM compared to day 1 were found to be statistically significant (p < 0.05). 
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Syndecans 1 and 4 were present in all the ECM samples, former being more abundant at all 
the time points investigated. Although the highest raw peptide abundances were observed 
on day 42 for both proteins, only that for syndecan 1 was significantly higher compared to 
that in the day 1 ECM (p = 0.026). Other transmembrane proteins identified in the ECM of 
HCjE-Gi cells were cadherin 1, CD44, CD47, CD109, EGF receptor, epithelial discoidin 
domain-containing receptor 1 (EDDR 1), Ly6/PLAUR domain-containing protein 3 (LYPD 3) 
and putative gamma-glutamyltranspeptidase 3 (GGT 3) proteins. All these proteins had the 
highest raw peptide abundances in the day 42 ECM, however, this was only found to be 
statistically significant compared to that in the day 1 ECM for cadherin 1, CD44, CD47 and 
LYPD 3 (p < 0.05).  
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Figure 2.31: Proportions of transmembrane proteins in the extracellular matrix from days 1 to 42. Data are presented as mean peptide abundance: total 
peptide abundance ± 1SD, n = 4. 
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2.3.4.3 SECRETED PROTEINS (Figures 2.23-2.29 and 2.32-2.33) 
Growth factors, binding proteins and cytokines 
There were fourteen proteins identified as GFs, their binding proteins and cytokines  that 
contributed to 17.53% of the day 1 ECM and 17.08% of the day 7 ECM, which was not 
statistically significant (p = 1.000). However, the percentage reduced statistically 
significantly from day 7 to day 28 (p < 0.05) and no statistically significant difference was 
observed between the day 28 and day 42 ECM samples (p = 0.213). These proteins 
contributed to only 4.4% of the day 42 ECM.  
 
C-X-C motif chemokine (CXCL) 11, FGF binding protein 1 (FGFBP 1), insulin, insulin-like GF 
binding protein (IGFBP) 3, IGFBP 10 (also known as protein CYR61 – cysteine rich angiogenic 
inducer 61), LTBP 2 and TGFβ-induced protein ig-h3 (TGFβ ig-h3) had the highest raw 
peptide abundances on day 7 and reduced thereafter. This increase in the day 7 ECM was 
not found to be statistically significant compared to the other time points in the case of 
CXCL 11 and insulin (p > 0.05). However, insulin was the most abundant protein in this 
category in the day 1 ECM and day 7 ECM contributing to 10.9% and 4.4% of the total ECM, 
respectively. CXCL 11 contributed to less than 1% of the total ECM at all the time points. 
The increase in the raw peptide abundances of FGFBP 1, IGFBP 10 and TGFβ ig-h3 in the day 
7 ECM were found to be statistically significant compared to that in the day 1 and day 14 
ECM samples (p < 0.05). The peptides of these proteins contributed to 3.8%, 3.7% and 3.6% 
of the day 7 ECM, respectively. A statistically significant increase to the raw peptide 
abundances of IGFBP 3 and LTBP 2 were observed in the day 7 ECM compared to day 1 (p < 
0.05), which significantly reduced after day 28 compared to that in the day 7 ECM (p < 
0.05).      
 
The raw peptide abundance of growth differentiation factor (GDF) 15 was highest on day 
14, which was significantly higher than that on day 1 and 7 (p < 0.05), however, was not 
significant compared to that on day 28 and day 42 (p > 0.05). The highest raw peptide 
abundance of midkine was also observed on day 14, which was significantly higher than 
that on day 1, 28 and 42 (p < 0.05). The raw peptide abundance of CXCL 14 was highest in 
the day 28 ECM, which was significantly higher compared to that in the day 1 and day 7 
ECM samples (p < 0.05). The raw peptide abundance of platelet derived growth factor A 
(PDGF-A) increased significantly on day 7 compared to day 1 (p = 0.001) and no significant 
differences were observed between days 7 and 42. Dermokine, granulins and macrophage 
migration inhibitory factor (MIF) had the highest raw peptide abundances in the day 42 
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ECM, which was not significantly different compared to that in the day 1 ECM (p > 0.05). All 
these proteins contributed to less than 1% of the ECM throughout the six weeks.  
 
Proteases and inhibitors 
The ECM of the HCjE-Gi cells consisted of seventeen proteases and their inhibitors that 
contributed to 7.10% of the day 1 ECM, which increased statistically significantly to 
contribute to 14.49% of the day 7 ECM (p < 0.001). There was no statistically significant 
difference to the percentage between the day 7 and day 42 ECM samples (p = 1.000). The 
proportion of proteases to their inhibitors varied over the six weeks culture period (figure 
2.34). The peptide abundance of proteases increased, whereas that of the inhibitors 
decreased from days 1 to 42 (p < 0.001). There were significantly higher proportions of 
proteases in the ECM of days 7 to 42 compared to their inhibitors (p < 0.001).  
 
The most abundant protein in this category at all the time points was serine protease high-
temperature requirement A1 (HTRA1), which contributed to 2.2% of the day 1 ECM and 
13.3% of the day 42 ECM. Its raw peptide abundance significantly increased in the day 7 
ECM compared to day 1 (p = 0.023) and no further differences were observed between day 
7 and day 42 (p = 0.198). The next most abundant protein was tissue factor pathway 
inhibitor 2 (TFPI 2). The raw peptide abundance was significantly higher in the day 7 ECM (p 
< 0.001) compared to the other points and the abundance gradually reduced with time. It 
contributed to 2.6% of the day 7 ECM and 0.3% of the day 42 ECM.  
 
All the other proteins contributed to less than 1% of the ECM at all the time points 
investigated. Proteases that were present in the ECM were ADAM 10, ADAM 17, ADAMTS-
like protein 6, MMP 14, MMP 28, membrane type serine protease 1 (MT-SP 1) and serine 
protease 23. The raw peptides abundances of all these proteins, except that of serine 
protease 23, increased significantly over the six weeks (p < 0.05). The raw peptide 
abundance of serine protease 23 was significantly higher on day 7 compared to day 1 and 
14 (p = 0.029 and p = 0.035, respectively). Although the highest peptide abundance was 
observed on day 42, this was not found to be significantly different from that observed on 
day 7 (p = 0.235).  
 
The raw peptide abundances of antileukoproteinase, glia-derived nexin and hepatocyte GF 
activator inhibitor type 1 (HAI 1) significantly increased in the day 42 ECM compared to the 
day 1 ECM (p < 0.05). Although increases to the raw peptide abundances were also 
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observed in the day 42 ECM compared to the day 1 ECM for elafin, plasminogen activator 
inhibitor (PAI), retinoid-inducible serine carboxypeptidase (RISC) and serpin B5, these were 
not found to be statistically significant (p < 0.05). There was a statistically significant 
increase to the raw peptide abundance of TIMP 3 in the day 7 ECM compared to the day 1 
and day 14 (p = 0.007 and p = 0.039). The raw peptide abundance gradually increased with 
time, however, this was not found to be significant between the ECM of day 7 and day 42 (p 
= 0.323).  
 
Secreted - other 
There were twenty-five other secreted proteins identified as being present in the ECM of 
the HCjE-Gi cells. There was a statistically significant reduction to the percentage of 
peptides in this category in the day 7 ECM compared to the day 1 ECM (p < 0.001), 
however, no further significant differences were observed from day 7 to day 42.   
 
In the day 1 ECM, the most abundant protein was annexin A2, the raw peptide abundance 
of which gradually increased over the six weeks. However, this increase was not statistically 
significant (p = 0.079). It contributed to 11.4% of the day 1 ECM and its proportion relative 
to the other proteins reduced with time and only contributed to 1.7% of the day 42 ECM. 
The highest proportion of galectin-3-binding protein was in in the day 14 to day 42 ECM 
samples. Its raw peptide abundance significantly increased gradually over the six weeks (p = 
0.025), contributing to 3.9% of the day 42 ECM. The raw peptide abundance of galectin 1 
was higher than that of galectin 3 at all the time points. Although, the raw peptide 
abundance of both increased over the six weeks, this was not found to be statistically 
significant (p > 0.05).  
 
There were four Wnt ligands, Wnt 6, 7a, 7b and 10a that are associated with the Wnt 
signalling pathway. Wnt 10a was the most abundant out of the four throughout the six 
weeks. The raw peptide abundances of the four proteins significantly increased over the six 
weeks (p < 0.05), however, their contribution to the ECM was less than 1% at all the time 
points investigated. Dickkopf-related protein 1 (Dkk 1), a canonical Wnt signalling 
antagonist, was also present, significantly higher in the day 7 ECM compared to the other 
time points (p < 0.001).  
 
The raw peptide abundance of the coiled-coil domain-containing protein 80 (CCDC 80) was 
significantly higher on day 7 than the other time points (p < 0.05). There was a significantly 
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higher raw peptide abundance of serotransferrin on day 7 compared to day 1 and 14 (p = 
0.003), however, the peptide abundance gradually increased and no significant difference 
was observed between day 7 and day 42 ECM samples (p = 0.716). Serotransferrin 
contributed to 1.3% of the day 1 ECM and reduced to 0.4% of the day 42 ECM.  Similar 
pattern of raw peptide abundance was observed for tissue factor as well. Vasopressin-
neurophysin 2-copeptin (AVP-NPII) had a significantly lower raw peptide abundance in the 
day 14 ECM compared to day 7 (p = 0.034), but the peptide abundance gradually increased 
with time and no significant difference was observed between day 7 and day 42 ECM 
samples (p= 0.979). The raw peptide abundance of peroxidasin homolog significantly 
increased on day 7 compared to day 1 (p = 0.041), however, no significant difference was 
observed between days 7 and 42 (p = 0.431). Serum albumin contributed to 1.6% of the day 
1 ECM and reduced with time. Its raw peptide abundance was highest in the day 7 ECM, 
which was not statistically significant compared to the other time points (p > 0.05). 
Adrenomedullin (ADM) had significantly higher raw peptide abundance in the day 14 ECM 
compared to other time points (p < 0.001).  
 
The raw peptide abundances of apolipoprotein E and J (also known as clusterin) and serum 
amyloid A-1 (SAA 1) protein gradually increased with time and were significantly higher in 
the day 42 ECM compared to the day 1 ECM (p < 0.05). Proteins that exhibited a gradual 
increase in the raw peptide abundances but were not found to be statistically significant on 
day 42 compared to the day 1 ECM were β-2-microglobulin, endothelial lipase, hemopexin, 
inter-alpha-trypsin inhibitor (ITI) heavy chain H4, peroxiredoxin 4 and phospholipase 
transfer (PL) protein (p > 0.05).  
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Figure 2.32: Proportions of secreted proteins in the extracellular matrix from days 1 to 42 (1). Data are presented as mean peptide abundance: total 
peptide abundance ± 1SD, n = 4. 
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Figure 2.33: Proportions of secreted proteins in the extracellular matrix from days 1 to 42 (2). Data are presented as mean peptide abundance: total 
peptide abundance ± 1SD, n = 4. 
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Peptide abundances of proteases and their inhibitors 
 
 
 Peptide abundance (%) 
 Day 1 Day 7 Day 14 Day 28 Day 42 
Proteases 39.9 77.5 83.0 88.1 92.9 
Inhibitors 60.1 22.5 17.0 11.9 7.1 
 
Figure 2.34: A. Peptide abundances of proteases and their inhibitors in the extracellular 
matrix from days 1 to 42. Data are presented as mean peptide abundance (%), n = 4. The 
peptide abundances of proteases increased, whereas that of the inhibitors decreased 
from days 1 to 42 (p < 0.001). The proportion of proteases in the extracellular matrix of 
days 7 to 42 was significantly higher compared to their inhibitors (p < 0.001). (Two-way 
ANOVA; Bonferroni post hoc test). B: Mean peptide abundance (%) in the extracellular 
matrix from days 1 to 42. 
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2.3.5 GROWTH OF HCjE-Gi CELLS ON CELL-SECRETED EXTRACELLULAR MATRIX 
The ratio of ECM:TCP cell number was highest when HCjE-Gi cells were cultured on the ECM 
derived from cells that were in culture for three and five days (figure 2.35A). The effects of 
ECM day and culture day on the ECM:TCP cell number ratio were statistically significant 
within the model (p = 0.031 and p < 0.001, respectively). There was a statistically significant 
increase to the ECM:TCP cell number ratio when HCjE-Gi cells were cultured on the ECM 
derived from cells that were in culture for three and five days (p = 0.001 and p < 0.001, 
respectively). Moreover, the highest ECM:TCP cell number ratio was observed on culture 
day five, which was found to be statistically significant (p = 0.011) (figure 2.35B).     
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Growth of HCjE-Gi cells on cell-secreted extracellular matrix 
 
 
 
 
Figure 2.35: Growth of HCjE-Gi cells on cell-secreted extracellular matrix. Data are 
presented as mean ECM:TCP cell number, n = 9. There was a significant increase to the 
ECM:TCP cell number ratio when HCjE-Gi cells were cultured on the extracellular matrix 
derived from cells that were in culture for three and five days (p = 0.001 and p < 0.001, 
respectively) (A). Moreover, the highest ECM:TCP cell number ratio was observed on 
culture day five (p = 0.011) (B);  p < 0.05. (Generalised linear model).  
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2.3.6 ADSORPTION OF PROTEINS ONTO TISSUE CULTURE POLYSTYRENE 
Adsorption of type IV collagen protein onto TCP was initially investigated by diluting it in 
either 0.5M acetic acid or PBS to determine any differences in the solubility (figure 2.36). 
There were twenty-one outliers in the data set and all groups, except the acetic acid - 
0µg/mL group, were normally distributed. There was homogeneity of variances. There was 
a statistically significant interaction effect between the diluent and the concentration of the 
protein solution on the mean absorbance, p < 0.001. There were statistically significant 
increases to the mean absorbance when type IV collagen was diluted in acetic acid to make 
0.5 and 1µg/mL solutions (p = 0.003 and p < 0.001, respectively) compared to when diluted 
in PBS. However, there were statistically significant increases to the mean absorbance 
when type IV collagen was diluted in PBS to make 10 and 20µg/mL solutions (p = 0.031 and 
p < 0.001, respectively) compared to when diluted in acetic acid. When the outliers were 
removed, a statistically significant increase to the mean absorbance was also observed 
when diluted in acetic acid to make a 2µg/mL solution compared to when diluted in PBS. 
Since PBS is less toxic to cells, this was used as the diluent for type IV collagen in the 
subsequent experiments. 
 
Adsorption of type IV collagen protein onto TCP reached a saturation point when pre-
adsorbed from a 5μg/mL solution (figure 2.37). There were ten outliers. All data were 
normally distributed and there was homogeneity of variances. Mean absorbance was 
statistically significantly different between the different concentration groups, p < 0.001. 
There was a statistically significant increase in the absorbance when type IV collagen was 
pre-adsorbed from a 0.5μg/mL solution (p = 0.003) compared to the control. This continued 
to increase until a saturation point was reached when type IV collagen was pre-adsorbed 
from a 5μg/mL solution (p < 0.001). There was no change to the overall result when the 
outliers were removed. 
 
Adsorption of laminin 111 protein onto TCP reached a saturation point when pre-adsorbed 
from a 0.5μg/mL protein solution (figure 2.38). There were three outliers and all groups 
were normally distributed, except the control and 5μg/mL groups. There was homogeneity 
of variances. There was a statistically significant difference in the mean absorbance 
between the concentration groups, p < 0.001. There was an increase to the absorbance 
when laminin 111 was pre-adsorbed from a 0.5µg/mL solution compared to the control (p < 
0.001). There were no significant differences in the absorbance when laminin 111 was pre-
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adsorbed from 0.5-20μg/mL solutions (p > 0.05). No change to the overall result was 
observed when analysed without the outliers. 
 
Adsorption of fibronectin onto TCP reached a saturation point when pre-adsorbed from a 
5μg/mL solution (figure 2.39). There were five outliers and all groups assumed a normal 
distribution, except the control group. There was homogeneity of variances. The 
absorbance was statistically significantly different between the concentration groups, p < 
0.001. There was a statistically significant increase in the mean absorbance when 
fibronectin was pre-adsorbed from a 0.5μg/mL solution (p < 0.001) compared to the control 
group. This continued to increase until it reached a saturation point when fibronectin was 
pre-adsorbed from a 5μg/mL solution (p < 0.001). There were no significant differences in 
the mean absorbance values when pre-adsorbed from 5-20μg/mL fibronectin solutions. The 
overall result was similar when the data were analysed without the outliers. 
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Adsorption of type IV collagen diluted in acetic acid or PBS  
 
 
 Mean 
(Acetic acid) 
SD Mean  
(PBS) 
SD 
0 0.011 0.020 0.000 0.003 
0.5 0.037 0.009 0.019 0.008 
1 0.060 0.016 0.033 0.012 
2 0.064 0.011 0.054 0.008 
5 0.071 0.009 0.080 0.011 
10 0.077 0.014 0.089 0.016 
20 0.079 0.010 0.100 0.008 
 
Figure 2.36: A. Adsorption of type IV collagen when diluted in either 0.5M acetic acid or 
PBS as determined by indirect ELISA. Data are presented as mean absorbance measured 
at 405nm ± 1SD, n = 9.There was a significant increase in the mean absorbance when type 
IV collagen was diluted in 0.5M acetic acid to make 0.5-1μg/mL solutions, whereas a 
significant increase in the mean absorbance was observed when diluted in PBS to make 
10-20µg/mL solutions; *p < 0.05 and **p < 0.001. (Two-way ANOVA; Bonferroni post hoc 
test). B. Mean absorbance at 405nm (OD – optical density) when diluted in either 0.5M 
acetic acid or PBS and 1SD. 
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Adsorption of type IV collagen onto tissue culture polystyrene 
 
 
 Mean SD 
0 0.000 0.003 
0.5 0.019 0.008 
1 0.033 0.012 
2 0.054 0.008 
5 0.080 0.011 
10 0.089 0.016 
20 0.100 0.008 
 
Figure 2.37: A. Adsorption of type IV collagen onto tissue culture polystyrene as 
determined by indirect ELISA. Data are presented as mean absorbance at 405nm ± 1SD, n 
= 9. There was a significant increase to mean absorbance when type IV collagen was pre-
adsorbed from a 0.5μg/mL solution (p = 0.003). The mean absorbance continued to 
increase to reach a saturation point when type IV collagen was pre-adsorbed from a 
5μg/mL solution (p < 0.001); *p < 0.05 and ** p < 0.001. (One-way ANOVA; Tukey post hoc 
test). B. Mean absorbance at 405nm (OD – optical density) and 1SD. 
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Adsorption of laminin 111 onto tissue culture polystyrene 
 
 
 Mean SD 
0 0.014 0.033 
0.5 0.081 0.018 
1 0.081 0.017 
2 0.087 0.015 
5 0.090 0.019 
10 0.091 0.004 
20 0.100 0.004 
 
Figure 2.38: A. Adsorption of laminin 111 onto tissue culture polystyrene as determined by 
indirect ELISA. Data are presented as mean absorbance at 405nm ± 1SD, n = 9. There was 
a significant increase in the mean absorbance when laminin 111 was pre-adsorbed from a 
0.5μg/mL solution (p < 0.001). There were no significant differences in the mean 
absorbance when laminin 111 was pre-adsorbed from 0.5-20μg/mL protein solutions; ** p 
< 0.001. (One-way ANOVA; Tukey post hoc test). B. Mean absorbance at 405nm (OD – 
optical density) and 1SD. 
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Adsorption of fibronectin onto tissue culture polystyrene 
 
 
 Mean SD 
0 0.013 0.014 
0.5 0.091 0.010 
1 0.108 0.005 
2 0.124 0.008 
5 0.143 0.012 
10 0.144 0.012 
20 0.152 0.012 
 
Figure 2.39: A. Adsorption of fibronectin onto tissue culture polystyrene as determined by 
indirect ELISA. Data are presented as mean absorbance at 405nm ± 1SD, n = 9. There was 
a significant increase in the mean absorbance when fibronectin was pre-adsorbed from a 
0.5μg/mL solution (p < 0.001). The mean absorbance continued to increase to reach a 
saturation point when fibronectin was pre-adsorbed from a 5μg/mL solution (p < 0.001); 
** p < 0.001. (One-way ANOVA; Tukey post hoc test). B. Mean absorbance at 405nm (OD 
– optical density) and 1SD. 
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2.3.7 ADHESION OF HCjE-Gi CELLS ON PRE-ADSORBED PROTEINS 
Pre-adsorption of type IV collagen from a 2μg/mL solution increased the adhesion of HCjE-
Gi cells (figure 2.40). The adhesion of cells increased as the concentration of type IV 
collagen solution increased. There were six outliers and homogeneity of variances was 
violated (p = 0.036). All groups were normally distributed, except the 1µg/mL group. There 
was a statistically significant difference to the mean number of cells between the 
concentration groups, p < 0.001. There was a statistically significant increase to the number 
of cells when cultured on type IV collagen pre-adsorbed from a 2µg/mL solution (p < 0.001) 
compared to that on TCP. There were no statistically significant differences to the number 
of cells when cultured on pre-adsorbed type IV collagen from 2-10μg/mL solutions. The 
results were similar when analysed without the outliers. 
 
Pre-adsorption of laminin 111 did not affect the adhesion of the HCjE-Gi cells (figure 2.41). 
There were four outliers, however, all groups assumed normal distribution and there was 
homogeneity of variances. There was no statistically significant change to the adhesion of 
cells on laminin 111 pre-adsorbed from 0.1-1μg/mL solutions compared to the control, p > 
0.05. The results were similar when analysed without the outliers.  
 
Pre-adsorption of fibronectin from a 0.5μg/mL solution increased the adhesion of HCjE-Gi 
cells (figure 2.42). The adhesion of cells increased as the concentration of fibronectin 
solution increased. There were no outliers and all groups were normally distributed, except 
the 0.5μg/mL group. There was heterogeneity of variances (p = 0.026). There was a 
statistically significant difference to the mean number of cells between the groups, p < 
0.001. There was a statistically significant increase to the cell number when cultured on 
fibronectin pre-adsorbed from a 0.5µg/mL solution compared to that on TCP (p = 0.001). 
The cell adhesion continued to increase with increasing concentrations of fibronectin 
solutions up to 5μg/mL (p < 0.001). There was no difference to the cell number when 
cultured on fibronectin pre-adsorbed from 5-10μg/mL solutions. 
 
Pre-adsorption of α-2-HS-GP did not affect the adhesion of the HCjE-Gi cells (figure 2.43). 
There were six outliers, however, all groups assumed normal distribution and there was 
homogeneity of variances. There was no statistically significant change to the adhesion of 
cells on α-2-HS-GP pre-adsorbed from 0.5-20μg/mL solutions compared to the control, p > 
0.05. There was no change to the overall result when analysed without the outliers.  
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Adhesion of HCjE-Gi cells on type IV collagen 
 
 
 Mean SD 
0 3554.5 631.8 
0.5 5090.1 1622.1 
1 5747.1 1806.6 
2 6769.5 1064.0 
5 9233.6 2586.0 
10 9261.6 2331.8 
 
Figure 2.40: A. Adhesion of HCjE-Gi cells on pre-adsorbed type IV collagen. Data are 
presented as mean cells/cm2 (x103) ± 1SD, n = 9. The adhesion of cells increased with 
increasing concentrations of type IV collagen solutions. There was a significant increase to 
the mean number of cells adhered on type IV collagen pre-adsorbed from a 2μg/mL 
solution compared to the control (p < 0.001). There were no significant differences to the 
adhesion of cells on type IV collagen pre-adsorbed from 2-10μg/mL solutions; **p < 0.001. 
(One-way ANOVA; Games-Howell post hoc test). B. Mean number of cells/cm2 and 1SD. 
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Adhesion of HCjE-Gi cells on laminin 111 
 
 
 Mean SD 
0 6020.6 1323.4 
0.1 5771.0 1662.9 
0.25 5767.0 1204.0 
0.5 5485.5 965.1 
1 6138.5 832.0 
 
Figure 2.41: A. Adhesion of HCjE-Gi cells on pre-adsorbed laminin 111. Data are presented 
as mean number of cells/cm2 (x103) ± 1SD, n = 9. There was no significant difference to the 
cell adhesion on laminin 111 pre-adsorbed from 0.1-1μg/mL solutions compared the 
control (p > 0.05). (One-way ANOVA; Tukey post hoc test). B. Mean number of cells/cm2 
and 1SD. 
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Adhesion of HCjE-Gi cells on fibronectin 
 
 
 Mean SD 
0 2202.6 550.5 
0.5 3856.0 747.5 
1 4473.0 946.3 
2 5475.5 690.6 
5 6701.6 1310.1 
10 7652.1 1391.5 
 
Figure 2.42: A. Adhesion of HCjE-Gi cells on pre-adsorbed fibronectin. Data are presented 
as mean cells/cm2 (x103) ± 1SD, n = 9. There was a significant increase to the mean 
number of cells adhered on fibronectin pre-adsorbed from a 0.5μg/mL solution compared 
to the control (p = 0.001). The mean number of cells continued to increase with increasing 
concentrations of fibronectin solutions up to 5μg/mL (p < 0.001). There was no difference 
to the cell number when cultured on fibronectin pre-adsorbed from 5-10μg/mL solutions; 
*p < 0.05 and **p < 0.001. (One-way ANOVA; Games-Howell post hoc test). B. Mean 
number of cells/cm2 and 1SD. 
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Adhesion of HCjE-Gi cells on α-2-HS-glycoprotein 
 
 
 Mean SD 
0 4588.9 1192.5 
0.5 4536.9 1039.9 
1 4525.0 1129.6 
2 4377.2 1149.3 
5 4257.4 906.9 
10 4165.5 870.5 
20 4125.6 901.3 
 
Figure 2.43: A. Adhesion of HCjE-Gi cells on pre-adsorbed α-2-HS-glycoprotein. Data are 
presented as mean cells/cm2 (x103) ± 1SD, n = 9. There was no statistically significant 
differences to the mean number of cells adhered on α-2-HS-glycoprotein pre-adsorbed 
from 0.5-20μg/mL solutions compared to the control (p > 0.05). (One-way ANOVA; Tukey 
post hoc test). B. Mean number of cells/cm2 and 1SD. 
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2.3.8 GROWTH AND DIFFERENTIATION OF HCjE-Gi CELLS ON PRE-ADSORBED PROTEINS 
There were significant increases to the cell number on days five and seven when cultured 
on pre-adsorbed type IV collagen compared to TCP (figure 2.44). There were ten outliers 
and three groups (day 1 - 10µg/mL, day 7 – TCP and day 7 - 10µg/mL) were not normally 
distributed. Homogeneity of variances was violated (p < 0.001). There was a statistically 
significant interaction effect between the protein concentration and culture day on the 
mean cell number, p < 0.001. As expected, there were statistically significant increases to 
the mean cell number over the seven day culture period for all the protein concentrations 
investigated (p < 0.05). There was a statistically significant difference to mean cell number 
between the concentrations on day five (p < 0.001) and day seven (p < 0.001). On culture 
day five, statistically significant increases to the cell number were observed when cultured 
on type IV collagen pre-adsorbed from 5 and 10µg/mL solutions compared to TCP (p < 
0.001 and p = 0.011, respectively). There were statistically significant increases to the cell 
number when cultured on type IV collagen pre-adsorbed from 5µg/mL solution compared 
to when pre-adsorbed from 0.5µg/mL (p = 0.002) and 1µg/mL (p = 0.013) solutions. On 
culture day seven, statistically significant increases to the cell number were observed when 
cultured on type IV collagen pre-adsorbed from 0.5-10µg/mL solutions compared to TCP (p 
< 0.001). There was also a statistically significant increase to the cell number on type IV 
collagen pre-adsorbed from a 5µg/mL solution compared to when pre-adsorbed from a 
1µg/mL solution (p = 0.031). When analysed without the outliers, a significant increase to 
the cell number was seen on type IV collagen pre-adsorbed from a 5µg/mL solution 
compared to when pre-adsorbed from a 2µg/mL solution on day five. On day seven, 
significant increases were also observed on type IV collagen pre-adsorbed from a 10µg/mL 
solution compared to when pre-adsorbed from 0.5-2µg/mL solutions, and when pre-
adsorbed from a 5µg/mL solution compared to when pre-adsorbed from a 0.5µg/mL 
solution.  
 
Pre-adsorption of laminin 111 did not affect the growth curve of HCjE-Gi cells over a culture 
period of seven days (figure 2.45). There were eleven outliers and three groups were not 
normally distributed (day 1 – TCP, day 3 – TCP and day 7 – TCP). There was heterogeneity of 
variances (p < 0.001). There was no statistically significant interaction effect between the 
protein concentration and culture day on the cell number, p = 0.073. Analysis of main effect 
between the protein concentrations showed no statistically significant difference (p = 
0.127), whereas a significant difference was observed between the culture days (p < 0.001). 
When the outliers were removed, an interaction effect was observed between the protein 
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concentration and culture day on the cell number (p = 0.002). There were significant 
reductions to the cell number on laminin 111 pre-adsorbed from 0.25 and 1µg/mL solutions 
compared to that on TCP (p < 0.05) on culture day seven. Moreover, significant reductions 
to the cell number were also observed on laminin 111 pre-adsorbed from 0.25-1µg/mL 
solutions compared to that on laminin 111 pre-adsorbed from a 0.1µg/mL solution (p < 
0.05) on culture day seven.  
 
The growth of HCjE-Gi cells on pre-adsorbed fibronectin was comparable to that on TCP 
(figure 2.46). There were fourteen outliers and three groups were not normally distributed 
(day 1 - 5µg/mL, day 5 - 2µg/mL and day 7 - 10µg/mL). There was heterogeneity of 
variances (p < 0.001).  There was no significant interaction effect between protein 
concentration and culture day on the mean cell number, p = 0.364. Analysis of the main 
effect between protein concentrations showed a statistically significant difference (p = 
0.04). Further analysis showed a statistically significant increase to the cell number on 
fibronectin pre-adsorbed from a 5µg/mL compared to TCP (p = 0.037). There were 
statistically significant increases to the cell number over the culture period of seven days in 
all protein concentration groups investigated. When analysed without the outliers, a 
statistically significant interaction was observed between the protein concentration and 
culture day on the mean cell number (p = 0.003). There were significant increases to the cell 
number on day seven when cultured on fibronectin pre-adsorbed from 0.5, 5 and 10µg/mL 
solutions compared to TCP (p < 0.05). Additionally, significant increases to the cell number 
were observed on fibronectin pre-adsorbed from a 10µg/mL solution compared to 0.5-
2µg/mL solutions (p < 0.05), and on fibronectin pre-adsorbed from a 5µg/mL solution 
compared to that pre-adsorbed from a 1µg/mL solution (p < 0.05).  
 
There were significant increases to the cell number when cultured on pre-adsorbed α-2-HS-
GP for five to seven days (figure 2.47). There were eleven outliers and two groups were not 
normally distributed (day 1 - 5µg/mL and day 5 - 2µg/mL). There was heterogeneity of 
variances (p < 0.001). There was a statistically significant interaction effect between the 
protein concentration and culture day on the mean cell number, p < 0.001. There were 
statistically significant increases to the mean cell number over the seven day culture period 
for all the protein concentrations investigated. There was a statistically significant 
difference to the mean cell number between the concentrations on day five (p < 0.001) and 
day seven (p < 0.001). On culture day five, statistically significant increases to the cell 
number were observed when cultured on α-2-HS-GP pre-adsorbed from 10-20µg/mL 
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solutions compared to TCP and α-2-HS-GP pre-adsorbed from 0.5-5µg/mL solutions (p < 
0.05). On culture day seven, there were statistically significant increases to the cell number 
when cultured on α-2-HS-GP pre-adsorbed from a 20µg/mL solution compared to TCP and 
α-2-HS-GP pre-adsorbed from 0.5µg/mL and 5µg/mL solutions (p < 0.05). When analysed 
without the outliers, significant increases to the cell numbers were observed on culture day 
five on α-2-HS-GP pre-adsorbed from 10-20µg/mL solutions compared to TCP and α-2-HS-
GP pre-adsorbed from 0.5-2µg/mL solutions (p < 0.001). Further significant increases were 
observed on α-2-HS-GP pre-adsorbed from a 5µg/mL solution compared to TCP and α-2-HS-
GP pre-adsorbed from 0.5-1µg/mL solutions (p < 0.05), and on α-2-HS-GP pre-adsorbed 
from a 2µg/mL solution compared to that on α-2-HS-GP pre-adsorbed from 0.5-1µg/mL 
solutions (p < 0.05). On culture day seven, significant increases to the cell number were 
observed on α-2-HS-GP pre-adsorbed from a 20µg/mL solution compared to TCP and α-2-
HS-GP pre-adsorbed from 0.5-1µg/mL and 5µg/mL solutions (p < 0.05). There were 
significant increases to the cell number observed on α-2-HS-GP pre-adsorbed from a 
10µg/mL solution compared to TCP, and α-2-HS-GP pre-adsorbed from 0.5µg/mL and 
5µg/mL solutions (p < 0.05). A further significant increase to the cell number was also 
observed on α-2-HS-GP pre-adsorbed from a 2µg/mL solution compared to α-2-HS-GP pre-
adsorbed from a 5µg/mL solution (p = 0.046).  
 
The HCjE-Gi cells formed a monolayer by day seven when cultured on pre-adsorbed type IV 
collagen, laminin 111, fibronectin and α-2-HS-GP. There was positive staining for keratin 19, 
a simple epithelial cell marker, on culture day seven on all the substrates investigated 
(figures 2.48-2.51). There was no evidence, however, of expression of keratin 4, a marker of 
non-keratinised stratified epithelial cells, on culture day seven on any of the substrates. 
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Growth curve of HCjE-Gi cells on type IV collagen 
 
 
 
 Day 1  Day 3  Day 5  Day 7  
 Mean SD Mean SD Mean SD Mean SD 
0 5437.5 1579.3 16 025.1 1934.1 35 079.4 11 594.8 83 681.8 16 671.2 
0.5 7348.6 1208.9 19 100.3 3657.7 37 905.0 11 192.2 112 441.1 6318.7 
1 7504.3 1282.4 17 898.2 2508.6 39 832.0 4107.8 110 570.0 8748.4 
2 7568.2 1766.6 16 214.8 4345.4 42 841.4 5454.8 114 112.5 7664.3 
5 7722.0 966.5 17 838.3 3594.9 51 675.6 5339.9 121 495.0 10 687.4 
10 8195.3 1831.9 21 616.4 4267.5 47 120.7 11 118.9 116 668.5 14 561.3 
 
Figure 2.44: A. Growth curve of HCjE-Gi cells cultured on pre-adsorbed type IV collagen. 
Data are presented as mean number of cells/cm2 (x103) ± 1SD, n = 9. There was a 
significant interaction effect between the protein concentration and culture day on the 
mean cell number (p < 0.001). The cell number significantly increased during the culture 
period on all protein concentrations. On day five, there were significant increases to the 
cell number when cultured on type IV collagen pre-adsorbed from 5 and 10µg/mL 
solutions compared to tissue culture polystyrene (p < 0.001 and p = 0.011, respectively). 
On day seven, there were significant increases to the cell number when cultured on type 
IV collagen pre-adsorbed from 0.5-10µg/mL solutions compared to tissue culture 
polystyrene (p < 0.001); *p = 0.05 and ** p < 0.001. (Two-way ANOVA; Bonferroni post 
hoc test). B. Mean number of cells/cm2 and 1SD. 
 
0
40
80
120
160
200
0 1 2 3 4 5 6 7
M
e
an
 c
e
lls
/c
m
2
(x
1
0
3 )
Culture day
0
0.5
1
2
5
10
Type IV 
collagen
(µg/mL)
A
B 
165 
 
Growth curve of HCjE-Gi cells on laminin 111 
 
 
 
 Day 1  Day 3  Day 5  Day 7  
 Mean SD Mean SD Mean SD Mean SD 
0 5605.3 3172.7 10885.1 3676.8 21 235.0 4455.0 67 682.7 26 178.6 
0.1 4710.7 1657.9 8786.3 1603.0 23 723.1 3918.8 86 156.0 21 694.7 
0.25 4091.6 955.9 9203.7 2778.5 20 582.0 4069.4 65 582.0 26 888.7 
0.5 4986.2 1956.4 7751.9 1823.7 20 915.5 3573.3 75 480.6 12 698.9 
1 4501.0 1458.1 11 280.5 4667.3 20 238.5 4056.8 60 551.8 22 988.7 
 
Figure 2.45: A. Growth curve of HCjE-Gi cells cultured on pre-adsorbed laminin 111. Data 
are presented as mean number of cells/cm2 (x103) ± 1SD, n = 9. There was no significant 
interaction effect observed between protein concentration and culture day on the mean 
cell number (p = 0.073). The cell number significantly increased during the culture period 
on all protein concentrations. There was no significant change to the cell number when 
cultured on laminin 111 protein pre-adsorbed from 0.1-1µg/mL solutions (p > 0.05). (Two-
way ANOVA; Bonferroni post hoc test). B. Mean number of cells/cm2 and 1SD. 
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Growth curve of HCjE-Gi cells on fibronectin 
 
 
 
 Day 1  Day 3  Day 5  Day 7  
 Mean SD Mean SD Mean SD Mean SD 
0 4067.7 473.8 12 720.2 2837.2 29 753.7 6650.6 83 901.5 16 932.5 
0.5 3756.2 764.2 11 951.4 2354.5 31 179.5 5606.7 96 040.6 7524.4 
1 3159.1 623.6 11 380.3 2032.6 30 963.8 7504.8 91 653.4 7673.2 
2 3834.0 575.3 10 256.0 1081.6 35 121.4 6652.7 92 530.1 10 713.6 
5 4085.6 1100.6 13 525.0 2446.3 35 490.8 11 429.3 101 218.6 10 323.3 
10 4752.6 577.8 16 150.9 1872.6 33 731.5 8035.6 94 748.6 24 733.6 
 
Figure 2.46: A. Growth curve of HCjE-Gi cells cultured on pre-adsorbed fibronectin. Data 
are presented as mean number of cells/cm2 (x103) ± 1SD, n = 9. There was no significant 
interaction effect between protein concentration and culture day on the mean cell 
number (p = 0.364). The cell number significantly increased during the culture period on 
all protein concentrations. Analysis of main effect for protein concentration showed a 
significant increase to the cell number when cultured on fibronectin pre-adsorbed from a 
5µg/mL solution compared to TCP (p = 0.037). (Two-way ANOVA; Bonferroni post hoc 
test). B. Mean number of cells/cm2 and 1SD.  
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Growth curve of HCjE-Gi cells on α-2-HS-glycoprotein 
 
 
 
 Day 1  Day 3  Day 5  Day 7  
 Mean SD Mean SD Mean SD Mean SD 
0 3872.0 874.3 13 560.9 2032.7 56 374.3 13 072.9 117 239.6 15 317.2 
0.5 3840.0 711.9 12 252.9 2785.1 49 998.2 13 302.4 113 267.8 14 444.1 
1 3258.9 1151.3 13 209.5 2942.7 48 702.2 15 119.1 121 754.6 13 857.3 
2 5174.0 1548.9 11 116.7 2207.1 64 385.9 10 670.5 124 967.6 12 755.6 
5 4271.4 1861.6 14 533.4 3000.6 66 286.9 28 024.7 110 606.0 11 225.7 
10 4113.6 1520.8 16 757.9 3898.7 84 955.9 14 983.4 124 532.3 37 109.1 
20 3764.1 847.5 17 562.7 3171.8 86 371.7 8172.1 138 708.3 12 932.7 
 
Figure 2.47: A. Growth curve of HCjE-Gi cells cultured on pre-adsorbed α-2-HS-
glycoprotein. Data are presented as mean number of cells/cm2 (x103) ± SD, n = 9. There 
was a significant interaction effect between the protein concentration and culture day on 
the mean cell number (p < 0.001). On culture day five, significant increases to the cell 
number were observed when cultured on α-2-HS- glycoprotein pre-adsorbed from 10-
20µg/mL solutions compared to tissue culture polystyrene and α-2-HS- glycoprotein pre-
adsorbed from 0.5-5µg/mL solutions (p < 0.05). On culture day seven, there were 
statistically significant increases to the cell number when cultured on α-2-HS- glycoprotein 
pre-adsorbed from a 20µg/mL solution compared to tissue culture polystyrene and α-2-
HS- glycoprotein pre-adsorbed from 0.5µg/mL and 5µg/mL solutions (p < 0.05); *p < 0.05. 
(Two-way ANOVA; Bonferroni post hoc test). B. Mean number of cells/cm2 and 1SD. 
0
40
80
120
160
200
0 1 2 3 4 5 6 7
M
e
an
 c
e
lls
/c
m
2
(x
1
0
3
)
Culture day
0
0.5
1
2
5
10
20
α-2-HS-GP
(µg/mL)
B 
A 
168 
 
Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed type IV collagen 
 
Figure 2.48: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed type IV collagen (C4) for seven days; K4 – keratin 4 (green), K19- 
keratin 19 (purple) and DAPI (blue).  
 
 
Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed laminin 111 
 
Figure 2.49: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed laminin 111 (LN) for seven days; K4 – keratin 4 (green), K19- 
keratin 19 (purple) and DAPI (blue).  
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Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed fibronectin 
 
Figure 2.50: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed fibronectin (FN) for seven days; K4 – keratin 4 (green), K19- 
keratin 19 (purple) and DAPI (blue).  
 
 
Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed α-2-HS-glycoprotein 
 
Figure 2.51: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on pre-adsorbed α-2-HS-glycoprotein (A2) for seven days; K4 – keratin 4 (green), 
K19- keratin 19 (purple) and DAPI (blue).  
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2.3.9 EXPRESSION OF STEM CELL MARKERS BY HCjE-Gi CELLS ON PRE-ADSORBED 
PROTEINS   
ΔNp63 
On culture day one, there was strong staining for ΔNp63 around the nuclei, however, by 
culture days seven and fourteen, the staining was weaker and co-localised with the DAPI 
staining in the nucleus (figure 2.52).  
    
Pre-adsorption of proteins did not affect the expression of ΔNp63 compared to TCP over a 
culture period of fourteen days (figure 2.53). There were seven outliers and three groups 
did not exhibit normal distribution (day 7 – laminin 111 0.5µg/mL, day 14 – TCP, and day 14 
– type IV collagen 10µg/mL). There was heterogeneity of variances (p < 0.001). There was a 
statistically significant interaction effect between substrate and culture day on the 
expression ΔNp63 protein, p = 0.015. There were statistically significant differences 
between the culture days for each substrate (p < 0.001), where there were significant 
reductions to the percentage of stained cells on days seven and fourteen compared to day 
one. There were no statistically significant differences between the substrates pre-
adsorbed with proteins and TCP (p < 0.05). On culture day fourteen, there were statistically 
significant increases to the percentage of stained cells on substrates pre-adsorbed with 
fibronectin from 2 and 10µg/mL solutions compared to those pre-adsorbed with type IV 
collagen from a 10µg/mL solution (p = 0.008 and p = 0.047, respectively). Additionally, there 
was a significant increase to the percentage of stained cells on substrates pre-adosrbed 
with fibronectin from a 2µg/mL solution compared to those pre-adsorbed with laminin 111 
from a 0.5µg/mL solution (p = 0.048). When the data were analysed without the outliers, 
further significant differences were observed on day one, where there were significant 
reductions to the percentage of stained cells on substrates pre-adsorbed with fibronectin 
from a 10µg/mL solution compared to those pre-adsorbed with fibronectin from a 2µg/mL 
solution and laminin 111 pre-adsorbed from 0.5 and 1µg/mL solutions (p < 0.05).  
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Expression of ΔNp63 by HCjE-Gi cells 
 
 
Figure 2.52: Expression of ΔNp63 by HCjE-Gi cells; ΔNp63 (purple) and DAPI (blue). On 
culture day one, there was strong staining for ΔNp63 around the nuclei; however, by 
culture days seven and fourteen, the staining was weaker and co-localised with the DAPI 
staining in the nucleus. 
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Expression of ΔNp63 by HCjE-Gi cells on pre-adsorbed proteins 
  
 
 Day 1  Day 7  Day 14  
 Mean SD Mean SD Mean SD 
TCP 61.9 21.5 7.2 4.4 15.7 17.1 
2 C4 57.0 33.9 18.8 8.8 21.7 6.8 
10 C4 65.7 30.1 17.2 11.5 2.0 6.4 
0.5 LN 67.8 23.2 11.8 8.8 6.0 4.5 
1 LN 70.7 27.5 6.1 4.2 13.3 7.9 
2 FN 75.6 19.2 17.6 11.0 29.4 7.6 
10 FN 55.0 26.3 7.8 6.6 25.4 9.4 
 
Figure 2.53: A. Expression of ΔNp63 by HCjE-Gi cells on pre-adsorbed proteins. Data are 
presented as mean percentage (%) of stained cells per view ± 1SD, n = 2. There were 
significant reductions to the percentage of stained cells on days seven and fourteen 
compared to day one (p < 0.001). There were no significant differences between the 
substrates pre-adsorbed with proteins and tissue culture polystyrene. On day fourteen, 
there were significant increases to the percentage of stained cells on fibronectin pre-
adsorbed from 2 and 10µg/mL solutions compared to that on type IV collagen pre-
adsorbed from a 10µg/mL solution, and on fibronectin pre-adsorbed from a 2µg/mL 
solution compared to that on laminin 111 pre-adsorbed from a 0.5µg/mL solution (p < 
0.05); *p < 0.05. (Two-way ANOVA; Bonferroni post hoc test). B. Mean percentage of 
stained cells per view on culture days 1, 7 and 14, and 1SD; C4 - type IV collagen 2 and 
10µg/mL, LN - laminin 111 0.5 and 1µg/mL and FN – fibronectin 2 and 10µg/mL. 
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ABCG2 
On culture days one and seven, there was positive staining for ABCG2 in the nucleus, 
cytoplasm and cell membranes (figure 2.54). A granular staining pattern was observed in 
the cytoplasm. By culture day fourteen, the staining was mostly transmembrane and no 
evidence of nuclear staining was present.  
 
Pre-adsorption of type IV collagen from a 10µg/mL solution increased the expression of 
ABCG2 protein in HCjE-Gi cells compared to TCP on culture day one (figure 2.55). There 
were seven outliers and six groups were not normally distributed (day 1 – fibronectin 
10µg/mL, day 7 – laminin 111 1µg/mL, day 14 – TCP, day 14 – laminin 111 0.5µg/mL, day 14 
– laminin 111 1µg/mL, and day 14 – fibronectin 2µg/mL). There was heterogeneity of 
variances (p < 0.001). There was a statistically significant interaction effect between 
substrate and culture day on the expression of ABCG2 protein, p = 0.018. There were 
statistically significant differences between the culture days for each substrate (p < 0.001), 
where there were significant reductions to the percentage of stained cells on days seven 
and fourteen compared to day one. There were statistically significant differences to the 
percentage of stained cells between the substrates on culture day one (p < 0.001). There 
were significant increases to the percentage of stained cells on substrates pre-adsorbed 
with type IV collagen from a 10µg/mL solution compared to TCP (p = 0.028). In addition, 
there were significant reductions to the percentage of stained cells on substrates pre-
adsorbed with laminin 111 from 0.5 and 1µg/mL solutions compared to those pre-adsorbed 
with type IV collagen from 2 and 10 µg/mL solutions (p < 0.05). The percentage of stained 
cells on substrates pre-adsorbed with laminin 111 from a 0.5µg/mL solution was 
significantly lower compared to the substrates pre-adsorbed with fibronectin from a 
2µg/mL solution (p = 0.011). When the outliers were removed, all the substrates pre-
adsorbed with fibronectin and type IV collagen had significantly higher percentage of 
stained cells compared to TCP and substrates pre-adsorbed with laminin 111 on culture day 
one (p < 0.05). 
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Expression of ABCG2 by HCjE-Gi cells 
 
 
Figure 2.54: Expression of ABCG2 by HCjE-Gi cells; ABCG2 (green) and DAPI (blue). On 
culture days one and seven, there was positive staining for ABCG2 in the nucleus, 
cytoplasm and cell membranes. A granular staining pattern was observed in the 
cytoplasm. By culture day fourteen, the staining was mostly transmembrane and no 
evidence of nuclear staining was present. 
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Expression of ABCG2 by HCjE-Gi cells on pre-adsorbed proteins 
 
 
 Day 1  Day 7  Day 14  
 Mean SD Mean SD Mean SD 
TCP 47.4 17.2 6.6 5.0 3.2 2.9 
2 C4 62.4 11.5 15.0 11.8 0.8 0.6 
10 C4 68.3 20.7 9.9 6.9 2.4 0.9 
0.5 LN 35.8 25.7 6.3 4.5 1.1 1.6 
1 LN 41.9 17.6 10.1 10.7 5.6 6.7 
2 FN 58.4 28.2 20.5 20.1 4.6 5.9 
10 FN 54.2 26.5 14.5 12.4 5.7 3.1 
 
Figure 2.55: A. Expression of ABCG2 by HCjE-Gi cells on pre-adsorbed proteins. Data are 
presented as mean percentage (%) of stained cells per view ± 1SD, n = 2. There were 
significantly lower percentages of stained cells on days seven and fourteen compared to 
day one (p < 0.001). There was a significantly higher percentage of stained cells on type IV 
collagen pre-adsorbed from a 10µg/mL solution compared to tissue culture polystyrene 
on culture day one (p = 0.028). Moreover, there were significantly higher percentages of 
stained cells on type IV collagen pre-adsorbed from 2 and 10 µg/mL solutions compared 
to laminin 111 pre-adsorbed from 0.5-1µg/mL solutions, and on fibronectin pre-adsorbed 
from a 2µg/mL solution compared to laminin 111 pre-adsorbed from a 0.5µg/mL solution 
on day one (p = 0.011); *p < 0.05. (Two-way ANOVA; Bonferroni post hoc test). B. Mean 
percentage of stained per view on culture days 1, 7 and 14, and 1SD; C4 - type IV collagen 
2 and 10µg/mL, LN - laminin 111 0.5 and 1µg/mL and FN – fibronectin 2 and 10µg/mL. 
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2.3.10 EXPRESSION OF GOBLET CELL MARKERS BY HCjE-Gi CELLS ON PRE-ADSORBED 
PROTEINS 
MUC5AC 
There was positive staining for MUC5AC in the cytoplasm of HCjE-Gi cells (figure 2.56). The 
staining was mostly observed in colonies of cells.  
 
Pre-adsorption of proteins did not affect the expression of MUC5AC by HCjE-Gi cells over a 
culture period of fourteen days (figure 2.57). There were eight outliers in the data set and 
nine groups were not normally distributed (day 1 – type IV collagen 10µg/mL, day 1 - 
laminin 111 1µg/mL, day 7 – TCP, day 7 – type IV collagen 2µg/mL, day 7 - laminin 111 
0.5µg/mL, day 7 - laminin 111 1µg/mL, day 7 - fibronectin 10µg/mL, day 14 – TCP, and day 
14 – laminin 111 1µg/mL). There was heterogeneity of variances (p < 0.001). The 
interaction effect between substrate and culture day on the expression of MUC5AC protein 
was not statistically significant (p = 0.234). Analysis of the main effect between the 
substrates showed no statistically significant difference, p = 0.543. However, there was a 
significant difference between the culture days, specifically; there were higher percentages 
of stained cells on days seven and fourteen compared to day one (p < 0.001). When the 
outliers were removed, there was no change to the overall result.  
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Expression of MUC5AC by HCjE-Gi cells 
 
 
Figure 2.56: Expression of MUC5AC by HCjE-Gi cells; MUC5AC (green) and DAPI (blue). 
There was positive staining for MUC5AC in the cytoplasm of HCjE-Gi cells, mostly in 
colonies of cells. 
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Expression of MUC5AC by HCjE-Gi cells on pre-adsorbed proteins 
 
 
 Day 1  Day 7  Day 14  
 Mean SD Mean SD Mean SD 
TCP 0 0 1.1 1.3 9.2 7.2 
2 C4 0 0 2.2 2.2 10.0 6.9 
10 C4 4.6 10.6 0.9 0.7 10.6 5.2 
0.5 LN 0 0 2.7 3.8 10.9 7.3 
1 LN 4.3 6.1 2.5 2.9 8.9 7.1 
2 FN 0 0 4.4 4.0 13.6 8.2 
10 FN 0 0 3.1 3.6 12.5 7.8 
 
Figure 2.57: A. Expression of MUC5AC by HCjE-Gi cells on pre-adsorbed proteins. Data are 
presented as mean percentage (%) of stained cells per view ± 1SD, n = 2. The interaction 
effect between substrate and culture day on the mean percentage of stained cells was not 
significant (p = 0.234). There was no significant difference to the percentage of stained 
cells between the substrates (p = 0.543). However, there were significant increases to the 
percentage of stained cells on culture days seven and fourteen compared to culture day 
one (p < 0.001). (Two-way ANOVA; Bonferroni post hoc test). B Mean percentage of 
stained per view on culture days 1, 7 and 14, and 1SD; C4 - type IV collagen 2 and 
10µg/mL, LN - laminin 111 0.5 and 1µg/mL and FN – fibronectin 2 and 10µg/mL. 
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UEAI and keratin 7 
There was positive staining for keratin 7 in all the cells from culture days one to fourteen on 
ICC (figure 2.58). The staining for UEAI was peri-nuclear on day one with some weak 
staining of the cytoplasm. By day seven, there was stronger cytoplasmic staining and 
granular staining pattern in some cells. On culture day fourteen, there was strong staining 
of the cell membranes with some granular staining pattern in the cytoplasm of cells.  
 
Pre-adsorption of proteins did not affect the co-expression of keratin 7 and UEAI by HCjE-Gi 
cells over a culture period of fourteen days (figure 2.59). There were seven outliers in the 
data set and seven groups were not normally distributed (day 1 – TCP, day 1 – type IV 
collagen 2µg/mL, day 1 - type IV collagen 10µg/mL, day 1 - laminin 111 1µg/mL, day 1 - 
fibronectin 10µg/mL, day 14 – laminin 111 1µg/mL, and day 14 – fibronectin 2µg/mL). 
There was heterogeneity of variances (p < 0.001). The interaction effect between substrate 
and culture day on the co-expression of keratin 7 and UEAI was not statistically significant 
(p = 0.072). Analysis of the main effect between the substrates and between the culture 
days showed no statistically significant differences, p = 0.226 and p = 0.900, respectively. 
When the outliers were removed, there was a statistically significant interaction effect 
observed between substrate and culture day on the co-expression of keratin 7 and UEAI (p 
= 0.005). There were significant reductions to the percentage of stained cells on day one 
when cultured on fibronectin pre-adsorbed from a 10µg/mL solution compared to that 
when cultured on fibronectin from a 2µg/mL solution and laminin 111 pre-adsorbed from a 
1µg/mL solution (p = 0.003 and p = 0.001, respectively). There were also significant 
increases to the percentage of stained cells on day one when cultured on laminin 111 pre-
adsorbed from a 1µg/mL solution compared to that when cultured on type IV collagen pre-
adsorbed from a 10µg/mL solution (p = 0.016), and when cultured on fibronectin pre-
adsorbed from a 2µg/mL solution compared to that when cultured on type IV collagen pre-
adsorbed from a 10µg/mL solution (p = 0.006). Additionally, a statistically significant 
increase to the percentage of stained cells was observed on type IV collagen pre-adsorbed 
from a 10µg/mL solution on culture day seven compared to day one (p = 0.002). Lastly, 
statistically significant increases to the percentage of stained cells were observed on 
fibronectin pre-adsorbed from a 10µg/mL solution on culture days seven and fourteen 
compared to day one (p = 0.001 and p = 0.043, respectively).   
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Co-expression of UEAI and keratin 7 by HCjE-Gi cells 
 
 
Figure 2.58: Co-expression of UEAI and keratin 7 by HCjE-Gi cells; UEAI (green), keratin 7 
(K7, purple) and DAPI (blue). There was positive staining for keratin 7 in all the cells from 
culture days one to fourteen. The staining for UEAI was peri-nuclear on day one with 
some weak staining of the cytoplasm. By day seven, there was stronger cytoplasmic 
staining and granular staining pattern in some cells. On culture day fourteen, there was 
strong staining of the cell membranes with some granular staining pattern in the 
cytoplasm of cells. 
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Co-expression of UEAI and keratin 7 by HCjE-Gi cells on pre-adsorbed 
proteins 
 
 
 Day 1  Day 7  Day 14  
 Mean SD Mean SD Mean SD 
TCP 8.2 10.1 10.7 7.5 12.7 4.5 
2 C4 7.7 11.4 6.9 5.6 8.6 3.6 
10 C4 3.6 7.9 12.6 5.9 9.9 4.6 
0.5 LN 10.0 7.8 9.9 5.7 8.3 4.2 
1 LN 21.5 32.2 8.7 5.4 12.6 10.5 
2 FN 13.6 12.4 8.2 4.3 11.5 5.0 
10 FN 3.7 7.8 13.3 8.0 10.0 4.6 
 
Figure 2.59: A. Co-expression of UEAI and keratin 7 by HCjE-Gi cells on pre-adsorbed 
proteins. Data are presented as mean percentage (%) of stained cells per view ± 1SD, n = 
2. The interaction effect between substrate and culture day on the mean percentage of 
stained cells was not significant (p = 0.072). There was no significant difference in the 
percentage of stained cells between the substrates or between the culture days (p = 0.226 
and p = 0.900, respectively). (Two-way ANOVA; Bonferroni post hoc test). B. Mean 
percentage of stained per view on culture days 1, 7 and 14, and 1SD; C4 - type IV collagen 
2 and 10µg/mL, LN - laminin 111 0.5 and 1µg/mL and FN – fibronectin 2 and 10µg/mL. 
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2.4 DISCUSSION 
2.4.1 Ammonium hydroxide successfully isolated the proteins of the extracellular 
matrix of HCjE-Gi cells  
The choice of decellularisation method varies for each cell or tissue type. The aim of the 
decellularisation method is to remove all the cellular material without disrupting the 
composition, biological activity or the mechanical properties of the ECM. A typical 
decellularisation protocol involves cell lysis using physical methods or ionic treatments, 
then separation of the cells from the underlying ECM using enzymes, solubilising the 
cellular organelles using detergents, and lastly removing the cellular debris.(130) In the 
present study, we showed that 1% NH4OH was sufficient to successfully isolate the ECM of 
the HCjE-Gi cells (figures 2.10-2.11). Thorough washes with PBS were required to ensure 
that all the cell debris was removed from the isolated ECM. It is imperative that the cell 
debris is adequately washed off to ensure that they do not adsorb onto the remaining 
matrix, which could give rise to sources of immunogenicity when the ECM scaffolds are 
subsequently transplanted in vivo.(130) Additionally, thorough washes remove the 
chemicals used in the decellularisation process that could potentially be toxic to the 
cells.(130, 131) The NH4OH protocol is also known to isolate the transmembrane proteins 
that are associated with the ECM proteins.(123) Studies will be required to investigate the 
immunogenicity of these proteins when undertaking in vivo studies.  
 
NH4OH is a hypertonic solution that disrupts the cells by osmotic shock.(130) Additionally, 
alkaline solutions denature proteins, solubilise cell organelles and remove nucleic 
acids.(130) However, they may remove GAGs from collagenous tissues.(131) Most physical 
methods are known to maintain the architecture and collagen content in the ECM.(132) 
Sodium dodecyl sulfate is an ionic detergent, whose negative charge leads to increased 
water content and swelling of cells thereby disrupting the cell membranes.(56) Studies on 
porcine conjunctival tissue have shown that more than 92% of the DNA was removed and 
that more than 90% of GAGs and hydroxyproline were intact following decellularisation 
using sodium dodecyl sulfate.(56) However, it may disrupt the architecture of collagens due 
to the swelling.(131) Triton X-100 is a non-ionic detergent, which disrupts lipid-lipid and 
lipid-protein interactions but maintains protein-protein interactions.(131) It has been 
shown to reduce the contents of GAGs, laminin and fibronectin.(130) Long-term exposure 
to enzymes is known to damage the ultrastructure of the ECM by removing the contents of 
collagen, elastin, laminin, fibronectin and GAGs. (130)  
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2.4.2 Immunofluorescence staining and mass spectrometry experiments were 
undertaken to identify and quantify the protein composition of the extracellular 
matrix of HCjE-Gi cells 
IF staining of ECM samples is a qualitative measure of assessing the presence and the 
distribution of individual proteins. This method relies on the interactions between a target 
protein antigen and an antibody (primary antibody), that is visualised via a fluorescence tag 
(secondary antibody) that is targeted to bind the primary antibody.(42) Accuracy of results 
obtained from IF staining depends on the specificity of antibodies and prevention of non-
specific binding to proteins in the samples, which is a major limitation of this method.  
 
The ECM is a dynamic protein structure in which the composition of proteins and their 
quantities may vary with age. As well as identifying the proteins present in the ECM, mass 
spectrometry allows quantification of individual proteins. Thus, mass spectrometry can be 
employed as a complementary quantitative method to IF staining to determine the protein 
profile of the ECM of the HCjE-Gi cells. As described in section 2.2.4, trypsin cleaves 
proteins by targeting the C-termini of lysine and arginine to produce a mixture of peptides. 
Mass spectrometry involves analysis of the individual peptides that are present in a sample 
to produce a protein profile with their relative abundances.(42) First, the mass 
spectrometer ionises the peptides to produce a stream of positive ions.(133) These are 
then accelerated to produce a stream of ions that have equal kinetic energies. The positive 
ions enter a magnetic field and are deflected according to their mass/charge ratios. These 
are then detected as an electric current that is amplified and recorded. The electric current 
increases proportionately to the number of ions arriving at the detector. The output from 
the mass spectrometer shows the relative abundance, as determined by the electric 
current, for each mass/charge ratio.(133) Data-dependent LC-MS/MS undertaken in the 
present study involves two mass spectrometers that increase the accuracy of the results. 
The first spectrometer separates the ions according to their mass/charge ratios.(42) Then 
ions with a selected mass/charge ratio (precursor ions) undergo collisional activation to 
produce fragment ions (product ions).The second spectrometer separates these product 
ions according to their masses. The number of peptides formed from each protein during 
sample preparation depends on the number of lysine and arginine present in the parent 
protein and the size of the parent protein. Although this is not a problem when 
investigating the change to the abundances of individual proteins with time, it may be a 
limitation when determining protein ratios relative to each other at each time point. 
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2.4.3 The protein composition of the extracellular matrix of HCjE-Gi cells varied over six 
weeks in culture in vitro 
2.4.3.1 There was no change to the proportion of structural collagens in the 
extracellular matrix of the HCjE-Gi cells over six weeks in culture  
Type XVIII collagen was the only structural collagen detected by mass spectrometry from 
ECM days 1 to 42 (figure 2.24). IF staining using an antibody targeting the non-collagenous 
domains of type XVIII collagen showed a granular staining pattern in the ECM of HCjE-Gi 
cells that were in culture for 21 to 42 days (figures 2.12-2.19). Positive staining for type IV 
collagen that co-localised with the staining for the laminin α3 chain was observed during IF 
staining (figures 2.12-2.19). However, type IV collagen was not detected by mass 
spectrometry. The raw abundance and the proportion of type XVIII collagen in the ECM 
increased over the six weeks culture period (0.18% in the day 1 ECM to 0.33% in the day 42 
ECM), although this was not found to be statistically significant.  
 
Type XVIII collagen is a non-fibrillar collagen-HSPG. There are three isoforms of type XVIII 
collagen: the short isoform is expressed in vascular and epithelial BMs, the medium isoform 
in liver and glomerular BMs and, the long isoform in glomerular BMs and a small amount in 
most tissues.(89) It plays a role in maintaining the structural integrity of BMs and has also 
been implicated in the regulation of cell survival and maintenance of stem and progenitor 
cells.(89) Genes regulating the production of type XVIII collagen have been shown to be up-
regulated in the haematopoietic SCs of the bone marrow and epidermal SCs of the hair 
follicle budge. The endostatin domain at the C-terminal has anti-angiogenic properties 
when cleaved from the parent protein.(134) The mass spectrometry experiments of the 
present study only detected peptides of the α1 chain of type XVIII collagen and no evidence 
of peptides of endostatin. This suggests that this peptide sequence may not be cleaved 
from the parent protein in the ECM secreted by the HCjE-Gi cells. Immunohistochemistry 
staining has shown the presence of type XVIII collagen in the BM of the OS (table 1.2). In 
contrast, moderate expression of endostatin was observed throughout corneal and limbal 
BMs, however, there was only focal expression or no expression of this protein in the 
conjunctival BM.(11) It is important that the cornea remains avascular to ensure its 
transparency, whereas conjunctival and limbal tissues are vascular tissues with a rich blood 
supply. Endostatin has also been found to be expressed in structures that border the 
anterior chamber (lens, iris, ciliary body and trabecular meshwork) and the vitreous 
(internal limiting membrane of the retina), suggesting a role in forming a “barrier” to 
185 
 
neovascularisation and thus allowing light rays to pass through ocular structures 
undisturbed.(135, 136)  
 
Type XVIII has been shown to co-localise with type IV collagen in the BM of the 
cornea.(137) A polarised orientation of type XVIII collagen within BMs has been 
demonstrated with the C-terminal endostatin facing the cells and N-terminal facing the 
connective tissue stroma.(89) This is similar to the orientation suggested for type IV 
collagen within the BMs. The endostatin domain has been shown to interact with integrin 
α5β1, glypican, laminin complex, nidogen, perlecan, fibulin, SPARC and type I, IV and VI 
collagens.(88, 89) It inhibits endothelial cell migration and proliferation and induces cell 
apoptosis by binding to integrin α5β1 and glypican.(88) In contrast to the monomeric 
endostatin molecule that has anti-migratory effects, the trimerised non-collagenous 
domains at the C-terminal of type XVIII collagen has been shown to bind to laminin 111 to 
induce cell migration.(138)  
 
Interestingly, mass spectrometry experiments of the present study failed to detect peptides 
of type IV collagen that is known to be one of the major proteins of all the BMs. However, 
staining for this protein was observed by IF experiments that co-localised with the staining 
for laminin α3 chain in the ECM of days 21 to 42. The target antigen for the antibody was 
the α1 chain of type IV collagen, which is known to be expressed in the limbal and 
conjunctival BMs and not in the corneal BM. Studies have shown that the non-collagenous 
domains at the C-termini of type IV collagen also have anti-angiogenic fragments, such as 
arrestin (α1 chain), canstatin (α2 chain) and tumstatin (α3 chain). The antibody used in the 
present study may have interacted with the C-terminal of the α1 chain of type IV collagen 
that may have similarities to that of the type XVIII collagen. However, the staining pattern 
for type IV and type XVIII collagens were different, which questions the specificity of the 
type IV collagen antibody used in IF experiments.  
 
The absence of type IV collagen observed in the present study may have been due to the 
culture substrate and the in vitro conditions. It may be that this protein is not deposited by 
the cultured HCjE-Gi cells on TCP and instead, type XVIII collagen is deposited as a structural 
collagen to provide adequate stability to the BM. Pöschl et al. showed that type IV collagen 
is important for the stability of BMs and maintenance of their structural integrity, especially 
in conditions of increasing mechanical demands, however, indispensable for the initial 
assembly of the BM in vivo.(139) They showed that mutant mice with inactivated Col4a1/a2 
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genes had normal embryonic development during the early stages with no changes to the 
mRNA expression of laminin α1 chain or nidogen 1. They also showed that these mice did 
not have compensatory expression of other type IV collagen isomers. However, by E10.5-
11.5 there were discontinuities and ruptures in the BM. In the present study, mass 
spectrometry experiments did not detect nidogen, a bridging protein between the laminin 
and type IV collagen networks. The lack of nidogen in the ECM show that this protein is not 
required as type IV collagen is not deposited by the HCjE-Gi cells cultured on TCP. Nidogen 
is not required for type XVIII collagen to bind to the laminin network.  
 
In the present study, mass spectrometry experiments detected integrins α5 and β1 in the 
ECM of the HCjE-Gi cells, although both accounted for less than 1% of the total peptides in 
the ECM at all the time points (figure 2.31). Both α5 and β1 increased significantly with time 
and this accounts for the increase in type XVIII collagen observed over the six weeks culture 
period (figure 2.24). The proportion of integrin β1 was always higher than that of integrin 
α5, which is expected as integrin β1 is known to associate with other α subunits. Integrins 
that are thought to be associated with type IV collagen are α1β1 and α2β1. Only integrin α2 
was present in the ECM of the HCjE-Gi cells, which accounted for less than 1% of the total 
peptides in the ECM at all the time points (figure 2.31). The increase in peptide abundance 
for this integrin on day 42 was not found to be statistically significant compared to that on 
day 1.  
 
2.4.3.2 Laminin chains that give rise to trimers 332, 311 and 511 were present in the 
extracellular matrix of the HCjE-Gi cells  
There were six laminin chains that were expressed in the ECM of the HCjE-Gi cells, α3, α5, 
β1, β3, γ1 and γ2 chains (figure 2.24). All these chains have previously been shown to be 
present in conjunctival tissue by immunohistochemistry (table 1.2). Combinations of these 
laminin chains can give rise to laminin trimers 332, 311 (α3β1γ1, also known as laminin 6) 
and 511. Previous studies have shown that laminins 111, 332, 311 and 511 are found in the 
BM of the cornea and additional trimers incorporating the α2 and β2 chains are found in the 
BM of the conjunctiva (laminin 211, 221 (α2β2γ1, also known as laminin 4) and 521 (α5β2γ1, 
also known as laminin 11)).(119) In the present study, there was no evidence of α2 and β2 
laminin chains in the ECM, which may explain the lack of expression of keratin 4 by the 
HCjE-Gi cells. 
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The most abundant structural protein in the ECM of HCjE-Gi cells was laminin α3 chain 
throughout the six weeks culture period, the raw abundance of which increased 
significantly on day 7 compared to day 1 (figures 2.24 and 2.30). Although the highest raw 
peptide abundance was observed in the day 42 ECM this was not found to be statistically 
significant compared to that on day 7. The next most abundant chains were laminin β3 and 
γ2 chains, whose raw peptide abundance followed a similar pattern to that observed for the 
laminin α3 chain. The proportion of laminin β3 in the ECM remained relatively stable, 
whereas that of γ2 chain reduced over the six weeks (figure 2.30). This may suggest that 
with time there is an increase in the formation of laminin 311 that contains the α3 chain. 
Nevertheless, the results of the present study indicated that the ECM secreted by the HCjE-
Gi cells is predominantly made up of laminin 332. The present study also showed the 
presence of the α3 chain of laminin using IF experiments. This protein was present in the 
day 1 ECM and continued to be deposited abundantly throughout the six weeks culture 
period (figures 2.12-2.19). Laminin 332 has been shown to be deposited into the provisional 
ECM within eight hours of epithelial wounding.(140)   
 
Laminins are deposited in various patterns by cultured cells that may suggest differences in 
the function of the laminin matrix or represent various stages of the matrix formation.(129) 
Human keratinocytes have been shown to deposit laminin 332 in a rosette-like pattern 
when stationary.(129) This is in contrast to that deposited by the migrating cells, which 
deposit laminin 332 in a trail-like pattern. Similar results were observed in the present 
study by IF staining for the laminin α3 chain (figures 2.12-2.19). Syndecan 1 has been 
implicated in the deposition of laminin 332, where a lack of syndecan 1 has been shown to 
deposit laminin 332 in arrowhead-like arrays by keratinocytes.(129) This was in contrast to 
the wild-type cells that deposited laminin 332 as cloud-like trails. The peptides of syndecan 
1 were present in the ECM secreted by the HCjE-Gi cells, which increased significantly over 
the six weeks (figure 2.24). Laminins 211 and 221 has been shown to be deposited as a 
mesh by Schwann cells and laminin 311 as fibrils by alveolar cells, where it plays a role in 
transmitting stretch signals to the cells.(129) The possibility of increased deposition of 
laminin 311 by HCjE-Gi cells with time may suggest a similar role in being able to transmit 
mechanical signals from a maturing ECM to the cells.  
 
Laminin 332 is secreted as a 460kDa molecule that is processed to form a 440kDa molecule 
by keratinocytes in the presence of low calcium (0.035mM) and a smaller mature molecule 
(400kDa) in the presence of high calcium (1mM).(140) This is due to the processing of the γ2 
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chain and the globular domains IV and V of the α3 chain. The α3 chain of laminin 332 has 
been shown to support the adhesion and migration of cells in vitro via integrins α6β4 and 
α3β1, respectively.(140) The processed mature laminin α3 chain has been shown to be 
involved in the formation of stable adhesions via hemidesmosomes, whereas the 
unprocessed chain is deposited by the migrating keratinocytes.(140) The proteolytic 
cleavage of the γ2 chain by MMPs 2 and 14 has been shown to enhance the migration of 
cells.(141) These studies show that the main cell binding site on the laminin α3 chain is 
located in the globular domains I-III.(141) However, studies have shown that globular 
domain IV has a strong affinity to heparin and has been shown to promote cell adhesion by 
binding to syndecans on the cell membranes.  
 
Laminin 332 is an important constituent of hemidesmosomes connecting epithelial cells to 
their BM and the underlying connective tissue stroma. The α3 chain of laminin interacts 
with integrin α6β4 on the cell membrane and the β4 integrin interacts with the keratin 
cytoskeleton via plectin.(140) These structures are strengthened by type XVII collagen that 
interact with laminin 332 and bullous pemphigoid antigen 230 that interacts with integrin 
β4.(140) Focal adhesions connect the laminin α3 chain to the actin cytoskeleton via integrin 
α3β1.(140) Integrin α6 was the most abundant integrin in the ECM of the HCjE-Gi cells from 
days 1 to 14 (7.7% and 11.6% of the total ECM peptides, respectively), whereas integrin β4 
was the most abundant integrin from days 28 to 42 (11.9 and 17.6%, respectively) (figure 
2.31). Integrins α3 and β1 were also present, although they only contributed to less than 1% 
of the ECM throughout the six weeks (figure 2.31). The raw peptide abundances of these 
integrins were significantly higher on day 42 than day 1, except for that of integrin α3. The 
ECM of the HCjE-Gi cells consisted of the transmembrane proteins type XVII collagen and 
CD151 (figure 2.24). The raw peptide abundances of both these proteins increased 
significantly by day 42. Plectin and bullous pemphigoid antigen 230 were also shown to be 
present in the samples by mass spectrometry, however, these were classified as 
intracellular proteins. These results demonstrate that the HCjE-Gi cells were able to form 
stable attachments to the underlying ECM via hemidesmosomes as the epithelium matured 
during the culture period.     
 
Another laminin trimer that may be present in the ECM of the HCjE-Gi cells is laminin 311. 
Although laminin 311 shares the same α3 chain as that in laminin 332, its cell adhesive and 
migratory properties have been found to be significantly less than that of laminin 332.(140) 
Hirosaki et al. showed that unprocessed laminin 311, laminin 311 without the IV-V globular 
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domains on the α3 chain and mature laminin 332 with processed α3 and γ2 chains supported 
cell adhesion via integrins α3β1 and α6β1 in human fibrosarcoma cells.(141) However, 
unprocessed laminin 311 did not support spreading or migration of the cells compared to 
the processed laminins 311 and 332. The authors suggested that the reduced cell spreading 
and migration in human fibrosarcoma cells may be due to steric hindrance of the cell 
binding globular domains I-III by the globular domain V of the unprocessed α3 chain. 
Hirosaki et al. also showed that mature laminin 332 supported cell migration more 
effectively than the processed laminin 311 lacking the IV-V globular domains of the α3 
chain. Thus, cell migration not only depends on the lack of the globular domains IV-V of the 
α3 chain, but also on the proteolytic processing of the γ2 chain of laminin 332 in these 
cells.(141) Additionally, studies on amniotic and skin tissues have shown that approximately 
half of the laminin 332 is covalently linked to either laminin 311 or 321 (α3β2γ1, also known 
as laminin 7).(141) These laminin complexes together with laminin 332-type VII collagen 
complexes synergistically are responsible for forming strong interactions between the 
epidermis and dermis.(141, 142)     
 
The peptides of laminin chains α5, β1 and γ1 contributed to less than 1% of the total ECM 
from day 1 to 42 (figure 2.30). Although the raw peptide abundances of all the chains 
increased with time, significant increases were only observed from day 1 to 7 for the α5 
chain, and from day 1 to 14 for β1 and γ1 chains. Laminin 511 together with laminin 521 are 
known as placental laminins.(119) The lack of the α5 chain has been shown to lead to death 
during late embryogenesis and has been shown to be present in fetal and adult 
tissues.(143) Hasenson et al. showed that the α5 chain mediates cell adhesion and 
spreading via integrins α3β1 and BCAM on the membranes of corneal epithelial cells.(143) In 
addition to integrin α3β1, BCAM was also present in the ECM of the HCjE-Gi cells (figure 
2.24), although there was no significant difference to its peptide abundance between 
culture days 1 and 42. It only contributed to 0.6% of the total peptide abundance in the day 
42 sample (figure 2.31). Additionally, Hasenson et al. suggested that these transmembrane 
proteins bind to the globular domains I-III of the laminin α5 chain independently of each 
other to mediate intracellular signalling.(143) Lin et al. showed that the conjunctival 
epithelial cells interacted with the globular domain IV of the α5 chain via syndecan 4. 
Blocking this specific domain on the laminin α5 chain only reduced cell adhesion by 16% 
suggesting the presence of alternative binding sites on laminin 511.(144) Syndecan 4 was 
present in the ECM of the HCjE-Gi cells (figure 2.24), although its raw peptide abundance 
was less than that observed for syndecan 1. It contributed to less than 1% of the total 
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peptide abundance throughout the six weeks (figure 2.31) and there was no significant 
difference in the peptide abundances between the day 1 and day 42 samples. Nakashima et 
al. showed that the short arm of the β3 chain of laminin 332 stimulates human embryonic 
kidney cells to deposit laminin 511 to enhance laminin 511-dependent adhesion and 
spreading.(142) It is likely that the laminin 332, 311 and 511 interact with each other in a 
synergistic manner to enhance adhesion, spreading and migration of HCjE-Gi cells in vitro. 
 
2.4.3.3 Thrombospondins 1 and 2 were present but thrombospondin 4 was absent in 
the extracellular matrix of HCjE-Gi cells  
Thrombospondin 1 was the next most abundant GP in the ECM of the HCjE-Gi cells after 
laminin 332 chains. It contributed to 4.4-6.5% of the ECM from days 7 to 42 (figure 2.30). 
Thrombospondin 2 was also present in the ECM of the HCjE-Gi cells, however, contributed 
to less than 1% of the ECM throughout the six weeks (figure 2.30). Thrombospondins 1 and 
2 are anti-angiogenic, whereas thrombospondin 4 is pro-angiogenic, which has been shown 
to have a focal distribution in conjunctival tissues by immunohistochemistry.(145) The 
conjunctiva is a vascular tissue, however, thrombospondin 4 was not present in the ECM 
secreted by the HCjE-Gi cells. These findings suggest that thrombospondins 1 and 2 may 
play a role different to an anti-angiogenic role in the conjunctival tissues. Contreras-Ruiz et 
al. showed the presence of conjunctival inflammation and associated loss of GC function in 
thrombospondin 1-null mice.(94) Soriano-Romani et al. showed the expression of small 
amounts of thrombospondin 1 by conjunctival epithelial cells in vitro.(106) 
Thrombospondin 1 is thought to mediate its effects via CD36 and CD47 (also known as 
platelet glycoprotein 4 and leukocyte surface antigen CD47, respectively). The present 
study did not show the expression of CD36, however, the raw peptide abundance of CD47 
increased significantly on day 42 compared to that on day 1 (figure 2.24). Soriano-Romani 
et al. showed that the conjunctival epithelial cells predominantly exerted its anti-
inflammatory effects via CD47 rather than CD36.(106) Thus, thrombospondin 1, and maybe 
2, may play an immunomodulatory role via CD47 in the HCjE-Gi cells to maintain the normal 
tissue homeostasis. 
 
2.4.3.4 The highest peptide abundance of adhesive glycoproteins were in the 
extracellular matrix of the HCjE-Gi cells that has been in culture for seven days 
The adhesive GPs found to be expressed in the ECM of the HCjE-Gi cells were fibronectin, 
nephronectin and vitronectin (figure 2.24). The peptide abundances of all these proteins 
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were highest in the day 7 ECM, however, only that of fibronectin and nephronectin were 
statistically significant compared to the other time points.  
 
The proportion of fibronectin was highest in the day 1 and 7 ECM samples (0.8% and 0.7%, 
respectively) (figure 2.30). Fibronectin only contributed to 0.2% of the total peptide 
abundance in the day 42 ECM. This was confirmed by IF staining that showed a ‘spike-like’ 
staining pattern around the staining for the laminin α3 chain, the expression of which 
reduced after day 7 (figures 2.12-2.19). In wound healing, cells secrete and migrate over a 
provisional matrix made up of laminin 332 and fibronectin.(103, 146) This provisional 
matrix is degraded and remodelled by the cells by secreting new matrix proteins.(103) As 
cultured cells migrate the focal complexes at the edge of cell mature into focal contacts, 
which together with the actin cytoskeleton produce the tractional forces required to pull 
the cell forward.(103) At the opposite end of the cell, the focal contacts disassemble 
allowing the cell to detach from the underlying matrix, again allowing the movement of cell 
forward.(103) Kligys et al. showed that laminin 332 enhanced bronchial epithelial cell 
migration, whereas fibronectin reduced cell migration by enhancing cell adhesion.(146) The 
main integrin that fibronectin is thought to be associated with is α5β1. The highest 
proportion of fibronectin in the present study was found in the ECM secreted by the cells 
that have been in culture for 1 to 7 days. However, the proportions of laminin α3 and γ2 
chains, thought to enhance cell migration, in the day 1 ECM were approximately nine-folds 
higher than that of fibronectin. It may be that the provisional matrix of the HCjE-Gi cells 
provides a balanced matrix that supports initial cell adhesion as well as cell migration.  
 
Vitronectin was present in the ECM of the HCjE-Gi cells, which has not been shown to be 
present in conjunctival tissue previously using immunohistochemistry (table 1.2). In 
contrast, weak staining for this protein has been observed in the cornea and as a sub-BM 
layer in the limbus. Like fibronectin, it is thought to play an adhesive role in the provisional 
matrix. In the present study, although there was no significant change to the raw peptide 
abundance over the six weeks, the highest proportion of this protein was observed in the 
day 1 and day 7 ECM samples (approximately 0.06%) (figure 2.30). Moreover, vitronectin 
has also been shown to enhance cell migration and rate of wound closure in corneal 
epithelial cells.(92) Vitronectin is thought to mediate its effects by binding to integrins αvβ3 
and αvβ5.(92) The ECM of the HCjE-Gi cells did not express these β subunits. However, 
Huang et al. showed that β6-null mouse keratinocytes exhibited reduced cell migration 
when cultured on vitronectin and fibronectin in vitro, suggesting that these proteins 
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interacted with integrin αvβ6 to mediate their effects on the cells.(147) Similarly, the HCjE-
Gi cells may interact with vitronectin via integrin αvβ6. The peptide abundance of the αv 
subunit increased significantly over the six weeks, whereas that of the β6 subunit did not 
(figure 2.24).  
 
Gildner et al. showed that fibronectin-null mouse embryonic fibroblasts when cultured on 
vitronectin deposited fibronectin fibrils that were less extended than when cultured on 
type I collagen, although the amount of fibronectin deposited was similar on both 
substrates.(91) Moreover, they showed that the cells cultured on vitronectin had a lower 
proliferation rate than when cultured on type I collagen, which they suggested was due to 
the altered conformation of the fibronectin fibril and therefore the exposure of its growth 
promoting domains. The altered functionality of the cells may also be due to independent 
effects of the two substrates alone, where type I collagen may induce a higher proliferative 
effect on fibroblasts than vitronectin. In the present study, the peptide abundances of both 
proteins followed a similar pattern in the ECM of the HCjE-Gi cells, although the peptide 
abundance of fibronectin was approximately ten times higher than that of vitronectin on 
days 1 and 7. This may be due to differences in the sizes of the two proteins. A future study 
would be to look at the functional effects on HCjE-Gi cells in the presence of these two 
proteins alone and together.  
 
To our knowledge to date, nephronectin has not been shown to be present in the ECM of 
the conjunctiva. We showed that it is present in the ECM of HCjE-Gi cells cultured in vitro, 
the highest raw peptide abundance and proportion (0.03%) being observed in the day 7 
ECM (figure 2.30). It has been shown to support the adhesion and migration of rat 
cardiomyocytes via its RGD domain by interacting with integrin α8β1 on cell 
membranes.(148) However, the present study failed to show the presence of the integrin 
subunit α8 in the ECM of the HCjE-Gi cells. This suggests the presence of another binding 
site for nephronectin. Sato et al. showed that nephronectin binds to HSPG in the ECM, such 
as perlecan and agrin, via its MAM (meprin, A5 protein, protein-tyrosine phosphatase mu) 
domain.(149) However, the physiological relevance of this interaction remains unknown. 
Further studies are required to investigate the importance of nephronectin on conjunctival 
cells. 
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2.4.3.5 The highest proportion of α-2-HS-glycoportein and annexin A2 was in the 
extracellular matrix of the HCjE-Gi cells that has been in culture for one day 
The highest raw peptide abundance and proportion (4.3%) of α-2-HS-GP was in the day 1 
ECM (figures 2.24 and 2.30). Although there was no significant difference to the peptide 
abundance of annexin A2 in the ECM over the six weeks, its highest proportion was found 
in the day 1 ECM (11.4%) (figure 2.33). To our knowledge to date, α-2-HS-GP has not been 
shown to be expressed in the ECM of the normal conjunctiva or the ocular surface. Fetuin-
A, its bovine homologue, was first detected in fetal and new born calf serum. It is one of the 
major components of fetal calf serum that is thought to mediate cell adhesion and 
migration when used in the culture medium in vitro. In humans, it is predominantly found 
in fetal tissue compared to adult tissue. α-2-HS-GP has been shown to have cell adhesive 
properties that are mediated via annexins A2 and A6 in intestinal epithelial cells and breast 
carcinoma cells, respectively.(98) In breast carcinoma cells, adhesion has also shown to be 
mediated via integrin β1 in the presence of magnesium ions.(96) Studies involving primary 
keratinocytes have shown significant increases to rates of cell migration and wound closure 
when cultured in serum-free media in the presence of α-2-HS-GP.(96) Additionally, α-2-HS-
GP has been shown to promote scarless healing in an ovine burn model.(97) It is an 
antagonist of TGFβ and bone morphogenetic proteins (TGFβ related proteins), thus 
improving the outcome of burns by reducing the inflammatory responses and 
myofibroblast formation.   
 
2.4.3.6 Perlecan was the most abundant proteoglycan from days one to fourteen, 
whereas agrin was the most abundant proteoglycan from days twenty-eight to 
forty-two in the extracellular matrix of the HCjE-Gi cells 
Perlecan was the most abundant PG in the ECM of HCjE-Gi cells on culture day 1 (5.7% of 
the total peptides), the highest proportion being observed on day 14 (7.1%) (figure 2.30). 
Its raw peptide abundance significantly increased on day 7 compared to day 1 and, no 
further significant differences were observed thereafter. By day 28, the proportion of agrin 
surpassed that of perlecan contributing to 5.8% of the total ECM on day 42 (figure2.30). 
 
Perlecan is a large multi-domain HSPG found throughout the OS. It has been associated 
with various cellular functions, including wound healing, cell proliferation, survival and 
terminal differentiation.(150) Inomata et al. showed that mice that lacked perlecan in 
ocular tissues had microphthalmos and small palpebral fissures.(150) Although, these mice 
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had structurally normal corneal BMs on transmission electron microscopy, the overlying 
epithelium was thin consisting of an undifferentiated wing cell layer compared to that in 
the wild-type mice.(150) These findings were thought to be due to the lack of perlecan 
important for cell proliferation and terminal differentiation.(150) To our knowledge to date, 
although the presence of perlecan has been shown in the BM of the conjunctiva (table 1.2), 
functional studies in the conjunctiva have not been undertaken. It is likely that perlecan 
supports cell proliferation and differentiation of HCjE-Gi cells, similar to that observed with 
corneal cells.  
 
Miosge et al. showed that approximately half of the endostatin domains of type XVIII 
collagen co-localised with perlecan and not nidogen 1 in adult mouse kidney BMs in 
vivo.(134) This explains the results observed in the present study, which showed the 
presence of type XVIII collagen and perlecan and not nidogen in the ECM secreted by the 
HCjE-Gi cells. This demonstrates one mechanism by which the type XVIII collagen network 
may interact with the rest of the ECM laid down by the cells. The interaction with 
endostatin is thought to be mediated via domain V of perlecan that has three globular 
domains, homologous to the globular domains of laminin, separated by two EGF-like 
domains.(88) This domain on perlecan has also been shown to bind to the laminin-nidogen 
complex and integrin α2β1 of cells. Domain I of perlecan consists of heparan sulphate side 
chains that interact with type IV collagen, laminin 111, thrombospondin, fibronectin and 
GFs. Binding of perlecan to GFs modulate their functions and plays a role in the 
maintenance of homeostasis of BMs in tissues.(88)     
 
Agrin is a modular HSPG that has been shown to be present throughout the OS, however, 
has a specialised role in the development of neuromuscular junctions.(88) It has been 
shown to be associated with limbal SCs of the OS. It is possible that agrin plays a similar role 
in the BM of the conjunctiva. In the present study, its proportion increased more than that 
of perlecan from days 28 to 42 (figure 2.30). This increase in the proportion of agrin in the 
late ECM of the HCjE-Gi cells may support the maintenance of SCs during long term culture 
in vitro. However, other roles in the conjunctiva, possibly related to the heparan sulphate 
side chains, cannot be excluded. Therefore, further studies are required to elicit the 
functional roles of agrin in the BM of conjunctiva.  
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2.4.3.7 The highest proportions of growth factors and their binding proteins were in the 
extracellular matrix of the HCjE-Gi cells that have been in culture for one to 
seven days  
GFs are soluble proteins produced by cells that bind to other ECM proteins, especially the 
PGs. The proteases in the ECM ensure the controlled release of bound GFs into the ECM. 
GFs modulate cellular functions, including the production of ECM proteins, via autocrine, 
juxtacrine or paracrine mechanisms. In the present study, the highest proportion of GFs and 
their binding proteins were in the day 1 and 7 ECM samples (approximately 17% of the total 
peptides) (figure 2.23). This proportion reduced from day 14 to day 42. One reason for this 
reduction in GFs may be due to the simultaneous increase in proteases observed from day 
7 (figure 2.34). The proteases may cleave the GFs from the other ECM proteins and due to 
their soluble nature, could have been washed during sample preparation. However, a true 
reduction in the synthesis of GFs and their binding proteins by the HCjE-Gi cells cannot be 
excluded.  
 
Insulin was the most abundant protein in this category in the day 1 ECM (figure 2.32). Its 
raw peptide abundance was highest in the day 7 ECM (figure 2.24), although this was not 
found to be statistically significant compared to the other time points. Insulin and insulin-
like GFs has been shown to promote migration, growth, glucose metabolism and hydration 
of corneal epithelial cells in vitro.(151) In the present study, we did not observe insulin-like 
GFs, however, there were IGFBPs 3 and 10 in the ECM of the HCjE-Gi cells (figure 2.24). 
IGFBP bind to insulin-like GFs and regulate their biological actions by prolonging their half-
lives.(152) High expression of IGFBP 3 has been shown to be protective against carcinomas, 
whereas low levels have been associated with increased risk of carcinomas.(153) Down-
regulation of IGFBP 3 has been shown to be associated with uncontrolled cell proliferation 
in conjunctival tissue obtained from patients with pterygia.(153)   
 
IGFBP 10, also known as protein CYR61 due to its cysteine-rich structure, belongs to the 
family of CCN (CYR61, Connective tissue GF and Neuroblastoma overexpressed) 
proteins.(154) All the proteins in this family are thought to interact with various proteins 
due to their modular structure consisting of IGFBP, von Willebrand factor type C repeat and 
thrombospondin 1 repeat modules. This class of proteins are thought to be involved in 
angiogenesis. IGFBP 10 in particular has been shown to promote adhesion, migration and 
proliferation of endothelial cells by interacting with integrins αVβ3, αVβ5 and α6β1 in vitro. 
Studies have also shown that the presence of this protein in the cornea can induce 
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neovascularisation in vivo. Since conjunctiva is a vascular tissue, the presence of this 
protein is likely to be physiological. Moreover, IGFBP 10 has also been shown to bind to 
HSPGs in the ECM, displacing other GFs, and subsequently promoting their roles within the 
ECM.(154) 
 
In the present study, there was no evidence of TGFβ, however, TGFβ ig-h3 and LTBP 2 
proteins were present (figure 2.24). The raw peptide abundance of TGFβ ig-h3 was 
significantly higher on day 7 compared to the other time points, contributing to 3.7% of the 
day 7 ECM (figure 2.32). However, LTBP 2 increased significantly on day 7 compared to day 
1 and reduced on day 28 compared to day 7. It contributed to less than 1% of the ECM at all 
the time points (figure 2.32). TGFβ promotes differentiation of epithelial cells and inhibits 
their proliferation and production of inflammatory proteins.(151) In contrast, it stimulates 
the proliferation of myofibroblasts and the production of ECM proteins. The expression of 
TGFβ ig-h3 is thought be stimulated by a complex mixture of proteins including TGFβ.(155) 
TGFβ ig-h3 has been shown to bind to fibrillar collagens, type IV collagens, laminins, 
fibronectin and small leucine-rice PGs in the ECM.(155) Maeng et al. showed that TGFβ ig-
h3 promoted the adhesion, migration and proliferation of corneal epithelial cells in a dose 
dependent-manner.(156) This is thought to be mediated via the binding of this protein to 
integrin α3β1.(155) Moreover, they showed that this protein plays a role in the 
differentiation of cells and increased the mRNA levels of membrane-type and gel-forming 
mucins in corneal and conjunctival epithelial cells.(156) Further studies are required to 
investigate the functional roles of this protein on HCjE-Gi cells cultured in vitro, in particular 
the expression of MUC5AC producing GCs. 
 
LTBPs are known to bind predominantly to fibrillins, however, have been shown to bind to 
fibronectin, fibulins, HSPGs and ADAMTS-like proteins.(157) LTBP 2 is the only protein in 
this family that does not bind to any TGFβ isoforms. Instead, it has been shown to interact 
with other GFs, such as GDF 8. Although this specific GF was not present in the ECM of the 
HCjE-Gi cells, GDF 15 was present, which might be interacting with LTBP 2. The highest 
proportion of growth differentiation factor 15 was observed in the day 14 ECM, in which it 
contributed to 2.3% of the ECM (figure 2.32). However, the functional significant of this on 
the HCjE-Gi cells is unknown. It may be that interaction of GFs with LTBP 2 promotes 
increased production of ECM proteins by binding to other ECM proteins, such as 
fibronectin.  
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FGFBP 1 was another protein in this category, whose highest proportion and raw peptide 
abundance were observed in the day 7 ECM (figures 2.24 and 2.32). FGFBP 1 is thought to 
enhance the activity of FGF.(158) FGF induces migration and proliferation of endothelial 
cells and is therefore important for angiogenesis. Moreover, FGF inhibits differentiation of 
smooth muscle cells. Briones et al. showed that the presence of TGFβ can down-regulate 
the expression of FGFBP 1 mRNA during smooth muscle differentiation in vitro.(158) The 
present study did not show evidence of presence of FGF, thus, further studies are required 
to investigate the functional significance of FGFBP 1 on HCjE-Gi cells.  
 
2.4.3.8 The expression of proteases and their inhibitors increased and decreased, 
respectively, in the extracellular matrix of HCjE-Gi cells over six weeks in culture 
The proportion of proteases in the day 1 ECM of HCjE-Gi cells was 40.1%, whereas that of 
protease inhibitors was 59.9% (figure 2.34). By day 7, there were more proteases than 
there were protease inhibitors (77.9% and 22.1%, respectively). The proportion of 
proteases in the ECM continued to increase, whereas that of protease inhibitors decreased 
from day 7 to day 42. The balance between the proteases and their inhibitors is important 
for normal tissue homeostasis and prevention of pathological states.  
 
Serine protease HTRA1 was the most abundant protein in this category throughout the six 
weeks culture period, its peptide abundance significantly increased on day 7 compared to 
day 1 (figures 2.24 and 2.32). This protein may account for the significant reduction in 
fibronectin, vitronectin, LTBP 2 and TGFβ ig-h3 observed after day 7. It has been shown to 
be expressed in various tissues, highest expression being found in the mature epidermis 
and placenta, where it has been shown to have non-specific protease activity, including 
degradation of fibronectin, aggrecan and IGFBP 5.(159) An et al. showed that serine 
protease HTRA1 breaks down proteins that are associated with the complement pathway 
(vitronectin, apolipoprotein J and fibromodulin) and with deposition of amyloid (α-2-
macroglobulin, apolipoprotein J and ADAM 9) in retinal pigment epithelial cells in vitro, 
linking it to the pathogenesis of age-related macular degeneration.(159) In this study, 
fibronectin was not shown to be degraded by serine protease HTRA1. Moreover, Karring et 
al. showed that serine protease HTRA1 breaks down a mutant form of TGFβ ig-h3, a protein 
that is found abundantly in amyloid deposits of the cornea in lattice corneal 
dystrophy.(160) They also suggested that the glia derived nexin inhibits the activity of 
serine proteases, thus regulating the proteolytic processing of amyloid deposits. Oka et al. 
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showed that serine protease HTRA1 protein binds to a range of TGFβ family proteins, 
including TGFβ 1 and 2, bone morphogenetic protein 4 and GDF 5, to inhibit their functions 
in a mouse myoblast cell line.(161) This suggests that serine protease HTRA1 may be 
responsible for the reduction of GFs and their binding proteins observed in the ECM of 
HCjE-Gi cells from day 7 onwards.  
 
Studies on human conjunctival tissue have shown the expression of MMPs 1, 2, 3 and 9 in 
the epithelium and stroma, as well as the expression of TIMPs 1, 2, and 3.(162) A study by 
Girolamo et al. however, failed to show the presence of MMPs 1 and 2 and TIMPs 1 and 2, 
whereas TIMP 3 was observed only in approximately 27% of the normal conjunctival 
tissues.(163) They showed that these proteins are up-regulated in tissues of patients with 
pterygia suggesting roles in tissue inflammation, remodelling and angiogenesis. A study by 
Liu et al. showed expression of mRNA of MMPs 1, 2, and 14 and TIMP 1 in rabbit 
conjunctival tissue but failed to demonstrate the expression of MMPs 3 and 9.(164) In the 
present study, mass spectrometry experiments showed the expression of MMPs 14 and 28 
in the ECM secreted by the HCjE-Gi cells in vitro (figure 2.24). The peptide abundance of 
MMP 14 was higher than that of MMP 28 throughout the six week culture period and the 
raw peptide abundance of both proteins increased significantly with time. The HCjE-Gi cells 
also secreted TIMP 3 (figure 2.24), which had a significantly higher raw peptide abundance 
on day 7 compared to days 1 and 14, however, the peptide abundance at day 42 was 
similar to that observed on day 7. MMP 1 is thought degrade fibrillar collagens, MMPs 2 
and 9 degrade type IV collagen, and MMP 3 degrade laminins, fibronectin and PGs.(163) 
The lack of fibrillar and BM-associated type IV collagen in the ECM of the HCjE-Gi cells may 
explain the lack of MMPs 1, 2 and 9 in the present study. Endostatin, the biologically active 
domain of type XVIII collagen, was not observed in the ECM secreted by the HCjE-Gi cells. 
This is likely to be due to the lack of the MMPs 3, 7, 9, 13 and 20 that has been shown to 
cleave this domain from the parent protein in previous studies.(137, 165)  
 
MMP 14 is a transmembrane protease found in the cornea, lens, choroid, retina, retinal 
pigment epithelium and the sclera in human tissues.(166) To date, MMPs 2 and 14 are the 
only MMPs known to cleave laminin 332 in vitro.(167) Koshikawa et al. showed that 
migration of epithelial cells was mediated by the presence of MMP 14 to cleave the γ2 chain 
of laminin 332.(168) They suggested that MMP 2 may be acting as an adjunct that enhances 
the effects of MMP 14. Moreover, it has been suggested that cell lines that secrete MMP 14 
degrade laminin 332 into its migratory form, whereas those that do not secrete MMP 14 
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allow laminin 332 to be employed to form hemidesmosomes that are present in non-
migratory cells.(168) This is in contrast to the theories that have been suggested for MMP 
28. Heiskanen et al. showed that MMP 28 is deposited into the ECM of cultured epithelial 
cells lines, such as A549 (human lung adenocarnicoma), MDCK (Madin-Darby canine kidney 
epithelial cells) and HeLa (human cervix carcinoma cells).(169) Saarialho-Kere et al. showed 
that MMPs 3 and 28 were produced by non-migrating proliferating keratinocytes.(167) 
They showed that MMP 28 positive areas of tissue consisted of highly proliferative cells 
with a BM composed of type IV collagen. This was in contrast to that observed around 
migrating cells, which consisted of a BM predominantly made up of laminin 332. MMPs 14 
and 28 may play roles in migration and adhesion, respectively, in HCjE-Gi cells cultured in 
vitro.  
 
2.4.3.9 The highest proportions of galectin-3-binding protein was in the extracellular 
matrix of the HCjE-Gi cells that have been in culture for fourteen to forty-two 
days  
The highest proportion of galectin-3-binding protein was in the day 14 to day 42 ECM 
samples, contributing to 4.2-5.9% of the peptides (figure 2.33). The ECM of HCjE-Gi cells 
also expressed peptides of galectins 1 and 3 (figure 2.24). The peptide abundance of 
galectin 1 was higher than that of galectin 3 at all the time points investigated. Argueso et 
al. presented a model where galectin 3 was shown to bind to MUCs 1 and 16 on the OS, to 
form an epithelial barrier.(170) Moreover, Cao et al. showed that there was a significant 
reduction in re-epithelialisation of corneal wounds in the absence of galectin 3, whereas 
absence of galectin 1 did not affect the rates of wound closure.(171) They also showed that 
addition of exogenous galectin 3 did not have a rescue effect on the corneal wounds and 
suggested that endogenous galectin 3 production must influence the expression of other 
proteins that promote cell migration. Previous studies have shown that breast carcinoma 
cells overexpressing galectin 3 consists of high expression of integrins α4β7 and α6β1, and 
increased adhesion to laminin, fibronectin and vitronectin compared to cells that did not 
express galectin 3.(171) Tinara et al. showed that galectins 1 and 3 bound to different sites 
on galectin-3-binding protein.(172) All three proteins have been found to be over-
expressed in carcinoma cells where they may play a role in their progression.  
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2.4.3.10 The proportions of serotransferrin and serum albumin were highest in the day 
one extracellular matrix of the HCjE-Gi cells 
Serotransferrin contributed 1.3% of the day 1 ECM and 0.4% of the day 42 ECM (figure 
2.33). Its raw abundance was highest on day 7, which was significantly higher compared to 
that on day 1 and 14, however, not day 42. Serotransferrin is a protein that is responsible 
for maintaining physiological levels of iron in serum.(152) Tears on the OS have also been 
shown to contain transferrin. Weinzimer et al. showed that serotransferrin increased the 
growth of sheep bladder smooth muscle cells and reduced apoptosis of prostate carcinoma 
cells compared to the controls.(152) Moreover, they showed that serotransferrin is a ligand 
for IGFBP 3 and culturing cells with serotransferrin-IGFBP 3 together inhibited the growth of 
cells. Interestingly, this combination also reduced cell apoptosis induced by IGFBP 3 alone. 
It may be possible that serotransferrin plays multiple functions in the ECM of the HCjE-Gi 
cells, including maintaining physiological levels of iron that may be toxic to cells if present 
at too higher levels, and modulate cell proliferation and their viability.  
   
Serum albumin contributed to 1.6% of the day 1 ECM and reduced with time (figure 2.33). 
Its raw peptide abundance was highest in the day 7 ECM, although this was not found to be 
statistically significant. Koblinski et al. showed that BSA, SPARC and cytochrome C ‘activate’ 
adhesive proteins, such as laminin, fibronectin and vitronectin when present in 
concentrations too low to exert a biological activity.(173) The authors showed that the 
increase in cell adhesion was only observed when these proteins are added prior to or 
together with the adhesive proteins, whereas no increase to the cell adhesion was 
observed when added after the adhesive proteins. They suggested that these proteins 
activate the adhesive proteins by affecting the conformation by which the adhesive 
proteins are pre-adsorbed onto a substrate and therefore exposing important integrin 
binding sites.(173) In the present study, fibronectin and vitronectin had the highest raw 
peptide abundances on day 7 and the highest proportions of these proteins were in the day 
1 and day 7 ECM samples. Peptides of fibronectin and vitronectin contributed to 0.8% and 
0.06% of the total ECM on day 1, respectively, which gradually reduced over the six weeks 
(figure 2.30). It may be that serum albumin plays a role in activating fibronectin and 
vitronectin, which appear to be present in low concentrations in the ECM of the HCjE-Gi 
cells, thereby enhancing their cell-adhesive properties. 
 
Apolipoprotein J, also known as clusterin, is an extracellular chaperone protein that 
regulates the clearance of partially unfolded proteins by promoting endocytosis and 
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lysosomal degradation that may aggregate to cause pathology.(174) Serum albumin has 
been shown to bind to apolipoprotein J to serve as a vehicle for the transportation of the 
abnormal proteins. This suggests another possible role for serum albumin in the ECM of the 
HCjE-Gi cells. As expected, the raw abundance of apolipoprotein J increased significantly 
over the six weeks, which is likely to be due to the presence of increased amount of 
abnormal proteins associated with increased oxidative stress during the ageing process of 
the ECM.   
 
2.4.4 Type IV collagen and fibronectin increased the adhesion, and type IV collagen, α-
2-HS-GP and the extracellular matrix derived from cells that were in culture for 
three and five days increased the growth of HCjE-Gi cells in vitro 
In the present study, we showed that the cell-secreted ECM derived from cells that were in 
culture for three and five days enhanced the growth of HCjE-Gi cells compared to that on 
TCP (figure 2.35). This could be explained by the various changes to the composition and 
quantity of proteins that occurred in the ECM of HCjE-Gi cells during this time. The raw 
abundances of most proteins increased significantly from day 7 onwards. However, there 
were few proteins that were most abundant in the day 1 ECM compared to the other time 
points investigated. It is likely that synergistic effects of a combination of proteins that were 
present in the early cell-secreted ECM contributed to the enhanced cell growth observed in 
the present study (table 2.9). Moreover, we also investigated the individual effects of pre-
adsorbed type IV collagen, laminin 111, fibronectin and α-2-HS-GP on the adhesion and 
growth of HCjE-Gi cells.  
 
Pre-adsorbing laminin 111 from 0.1-1µg/mL protein solutions did not affect the adhesion or 
the growth of HCjE-Gi cells over seven days in culture (figures 2.41 and 2.45). Laminin 111, 
a developmental protein, is the most abundant laminin in all BMs. Although the ECM of the 
HCjE-Gi cells expressed the β1 and the γ1 chains, there was no evidence of expression of the 
α1 chain in vitro. This together with the functional studies suggests that laminin 111 does 
not play an important role in the growth of HCjE-Gi cells in vitro. Koblinski et al. suggested 
that laminin 111 when pre-adsorbed from a 2µg/mL solution was too low to enhance cell 
adhesion and requires non-adhesive proteins, such as SPARC or serum albumin.(173) They 
suggested that these non-adhesive proteins ensure that laminin 111 is pre-adsorbed in such 
a conformation that the integrin binding sites are exposed. Further studies could be 
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undertaken to investigate if adding non-adhesive proteins enhanced the cellular functions 
of HCjE-Gi cells when cultured on pre-adsorbed laminin 111.   
 
The functions of each laminin chain depend on the domains exposed and other laminin 
chains they interact with to form specific laminin trimers.(140) The present study showed 
that the HCjE-Gi cells secrete laminin chains that form trimers 332, 311 and 511 (figure 
2.24). Thus, further studies are required to investigate the effects on adhesion and growth 
of HCjE-Gi cells when cultured on pre-adsorbed laminin 332, 311 or 511 in vitro. Laminin 
332 and fibronectin are known to be present in the provisional matrix during wound 
healing that promote adhesion and migration of epithelial cells. The proportion of peptides 
of laminin α3 chain increased on day 7 compared to day 1 (figure 2.30). However, that of 
laminin γ2 chain was highest in the day 1 ECM compared to the other time points. It is likely 
that the laminin γ2 chain enhances the migration of HCjE-Gi cells via integrin α3γ1 in the 
early ECM. As discussed previously, although laminin chains β1 and γ1 contributed to less 
than 1% of the total peptides in the ECM of HCjE-Gi cells, laminin 332 is likely to act 
synergistically with laminins 311 and 511 to enhance cell adhesion and migration.  
 
Fibronectin, a well-known cell adhesive protein, increased the adhesion of HCjE-Gi cells 
when pre-adsorbed from 0.5-10µg/mL solutions in a dose dependent manner (figure 2.42). 
However, no change to the growth of cells was observed when cultured on fibronectin pre-
adsorbed from 0.5-10µg/mL solutions compared to that on TCP over a culture period of 
seven days (figure 2.46). Sottile et al. showed that the presence of the RGD peptide of 
fibronectin promoted clustering of integrin α5β1 and therefore the adhesion of fibronectin-
null mouse embryonic cells, but there was no change to the growth of cells.(175) However, 
culturing these cells in the presence of exogenously added fibronectin enhanced the 
growth of the cells in an adhesion-dependent manner. Moreover, the authors showed that 
this growth was only observed in the presence of fibronectin matrix assembly possibly by 
exposing cryptic binding sites on the protein.(175) In the present study, we showed that the 
highest proportion of fibronectin was present in the day 1 ECM of HCjE-Gi cells and reduced 
with time (figure 2.30). This suggests lack of fibronectin matrix assembly at the later time 
points and that fibronectin is employed by the HCjE-Gi cells for the initial adhesion, 
however, is not required for the subsequent growth of cells. Moreover, serum albumin is 
known to have a synergistic effect with the adhesive proteins, which together are likely to 
be enhancing cell adhesion on the early ECM compared to the ECM secreted by the cells 
after seven days in culture.  
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Moreover, the higher proportion of α-2-HS-GP and annexin A2 may also be responsible for 
the increased growth observed on the early ECM by promoting cell adhesion and migration. 
There was no change to the adhesion of HCjE-Gi cells when cultured on α-2-HS-GP pre-
adsorbed from 0.5-20µg/mL solutions compared to TCP (figure 2.43). However, there was a 
significantly higher cell number on day five when cultured on α-2-HS-GP pre-adsorbed from 
10-20µg/mL solutions, and on day seven when cultured on α-2-HS-GP pre-adsorbed from a 
20µg/mL solution compared to that on TCP (figure 2.47). α-2-HS-GP is the human 
homologue of fetuin A found in fetal calf serum that is thought to be one of the many cell-
adhesive proteins present in serum used in tissue culture. Although we did not observe a 
change to the adhesion of HCjE-Gi cells in the present study, there was an increase to the 
cell number on culture days five and seven when cultured on α-2-HS-GP pre-adsorbed from 
10-20µg/mL solutions. Studies involving primary keratinocytes have shown significant 
increases to rates of cell migration and wound closure when cultured in serum-free media 
in the presence of α-2-HS-GP.(95) However, the wound closure rates when cultured in 
complete KSF media containing bovine pituitary extract and EGF was similar to that when 
cultured in KSF media alone containing 0.5-1mg/mL α-2-HS-GP.(100) The KSF media used in 
the present study contained 25µg/mL bovine pituitary extract and 0.2ng/mL EGF (table 2.1). 
Bovine pituitary extract and EGF at these concentrations may be inducing a similar effect on 
the adhesion of HCjE-Gi cells as when cultured on α-2-HS-GP pre-adsorbed from 0.5-
20µg/mL solutions. Similarly, these proteins may be inducing a similar effect on the growth 
of cells as that observed when cultured on α-2-HS-GP pre-adsorbed from 0.5-5µg/mL 
solutions. Higher concentrations of α-2-HS-GP, similar to that used by Wang et al, may 
show an effect on the adhesion and a larger effect on the growth of HCjE-Gi cells. The 
interaction between α-2-HS-GP and annexin A2 is thought to be mediated via calcium, 
which was present in the KSF culture media used in the present study (table 2.1).(96)  
 
The present study showed that type IV collagen as a substrate enhanced the adhesion of 
HCjE-Gi cells when pre-adsorbed from a 2µg/mL solution and the growth of cells on day 
seven when pre-adsorbed from 0.5-10µg/mL solutions (figures 2.40 and 2.44). He et al. 
showed that primary human corneal epithelial cells attached and formed a stratified 
epithelium when cultured on collagen shields pre-adsorbed with type IV collagen.(176) This 
was in contrast to collagen shields pre-adsorbed with matrigel, a mixture of ECM proteins 
derived from the mouse EHS sarcoma, on which the cells failed to reach confluence. 
Iwashita et al. showed that pre-adsorbing substrates with type IV collagen from a 10µg/mL 
significantly increased the adhesion of lung carcinoma cells, however, did not affect the cell 
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number at thirty hours.(177) In the present study, significant increases to the cell number 
was only observed from culture day five onwards. Type IV collagen is known to bind to 
integrins via the CB3-region on the collagenous domains. It has a higher affinity for integrin 
α1β1 than for integrin α2β1.(178) Öhlund et al. showed that the growth of pancreatic cancer 
cells on culture day two increased as the pre-adsorbed concentration of type IV collagen 
increased from 0.01 to 0.5µg/cm2.(178) Moreover the authors showed that the cell 
migration was significantly higher and cell apoptosis after two days is significantly lower 
when cultured on type IV collagen (0.5µg/cm2) than when cultured on BSA. Blocking the 
integrins that are known to associate with type IV collagen reduced the cell growth. This 
reduction was dose-dependent when integrins α1 and β1 were blocked. Blocking the CB3-
region of type IV collagen also led to a reduction in cell growth, however, blocking the non-
collagenous region at the C-terminal, also known to bind to integrins, did not affect the cell 
growth. Down-regulation of synthesis of the α1 chain of type IV collagen reduced the cell 
growth by 20% at forty hours compared to the control, which could be rescued by culturing 
the cell on pre-adsorbed type IV collagen.(178) Although, type IV collagen was not present 
in the ECM of the HCjE-Gi cells cultured in vitro, this protein may be employed in future 
studies to modify the surface of substrates to enhance the growth of conjunctival cells.  
 
Moreover, the present study showed that the day 1 and day 7 ECM samples had the highest 
proportion of GFs and their binding proteins (figure 2.23). In particular, the peptides of 
insulin contributed to 10.9% of the day 1 ECM (figure 2.32). Insulin is a growth promoting 
GF. Lastly, the ratio of proteases and their inhibitors changed between the day 1 and day 7 
ECM samples (figure 2.34). The increase in the proportion of proteases observed in the day 
7 ECM may be responsible for remodelling the proteins of the ECM that expose cryptic 
domains on the ECM that modulate the growth of HCjE-Gi cells.  
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The major differences observed between the early and late stages  
of the extracellular matrix secreted by HCjE-Gi cells 
 
PROTEIN CATEGORY EARLY ECM 
(Day 1 ECM) 
LATE ECM 
(Day 7 to day 42 ECM) 
GLYCOPROTEINS Highest proportions of α-2-HS-GP and annexin A2 Proportion of laminin α3 chain increased 
 Highest proportion of fibronectin Proportion of thrombospondin 1 increased 
 Highest proportion of laminin γ2 chain  
 Highest proportion of tenascin C 
 
 
INTEGRINS  Proportions of integrins α6 and β4 subunits increased 
  Proportion of basigin increased 
 
GROWTH FACTORS Highest proportion of insulin 
 
 
PROTEASES AND INHIBITORS Highest proportions of PAI 1 and serpin B5 Proportion of serine protease HTRA1 increased  
 
OTHER SECRETED PROTEINS Highest proportion of serotransferrin  
 Highest proportion of serum albumin  
Table 2.9: The major differences observed between the early and late stages of the extracellular matrix secreted by HCjE-Gi cells. 
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2.4.5 The expression of stem cell markers by HCjE-Gi cells reduced over fourteen days 
in culture in vitro 
Studies investigating the expression of conjunctival SCs on exogenous proteins are limited 
in comparison to those investigating the expression of limbal SCs. In the present study, the 
positive staining for ΔNp63 and ABCG2 proteins reduced significantly from culture day 
seven onwards on all the substrates investigated (figures 2.53 and 2.55). The mean number 
of cells expressing ΔNp63 protein reduced from 64.8% to 16.2%, whereas those expressing 
ABCG2 reduced from 52.6% to 3.3% from culture days one to fourteen. Further 
experiments that are more quantitative than the method used in the present study are 
required to support these findings.  Rama et al. showed that limbal epithelial tissue used for 
transplantation must consist of 3% or more ΔNp63 positive cells to ensure a better 
prognosis.(179) ΔNp63 is formed by truncation of the N-terminus of the p63 proteins. This 
truncated transcript has three isoforms, of which the α isoform has been shown to identify 
epithelial SCs, whereas isoforms β and γ are thought to promote epithelial cell 
differentiation.(180) ΔNp63 positive cells are thought to represent a pool of SCs that have 
the ability to form holoclones.(179) ABCG2 protein has also been shown to be a marker of 
limbal SCs, however, there is a possibility that TACs may also be stained during ICC. (180)  
 
In general, the expression of ΔNp63 and ABCG2 proteins was higher in HCjE-Gi cells 
cultured on pre-adsorbed type IV collagen and fibronectin compared to TCP and laminin 
111 (figures 2.53 and 2.55). To date, no studies have been undertaken to show associations 
between ECM proteins and the expression of conjunctival SCs. Li et al. showed that primary 
limbal epithelial cells that adhered within twenty minutes onto type IV collagen pre-
adsorbed from a 20µg/mL solution were label-retaining cells that had the highest 
proliferative capacity compared to the cells that took a longer time to adhere onto type IV 
collagen. (181) They also showed that these cells expressed the highest mRNA levels of 
integrin β1, p63 and ABCG2, and consisted of the highest population of cells expressing 
integrin β1 and p63 proteins. In addition, they also showed that the cells that adhered 
within twenty minutes had a low expression of corneal differentiation markers. Igarashi et 
al. showed that oral epithelial progenitor cells that adhered onto type IV collagen within 
ten minutes were label-retaining cells that had a higher proliferative capacity compared to 
the cells that took a longer time to adhere onto type IV collagen.(182) They also showed 
that these rapidly attached cells had higher expression of integrins α6 and β1 compared to 
the cells that took a longer time to adhere onto type IV collagen. These results show that 
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type IV collagen is important for isolating epithelial SCs and that integrins β1 and α6 may 
play a role in the interaction between the SCs and type IV collagen.  
Laminins 111 and 511 are important for early mouse embryogenesis and have been shown 
to be deposited by human embryonic SCs in vitro.(183) Vuoristo et al. showed that human 
embryonic SCs expressed integrins α3, α5, α6 αV, β1 and β3, as well as BCAM on their cell 
membranes.(183) The authors showed that these cells adhered to laminin 511 via integrin 
α3β1 and BCAM. They also showed that laminin 511 supported the proliferation and 
maintenance of embryonic SCs in an undifferentiated state. Although laminin 111 
supported the adhesion of cells, it stimulated the differentiation of embryonic SCs down a 
neural lineage. These studies suggest that laminin 511 expressed by the HCjE-Gi cells may 
play a role in the self-renewal of conjunctival SCs. Therefore, a future study would be to 
investigate the role of laminin 511 in the maintenance of SCs via integrin α3β1 and BCAM in 
vitro. Embryonic SCs were shown to have a higher growth rate on recombinant laminin 332 
than laminin 511 and laminin 111, and the cells maintained the undifferentiated state on all 
laminin trimers.(184) The authors showed that the laminins interacted with cells via 
integrin α6β1. In contrast, other studies have shown that culture of embryonic SCs on 
laminin 332 stimulates the differentiation of cells down an osteogenic lineage.(185) 
 
Previous studies have shown that fibronectin supports the long-term maintenance of 
human embryonic SCs.(186) Moreover, various media that are used commercially for 
culture of SCs is known to contain fibronectin.(187) Kalaskar et al. showed that only one-
quarter of a surface needed to be saturated with fibronectin to promote adhesion, growth 
and maintenance of human embryonic SCs.(186) They showed that this saturation level can 
be achieved by pre-adsorbing a surface from a solution of approximately 10µg/mL of 
fibronectin. In contrast, other studies have shown that culture of human embryonic SCs on 
fibronectin for a long period of time stimulate cells to lose their undifferentiated state.(184)   
 
There are numerous proteins in the ECM of HCjE-Gi cells that may influence the 
maintenance of SCs (figure 2.60). Further studies are required to investigate the effects of 
these proteins on the expression of conjunctival SC markers. In addition, studies may be 
undertaken to investigate the expression of SC markers on cell-secreted ECM. The sample 
number in the present study was too low to determine accurate conclusions regarding the 
effect of pre-adsorbed proteins on the expression of SC markers, thus requiring further 
experiments with larger sample sizes.   
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Proteins in the extracellular matrix of HCjE-Gi cells that may influence 
the maintenance of stem cells 
 
COLLAGENS Type XVIII collagen (89) 
  
 
 
GLYCOPROTEINS 
 
α-2-HS-GP (188) 
Laminin chains α3, α5, β2 and γ2  
Nephronectin (189) 
Tenascin C (11) 
Vitronectin (190) 
  
PROTEOGLYCANS 
 
Agrin (11) 
Perlecan (191) 
Tsukushin (192) 
  
INTEGRINS AND 
TRANSMEMBRANE PROTEINS 
Integrins α6 (182), αV (193), β1 (185)  
Basigin (194) 
EGF receptor (195) 
CD44 (196) and CD109 (197) 
  
MATRIX METALLOPROTEINASES 
AND INHIBITORS 
ADAMs 10 and 17 (198) 
PAI 1 (187) 
  
OTHER SECRETED PROTEINS Galectins 1 (199) and 3 (200) 
Wnt proteins (inhibited by Dkk1) (201) 
 
Figure 2.60: Proteins in the extracellular matrix of HCjE-Gi cells that may influence the 
maintenance of stem cells. Previous studies have shown these proteins to be associated 
with stem cell niches or support the maintenance of stem cells in vitro. 
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2.4.6 The expression of goblet cell markers by HCjE-Gi cells increased over fourteen 
days in culture in vitro 
In the present study, we investigated the expression of MUC5AC and co-expression of 
keratin 7 and UEAI by HCjE-Gi cells cultured on pre-adsorbed type IV collagen, fibronectin 
and laminin 111. MUC5AC is a gel-forming secreted mucin produced by the GCs. Keratin 7 is 
expressed by glandular epithelia, and the clone OV-TL 12/30 has been shown to be 
expressed in conjunctival tissue.(202) Mucins are GPs that have a carbohydrate side chain. 
UEAI is a lectin that binds to fucose. Although we observed positive staining in HCjE-Gi cells 
when probed with UEAI, Kawano et al. showed that this lectin did not bind to most GCs in 
the human conjunctiva indicating that there is only very little or no fucose in the mucins 
produced by the GCs.(203) In contrast, the authors showed that most GCs stained positive 
when probed with wheat germ agglutinin and soybean agglutinin that bind to N-acetyl-
glucosamine and N-acetyl-galactosamine on the mucins, respectively.(203)  
 
In the present study, we did not observe any significant differences to the percentage of 
cells that stained positive for GC markers when cultured on pre-adsorbed proteins 
compared to TCP (figures 2.57 and 2.59). However, further experiments are required with 
larger sample sizes to determine the effect of pre-adsorbed proteins on the expression of 
GC markers more accurately. There was a significant increase to the percentage of cells that 
stained positive for protein MUC5AC on culture day seven and fourteen compared to 
culture day one. In contrast, there were no significant differences to the percentage of cells 
that stained positive for keratin 7 and UEAI between culture days one, seven and fourteen. 
Studies on human tissue have shown that the amount of GCs vary between the bulbar, 
forniceal and palpebral conjunctiva. LSCM studies on human conjunctival tissue have shown 
that approximately 4.8% and 50.7% of the bulbar and palpebral conjunctiva consist of GCs, 
respectively. Impression cytology studies have shown that there are approximately one GC 
for every eight epithelial cells in the superior bulbar conjunctiva of healthy individuals.(13) 
MUC5AC is produced by GCs, however, can be extracellular when secreted. Therefore, it is 
difficult to accurately determine the percentage of GCs by ICC. The cells that stained 
positive for MUC5AC in the present study could be true GCs or non-secretory epithelial cells 
that the secreted mucins bound to. On the other hand, the cells that co-expressed keratin 7 
and UEA1 could be the true GCs. However, it is not possible to ascertain if these cells are 
immature GCs or actively secreting mature GCs.  
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Iwashita et al. showed that MUC5AC production was down-regulated when human lung 
carcinoma cells were cultured on type IV collagen pre-adsorbed from a 33µg/mL solution, 
whereas no change was observed when cultured on type IV collagen pre-adsorbed from a 
10µg/mL solution, which was independent of cell density.(177) No change to the MUC5AC 
production was observed when cells were cultured on fibronectin, however, the production 
increased in a dose-dependent manner when cultured on laminin and Matrigel. Ito et al. 
showed that MUC5B, another gel-forming secreted mucin, is up-regulated when these cells 
were cultured on fibronectin and laminin in a dose-dependent manner, however, was 
unaffected when cultured on type IV collagen.(204) Blocking integrin β1 down-regulated the 
production of both MUCs 5AC and 5B. The down-regulation of MUC5AC on type IV collagen 
was shown to be due to the activation of the Akt pathway, which was suppressed when the 
cells were cultured on laminin.(205) Studies have shown that the up-regulation of MUCs 
5AC and 5B are mediated via the action of EGF receptors that activate intracellular 
pathways, such as the ERK pathway, that increases the production of NF-κB transcription 
factor.(177, 204) These results showed that these mucins are regulated differentially in cells 
cultured on type IV collagen and fibronectin, whereas both are up-regulated when cultured 
on laminin. Although the authors did not specify the laminin trimer, the cells appear to be 
studied on pre-adsorbed laminin 111. Thus, it would be interesting to investigate the effect 
of laminins found to be present in the ECM of the HCjE-Gi cells on the differentiation of 
GCs. 
 
In the present study we showed that the addition of fetal calf serum and a higher 
concentration of calcium increased the expression of MUC5AC, although the difference 
between culture days seven and fourteen was not statistically significant. The presence of 
GCs on culture day seven indicates that fetal calf serum is not essential for the 
differentiation process. Thus, a future study would be to investigate the presence of GCs in 
serum-free media over a longer culture period. In addition to the above mentioned 
extracellular proteins, other proteins that were found to be present in the ECM of the HCjE-
Gi cells could influence the differentiation of GCs and the production of gel-forming mucins 
(figure 2.61). Further studies are required to investigate the effects of these proteins 
individually or in combination on the differentiation of GCs. Moreover, it would be 
interesting to study the ECM proteins present in an isolated culture of GCs. Lastly, another 
further study would be to investigate the variations in the protein composition of the ECM 
secreted by the conjunctival cells of the bulbar, forniceal and palpebral regions that could 
explain the variations in the quantities of GCs observed in these regions of the native tissue.   
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Proteins in the extracellular matrix of HCjE-Gi cells that may influence 
the differentiation of goblet cells and the production of MUC5AC 
 
COLLAGENS Type IV collagen (down-regulates production) 
  
GLYCOPROTEINS 
 
Laminin 
Thrombospondin 1 (206) 
  
INTEGRINS AND 
TRANSMEMBRANE PROTEINS 
Integrin β1 
CD44 (via hyaluronan) (207) 
EGF receptor (208) 
  
GROWTH FACTORS AND 
BINDING PROTEINS 
GDF 15 (209) 
TGFβ ig-h3 (155) 
  
MATRIX METALLOPROTEINASES 
AND INHIBITORS 
ADAM 17 (may be inhibited by TIMP 3) (210) 
Elafin (down-regulates production) (211) 
MMP 14 (212) 
  
OTHER SECRETED PROTEINS Annexin A2 (up-regulates secretion) (213)  
 
Figure 2.61: Proteins in the extracellular matrix of HCjE-Gi cells that may influence the 
differentiation of goblet cells and the production of MUC5AC. Previous studies, 
predominantly using lung carcinoma cells, have shown that these proteins either up-
regulate or down-regulate the production and/or the secretion of MUC5AC protein by 
goblet cells.  
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Summary of key findings 
 Ammonium hydroxide successfully isolated the ECM proteins and the transmembrane 
proteins associated with the ECM of the HCjE-Gi cells cultured in vitro. 
 The protein composition of the ECM of the HCjE-Gi cells cultured in vitro varied over six 
weeks (figure 2.62).  
o Type IV collagen was absent; however, type XVIII collagen was deposited as a 
structural collagen. 
o Laminin 332 was the most abundant glycoprotein in the ECM. Other possible 
laminin trimers that may be present in the ECM were laminins 311 and 511.  
o The highest peptide abundances of fibronectin, nephronectin and vitronectin 
were in the day seven ECM. 
o α-2-HS-GP was present in the ECM, which has not been shown to be present in 
the conjunctival ECM previously, the highest proportion being observed in the 
day one ECM. 
o Perlecan and agrin were the most abundant proteoglycans in the early and late 
ECMs, respectively.   
o Integrins α6 and β4 subunits were the most abundant transmembrane proteins 
in the ECM.  
o The highest proportion of growth factors, their binding proteins and cytokines 
were in the day one and seven ECM samples. 
o The expression of proteases and their inhibitors in the ECM increased and 
decreased, respectively, with time.  
 The adsorption of type IV collagen and fibronectin onto TCP reached a saturation point 
when pre-adsorbed from a 5µg/mL solution, whereas the adsorption of laminin 111 
onto TCP reached a saturation point when pre-adsorbed from a 0.5µg/mL solution.  
 Type IV collagen pre-adsorbed from 2-10µg/mL solutions and fibronectin pre-adsorbed 
from 0.5-10µg/mL solutions increased cell adhesion compared to TCP.  
 Type IV collagen pre-adsorbed from 0.5-10µg/mL solutions and α-2-HS-HP pre-
adsorbed from a 20µg/mL solution increased the growth of HCjE-Gi cells on culture day 
seven. Moreover, ECM derived from cells that were in culture for three and five days 
increased the growth of HCjE-Gi cells in vitro.  
 Preliminary data show that the expression of stem cell markers by HCjE-Gi cells 
decreased, whereas the expression of goblet cell markers by HCjE-Gi cells increased 
over fourteen days in culture in vitro.  
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The protein composition of the ECM of the HCjE-Gi cells 
 
 
Figure 2.62: The protein composition of the ECM of HCjE-Gi cells. A schematic diagram 
summarising the protein composition of the ECM of HCjE-Gi cell line cultured in vitro over 
six weeks in keratinocyte serum-free media. 
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3 CELLULAR RESPONSE OF HCjE-Gi CELLS ON 
SURFACE MOFIDIED PεK HYDROGELS  
3.1 AIMS AND OBJECTIVES 
To establish the cellular response of HCjE-Gi cells cultured on surface modified PεK 
hydrogels.  
 
1. To determine the adhesion of HCjE-Gi cells on PεK hydrogels with and without pre-
adsorbed proteins.  
 
2. To determine the growth and differentiation of HCjE-Gi cells on PεK hydrogels with 
and without pre-adsorbed proteins over a culture period of fourteen days. 
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3.2 METHODS 
3.2.1 SYNTHESIS OF PεK HYDROGELS 
PεK hydrogels consisting of homopolymers of PεK chemically cross-linked with dicarboxylic 
acids were synthesised according to the protocol given by SpheriTech Ltd. The quantities of 
reagents were taken from an Excel spreadsheet provided by the company (appendix 2). By 
taking into account the data from previous research, it was decided to synthesise gels with 
a PεK density of 0.1g/mL and a cross-linking density of 60% (60:10 PεK gels) for the 
following experiments. Two dicarboxylic acids, azelaic acid (AA) and suberic acid (SA), were 
investigated in this study.  
 
The appropriate quantities of PεK (Zhengzhou Bainafo Bioengineering Co.,Ltd) to make AA 
and SA cross-linked PεK gels were weighed out into two separate tubes and were dissolved 
in dH2O with Tween 80 (Fisher Scientific T/4203/60). The volume of Tween 80 was 
calculated as 1% of the final volume of the PεK gel solution that was to be made. The PεK 
solutions were mixed on a tube roller mixer (Denley Spiramix 5). The dicarboxylic acids, AA 
(TCI A1318) and SA (Sigma Aldrich 60930) were dissolved in dH2O and 4-Methylmorpholine 
(NMM) (Alfa Aesar A12158) in two separate tubes. NMM was added as a solvent to aid the 
solubility of the dicarboxylic acids in water. These solutions were left in a sonicator bath 
(Grant XUBA3) until fully dissolved. Just prior to the initiation of the polymerisation 
reaction, N-Hydroxysuccinimide (NHS) (Sigma-Aldrich 130672) and 1-(3-
Dimethylaminopropyl)-3-ethylcarbodiimide HCl (EDCI) (Carbosynth FD05800) were 
dissolved in dH2O in two separate tubes for each type of PεK gel. The NHS and EDCI activate 
the carboxyl groups on the dicarboxylic acids that are used to form peptide bonds with the 
amine groups on the PεK homopolymer. Each dicarboxylic acid solution was mixed with the 
corresponding PεK solution on a tube roller mixer. The NHS and EDCI solutions were added 
together and mixed on a tube roller mixer. Each PεK-dicarboxylic acid solution and the 
corresponding NHS-EDCI solution were mixed together and the tubes were inverted five 
times. Lastly, the PεK gel solutions were filtered using 0.2µm syringe filters (Sartorius 
16534K) and the appropriate volumes of gel solution was pipetted into petri dishes (Greiner 
bio-one 633185). The gel solutions were left exposed to air at RT to be polymerised 
overnight.  
 
The next day, the polymerised gels were washed in dH2O. Circular gels with an area of 1cm2 
were cut using a 11.5mm trephine (figure 3.1A) and were stored in dH2O until the day of 
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the experiment. The gels were washed in 70% ethanol (Department of Chemistry, University 
of Liverpool) for two hours and then washed three times in PBS inside a class II biosafety 
cabinet prior to cell culture. The gels were handled with a non-toothed and non-serrated 
forceps (figure 3.1B).     
 
3.2.2 THICKNESS OF PεK HYDROGELS 
To determine the thickness of the hydrogels, 2mL, 3mL, 4mL and 5mL of 60:10 PεK gel 
solutions were pipetted into 94mm wide petri dishes (Greiner bio-one 633185).The 
polymerised gels were cut into 1cm2 circular gels as described previously. The circular gels 
were placed on the lids of the petri dishes and the thickness of each gel was measured 
using a dial thickness gauge (figure 3.2). The thickness of the lid of the petri dish alone, and 
the thickness of the gel and the lid together were measured. The former measurement was 
subtracted from the total thickness of the gel and the lid to obtain the thickness of the PεK 
hydrogel. The dial thickness gauge was used instead of a vernier caliper to ensure a uniform 
load was used to press the gel and therefore avoid potential human errors. The thickness of 
both AA and SA cross-linked PεK gels were measured in three sets of triplicates. 
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Instruments used to prepare and handle PεK gels 
 
 
 
Figure 3.1: Instruments used to prepare and handle PεK hydrogels. The 11.5mm trephine 
used to cut 1cm2 circular gels (A) and the non-toothed and non-serrated forceps used to 
handle gels (B).  
 
 
Dial thickness gauge 
 
  
 
Figure 3.2: Dial thickness gauge used to measure the thickness of PεK hydrogels. 
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3.2.3 ADHESION OF HCjE-Gi CELLS ON PεK HYDROGELS 
Type IV collagen (2 and 10µg/mL), laminin 111 (0.5 and 1µg/mL), fibronectin (2 and 
10µg/mL) and α-2-HS-GP (2 and 10µg/mL) protein solutions were prepared in PBS. The 
60:10 PεK gels were placed in wells of forty-eight well plates on the day of the experiment 
and incubated with 200µL of protein solution for one hour at 37°C. PεK gels and TCP 
incubated with PBS alone were used as controls. All the gels were washed three times in 
PBS, and due to the highly hydrophilic nature of the gels, these were air-dried briefly while 
cells were sub-cultured. This is to ensure that the aliquots of cells remained beaded until 
the cells attached onto the gels without spreading outside it. HCjE-Gi cells were seeded at a 
density of 3x104 cells/cm2 in a volume of KSF media not exceeding 15µL. No additional 
media was added into wells to prevent the cells from being washed off the gel before 
attachment. The cells were incubated in a humidifying incubator set at 37°C with 5% CO2 
for three hours, following which the wells were gently washed once in PBS. Then the cells 
were fixed in 100% methanol for two minutes and the nuclei were stained with DAPI. Five 
images from each well were taken with a 10X objective of a Nikon Eclipse Ti-E microscope. 
The cell nuclei were counted using the Image-based Tool for Counting Nuclei plugin on 
Image J software, as described in chapter 2. The mean number of nuclei per view 
(0.011cm2) was calculated to determine the number of cells per cm2 on all the substrates 
investigated. These experiments were done in one set of triplicates. 
 
3.2.4 GROWTH OF HCjE-Gi CELLS ON PεK HYDROGELS 
As before, the 60:10 PεK gels were placed in wells of forty-eight well plates on the day of 
the experiment and incubated with protein solutions for one hour at 37°C. The PεK gels and 
TCP incubated with PBS were used as controls. The gels were washed in PBS and briefly air-
dried while cells were sub-cultured. HCjE-Gi cells were seeded at a density of 1x104 
cells/cm2 in a volume of media not exceeding 15µL. The cells were allowed to adhere for 
three hours prior to adding more media (400µL per well). The cells were cultured for seven 
days in KSF medium and then switched to the differentiation and stratification medium for 
a further seven days. On culture days one, four, seven, eleven and fourteen, the cells were 
fixed in 100% methanol and nuclei were stained with DAPI. Five images from each well 
were taken with a 10X objective of a Nikon Eclipse Ti-E microscope. The mean number of 
nuclei per view was calculated to determine the number of cells per cm2 on all the 
substrates for each culture day investigated. These experiments were done in one set of 
triplicates.  
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3.2.5 DIFFERENTIATION OF HCjE-Gi CELLS ON PεK HYDROGELS 
On culture days seven and fourteen, the PεK gels with and without pre-adsorbed proteins 
were stained for conjunctival cell differentiation markers and GC markers. The PεK gels pre-
adsorbed with type IV collagen from a 10µg/mL solution, fibronectin from a 10µg/mL 
solution and laminin 111 from a 1µg/mL solution were used in this study. The same 
protocols and reagents as described in chapter 2 for ICC staining for keratin 4, keratin 19 
and MUC5AC were used. The cells were fixed in 10% NBF for ten minutes and were 
permeabilised with 0.2% Triton X-100 for fifteen minutes at RT. Next, the cells were blocked 
with 10% goat serum for one hour and probed with antibodies against keratin 4, keratin 19 
and MUC5AC overnight at 4°C. The next day, the cells were incubated with appropriate 
secondary antibodies for one hour at 37°C and the nuclei were stained with DAPI. Cells 
cultured on PεK gels that were probed with secondary antibodies only were used as 
negative controls. Images were taken with a 20X objective of a Nikon Eclipse Ti-E 
microscope. 
 
3.2.6 STATISTICS 
All the data were analysed using the SPSS Statistics 22 software. Significance level of 0.05 
was set for all the experiments. 
 
One-way ANOVA 
 The adhesion of HCjE-Gi cells on AA and SA cross-linked PεK gels with and without 
pre-adsorbed proteins. 
 
One-way ANOVA was undertaken as described in chapter 2.  
 
Two-way ANOVA 
 The thickness measurements between the volumes of gel solution used in the 
polymerisation reaction for AA and SA cross-linked PεK gels. 
 The growth of HCjE-Gi cells on AA and SA cross-linked PεK gels with and without 
pre-adsorbed proteins. 
 
Two-way ANOVA was undertaken as described in chapter 2. All the data that were analysed 
in this chapter did not show an interaction effect between the two independent variables, 
thus analysis of the main effect for each independent variable was performed.  
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3.3 RESULTS 
3.3.1 PHYSICAL PROPERTIES OF PεK HYDROGELS  
The 60:10 PεK gels had excellent transparency, although the SA cross-linked gels had a 
slight yellow tinge compared to the AA cross-linked gels (figure 3.3). Both types of PεK 
hydrogels were easy to handle with the non-toothed and non-serrated forceps. However, 
the SA cross-linked hydrogels were more brittle than those cross-linked with AA and had a 
tendency to crack when folded. This is a limitation in conjunctival reconstruction, where the 
substrate needs to be able to conform to the surface, especially the fornices. 
 
Two-way ANOVA was conducted to examine the effects of gel type and the volume of gel 
solution used in the polymerisation reaction on the thickness of the gels. There was one 
outlier in the AA - 5mL group as assessed by box plot diagrams, however, excluding this did 
not affect the overall result. The residuals were normally distributed and there was 
homogeneity of variances. The interaction effect between the gel type and the volume of 
gel solution on the thickness of gels was not statistically significant (p = 0.123). In general, 
the PεK hydrogels cross-linked with AA were thinner than those cross-linked with SA (figure 
3.4). Analysis of the main effect between gel types showed that this difference was 
statistically significant, p = 0.012. As expected, the thicknesses of AA and SA cross-linked 
PεK hydrogels increased with increasing volumes of PεK gel solution used in the 
polymerisation reaction. Analysis of the main effect between volumes of gel solution 
showed that this difference was statistically significant, p < 0.001. Statistically significant 
differences were observed between 2mL and 4mL, 2mL and 5mL, 3mL and 4mL, and 3mL 
and 5mL groups (p < 0.001). The gels that were made with 2mL and 3mL gel solutions were 
sufficiently thin to be folded easily compared to the thicker gels. Due to easier handling 
during in vitro studies, gels synthesised with a volume of 3mL of PεK gel solution were used 
in the subsequent experiments. These hydrogels had a mean thickness of 0.17mm and 
0.24mm when cross-linked with AA and SA, respectively.  
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Transparency of the 60:10 PεK gels 
 
 
 
Figure 3.3: Transparency of the 60:10 PεK hydrogels. The gels were synthesised with a PεK 
density of 0.1g/mL and a cross-linking density of 60% with either azelaic acid (A) or 
suberic acid (B). Both types of PεK hydrogels exhibited excellent transparency, although 
gels cross-linked with suberic acid had a slight yellow tinge compared to those cross-
linked with azelaic acid. 
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Thickness of AA and SA cross-linked PεK gels 
 
 
  Mean SD 
AA 2 0.15 0.07 
 3 0.17 0.10 
 4 0.30 0.15 
 5 0.41 0.11 
SA 2 0.12 0.09 
 3 0.24 0.13 
 4 0.47 0.17 
 5 0.49 0.10 
 
Figure 3.4: A. Thickness of AA and SA cross-linked PεK hydrogels. Data are presented as 
mean thickness (mm) ± 1SD, n = 9. There was no significant interaction effect between the 
gel type and the volume of PεK gel solution on the thickness of gels. Analysis of the main 
effect between gel types showed that the thicknesses of SA cross-linked gels were 
significantly higher than those cross-linked with AA (p = 0.012). There was also a 
significant difference in the main effect between the volumes of gel solution (p < 0.001), 
where significant increases were seen between 2mL and 4mL, 2mL and 5mL, 3mL and 
4mL, and 3mL and 5mL groups; **p < 0.001. (Two-way ANOVA; Bonferroni post hoc test). 
B. Mean thickness of PεK hydrogels (mm) and 1SD.  
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3.3.2 ADHESION OF HCjE-Gi CELLS ON PεK HYDROGELS 
The HCjE-Gi cell adhesion on AA cross-linked PεK gels three hours post seeding were 
comparable to that on TCP without pre-adsorbed proteins (figure 3.5). All data within all 
groups were normally distributed, except the laminin 111 1µg/mL and α-2-HS-GP 10µg/mL 
groups. There were no outliers and there was heterogeneity of variances (p = 0.003). There 
was a statistically significant difference in the cell adhesion between the substrate groups, 
p = 0.001. There was no difference in the cell adhesion on AA cross-linked PεK gels with and 
without pre-adsorbed proteins compared to that on TCP (p > 0.05). Moreover, there were 
no differences to the cell number on gels with pre-adsorbed proteins compared to those 
without pre-adsorbed proteins (p > 0.05). The highest mean cell number was observed on 
PεK gels with fibronectin pre-adsorbed from a 10µg/mL solution. Although the cell number 
was two-fold higher than that observed on PεK gels without pre-adsorbed proteins, this 
was not found to be statistically significant (p = 0.803). However, there was a significant 
reduction to the cell number observed when cultured on gels with laminin 111 pre-
adsorbed from a 1µg/mL solution (p = 0.033) and gels with α-2-HS-GP pre-adsorbed from a 
2µg/mL solution (p = 0.007) compared to that on gels with type IV collagen pre-adsorbed 
from a 10µg/mL solution.  
 
The adhesion of HCjE-Gi cells on SA cross-linked gels was comparable to that on TCP 
without pre-adsorbed proteins (figure 3.6). Data within all groups were normally 
distributed, except the α-2-HS-GP 10µg/mL group. There were no outliers within the data 
set and there was homogeneity of variances. One-way ANOVA did not show any statistically 
significant differences between the substrate groups, p = 0.068. Although there was a 3.5-
fold reduction in the cell number on SA cross-linked PεK gels without pre-adsorbed proteins 
compared to that on TCP, this was not found to be statistically significant (p = 0.456). 
Similarly, there were no statistically significant differences to the cell number on gels with 
pre-adsorbed proteins and TCP (p > 0.05). However, a significant five-fold increase in the 
cell adhesion was observed on the SA cross-linked PεK gels with type IV collagen pre-
adsorbed from a 2µg/mL solution compared to that on gels without pre-adsorbed proteins 
(p = 0.036). There were no differences to the cell adhesion between the gels pre-adsorbed 
with other proteins and those without pre-adsorbed proteins (p > 0.05).   
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Adhesion of HCjE-Gi cells on AA cross-linked PεK gels 
 
 
 Mean SD 
TCP 4301.3 944.2 
AA 4235.4 2843.9 
2 C4 2474.2 1443.3 
10 C4 6014.6 314.0 
0.5 LN 5044.2 4497.5 
1 LN 1935.0 752.3 
2 FN 6469.9 3705.5 
10 FN 9698.9 5209.2 
2 A2 1863.1 526.5 
10 A2 4211.4 4167.2 
 
Figure 3.5: A. Adhesion of HCjE-Gi cells on AA cross-linked PεK hydrogels. Data are 
presented as mean number of cells/cm2 (x103) ± 1SD, n = 3. There was a significant 
increase in the number of cells adhered on AA cross-linked PεK gels with type IV collagen 
pre-adsorbed from a 10µg/mL solution compared to those with laminin 111 and α-2-HS-
GP pre-adsorbed from 1µg/mL (p = 0.033) and 2µg/mL (p = 0.007) solutions, respectively; 
*p < 0.05. (One-way ANOVA; Games-Howell post hoc test). B. Mean number of cells/cm2 
and 1SD; C4 - type IV collagen 2 and 10µg/mL, LN - laminin 111 0.5 and 1µg/mL, FN – 
fibronectin 2 and 10µg/mL and A2 – 2 and 10µg/mL. 
 
 
0
2
4
6
8
10
12
14
16
TCP AA 2 C4 10 C4 0.5 LN 1 LN 2 FN 10 FN 2 A2 10 A2
M
e
an
 c
e
lls
/c
m
2
(x
1
0
3 )
Substrate
*
A 
B 
225 
 
Adhesion of HCjE-Gi cells on SA cross-linked PεK gels 
 
 
 Mean SD 
TCP 5505.4 2614.9 
SA 1533.6 844.7 
2 C4 8069.4 4322.5 
10 C4 3139.1 898.7 
0.5 LN 3666.3 2309.5 
1 LN 2845.6 1036.2 
2 FN 2456.2 909.7 
10 FN 2737.7 1941.8 
2 A2 3288.9 2654.7 
10 A2 3576.4 1229.6 
 
Figure 3.6: A. Adhesion of HCjE-Gi cells on SA cross-linked PεK hydrogels. Data are 
presented as mean number of cells/cm2 (x103) ± 1SD, n = 3. There was a significant 
increase in the number of cells adhered on the SA cross-linked PεK gels with type IV 
collagen pre-adsorbed from a 2µg/mL solution compared to the gels without pre-
adsorbed proteins (p = 0.036); *p < 0.05. (One-way ANOVA; Tukey post hoc test). B. Mean 
number of cells/cm2 and 1SD; C4 - type IV collagen 2 and 10µg/mL, LN - laminin 111 0.5 
and 1µg/mL, FN – fibronectin 2 and 10µg/mL and A2 – 2 and 10µg/mL. 
 
0
2
4
6
8
10
12
14
16
TCP SA 2 C4 10 C4 0.5 LN 1 LN 2 FN 10 FN 2 A2 10 A2
M
e
an
 c
e
lls
/c
m
2
(x
1
0
3
)
Substrate
*
A 
B 
226 
 
3.3.3 GROWTH OF HCjE-Gi CELLS ON PεK HYDROGELS 
In general, all substrate groups supported the growth of HCjE-Gi cells over fourteen days. 
By culture day fourteen, nuclear staining of cells showed evidence of more than one layer 
of cells as there were two levels of focus during microscopy (figures 3.7-3.9).  
 
The growth of HCjE-Gi cells on AA cross-linked PεK gels with and without pre-adsorbed 
proteins over fourteen days in culture was comparable to that on TCP without pre-
adsorbed proteins (figure 3.10). The residuals were not normally distributed in four groups 
(day 4 - fibronectin 2µg/mL, day 7 - TCP, day 7 – type IV collagen 2µg/mL, and day 14 – α-2-
HS-GP 10µg/mL groups). There was heterogeneity of data (p < 0.001) and there were no 
outliers present. The interaction effect between substrate and culture day on the cell 
number was not statistically significant (p = 0.218). Analysis of the main effect between 
substrates showed that the differences were not statistically significant, p = 0.508. 
However, analysis of the main effect between culture days showed a statistically significant 
difference, p < 0.001. Statistically significant increases in the cell number were observed on 
culture days 7 to 14 compared to culture days 1 to 4, and culture days 11 to 14 compared 
to culture day 7 (p < 0.05). These results show that the HCjE-Gi cells were in the lag phase 
during culture days 1 to 4, log phase during days 4 to 11 and plateau phase during days 11 
to 14 when cultured on AA cross-linked PεK gels. 
 
The growth of HCjE-Gi cells on SA cross-linked PεK gels with and without pre-adsorbed 
proteins over fourteen days in culture was comparable to that on TCP without pre-
adsorbed proteins (figure 3.11). The residuals were not normally distributed in three groups 
(day 7 – α-2-HS-GP 2µg/mL, day 11 – laminin 111 0.5µg/mL, and day 11 – fibronectin 
10µg/mL groups). There was heterogeneity of variances (p < 0.001) and there were no 
outliers. There was no statistically significant interaction effect between substrate and 
culture day on the cell number (p = 0.466). Analysis of the main effect between substrates 
showed that the differences were not statistically significant, p = 0.111. However, analysis 
of the main effect between culture days showed a statistically significant difference, p < 
0.001. Statistically significant increases in the cell number were observed on culture days 7 
to 14 compared to culture days 1 to 4, culture days 11 to 14 compared to culture day 7, and 
culture day 14 compared to culture day 11 (p < 0.001). The HCjE-Gi cells were in the lag 
phase from days 1 to 4, following which they entered the log phase. In contrast to the cells 
cultured on AA cross-linked PεK gels, HCjE-Gi cells cultured on SA cross-linked PεK gels have 
not yet entered the plateau phase by day 14. 
227 
 
Nuclear staining of HCjE-Gi cells cultured on PεK gels 
 
Figure 3.7: Nuclear staining of HCjE-Gi cells cultured on azelaic acid and suberic acid cross-
linked PεK gels for fourteen days (8-bit images inverted on Image J software).  
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Nuclear staining of HCjE-Gi cells cultured on AA cross-linked PεK gels 
with pre-adsorbed proteins 
 
Figure 3.8: Nuclear staining of HCjE-Gi cells cultured on AA cross-linked PεK gels with pre-
adsorbed proteins for fourteen days (8-bit images inverted on Image J software); C4 - type 
IV collagen, LN - laminin 111, FN – fibronectin and A2 - α-2-HS-GP.   
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Nuclear staining of HCjE-Gi cells cultured on SA cross-linked PεK gels 
with pre-adsorbed proteins 
 
Figure 3.9: Nuclear staining of HCjE-Gi cells cultured on SA cross-linked PεK gels with pre-
adsorbed proteins for fourteen days (8-bit images inverted on Image J software); C4 - type 
IV collagen, LN - laminin 111, FN – fibronectin and A2 - α-2-HS-GP.  
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Growth of HCjE-Gi cells on AA cross-linked PεK gels 
 
 Day 1  Day 7  Day 14  
 Mean SD Mean SD Mean SD 
TCP 7895.7 3699.7 119 310.4 25 796.2 191 719.8 18 212.2 
AA 4157.5 1290.8 53 946.1 15 227.4 209 643.9 46 978.0 
2 C4 5307.7 834.9 47 877.5 18 931.9 226 339.9 21 777.3 
10 C4 5050.1 1578.7 58 061.7 37 561.4 191 504.1 102 647.3 
0.5 LN 4630.8 2705.6 49 920.4 18 173.1 185 483.5 28 964.6 
1 LN 11 130.7 4688.6 32 541.4 16 655.9 191 324.4 10 348.9 
2 FN 6955.1 2201.2 67 443.1 21 818.1 99 055.9 82 771.6 
10 FN 10 417.8 1857.5 51 460.0 19 307.0 158 417.6 35 930.9 
2 A2 3768.1 2002.0 50 225.9 17 469.5 142 662.1 58 465.7 
10 A2 7248.7 4667.8 22 650.8 11 122.1 173 004.9 77 203.9 
 
Figure 3.10: A. Growth of HCjE-Gi cells on AA cross-linked PεK hydrogels. Data are 
presented as mean number of cells/cm2 (x103) ± 1SD, n = 3. HCjE-Gi cells were cultured in 
KSF medium for seven days and in the differentiation and stratification medium for a 
further seven days. There was no significant interaction effect between substrate and 
culture day on the cell number (p = 0.218). Analysis of the main effect between the 
substrates showed no significant difference (p = 0.058). However, there was a significant 
difference to the main effect between the culture days (p < 0.001). (Two-way ANOVA; 
Bonferroni post hoc test). B. Mean number of cells/cm2 on culture days 1, 7 and 14, and 
1SD; C4 - type IV collagen 2 and 10µg/mL, LN - laminin 111 0.5 and 1µg/mL, FN – 
fibronectin 2 and 10µg/mL and A2 – 2 and 10µg/mL. 
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Growth of HCjE-Gi cells on SA cross-linked PεK gels 
 
 Day 1  Day 7  Day 14  
 Mean SD Mean SD Mean SD 
TCP 1701.4 760.9 95 874.9 5411.5 200 538.1 20 758.4 
SA 4511.0 921.8 43 546.3 21 401.3 191 516.1 46 421.3 
2 C4 4361.2 381.0 32 140.0 19 046.2 143 009.6 98 223.2 
10 C4 4505.0 2966.3 48 183.1 15 488.6 149 844.9 19 103.4 
0.5 LN 5577.3 3454.2 73 949.0 32 900.3 201 478.6 18 537.6 
1 LN 3564.5 2289.8 53 311.1 11 359.7 195 775.5 45 927.5 
2 FN 6925.2 2129.8 59 056.1 22 618.1 234 565.1 41 735.7 
10 FN 3822.1 1983.3 65 076.8 8495.9 160 933.7 61 631.0 
2 A2 4007.8 2343.0 39 155.1 7104.5 155 895.5 38 651.4 
10 A2 1631.0 1235.4 31 864.4 4325.4 139 181.5 25 996.8 
 
Figure 3.11: A. Growth of HCjE-Gi cells on SA cross-linked PεK hydrogels. Data are 
presented as mean number of cells/cm2 (x103) ± 1SD, n = 3. HCjE-Gi cells were cultured in 
KSF medium for seven days and in the differentiation and stratification medium for a 
further seven days. There was no significant interaction effect between substrate and 
culture day on the cell number (p = 0.466). Analysis of the main effect between the 
substrates showed no significant difference (p = 0.111). However, there was a significant 
difference to the main effect between the culture days (p < 0.001). (Two-way ANOVA; 
Bonferroni post hoc test). B: Mean number of cells/cm2 on culture days 1, 7 and 14, and 
1SD; C4 - type IV collagen 2 and 10µg/mL, LN - laminin 111 0.5 and 1µg/mL, FN – 
fibronectin 2 and 10µg/mL and A2 – 2 and 10µg/mL. 
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3.3.4 DIFFERENTIATION OF HCjE-Gi CELLS ON PεK HYDROGELS 
Keratin 19, a marker of simple epithelial cells, was expressed by all cells cultured for seven 
and fourteen days on AA and SA cross-linked PεK gels with and without pre-adsorbed 
proteins (figures 3.12-3.14). The morphology of the cells on culture day seven was similar 
on all substrates investigated. However, by culture day fourteen, the cells cultured on AA 
cross-linked PεK gels with and without pre-adsorbed proteins were larger and more 
flattened than those observed on culture day seven. The cells imaged are likely to be the 
cells of the superficial layer of the epithelium. Similar morphology was seen when cells 
were cultured on SA cross-linked PεK gels with pre-adsorbed fibronectin. In contrast, cells 
cultured on SA cross-linked PεK gels without pre-adsorbed proteins and those with pre-
adsorbed type IV collagen and laminin 111, consisted of a mixture of large flattened cells 
and smaller cells similar to those observed on culture day seven. This may be due to a 
lesser degree of differentiation and stratification of HCjE-Gi cells cultured on these 
substrates compared to those on AA cross-linked PεK gels and SA cross-linked PεK gels with 
pre-adsorbed fibronectin. This is further supported by staining for keratin 4, a marker of 
non-keratinised stratified epithelial cells, where a few cells stained positive when cultured 
on AA cross-linked PεK gels, whereas none stained positive when cultured on SA cross-
linked PεK gels.  
 
No positive staining for the GC marker, MUC5AC, was evident on culture day seven on any 
of the substrates investigated (figures 3.15-3.17). By culture day fourteen, after seven days 
in the differentiation and stratification medium, there was positive staining for MUC5AC in 
cells cultured on AA cross-linked PεK gels with and without pre-adsorbed proteins. In 
contrast, positive staining for MUC5AC was only observed in cells cultured on SA cross-
linked PεK gels with pre-adsorbed fibronectin, although qualitatively this appeared to be 
less than that seen on AA cross-linked gels. The staining pattern observed on imaging 
indicate that the MUC5AC protein is found intra- and extracellularly. There was no positive 
staining in cells cultured on SA cross-linked PεK gels without pre-adsorbed proteins and 
those pre-adsorbed with type IV collagen and laminin 111. 
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Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on PεK gels 
Figure 3.12: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on PεK hydrogels for seven (A) and fourteen (B) days; K4 – keratin 4 (green), K19 
– keratin 19 (purple) and DAPI (blue). 
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Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on AA cross-linked PεK gels with pre-adsorbed proteins 
Figure 3.13: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on AA cross-linked PεK hydrogels with pre-adsorbed proteins for seven (A) and 
fourteen (B) days; K4 – keratin 4 (green), K19 – keratin 19 (purple) and DAPI (blue). 
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Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on SA cross-linked PεK gels with pre-adsorbed proteins 
Figure 3.14: Expression of conjunctival cell differentiation markers by HCjE-Gi cells 
cultured on SA cross-linked PεK hydrogels with pre-adsorbed proteins for seven (A) and 
fourteen (B) days; K4 – keratin 4 (green), K19 – keratin 19 (purple) and DAPI (blue). 
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Expression of MUC5AC by HCjE-Gi cells cultured on PεK gels 
 
Figure 3.15: Expression of MUC5AC by HCjE-Gi cells cultured on PεK hydrogels for seven 
(A) and fourteen (B) days; MUC5AC (green) and DAPI (blue).  
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Expression of MUC5AC by HCjE-Gi cells cultured on AA cross-linked 
PεK gels with pre-adsorbed proteins 
 
Figure 3.16: Expression of MUC5AC by HCjE-Gi cells cultured on AA cross-linked PεK 
hydrogels with pre-adsorbed proteins for seven (A) and fourteen (B) days; MUC5AC 
(green) and DAPI (blue). 
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Expression of MUC5AC by HCjE-Gi cells cultured on SA cross-linked PεK 
gels with pre-adsorbed proteins 
 
Figure 3.17: Expression of MUC5AC by HCjE-Gi cells cultured on SA cross-linked PεK 
hydrogels with pre-adsorbed proteins for seven (A) and fourteen (B) days; MUC5AC 
(green) and DAPI (blue). 
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3.4 DISCUSSION 
3.4.1 PεK hydrogels were thin, transparent and easy to handle 
We investigated a peptide-based hydrogel as a substrate for the ex vivo expansion of HCjE-
Gi cells. PεK hydrogels that were chemically cross-linked with either AA or SA to form three-
dimensional structures were investigated in the present study. Both the AA (nine carbon 
atoms long) and SA (eight carbon atoms long) cross-linked PεK hydrogels were transparent 
(figure 3.3). Gallagher et al. reported that qualitatively the transparency of these hydrogels 
decreased with increasing length of the carbon chain of the dicarboxylic acid used for cross-
linking the polymer.(112) Quantitative studies are required to accurately assess any 
significant differences in transparency between AA and SA cross-linked hydrogels. Although 
transparency of the substrate is not essential for conjunctival transplantation purposes, it is 
desirable as the conjunctiva in vivo is actually an almost transparent mucous membrane.  
 
In the present study, there was a slight yellow tinge to the hydrogels cross-linked with SA 
compared to those cross-linked with AA (figure 3.3). These hydrogels are known to be 
yellow in colour and this may be more apparent in the SA cross-linked hydrogels due to the 
larger thickness compared to those cross-linked with AA. The yellow tinge to the PεK 
hydrogels is an advantageous property when being considered for corneal transplantation, 
since it filters out the ultraviolet light. The intraocular lenses currently being employed to 
replace the natural crystalline lens in patients with cataracts is yellow in colour, which has 
been shown to filter out light of wavelengths of up to approximately 400nm.(214) This 
yellow colour mimics the physiological discolouration observed in ageing lenses of the 
human and does not affect the visual acuity or the contrast sensitivity.(214)   
 
All the PεK hydrogels were easy to handle with the non-toothed and non-serrated forceps. 
The surgical handle-ability of these hydrogels was verified by a consultant ophthalmologist 
(Professor S. B. Kaye), who demonstrated the ability of the thin gels to fold and unfold as 
required similar to the AM used clinically. This is useful in TE of the conjunctiva where the 
substrates need to be able to conform to the surface of the fornices. Gallagher et al. 
showed that the tensile strength of these gels can be manipulated by altering the density of 
PεK, carbon chain length of the dicarboxylic acids and the cross-linking density of the 
polymer.(112) They showed that the tensile strength generally increased as the carbon 
chain length increased from six carbon atoms to nine carbon atoms. Although they did not 
show the change to the elastic modulus with varying carbon chain lengths of the 
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dicarboxylic acids, it was evident in the present study that the SA cross-linked hydrogels 
were more brittle than those cross-linked with AA, especially when folded. This suggests 
that, similar to the tensile strength, the elasticity of these hydrogels also increase as the 
carbon chain length of the dicarboxylic acid increases. The hydrogels need to be 
mechanically strong but flexible to be employed to reconstruct the conjunctival fornices. 
Additionally, Gallagher et al. showed that the greatest effect on the tensile strength is the 
density of PεK, where approximately a two-fold increase was observed when the PεK 
density was increased from 0.066g/mL to 0.1g/mL.(112) Moreover, the authors showed 
that the tensile strength also increased by increasing the cross-linking density from 60% to 
80%.(112) The hydrogels synthesised for the current study had a PεK density of 0.1g/mL 
and a cross-linking density of 60%. The ability to vary the mechanical properties to suit 
tissue requirements is an appealing characteristic of these hydrogels for TE purposes.  
 
The conjunctival stroma has a rich blood supply from the anterior ciliary and palpebral 
vessels that supply the epithelium. Thin substrates are ideal for TE to ensure adequate 
interaction between the graft and the underlying stroma to allow rapid exchange of 
nutrients and waste products in and out of the cells when transplanted in vivo. Hydrogels 
that were synthesised with 2mL and 3mL of hydrogel solution had a mean thickness of 100-
250µm, which was comparable to that of the AM (figure 3.4). The reported thickness of AM 
varies between 20-500µm.(50) However, the hydrogels investigated in the present study 
were much thicker than the stretched PCL membranes developed by Ang et al., which were 
6µm thick.(35) In the present study, the PεK hydrogels cross-linked with AA were thinner 
than those cross-linked with SA (figure 3.4). This was an interesting finding since the carbon 
chain of AA is longer than that of SA. This may be due to the hydrophobicity of the longer 
chains and therefore the lower water content within the polymer, thus giving rise to a 
thinner hydrogel. Further studies are required to measure the water content of these 
hydrogels to investigate this hypothesis.  
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3.4.2 PεK hydrogels were able to support the adhesion, growth and differentiation of 
conjunctival cells ex vivo 
Next, we investigated the adhesion, growth and differentiation of HCjE-Gi cells on the AA 
and SA cross-linked PεK hydrogels. PεK is a naturally occurring, non-toxic polymer that is 
approved as a food preservative by the Food and Drug Administration. AA and SA are also 
naturally occurring products produced from oxidation of longer chain fatty acids in animals 
and plants. NHS and EDCI were used to activate the carboxyl groups on the dicarboxylic 
acids to form peptide bonds with the amine groups on the PεK homopolymer. The excess 
NHS and EDCI should be adequately washed off due to the toxic nature of these reagents. 
In the present study, the hydrogels were sterilised in 70% ethanol and thoroughly washed 
in dH2O prior to cell culture. Gallagher et al. demonstrated the cytocompatibility of the PεK 
hydrogels by monitoring the cell number of a corneal cell line over a culture period of eight 
days.(112) Moreover, Griffith et al. showed successful culture of primary human limbal 
epithelial cells on type III collagen scaffolds that were cross-linked with NHS and EDCI.(176)   
 
Both AA and SA cross-linked PεK hydrogels were able to support the adhesion and growth 
of HCjE-Gi cells comparable to that on TCP without pre-adsorbed proteins over a culture 
period of fourteen days (figures 3.5-3.6 and 3.10-3.11). The cells generally followed the lag 
and log phases of cultured cells in KSF media over the first seven days. Then the cells 
exhibited a gradual reduction in the rate of growth in the differentiation and stratification 
media in the next seven days, with some evidence of stratification by culture day fourteen. 
In chapter 2, I showed that TCP pre-adsorbed with type IV collagen and fibronectin 
increased the adhesion of cells and that pre-adsorbed with type IV collagen and α-2-HS-GP 
increased the growth of cells over seven days (figures 2.40, 2.42, 2.44 and 2.47). However, 
these experiments showed that PεK hydrogels pre-adsorbed with proteins did not affect 
the adhesion or the growth of HCjE-Gi cells. Chen et al. cultured rat islet tumour cells on 
TCP coated with ECM proteins, including type IV collagen, laminin, fibronectin and 
vitronectin, and poly(ι-lysine).(215) They showed that the adhesion and growth of these 
cells on poly (ι-lysine) over two days is comparable to that on TCP with pre-adsorbed ECM 
proteins. The surfaces of substrates may be optimised for cell attachment by adding cell 
adhesive peptides, adding chemical groups to alter the wettability of the surface or by 
having a cationic surface to allow negatively charged cell membranes to attach to the 
surface by electrostatic interactions.(216) We have shown that peptide-based hydrogels 
that carry positive charges on their amino groups are able to support the attachment and 
growth of HCjE-Gi cells without the need for surface modification by other biomolecules.  
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The sample size of the adhesion and growth experiments on PεK hydrogels in the present 
study was three. Thus, further experiments are required with larger sample size to draw 
accurate conclusions regarding the adhesion and growth of cells on PεK hydrogels with and 
without pre-adsorbed proteins. Another limitation of the present study is that we did not 
investigate the protein adsorption onto the hydrogels. Both surface charge and wettability 
of the substrates determine the balance between hydrophobicity and hydrophilicity that 
affects the adsorption of proteins.(217) Thus, a future study would be to investigate the 
protein adsorption onto PεK hydrogels by ELISA, as undertaken in chapter 2 to determine 
the protein adsorption onto TCP. Another future study would be to determine if the ECM 
proteins secreted by the HCjE-Gi cells when cultured on PεK hydrogels are similar to that 
observed when cultured on TCP. This may explain the results observed in the present study 
by showing that the biological and physical cues provided by the two ECMs are similar.  
 
All the cells cultured on AA and SA cross-linked PεK hydrogels with and without pre-
adsorbed proteins expressed keratin 19, a marker of simple epithelial cells, on culture days 
seven and fourteen (figures 3.12-3.14). After seven days in the differentiation and 
stratification medium containing 10% fetal bovine serum and higher concentrations of EGF 
and calcium, the cells on AA cross-linked PεK hydrogels exhibited a flattened morphology. 
The cells on SA cross-linked PεK hydrogels had a mixture of flattened cells and smaller cells 
observed on day seven, except those cultured on hydrogels with pre-adsorbed fibronectin 
that consisted of flattened cells only. These flattened cells could be the superficial cells of a 
stratified epithelium, although the morphology is different to the cells observed on TCP 
without pre-adsorbed proteins after seven days in the differentiation and stratification 
medium (figure 2.8). This difference in morphology observed on culture day fourteen 
between TCP and PεK hydrogels could be due to the absence and presence of serum in the 
culture media, respectively. The presence of positive staining for MUC5AC provided further 
evidence of possible higher degree of differentiation of cells cultured on AA cross-linked 
hydrogels and SA cross-linked hydrogels with pre-adsorbed fibronectin (figures 3.15-3.17). 
It is known that expression of this protein requires a higher degree of differentiation and 
stratification of conjunctival cells. However, further studies are required to assess the 
differentiation and stratification of conjunctival cells on the PεK hydrogels. In the present 
study, we have not looked at the presence of SCs following culture on these hydrogels. This 
is important as substrates employed for TE purposes must be able to support and maintain 
SCs, which will ensure the long-term survival of the transplant in vivo.   
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Lastly, further studies are required to investigate the biocompatibility of these hydrogels, as 
well as the growth and differentiation of conjunctival cells in vivo. Although, biodegradation 
is not essential, it is important to assess the fate of the substrate in vivo as this may be 
affected by the activity of local proteases, as well as activity of inflammatory cells, such as 
in the presence of chronic inflammation due to diseases.  
 
 
Summary of key findings 
 The PεK hydrogels were transparent and easy to handle. 
 The PεK hydrogels cross-linked with AA were thinner than those cross-linked with SA. 
 Both AA and SA cross-linked PεK hydrogels supported the adhesion and the growth of 
HCjE-Gi cells over fourteen days. 
 Pre-adsorption of type IV collagen, laminin 111, fibronectin and α-2-HS-GP onto PεK 
hydrogels did not enhance the adhesion or the growth of HCjE-Gi cells compared to 
those without pre-adsorbed proteins. 
 HCjE-Gi cells cultured for fourteen days on AA cross-linked PεK hydrogels with and 
without pre-adsorbed proteins and on SA cross-linked PεK hydrogels with pre-adsorbed 
fibronectin differentiated into MUC5AC producing GCs. However, this was not evident 
on SA cross-linked PεK hydrogels without pre-adsorbed proteins and those pre-
adsorbed with type IV collagen and laminin 111. 
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Comparison of physical, mechanical and biological properties of azelaic and suberic acid cross-linked PεK hydrogels 
Azelaic acid cross-linked hydrogels Suberic acid cross-linked hydrogels 
Azelaic acid structure nine carbon atoms long Suberic acid structure eight carbon atoms long 
 
Light transmission approximately 95% that is reduced at lower wavelengths 
(485nm) than at higher wavelengths of light (600nm) (unpublished data) 
 
Similar data to azelaic acid (unpublished data) 
 
Thinner (mean thickness 0.17mm) 
 
Thicker (mean thickness 0.24mm) 
Theoretically more hydrophobic than suberic acid Theoretically more hydrophilic than azelaic acid but no significant difference 
in contact angle measurements, 11-12° (unpublished data) 
 
Higher tensile strength 
 
 
Lower tensile strength 
Stiffness (Young’s modulus) approximately 0.25MPa (unpublished data) 
 
Stiffness (Young’s modulus) approximately 0.50MPa (unpublished data) 
 
More flattened and larger cells by culture day fourteen (with and without 
pre-adsorbed proteins) 
 
 
 
A mixture of smaller cells and larger and flattened cells on hydrogels without 
pre-adsorbed proteins and those pre-adsorbed with type IV collagen and 
laminin 111 by culture day fourteen. Hydrogels with pre-adsorbed 
fibronectin had larger and flattened cells only. 
Positive staining for MUC5AC protein by culture day fourteen (with and 
without pre-adsorbed proteins) 
Positive staining for MUC5AC proteins only on hydrogels with pre-adsorbed 
fibronectin by culture day fourteen, although qualitatively this was less than 
that observed on AA cross-linked hydrogels. 
Table 3.1: Comparison of physical, mechanical and biological properties of azelaic and suberic acid cross-linked PεK hydrogels.
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4 DISCUSSION 
The conjunctiva is a thin translucent mucous membrane that extends from the limbus to 
cover the majority of the OS; covering the posterior surfaces of the eyelids and ending at 
the muco-cutaneous junctions. It is an integral component of the OS system protecting the 
eyes from external insults by acting as a physical barrier against injury and entry of foreign 
bodies including pathogens. It also provides an immunological barrier against pathogens. 
The epithelial and goblet cells produce mucins, which in addition to acting as a barrier to 
pathogens, prevent desiccation of the epithelium. Despite the existence of multiple 
defence mechanisms of the OS, due to its exposure to the environment, the conjunctiva is 
prone to injury and entry of pathogens. Damage to the conjunctiva may also be caused by 
systemic autoimmune diseases. Subsequent scarring may lead to anatomical and functional 
impairment. In severe cases, the limbus and cornea may be impaired that will eventually 
lead to impairment of vision. Without restoration of function of the conjunctiva in such 
cases, surgical procedures such as limbal and corneal transplantation will fail. Thus, it is 
imperative that the health of the conjunctiva is restored prior to repair of the limbus and 
cornea. Therefore, when considering management of OS disorders, it is essential that the 
OS system as a whole is taken into account in preference to targeting a single component of 
the system. 
 
Initial management in most patients with OS disease is removal or control of the inciting 
agent if identifiable and prevention of disease progression. Unfortunately, there may be 
extensive tissue loss and scarring leading to a disturbance and loss of homeostasis of the 
OS. Therefore replacement of the damaged tissue with a suitable substrate containing 
healthy functional tissue is needed. The ideal graft is an autograft, however, the disease 
may involve both eyes and there is often insufficient uninvolved tissue in the fellow eye. 
Although allogenic grafts may be an option, this carries a risk of graft rejection and 
microbial disease transmission. Other limitations of autografts and allogenic grafts are lack 
of sufficient tissue to cover large defects and the risk of damage to the donor site with 
potential scar tissue formation. An alternative to a graft is the development of a functional 
tissue construct ex vivo that can be transplanted to restore the anatomical structure and 
functions of the original tissue. This could involve the ex vivo culture of cells from a small 
tissue biopsy on an appropriate substrate. The success of an ex vivo expanded tissue 
construct depends on three factors: the source of cells and the presence of SCs, the carrier 
substrate and the presence of GFs. The substrate provides the initial support for the 
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cultured cells and the appropriate physical and biological cues for growth of cells. 
Moreover, it facilitates the delivery of cultured cells to the site of interest and provides a 
three-dimensional scaffold for the formation of new tissue. A large number of studies have 
been carried out to investigate various biological and synthetic substrates in the search for 
an optimal substrate for the ex vivo culture of conjunctival epithelial cells.  
 
AM is widely used in the field of ophthalmology as a graft and as a substrate for the ex vivo 
expansion of conjunctival cells to replace damaged OS tissue.(50, 51) As discussed in 
chapter 1, although there are numerous advantages to using AM in the management of OS 
disease, there are limitations to its use. Despite precautions taken to collect the AM 
aseptically, process and store the samples in sterile conditions and testing of the donors for 
infectious agents, there is still a risk of potential microbial disease transmission. This is 
especially the case for diseases such as Creutzfeld-Jacob disease that do not have a 
screening test at present. Moreover, AM is prone to early degradation, in vivo shrinkage 
and lack SCs and adequate GCs. It is also not a standardised product and its composition 
may vary between donors. Lastly, it is an expensive product that may limit its availability to 
all patients. Other substrates that have been investigated for TE purposes include biological 
substrates, such as nasal and oral mucous membranes, and synthetic substrates, such as 
PCL and PLGA.(27, 31, 46, 70) Although synthetic substrates may have superior mechanical 
properties to biological substrates, they lack tissue-specific extracellular environments that 
are present in biological substrates. Thus, there is much scope for the development of a 
better substrate for conjunctival cell and tissue transplantation.  
 
The aim of the present study was to develop a synthetic substrate for conjunctival cell 
transplantation by establishing the role of ECM proteins on the functionality of conjunctival 
epithelial cells and using this information to modify the surfaces of PεK hydrogels. The 
working hypothesis was that the growth and differentiation of conjunctival epithelial cells 
on PεK hydrogels is optimal when the surfaces of these substrates are modified with ECM 
proteins to mimic that of the native tissue. The rationale for this hypothesis is the well-
known principle that the protein composition in the ECM regulates the growth and 
differentiation of the native cells by providing specific biological and physical cues. 
Therefore, gaining knowledge about the composition and structure of the native ECM of a 
given tissue and its role in cellular functions will benefit in developing an improved 
synthetic substrate for cell and tissue transplantation purposes.  
247 
 
In the present study, I was able to identify and quantify the protein composition of the ECM 
secreted by the HCjE-Gi cells over a culture period of six weeks in vitro. I found that the 
ECM secreted by cells between days three and five in culture, enhanced the growth of 
HCjE-Gi cells compared to the ECM secreted by cells during long-term culture in vitro. 
Specifically, pre-adsorbed type IV collagen and fibronectin increased the adhesion and pre-
adsorbed type IV collagen and α-2-HS-GP increased the growth of HCjE-Gi cells. I have 
shown that the PεK hydrogels that were cross-linked with AA and SA supported the 
adhesion and growth of HCjE-Gi cells. However, AA and SA cross-linked PεK hydrogels pre-
adsorbed with type IV collagen, laminin 111, fibronectin and α-2-HS-GP did not affect the 
adhesion or the growth of the HCjE-Gi cells compared to that on PεK hydrogels without pre-
adsorbed proteins. This rejects our hypothesis that the growth of conjunctival epithelial 
cells on PεK hydrogels is optimal when the surfaces of these substrates are modified with 
ECM proteins of the native tissue. It is possible that these peptide-based hydrogels already 
provide the necessary cues for the adhesion and the growth of the HCjE-Gi cells. 
Alternatively, the cationic charges on the surfaces of these hydrogels may support the pre-
adsorption of the cell-secreted ECM proteins and thereby support the growth of the cells.  
 
The above finding is in contrast to previous studies undertaken to investigate other 
synthetic substrates. These studies showed that surface modification of synthetic 
substrates by increasing the surface hydrophilicity or pre-adsorbing with biomolecules, such 
as ECM proteins, is required to optimise the adhesion and growth of cells.(35, 75) PCL and 
PLGA investigated as substrates for the growth of conjunctival epithelial cells are 
polyesters, unlike the PεK hydrogels that are homopolymers PεK. The knowledge about the 
composition of the native ECM and its role in cellular functions may be a benefit in 
developing peptides, such as the RGD peptide of fibronectin, which could be bound to the 
PεK hydrogels to enhance and optimise the growth and differentiation of cells on these 
substrates under some conditions.  
 
In the present study, we also showed that the AA and SA cross-linked PεK hydrogels 
supported the conjunctival cell differentiation and maybe the stratification of cells ex vivo. 
Moreover, we showed that the hydrogels that were cross-linked with AA supported the 
culture of mucin producing GCs. It is important to develop tissue constructs that replace the 
function of the original tissue that was damaged, in this case the ability of the conjunctiva 
to contribute to the tear film and prevent desiccation of the OS. Further studies are 
required to determine the ECM proteins that are important for GC differentiation. This 
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information could be used to modify the surfaces of the PεK hydrogels to enhance the 
differentiation of conjunctival progenitor cells into mucus-producing GCs, especially on the 
SA cross-linked PεK hydrogels that did not show evidence of GC differentiation. Moreover, 
the substrate must be able to maintain a pool of SCs for epithelial renewal, especially when 
used to replace tissue with SC deficiency. In the present study, we have not investigated the 
ability of PεK hydrogels to support SCs in long-term culture. The ability of a substrate to 
maintain SCs will ensure the long-term survival of the transplant in vivo. Although, the PεK 
hydrogels were able to support the adhesion and growth of conjunctival cells without 
surface modification, it may be that it is required for the maintenance of SCs. Therefore, 
further studies could be undertaken to determine the ECM proteins that govern the 
maintenance of conjunctival SCs. This information may be employed to modify the surfaces 
of the PεK hydrogels to ensure its ability to support and maintain SCs in long-term culture 
ex vivo and in vivo.  
 
In chapter 1, I described the characteristics of an ideal substrate for conjunctival cell and 
tissue transplantation. In the present study, I have shown that the PεK hydrogels are a 
promising substrate for the ex vivo culture of conjunctival cells that could potentially be 
used to replace damaged conjunctival tissue (table 4.1). In the present study we cultured 
HCjE-Gi cells in serum-free media that contained 25μg/mL bovine pituitary extract. Future 
studies involving the culture of primary human conjunctival cells on PεK hydrogels will 
require the maintenance of these cells in similar serum- and BPE-free conditions to meet 
the standards of good manufacturing practice to be employed as a transplant substrate in 
humans.              
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PεK hydrogels as a substrate for conjunctival cell and tissue transplantation 
SUBSTRATE CHARACTERISTIC EVIDENCE FROM THE PRESENT STUDY FURTHER STUDIES REQUIRED 
1. Thin 
 
Yes, comparable to AM  
2. Porous allowing interaction between the 
graft and the underlying host tissue 
 
 Require in vivo studies 
3. Flexibility and surgical handle-ability  
 
Yes Require studies to investigate the ability of the 
hydrogel to be sutured onto the host 
 
4. Biocompatible 
 
 
Substrate was not toxic to cells in vitro Require in vivo studies 
5. Supports adhesion, migration and 
proliferation of epithelial cells 
 
Yes  
6. Supports mucus-producing goblet cells 
 
Yes  
7. Supports maintenance of SCs 
 
 Require further studies 
8. Biodegradability  
 
 
 Require further studies, especially in the 
presence of active inflammation 
9. Low in vivo shrinkage  Require in vivo  studies 
Table 4.1: PεK hydrogels as a substrate for conjunctival cell and tissue transplantation.   
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5 CONCLUSIONS 
 Ammonium hydroxide successfully isolated the extracellular proteins and the 
transmembrane proteins associated with the extracellular matrix of the HCjE-Gi 
cells in vitro.  
 
 The protein composition and their quantities in the extracellular matrix of the HCjE-
Gi cells varied over six weeks in culture in vitro. 
 
 TCP pre-adsorbed with type IV collagen and fibronectin increased the adhesion of 
HCjE-Gi cells compared to TCP without pre-adsorbed proteins.  
 
 TCP pre-adsorbed with type IV collagen, α-2-HS-GP and the extracellular matrix 
derived from the cells that were in culture for three and five days increased the 
growth of HCjE-Gi cells compared to TCP without pre-adsorbed proteins. 
 
 Preliminary data showed that the expression of stem cell and goblet cell protein 
markers by HCjE-Gi cells decreased and increased, respectively, over fourteen days 
in culture in vitro. 
 
 PεK hydrogels were thin, transparent and easy to handle.  
 
 PεK hydrogels that were cross-linked with AA and SA supported the adhesion and 
growth of HCjE-Gi cells. 
 
 Pre-adsorption of PεK hydrogels with type IV collagen, laminin 111, fibronectin and 
α-2-HS-GP did not enhance the adhesion or the growth of HCjE-Gi cells compared 
to PεK hydrogels without pre-adsorbed proteins. 
 
 HCjE-Gi cells cultured for fourteen days on AA cross-linked PεK hydrogels with and 
without pre-adsorbed proteins and on SA cross-linked PεK hydrogels with pre-
adsorbed fibronectin differentiated into MUC5AC producing goblet cells. However, 
this was not evident on SA cross-linked PεK hydrogels without pre-adsorbed 
proteins and those pre-adsorbed with type IV collagen and laminin 111. 
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Current literature 
 The ideal grafts to replace damaged conjunctival tissue are conjunctival autografts. 
  An alternative to conjunctival autografts and allografts are amniotic membranes 
that are used as a graft and as a substrate for the ex vivo expansion of conjunctival 
cells.  
 Other biological and synthetic substrates investigated as grafts or substrates for the 
ex vivo expansion of conjunctival cells have advantages and disadvantages peculiar 
to the material. 
 Immunohistochemistry studies have shown the differential expression of a selected 
array of proteins throughout the ocular surface.   
 
 
Contribution to the literature made by the present study 
 The change to the composition and the quantities of proteins in the extracellular 
matrix of a conjunctival epithelial cell line cultured over six weeks in vitro. 
 The extracellular matrix derived from cells that were in culture for three and five 
days increased the growth of conjunctival epithelial cells compared to tissue 
culture polystyrene.  
 Pre-adsorption of tissue culture polystyrene with type IV collagen and fibronectin 
increased the adhesion of cells and pre-adsorption of tissue culture polystyrene 
with type IV collagen and α-2-Heremans Schmid-glycoprotein increased the growth 
of conjunctival epithelial cells compared to tissue culture polystyrene without pre-
adsorbed proteins over seven days in culture.     
  PεK hydrogels cross-linked with azelaic acid and suberic acid supported the 
adhesion and growth of conjunctival cells over fourteen days ex vivo. Surface 
modification PεK hydrogels with pre-adsorbed proteins did not affect the adhesion 
or the growth of cells compared to those without pre-adsorbed proteins.   
 Azelaic acid cross-linked PεK hydrogels with and without pre-adsorbed proteins 
supported the differentiation of MUC5AC-producing goblet cells. However, only 
suberic acid cross-linked PεK hydrogels pre-adsorbed with fibronectin supported 
the differentiation of MUC5AC-producing goblet cells compared to those without 
pre-adsorbed proteins.   
 
252 
 
6 FUTURE STUDIES 
1. Investigate the composition of the extracellular matrix of HCjE-Gi cells when 
cultured on PεK hydrogels. This may explain the results observed in the present 
study where the growth of HCjE-Gi cells cultured on tissue culture polystyrene were 
comparable to that on the PεK hydrogels. 
 
2. Investigate the ability of the PεK hydrogels to support the adhesion, growth and 
differentiation of primary human conjunctival cells. Functional peptides of 
extracellular matrix proteins identified to enhance the growth and differentiation 
of conjunctival cells may be employed to optimise the growth and differentiation of 
primary human conjunctival cells if required. 
 
3. Investigate the ability of the PεK hydrogels to maintain a population of stem cells ex 
vivo and in vivo.  
 
4. Investigate the biocompatibility of the PεK hydrogels when transplanted in vivo. 
 
5. Investigate the ability of the PεK hydrogels with ex vivo expanded conjunctival cells 
to integrate into the host tissue and repair the anatomical and functional 
deficiencies. 
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7 APPENDICES 
Appendix 1: LC-MS/MS Instrumentation and software 
Data-dependent LC-MS/MS analyses were conducted on a QExactiveHF quadrupole-
Orbitrap mass spectrometer coupled to a Dionex Ultimate 3000 RSLC nano-liquid 
chromatograph (Hemel Hempstead, UK). Sample digests (15µL) was loaded onto a trapping 
column (Acclaim PepMap 100 C18, 75µm x 2cm, 3µm packing material, 100Å) using a 
loading buffer of 0.1% TFA (v/v) and 2% acetonitrile (v/v) (Fluka 34668) in water for seven 
minutes at a flow rate of 12µL/minute. The trapping column was then set in-line with an 
analytical column (EASY-Spray PepMap RSLC C18, 75µm x 50cm, 2µm packing material, 
100Å) and the peptides eluted using a linear gradient of 96.2% A (0.1% formic acid (v/v) 
(Biosolve 0006914143BS)), 3.8% B (0.1% formic acid (v/v) in water:acetonitrile [80:20] (v/v)) 
to 50% A:50% B over thirty minutes at a flow rate of 300nL/minute, followed by washing 
with 1% A:99% B for five minutes and re-equilibration of the column to starting conditions. 
The column was maintained at 40°C, and the effluent introduced directly into the 
integrated nano-electrospray ionisation source operating in positive ion mode. The mass 
spectrometer was operated in data dependent acquisition mode with survey scans 
between mass/charge ratios 350-2000 acquired at a mass resolution of 60,000 (full width 
half maximum) at mass/charge ratio 200. The maximum injection time was 100 
milliseconds, and the automatic gain control was set to 3x106. The eighteen most intense 
precursor ions with charge states of between 2+ and 5+ were selected for MS/MS with an 
isolation window of 1.2 m/z units.  The maximum injection time was 45 milliseconds, and 
the automatic gain control was set to 1x105.  Fragmentation of the peptides was by higher-
energy collisional dissociation using a stepped normalised collision energy of 28-30%.  
Dynamic exclusion of mass/charge ratio values to prevent repeated fragmentation of the 
same peptide was used with an exclusion time of 20 seconds. 
 
Raw mass spectral data files were processed using Progenesis-QI (version 2; Nonlinear 
Dynamics) to determine the total protein abundances. Protein quantification was based on 
averaging the individual abundances for every unique peptide for each protein and 
comparing them relatively across sample runs and between sample groups. The raw data 
file was imported into Progenesis QI for Proteomics (version 3.0.5995.47167 Nonlinear 
Dynamics, Newcastle upon Tyne UK; Waters Company). Samples were aligned according to 
retention time using a combination of manual and automatic alignment. Peak picking 
parameters were applied with sensitivity set to maximum and features with charges of 2+ 
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to 7+ were retained. A Mascot Generic File, created by Progenesis, was searched against 
the human reviewed database from Uniprot (20 187 sequences). Trypsin was specified as 
the protease with one missed cleavage allowed and with fixed carbamidomethyl 
modification for cysteine and variable oxidation modification for methionine. A precursor 
mass tolerance of 10 parts per million and a fragment ion mass tolerance of 0.01Da were 
applied. The results were then filtered to obtain a peptide false discovery rate of 1%. 
 
 
Appendix 2: Quantities of reagents used to synthesise 60:10 PεK hydrogels 
(1) AA cross-linked 60:10 PεK hydrogels 
 
 
 
 
 
 
 
 
No. residues 28.000
M.Wt parent 3602.000
Amount of poly-Lys 4.051 g (gross)
Strength of poly-Lys 72.200 %
Amount of poly-Lys 2.925 g (net)
Amount of poly-Lys 0.812 mmole
Amount of amino groups 23.547 mmole
Degree of neutralisation 100.000 % total amino groups
Amount of NMM required 23.547 mmole
Amount of NMM required 2.585 ml
% cross linking required 60.000 mole % 
Amount of dicarboxylic acid 7.064 mmole
M.Wt 188.220
Amount of dicarboxylic acid 1.330 g
Degree of acidification 50.000 % total amino groups
M.Wt NHS 115.090
Amount of NHS 1.355 g
Equivalents of WSC to dicarboxylic acid 2.500 times
M.Wt WSC 191.700
Amount of WSC 6.771 g
Amount of polymer 4.000 g
Swell 10.000 ml/g (poly-Lys)
Total volume 40.000 ml
Volume of buffer required 23.909 ml
Capacity 2.355 mmoles/g
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(2) SA cross-linked 60:10 PεK hydrogels 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
No. residues 28.000
M.Wt parent 3602.000
Amount of poly-Lys 4.154 g (gross)
Strength of poly-Lys 72.200 %
Amount of poly-Lys 2.999 g (net)
Amount of poly-Lys 0.833 mmole
Amount of amino groups 24.145 mmole
Degree of neutralisation 100.000 % total amino groups
Amount of NMM required 24.145 mmole
Amount of NMM required 2.651 ml
% cross linking required 60.000 mole % 
Amount of dicarboxylic acid 7.243 mmole
M.Wt 174.200
Amount of dicarboxylic acid 1.262 g
Degree of acidification 50.000 % total amino groups
M.Wt NHS 115.090
Amount of NHS 1.389 g
Equivalents of WSC to dicarboxylic acid 2.500 times
M.Wt WSC 191.700
Amount of WSC 6.943 g
Amount of polymer 4.000 g
Swell 10.000 ml/g (poly-Lys)
Total volume 40.000 ml
Volume of buffer required 23.602 ml
Capacity 2.414 mmoles/g
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